iso4217:EURiso4217:EURxbrli:shares724500E5WW4731JJ4G462025-12-31724500E5WW4731JJ4G462024-12-31724500E5WW4731JJ4G462025-01-012025-12-31724500E5WW4731JJ4G462024-01-012024-12-31724500E5WW4731JJ4G462023-12-31ifrs-full:IssuedCapitalMember724500E5WW4731JJ4G462023-12-31ifrs-full:SharePremiumMember724500E5WW4731JJ4G462023-12-31ifrs-full:OtherReservesMember724500E5WW4731JJ4G462023-12-31ifrs-full:RetainedEarningsMember724500E5WW4731JJ4G462023-12-31ifrs-full:NoncontrollingInterestsMember724500E5WW4731JJ4G462023-12-31724500E5WW4731JJ4G462024-01-012024-12-31ifrs-full:IssuedCapitalMember724500E5WW4731JJ4G462024-01-012024-12-31ifrs-full:SharePremiumMember724500E5WW4731JJ4G462024-01-012024-12-31ifrs-full:OtherReservesMember724500E5WW4731JJ4G462024-01-012024-12-31ifrs-full:RetainedEarningsMember724500E5WW4731JJ4G462024-01-012024-12-31ifrs-full:NoncontrollingInterestsMember724500E5WW4731JJ4G462024-12-31ifrs-full:IssuedCapitalMember724500E5WW4731JJ4G462024-12-31ifrs-full:SharePremiumMember724500E5WW4731JJ4G462024-12-31ifrs-full:OtherReservesMember724500E5WW4731JJ4G462024-12-31ifrs-full:RetainedEarningsMember724500E5WW4731JJ4G462024-12-31ifrs-full:NoncontrollingInterestsMember724500E5WW4731JJ4G462025-01-012025-12-31ifrs-full:IssuedCapitalMember724500E5WW4731JJ4G462025-01-012025-12-31ifrs-full:SharePremiumMember724500E5WW4731JJ4G462025-01-012025-12-31ifrs-full:OtherReservesMember724500E5WW4731JJ4G462025-01-012025-12-31ifrs-full:RetainedEarningsMember724500E5WW4731JJ4G462025-01-012025-12-31ifrs-full:NoncontrollingInterestsMember724500E5WW4731JJ4G462025-12-31ifrs-full:IssuedCapitalMember724500E5WW4731JJ4G462025-12-31ifrs-full:SharePremiumMember724500E5WW4731JJ4G462025-12-31ifrs-full:OtherReservesMember724500E5WW4731JJ4G462025-12-31ifrs-full:RetainedEarningsMember724500E5WW4731JJ4G462025-12-31ifrs-full:NoncontrollingInterestsMember
Avantium_Logo_White_Horizontal.svg
Rising
to the Challenge
Annual Report 2025
Avantium
Annual Report 2025
2
Contents
About This Report
Scope of the Annual Report
This Annual Report covers Avantium N.V., including all our
consolidated entities as stated in "note 2.2.1."
Our financial and non-financial results are presented in one report
and relate to all consolidated entities for the period of January 1
until December 31, 2025, unless stated otherwise.
Reporting Guidelines 
Avantium prepared this Annual Report in line with the
International Integrated Reporting Council (IIRC) Integrated
Reporting (IR) framework.
For the non-financial information included in this report,
we followed the sustainability priorities identified through our
double materiality assessment. To help guide readers, we have
provided indexes in line with the Global Reporting Initiative (GRI)
Standards and European Sustainability Reporting Standards
(ESRS).
The Consolidated Financial Statements of Avantium N.V. have
been prepared in accordance with the International Financial
Reporting Standards (IFRS) as adopted by the European Union
(EU). The Consolidated Financial Statements have been prepared
under the historical cost convention unless otherwise stated.
Reporting Structure
This Annual Report provides information on how Avantium
creates long-term sustainable value for its stakeholders. We start
by describing how our vision, mission, and strategy drive positive
impact (About Avantium on page 4), before focusing on our
performance and developments in 2025 (2025 in Review on
page 21). We also include a sustainability statement (page 40), in
which we discuss how we manage the sustainability topics that
are most material to our business. Together, the 2025 in Review
section and the sustainability statement constitute the
Management Board Report.
Assurance
The financial data and related disclosures in our financial
statements are subject to external assurance. While we have
strengthened our non-financial reporting and use the EU
Corporate Sustainability Reporting Directive (CSRD) as guidance,
we have chosen not to obtain external assurance on non-financial
information at this stage.
Audience
This Annual Report is designed for all stakeholder groups that
influence our business or are impacted by it, including
commercial and financial partners, investors and shareholders,
employees, and society at large. It provides a balanced overview
of our activities and Avantium’s ability to generate sustainable
long‑term value. Additional disclosures are available on our
website: www.avantium.com.
Safe Harbor Statement
This Annual Report may include forward-looking statements.
Other than reported financial results and historical information,
all statements featured in this Annual Report – including, without
limitation, those regarding our financial position, business strategy
and management plans, and objectives for future operations –
are forward-looking statements. These forward-looking
statements are based on our current expectations and
projections about future events and are subject to risks and
uncertainties that could cause actual results to differ materially
from those expressed in the forward-looking statements. Many of
these risks and uncertainties relate to factors that are beyond
Avantium’s ability to control or estimate precisely, such as future
market conditions, the behavior of other market participants and
the actions of governmental regulators. Readers are cautioned
not to place undue reliance on these forward-looking statements,
which speak only as of the date of this Annual Report and are
subject to change without notice. Other than as required by
applicable law or the applicable rules of any exchange on which
our securities may be traded, we have no intention or obligation
to update forward-looking statements.
About Avantium
Key Figures 2025
Financial
icon_Direct-Air-Capture-Solutions_04-Bordeaux.svg
Finance
Revenue
(in € million)
EBITDA
(in € million)
14.6
-36.1
2024: 21.0
-30.5%
2024: -33.3
-8%
Investments
(in € million)
Net cash outflow
(in € million)
20.7
61.4
2024: 58.6
-64.7%
2024: 106.1
42%
Number of government grants
Grant recognition
(in € million)
17
3.4
2024: 15
13.3%
2024: 4.6
-26%
Non-Financial
AVAcorp_icons_25-Bordeaux.svg
Technology
Newly granted patents
9
2024: 15
-40%
Newly reported inventions
25
2024: 45
-44.4%
AVAcorp_icons_18-1-Bordeaux.svg
Environment
Scope 1 emissions
(in tonnes CO 2e)
544
Scope 2 emissions
(in tonnes CO 2e)
2985
Scope 3 emissions
(in tonnes CO 2e)
3060
AVAcorp_icons_19-1-Bordeaux.svg
Social
Number of full-time equivalents                       
(on 31 December 2025)
Number of
nationalities
employed
259
29
2024: 287
-9.8%
2024: 35
-17.1%
Gender balance
(% of women in total workforce)
Women in senior
leadership positions
(% of total senior leadership positions)
26%
52%
2024:  26%
0.0%
2024: 39%
33.3%
Number of safety accidents
0
2024: 0
Avantium JV2025 Message from  the CEO.jpg
Message from the CEO
Dear Stakeholder,
In two decades as Chief Executive Officer (CEO) of Avantium,
I have never experienced a year quite like 2025. We achieved
the partial start-up of our Flagship Plant for the manufacture of
furandicarboxylic acid (FDCA) in Delfzijl, the Netherlands: a major
milestone on the path to commercializing production of our plant-
based, circular plastic, polyethylene furanoate (PEF), marketed
under the brand name releaf®. At the same time, construction-
related challenges resulted in delays in fully starting up our
Flagship Plant, and this had a significant impact on our financial
position. We also had to take some challenging organizational
initiatives, including implementing a strict cost‑saving program
and, regretfully, making numerous redundancies as part of our
necessary transition from a company focused on research and
development (R&D) to a commercial enterprise.
Looking ahead to 2026, despite the inevitable challenges on this
unique journey, I am optimistic for the future of our Company. I am
pleased that we have regained momentum in our Flagship Plant
activities and continue to see strong commercial traction for PEF
that reinforces our confidence in the road ahead. With our
innovative technologies and strong investor backing, we are
poised to make a positive impact that will be felt across our
industry and beyond.
Meeting Our Greatest Challenge
In 2025, Avantium faced delays in the start‑up of the FDCA
Flagship Plant. Consequently, we had to ensure the Company
was sufficiently capitalized to realize the start-up and ramp-up of
the Flagship Plant in Delfzijl. In June, we announced that we had
secured €10 million in financing – including a loan from the
Province of Groningen and a drawdown from the senior Debt
Financing Facilities provided by our consortium of lenders – to
address our short-term liquidity needs. The following month, we
secured a further €10 million in senior debt financing from Invest-
NL. At the same time, we worked on a comprehensive financing
plan including an agreement on new medium- and long-term
conditions with our lenders, agreeing a two-year extension to our
Debt Financing Facilities in August.
In the summer, we identified construction-related quality
deficiencies in the titanium welding of our FDCA Flagship Plant.
To ensure a safe and reliable start-up, we began an extensive
weld remediation program.
We launched an equity raise in September, despite turbulent
market conditions. Having initially targeted €65 million in funding,
we are delighted that new investors and our existing shareholder
base invested a total of almost €85 million in Avantium.
I am deeply grateful for the support of our longstanding and new
investors alike, and especially for the commitment of the Dutch
State, represented by the Ministry of Climate Policy and Green
Growth.
This was a decisive moment for Avantium, not only ensuring the
Company is well capitalized – and unlocking a critical debt
repayment extension – but also underlining our investors’
confidence in our strategy and their trust in our technology
and mission.
"2025 was an
unprecedented
year of progress
and challenges
for Avantium"
Tom van Aken
Avantium
About Avantium  |  Message from the CEO
7
Avantium JV2025 Message from  the CEO_02.jpg
Starting a Transformative Chapter
Since this strong vote of confidence from our stakeholders, we
have already been able to significantly advance progress toward
the commercialization of PEF. At the end of 2025, approximately
half of our FDCA Flagship Plant was commissioned and
operational, including a state-of-the-art sugar dehydration unit
that will validate the scalability of our YXY® Technology. We now
expect to complete the full Flagship Plant start-up by mid-2026
The achievement of full-scale production in our Flagship Plant
will demonstrate to customers that commercial-scale production
of the game-changing plastic PEF is a reality. We expect
commercial sales under existing offtake agreements to begin in
the second half of 2026, and from there we look forward to the
exciting moment when releaf® products will appear in the market
– from the supermarket shelves to premium fashion and textile
applications. Moreover, with far-reaching policies like the EU’s
Bioeconomy Strategy and the Plastic Packaging Waste
Regulation coming into effect, Avantium is poised not only to
"Reaching full production at our
FDCA Flagship Plant will show
customers that commercial‑
scale PEF is truly achievable"
deliver on our commercial potential but to be instrumental in
Europe’s move toward a circular bioeconomy, to be followed by
other regions in transforming their industries to rely on renewable
feedstock and circular products.
On the Road to Releaf®
The important strides we are making at our FDCA Flagship Plant
are just one element of our broader PEF commercialization
strategy. During the year, we signed numerous offtake and
capacity reservation agreements with manufacturers across many
industries. We are also in ongoing discussions with several
potential technology licensees. Licensing is the cornerstone of
our PEF commercialization strategy, and I look forward to seeing
the first of these agreements being executed.
In the meantime, we made further progress toward the
commercialization of releaf® by securing key approvals in 2025.
RecyClass, the European non-profit initiative dedicated to
advancing plastics circularity, validated that PET and PEF
multilayer bottles can be recycled in Europe, while the Japanese
Council for PET Bottle Recycling (CPBR) approved the use of PEF
in a multilayer PET/PEF bottle for recycling within Japan’s PET
bottle stream. In addition, FDCA has now also been added to
Japan’s “Positive List,” confirming its suitability for food-contact
applications and strengthening our position in a key global
market.
To support our focus on the commercialization of PEF, we are
exploring promising strategic divestment and partnering options
for Avantium’s other proprietary technologies, including Dawn
Technology®, Parana Technology and Volta Technology,
as well as the Avantium R&D Solutions business unit (see page 11
and ##). The execution of these initiatives will enable us to focus
our resources on making releaf® a commercial reality – thereby
accelerating our path to sustainable profitability and helping
support the global plastics transition.
Bringing It All Together as a Team
While a significant reorganization was an inevitable part of our
transition from an R&D company to a commercial organization,
saying goodbye to 40 Avantium colleagues was one of the most
painful challenges that we – and I personally – faced this year.
I am grateful to all our colleagues directly impacted by the
changes: to our former colleagues for their vital contributions to
our mission, but also to our remaining teams for their unstinting
collaborative commitment in very difficult  circumstances.
2025 was a tumultuous year for Avantium but I believe it has
created the platform for future commercial progress for our
Company. I believe this is the testament to the strength of the
teamwork demonstrated during the year, and I want to thank
all our stakeholders – including lenders, shareholders, the Dutch
government, partners, and customers – and, especially,
my talented, dedicated, and passionate colleagues who were
able to bring it all together. I also want to thank the members of
Avantium’s Supervisory Board for their efforts and collaboration
during a challenging year.
If 2025 was a year like no other, I am confident that 2026 will
set the stage for stability and success. With renewed momentum
behind us, I believe we can all look forward to seizing the
significant opportunities ahead, as we continue to lead the
transition to a fossil-free chemical industry.
Tom van Aken
CEO, Avantium
Who We Are
Our vision is clear: At Avantium, sustainability is at the core of who we are.
Through our products and technologies, we strive to de‑fossilize the chemical
industry, accelerate the shift to a circular economy, and create long‑term,
sustainable value for all our stakeholders.
megamenu_icon_08@8x.png
Years of R&D
Patent families
25+
179
Core products
Avantium Pef_red.svg
FDCA
PEF branded as releaf®
AVAcorp_Megamenu_Icons_05.svg
Strategic
& commercial
partners
Offtake
agreements
21
Capacity
reservations
13
License
agreement
1
megamenu_icon_08@8x.png
World-first commercial
FDCA Flagship Plant
Employees
1
274
Our Mission
To lead the transition to a fossil-free chemical
industry by 2050.
Our Strategy
To scale our technology globally through
our own production, strategic commercial
partnerships, and third-party licensing,
building strong collaborations across the
value chain to deliver meaningful impact
while fostering a safe, inclusive, and inspiring
workplace where people can thrive.
Our Values
We make a lasting impact
We are determined team players
We do the right things right
We are pragmatic idealists
We have fun
Avantium JV2025 our strategy.jpg
Making an Impact through Our Integrated Strategy
At Avantium, we aim to monetize our innovative
proprietary technologies and business units through
several pathways. These include: (i) licensing them
to third parties; (ii) applying them in our own
production assets or through partnerships and
joint ventures; (iii) divesting them to external
parties; and (iv) spinning out individual technologies
or business units with strategic partners who then
lead investment in the business while Avantium
retains minority shareholder status.
We continually assess these pathways to identify the best long-
term opportunities for each technology to reach its maximum
potential. Our management processes are designed to manage
risk, safeguard our strategic optionality, and increase shareholder
value. We plan, allocate, and deploy our resources in a way that
aims to best serve all our stakeholders, supporting our ambition
to profitably scale renewable and circular materials globally.
As we transition from an R&D organization into a commercial
company, we are also transforming Avantium’s business portfolio.
This aligns with our increased strategic focus on our lead
innovation, YXY® Technology, and the business area in which
it resides, Avantium Renewable Polymers.
In the following pages, we provide more information about our
specific strategy for Avantium Renewable Polymers, before
outlining the strategic directions we are pursuing for our other
proprietary technologies and business areas.
Sustainability is, and has always been, inseparable from our
overall commercial strategy. The visual below reflects the
integration of our four sustainability focus areas and the four parts
of our strategy. Together, this drives progress toward our vision
of a fossil-free world. For more information about our
sustainability focus areas, see “Sustainability Strategy.”
Climate Change
Industry-wide
emissions reduction
by deploying our
technology
Emissions intensity of
our own FDCA
Flagship Plant
Climate
Change
Circularity
Circularity of PEF
Sustainable feedstock
Valorization of waste/
by-products of our
technology
Strategic
Focus
Drive leadership
in plant-based and
circular polymers
with a clear focus
on PEF, branded
as releaf®
Strategic Partnerships
Build strong
collaborations across
the value chain to
create value
Business Conduct
Advocacy for a circular
and fossil-free
chemical industry
Consumer health and
safety
Business
Conduct
We believe
in a fossil-
free world.
Let’s go
Commercialization
& Licensing
Scale globally
through own
production,
partnerships,
and licensing
Circularity
Own Workforce
Health and safety in
our own operations
Development of
human capital
Workplace
Foster a safe, inclusive,
and inspiring work
environment where our
team can make a positive
impact
      Own
  Workforce
Avantium JV2025 Our Strategy_02.jpg
Avantium_2025_Innovation Funnel_04.svg
Business Areas
Avantium Renewable Polymers
Avantium Renewable Polymers is home to our
lead technology, YXY® Technology, which
transforms plant sugars into FDCA. FDCA is
the essential building block for creating our
next-generation polymer PEF, known under
the brand name and EU-registered trademark
releaf®.
Using 100% renewable carbon in PEF instead
of using fossil-based carbon in polyethylene
terephthalate (PET) can bring substantial
advantages. For example, when producing
500 ml bottles the use of PEF can reduce
greenhouse gas (GHG) emissions by 73% over
the bottles’ life cycle compared to PET.
Additionally, the emissions from bio-based
bottles upon incineration are offset by CO2
removal during the growth of the renewable
feedstock, ensuring no additional CO2 is
released into the atmosphere. Significant GHG
emission reductions (around 39%) can also be
achieved in multilayer packaging (PET/
polyamide (PA)) by replacing typical fossil-
based barrier layers with PEF. See our website
for full life-cycle assessment (LCA) results.
In addition, PEF can be recycled in existing
recycling streams.
Our strategy for Avantium Renewable Polymers
has four key parts: (i) to continue developing
the market for PEF by working with partners to
generate global demand, (ii) to prove YXY®
Technology at commercial scale at our FDCA
Flagship Plant, (iii) to ensure global availability
of PEF via technology licenses, (iv) to
continuously improve the technology and
maintain our technology leadership through
ongoing research and collaborations. In doing
so, we aim to create sustainable value for all
our stakeholders; indeed, sustainability is a
fundamental driver of our commercial strategy
(see our Sustainability Statement on page 40).
Innovation Funnel
Stage 1: Development
We evaluate an idea’s technical
and commercial potential and its
fit with Avantium’s strategy for
PEF and FDCA.
Stage 2: Pilot Plant
We secure, test, demonstrate,
and optimize the technology, as
well as validating its applications
at our FDCA pilot plant or our
FDCA Flagship Plant. 
Stage 3: Flagship Plant
We produce the technology at
commercial scale, either on our
own or in partnership.
Stage 4: Licensing Facilities
We license our validated
technology to industrial partners
and develop projects to enable
broader-scale deployment and
market adoption of PEF and
FDCA.
We use an innovation funnel to manage our
development activities from ideation to
commercial launch, including a stringent stage-
gate process to structure our decision-making.
Licensing is especially important to our
success. This is the fastest and most capital-
efficient way to commercialize our technology,
bring our sustainable solutions to market, and
deploy them around the world to meet the
demand for renewable and circular materials.
Close collaboration with strong partners
throughout our entire value chain is key to our
strategy. As such, we work with companies
who share our values and ambitions, and want
to build a better world for future generations.
Having started up the sugar dehydration unit of
our Flagship Plant in 2025, we expect to begin
producing FDCA in the second half of 2026.
Demonstrating YXY® Technology to the market
at commercial scale will represent a major
milestone in Avantium’s licensing strategy.
To prepare for this, we have developed a
licensing sales pipeline with potential clients in
Europe, Asia, and the Americas. Technology
licensees are expected to construct production
facilities with initial capacities of 100 kilotonnes
(or more) per year.
See page 24 for details of our progress.
Avantium JV2025 Our Strategy_03.jpg
Volta Technology
Volta Technology is our carbon capture
and utilization (CCU) platform. It uses
electrochemistry to harness the power of
air-based CO2, converting it into fossil-free
raw materials suitable for a broad range of
high-value chemical products.
Our Volta business unit focuses on formic
acid, oxalic acid, and glycolic acid – the last
of these being a key building block for
carbon-negative plastics like polylactic co-
glycolic acid (PLGA). PLGA offers an
excellent barrier against oxygen and
moisture, has good mechanical and thermal
properties, and is recyclable, home-
compostable, and marine-degradable.
These qualities make it a suitable candidate
for applications in plastic packaging, paper
coating and agri- and horticulture products.
Now proven in our laboratories and in
larger-scale container units, our Volta
Technology is ready to be further scaled
out to a pilot plant. We are therefore in
discussions with strategic and financial
partners with whom we can further
develop the technology, work
toward the commercialization of Volta
Technology and realize its full potential.
See page 27 for our progress.
Dawn Technology®
We have built a strong and unique
business case for the use of Dawn
Technology® to convert waste from
polycotton textiles into glucose and
chemically recyclable PET.
Not only does this help to address a major
challenge for the global textile industry,
but it also integrates with Avantium’s core
strategy for commercializing PEF, as the
technology can be used to produce
second-generation feedstock for FDCA.
In 2025, we began seeking strategic
and financial partners with the capital
and expertise required to take this
Dawn Technology® forward.
See page 27 for our progress.
Avantium JV2025 Our Strategy_04.jpg
Avantium Corporate Technology
Led by Avantium’s Chief Technology
Officer, Gert-Jan Gruter, this small team
of scientists and PhD students has strong
ties to the University of Amsterdam.
Corporate Technology serves as an
incubator for early-stage innovation,
complementing our other business units.
Part of our Corporate Technology team
works on optimizing our Dawn
Technology®, with other members focusing
on Parana Technology. Parana Technology
has enabled new and simpler ways to
synthesize several families of renewable,
high-performance polyesters, using
commercially available monomers and
assets. These bio-based polymers include a
class of oxalic acid-based polyesters known
as PISOX, which provide an unprecedented
combination of useful and sustainable
properties, including marine-degradability
and a carbon-negative footprint.
Given the growing market interest in bio-
based polymers and other bio-based
building blocks, our strategy is to spin out
the Parana Technology, with Avantium
retaining a minority shareholding in the new
business entity.
See page 28 for our progress.
megamenu_icon_07@8x.png
Avantium R&D Solutions
Avantium R&D Solutions is our revenue-
generating business unit, specializing in
advanced catalysis solutions for R&D
processes and sustainable chemistry
applications. We provide high-throughput
systems and services, as well as custom
R&D units, to customers worldwide.
The R&D Solutions business unit continues
to operate as a stand-alone entity while
strategic alternatives are evaluated.
See page 28 for our progress.
Ray Technology®
In 2023, Avantium decided to
prioritize the commercialization
and licensing of FDCA and PEF and,
therefore, to stop investments in Ray
Technology®. Avantium continues to
explore options for our Ray
Technology®, including the potential
sale of the technology (IP).
For the legal structure of Avantium,
please refer to note 2.2.1
Avantium JV2025 Map.jpg
Our Locations
FDCA Flagship Plant
Heveskeslaan 5
9936 HH Farmsum
Chemie Park Delfzijl
Dawn Pilot Biorefinery
Oosterhorn 4
9936 HD Farmsum
Chemie Park Delfzijl
61 people
Icon_HQ_MvB_01.svg
Avantium Headquarters
Zekeringstraat 29
1014 BV Amsterdam
166 people
At Avantium, we are united across our different business areas in
aiming to deliver innovative solutions for the renewable materials
transition, cut out plastic waste, and reduce CO2.
Avantium operates at four different locations:
Headquarters and laboratories at Amsterdam Zekeringstraat
Laboratories (in collaboration with the University
of Amsterdam) at the Amsterdam Science Park
Pilot plant and FDCA Flagship Plant at
Chemie Park Delfzijl
Pilot plant in Geleen Brightlands Chemelot
Science Park Laboratory
Matrix Building 6
Science Park 408
1098 XH Amsterdam
22 people
Industrial Park
In 2025, 188 (or 69%) of our employees mainly worked either in
research laboratories or in our offices (on, for example, business
development, analytics, strategy, project management, and
engineering). The remaining 86 (or 31%) of our employees worked
in our pilot plants and our FDCA Flagship Plant.
In 2025, our FDCA Flagship Plant focused on starting up
production, a process that will continue into 2026. This also
meant that the impact of Avantium’s operations in 2025
resembled that of an R&D‑focused organization rather than a full
commercial manufacturing business.
FDCA Pilot Plant
Urmonderbaan 22
6167 RD Geleen
Brightlands Chemelot Campus
25 people
Beyond our own operations, Avantium works with like-minded
partners to develop and commercialize our disruptive solutions.
Most of our suppliers are landlords and providers of management
Icon_world locations_MvB_01.svg
Globally
USA & Japan
2 people*
*employees of record
and consulting services, technical services, lab consumables, and
maintenance support; we also have a limited number of suppliers
of feedstock and input materials.
Avantium JV2025 Valuechain.jpg
FDCA and PEF Value Chain
Stakeholders
Upstream
-  Feedstock suppliers
-  Engineering partners and contractors
-  Plant-based MEG suppliers
Own Operations
-  Employees
-  Society
-  Regulators and authorities
(local, regional, national, international)
Downstream
Direct stakeholders
Offtake partners:
- Brands
- Retailers
- Converters
Indirect stakeholders
- End consumers/users
- Recyclers
Polymerization
Raw
Materials
 
  Plant-based MEG
Licensing
channel
Direct
stakeholders
FDCA
Offices
Laboratories and
pilot plants
FDCA Flagship Plant
Market and business
development
PEF
(releaf®)
Packaging
Fiber
Film
Raw
Materials
  Sugar
Consumer
goods
Recycling
Intellectual
property
Licensed factory
  PEF
  (releaf®)
Technology
licensing
agreement
Direct
stakeholders
Engineering and
constuction
Downstream
Licensing partners:
- Feedstock suppliers
- Chemical companies
- PET/polymer producers
Licensing
channel
Direct
stakeholders
Sustainability
Focus
Upstream
-  Sustainable feedstock
Own Operations
-  Emissions intensity of our own FDCA Flagship Plant
-  Valorization of waste/by-products from our technology
-  Health and safety in our own operations
-  Development of human capital
-  Advocacy for a circular and fossil-free chemical industry
Downstream
-  Industry-wide emission reductions enabled by
  deploying our technology
-  Consumer health and safety
-  Circularity of PEF
About Our Value Chain
Avantium develops innovative technologies that
enable a fossil-free and circular chemical industry.
At the center of this mission is our product PEF,
marketed as releaf®. Our value chain (page 14)
illustrates how Avantium produces releaf® and
distributes it through the offtake channel. It also
shows how Avantium licenses the YXY® Technology
we have developed to manufacture releaf® through
the licensing channel.
Offtake Channel
Through the offtake channel, we either produce FDCA at our
FDCA Flagship Plant in Delfzijl or PEF (using our own FDCA) with
the support of our polymerization partner Selenis. The process
begins with us procuring the raw materials we need to produce
FDCA, one of the key building blocks in PEF. The main feedstock
is sugar, which is currently high-fructose syrup derived from
wheat supplied by Tereos. Avantium then applies its YXY®
Technology process steps – sugar dehydration, oxidation, and
purification – at the FDCA Flagship Plant in Delfzijl, which will
have an annual production capacity of up to 5 kilotonnes of
FDCA. Most of this FDCA is further converted into PEF, while a
portion is sold directly to our offtake partners.
Our laboratories and pilot plants in Amsterdam and Geleen
continuously analyze, improve, and document the process, while
also supporting patent and trademark registrations. Our business
development, regulatory, and other teams work to ensure that
FDCA and PEF meet market demand and requirements as well as
customer expectations.
Most of the FDCA produced at the FDCA Flagship Plant is
transported to our polymerization partner for the final YXY®
Technology step. At this stage, the second building block – plant-
based MEG, currently procured from India Glycols – is added.
Production takes place at the polymerization partner’s facility
using its equipment and workforce, but strictly according to
Avantium’s specifications. This results in the production of PEF.
Avantium sells FDCA and PEF to offtake partners – first movers in
the innovative polymers market, typically brands, retailers, and
converters. Additional processing steps then take place before
FDCA and PEF are transformed into consumer products such as
bottles, films, adhesives, and more. After use, these products can
be recycled.
Licensing Channel
Licensing forms the core of Avantium’s strategy and builds on the
proven success of the offtake channel. The goal of the licensing
track is to enable large-scale FDCA and PEF production through a
business model where Avantium grants technology licenses to
partners such as feedstock suppliers, chemical companies, and
PET/polymer producers. These partners invest in building
production facilities and infrastructure and in securing the
necessary input materials.
Avantium’s role in this channel is to provide the intellectual
property, technical specifications, and services required for
partners to establish and operate the FDCA and PEF production
process, as defined in the licensing agreements.
The PEF produced by our licensing partners is then distributed
through their own value chains and converted into a wide range
of applications that ultimately reach end-users. After use, the PEF
can be recycled, creating the potential for a circular loop in which
used materials return as next-generation inputs.
Avantium JV2025 The World Around Us.jpg
The World Around Us
The global context in 2025 continued to present
both urgent challenges and emerging opportunities
for Avantium. Confirmed as one of the warmest
years on record, 2025 underscored the intensifying
impacts of climate change and how they are
affecting communities, ecosystems, and economic
systems worldwide. Nevertheless, we also saw
encouraging signs that the broader trajectory points
toward a circular bioeconomy, presenting a strong
opportunity for Avantium to play an important role
in the transition.
Navigating Global Headwinds
Geopolitical and economic headwinds continued to create
obstacles for the sustainable plastics movement and for
environmental progress more broadly. Many companies,
including Avantium, experienced the effects of ongoing
resistance to environmental, social, and governance (ESG)
considerations: the foundational concepts used to integrate and
assess sustainability and ethical impact within business strategy.
Geopolitical uncertainty contributed to a challenging financial
environment in the first half of the year, including tariff fluctuations
in major markets such as the United States. This also had an
impact on Avantium’s financial position. However, the successful
closing of our equity raise in September, with significant
participation from the Dutch government, is an encouraging
signal of investors’ continued confidence in our strategic
direction, our technology platform, and our releaf® product.
Heading Toward a Circular Bioeconomy
After all, there are promising signs of a longer-term shift toward a
circular bioeconomy: one that decouples economic growth from
fossil inputs and linear consumption. Business interest in circular
strategies is strengthening, with global leaders and industry
coalitions prioritizing regulatory frameworks, investment
mechanisms, and multi-stakeholder initiatives to accelerate
systemic change.
2025, one of the warmest
years on record, highlighted
the accelerating impacts of
climate change worldwide
Plastic bottles used
annually worldwide
Billion
481.6
Source: Reuters
Avantium
About Avantium  The World Around Us
17
Avantium JV2025 The World Around Us_02.jpg
Research published in 2025 shows that just 6.9% of global
material flows are recycled, illustrating how far the world still
is from circular systems – and where potential opportunities lie
for innovative technologies and business models to help close
the loop.
Alongside sustained business interest, we also see a wider shift
in the regulatory and international environment toward a circular
bioeconomy strategy.
Research in 2025 shows only
6.9% of global materials are
recycled - far from a circular world
At COP30, discussions mainly focused on energy
decarbonization, but they also broadened to include the role of
bio- and circular economy strategies in sustainable industrial
transformation. Key initiatives like the Bioeconomy Challenge aim
to scale investment and support decarbonization, innovation, and
equitable economic development.
In Europe, the adoption of the updated EU Bioeconomy and
Circular Economy Strategy signaled an increasing focus on
resource sovereignty, innovation, and the valorization of
secondary raw materials. These frameworks position circular
bioeconomy principles at the core of Europe’s future
competitiveness, resilience, and climate goals.
A key element of the updated EU Bioeconomy Strategy is its plan
to strengthen market demand for bio-based products through
bio-based content requirements – essential for creating a level
playing field with fossil‑based alternatives. Under the Packaging
and Packaging Waste Regulation (PPWR), criteria for bio-based
plastics will be defined by 2027, complementing recycled content
targets and ensuring a coherent approach across applications.
The EU Bioeconomy Strategy also reinforces the importance of
circularity. Its recognition of novel bio-based materials within the
PPWR, together with mandatory content targets for bio-based and
recycled materials, will help stimulate market uptake.
Fighting for a Brighter Future
At Avantium, we therefore believe that the currents of change are
moving in our favor. The combination of regulatory momentum,
international policy emphasis on circular bioeconomy strategies,
and continued commercial traction positions us to play an
increasingly important role in the materials transition.
Through the commercialization of plant-based plastics like releaf®
and the scale-up of our proprietary technology platforms, we are
helping to support a global shift toward sustainable, renewable
materials. In this challenging yet promising context, we remain
optimistic about our ability to contribute meaningfully to a future
that is less dependent on fossil resources and more sustainable
for generations to come.
Avantium JV2025 How We Create Value.jpg
How We Create Value
We maintain ongoing dialogues with our
stakeholders – the individuals, groups,
and organizations that can affect or be affected
by our business – about Avantium's strategy,
developments, and activities. We create value
for our stakeholders by working toward our
mission to help transition the chemical industry
to renewable feedstocks and to secure a
sustainable future for all. In addition, we work
closely with our ecosystem of strategic,
commercial, and financial partners, expert
suppliers and service providers, and academic
partners. See "Stakeholder Engagement" on
page 58 for more details.
We recognize various stakeholder groups. Each group is affected
by Avantium’s business activities and performance in a different
way. We take into account the varied interests and variable
expectations of these stakeholder groups when determining our
strategy.
In 2024/2025, we conducted a double materiality assessment
(DMA) to identify and prioritize the (sustainability) topics and
issues that are most material to Avantium's business and
stakeholders. See "Double Materiality Assessment" on page 41 for
more information.
Employees
Our talented and motivated employees are our biggest
competitive advantage. We aim to be a magnet for the best
people from a diverse array of backgrounds and to foster a safe,
inclusive, and inspiring workplace where everyone can thrive.
Avantium
About Avantium  How We Create Value
19
Safety is always our number-one priority: we strive for an
incident- and accident-free environment.
Commercial Partners, Licensing Partners, and Customers
An integral part of Avantium’s strategy and commercialization and
licensing roadmap is our collaboration with partners throughout
the entire value chain. We bring our technologies to the market in
collaboration with like-minded companies whose skills and
expertise complement our own and increase our chances of
success. Together, we develop and deliver innovative solutions
that benefit our customers and help them achieve their
sustainability goals.
We conduct dialogues with our partners and customers to identify
shared objectives, build partnerships, and create ecosystems to
commercialize our innovations around the world. Avantium's
global customer base, including industry leaders, positions us to
provide tailored services and deliver meaningful results.
Offtake Partners
We see offtake partners – those who buy FDCA from our
Flagship Plant or PEF made using FDCA from our Flagship Plant –
as a specific category within our commercial partners and
customers stakeholder group. These brands, retailers, and
converters are first-movers in the market, showcasing the
commercial potential of our innovative material and leading the
way in putting PEF products into consumers’ hands.
We maintain close relationships and open dialogues with our
offtake partners, aiming to build trust, manage expectations,
and drive momentum as we complete the start-up of our Flagship
Plant and advance our commercialization journey.
Shareholders
Avantium's shareholders rely on us to successfully execute our
strategy and create maximum value. By monetizing our innovative
technologies and commercializing our game-changing products
and technologies, we create the potential to deliver increased
value to our shareholders.
Financial Partners
Our financial partners are a crucial stakeholder group for
Avantium. This group includes a consortium of lenders comprising
ABN AMRO Bank, ASN Bank, ING Bank, Rabobank, the Dutch
government-backed impact investment fund Invest-NL, and loan
providers including the Province of Groningen and Fonds Nieuwe
Doen, as well as subsidy providers. These partners rely on us to
successfully execute our strategy and related projects.
Supply Chain Partners and Contractors
Our supply chain partners and contractors are integral partners as
we scale up our technologies efficiently and deliver on our
commitments to customers. Feedstock suppliers, in particular –
providing high‑fructose syrup and bio-based MEG (mono-
ethylene glycol) – play a crucial role in our responsible and
sustainable supply chain.
Recyclers are increasingly important supply chain partners for
Avantium as we work to demonstrate and accelerate the
circularity potential of our material PEF. By engaging with
recycling companies, we ensure that PEF applications can be
collected, sorted, and reprocessed effectively, supporting both
circular design and end‑of‑life value creation.
Governments and Authorities
Governments and regulatory authorities shape the legislative
and regulatory landscape in which Avantium operates.
At international, European, national, regional, and local levels,
they not only develop and enforce rules that influence our
business but also provide subsidies and permits that require
continuous engagement. Alongside these public bodies, we also
work closely with advocacy groups and industry associations that
help advance the transition to renewable and circular materials.
Policymakers and legislative institutions play a key role in creating
frameworks that enable the scale‑up of sustainable technologies,
while compliance oversight bodies safeguard adherence to legal
and reporting requirements. Certification and standards
organizations further contribute by defining technical
specifications and sustainability criteria that support market
acceptance of our products. Together, these stakeholders create
the conditions under which Avantium can innovate, operate, and
grow responsibly.
Society
Avantium also considers a range of other stakeholders in carrying
out our business. We align our (commercial and sustainability)
strategy with the needs of wider society, looking beyond our
immediate value chain. As well as engaging with students at
schools and universities – sharing our expertise and inspiring
young people to be excited about sustainable and renewable
chemistry – we maintain active dialogues with local communities,
industry associations, media organizations, and non-
governmental organizations (NGOs).
Avantium
About Avantium  How We Create Value
20
Value Created for Our Stakeholders
Outputs
Suppliers & Contractors
Improved ESG performance and
reputation by participating in pioneering
circular and renewable chemistry
Offtake Partners
Early access to and adoption of plant-based,
recyclable, high-performance polymer PEF
or monomer FDCA
Recycling endorsements
for PEF
4
Multi-year supply agreements
for feedstock and other input
materials
Offtake
agreements
21
Expected sales under
offtake agreements
H2 2026
Our Strategy
Financial Partners & Shareholders
Position at the forefront of high-growth
sustainable materials markets, with
exposure to multiple revenue pathways
Strategic
Partnerships
Building strong
collaborations across
the value chain
to create value
Commercialization
& Licensing
Scaling globally through
own production,
partnerships,
and licensing
Licensing Partners
Proven YXY® Technology,
complementary expertise, joint
innovation, and commercial demand
Consolidated revenues
and other income
€18.0 million
EBITDA
€-36.1 million
Strategic Focus
Driving leadership
in plant-based and
circular polymers with
a clear focus on PEF,
branded as releaf®
Workplace
Fostering a safe,
inclusive, and inspiring
workplace where our
people can make a
positive impact
Capacity reservations
13
License agreements
1
Society & Authorities
Accelerated adoption of technologies that
help realize the national and international
sustainability agenda
Employees
Safe, inclusive and collaborative
environment supporting continuous
learning and development
Students
engaged
(since 2020)
56,153
GHG reduction
for 500 ml PEF bottle
(compared to PET)
73%
Advocacy focused
on a fossil-free
chemical industry
100%
Average of training
hours per employee
120.4
Safety
accidents
0
Nationalities
29
PhDs
4
    Governance
Risk
Management
Figures are based on
2025 data
Input
Human
Employees
PhD students
Interns
Students and prospective employees
lntellectual
Patent families
R&D expertise
Natural
Bio-based feedstock
Other input materials
Energy
Water
Social & Relationship
Stakeholder engagement
Partnerships
Memberships and
industry associations
Manufactured
Laboratories
Pilot plants
FDCA Flagship Plant
Financial
Investments
Cash position
Impact
Sustainable Feedstock
Development of today’s
and tomorrow’s feedstocks;
mitigation of negative
impacts (both environmental
and social) in the
supply chain
Responsible Production
Improvement of Avantium’s
carbon emissions intensity;
valorization of waste and
by-products; high standards
of health and safety in our
own operations; development
of human capital
Circular Business
Reduction in industry-wide
emissions; high standards
of health and safety for
consumers;
circularity of PEF
Contribution to a
circular and fossil-
free chemical
industry
2025 in Review
Avantium JV2025 Highlights 2025.jpg
Highlights from 2025
Avantium_Icon_Low Res.png
Avantium Renewable Polymers
At the end of 2025, utilities and a state-of-
the-art sugar dehydration unit at our FDCA
Flagship Plant were commissioned and
operational.
Achieved certification for three key ISO
norms at our Flagship Plant.
Increased the total number of offtake
agreements for PEF to 21 through new
deals with companies including Amcor,
Hoogesteeger, PLIXXENT, and the Bottle
Collective.
Signed new capacity reservations with
multiple companies including Biovox,
Hordijk, and Logoplaste
  to secure  FDCA and PEF volumes from
future licensed facilities.
Formed a strategic alliance with Tereos
and LMVH GAÏA to scale the production
of PEF across Europe.
Awarded a €200,000 grant by the EU
Horizon Europe program for participation
in the CERISEA consortium.
Secured key recycling and food-contact
approvals for PEF from RecyClass and
relevant authorities in Japan.
Volta Technology
Continued scaling out Volta
Technology to a larger container
unit as part of the WaterProof
program.
megamenu_icon_03@8x.png
Company
Raised €84.8 million in equity to
continue commercialization of
our plant-based polymer PEF.
Secured amended debt terms
with a loan maturity extended to
June 2028, and lower, partly
payment-in-kind, interest rates.
Avantium JV2025 Highlights 2025_02.jpg
Highlights from 2025 (continued)
Dawn Technology®
Demonstrated a patented method to
recycle polycotton textiles by
converting cotton to glucose while
preserving polyester for fiber to fiber
recycling, as published in Nature
Communications.
Confirmed that Dawn Technology®
can remove elastane from PET,
unlocking another valuable
application.
Avantium R&D Solutions
Expanded Flowrence® technology
with a new two-zone hydrocracking
unit design, now mechanically proven
and attracting strong customer
interest for 2026.
Advanced our direct air capture
collaboration with Climeworks.
Parana Technology
Continued application testing with LEGO
and a major cosmetics brand.
Received grant for participation in the
NO-REGRET consortium.
Avantium JV2025 Performance by Business Area.jpg
Performance by
Business Area 2025
In a challenging year, we stayed the course –
moving ever closer to our vision of a fossil-free
world.
Avantium Renewable Polymers
Advancing Our FDCA Flagship Plant amid Challenges
Our lead business unit faced several major challenges in 2025.
We began the year by commencing start-up activities at our
FDCA Flagship Plant in Delfzijl, with the aim to put PEF into the
hands of customers by the end of the year. However, as a result
of a combination of technical and operational issues, the 
commissioning and start-up period for the FDCA Flagship Plant
was delayed, with a material impact on the Company's financial
position.
To meet our short-term liquidity needs, we secured €10 million
in financing in June, made up of a €4 million subordinated loan
from the Province of Groningen (the second tranche of the
agreed €9.9 million) and a €6 million drawdown from the
€20.1 million increase of the senior Debt Financing Facilities
provided by our consortium of lenders (Invest-NL, ABN AMRO,
ING, ASN, and Rabobank). In July, Invest-NL provided another
€10 million in senior debt financing, with the stipulation that it be
repaid from the proceeds of a planned equity raise.
This bridge funding enabled us to continue working on longer-
term options that would allow us to keep operating. In August, we
agreed a comprehensive financing package with the consortium
of lenders – amending our Debt Financing Facilities and
extending the repayment date from March 2026 to June 2028.
In the same month, we uncovered serious construction-related
quality issues in the welding at our Flagship Plant in Delfzijl.
This required us to delay our commissioning activities while we
undertook a comprehensive repair and remediation program to
ensure a safe and reliable start-up.
Bolstered by the successful start-up of the sugar dehydration unit
in August 2025 and utilities of the FDCA Flagship Plant earlier in
the year, we launched a capital increase in September, by means
of a fully committed and underwritten rights offer. We raised
84.8 million in equity, exceeding our initial expectation of
€65.4 million. This was thanks to the additional placement
of €15.0 million in new ordinary shares to the State of the
Netherlands, represented by the Ministry of Climate Policy and
Green Growth. This outcome reflects investor and government
confidence in our strategy and demonstrates a shared
commitment to pursuing the large market potential of FDCA and
PEF and accelerating the transition to sustainable materials.
Avantium also took responsibility by critically reviewing our
spending. As well as pausing non-essential spending and hiring,
we took the decision to reorganize our Company, including
letting go of 40 colleagues. Our evolution from an R&D-focused
company to a commercial company inevitably involves
transitioning the profile of our workforce. More information is
provided in the “Social” chapter of our Sustainability Statement
(see page 50).
With our finances restored to health, we were able to resume
focus on the crucial next steps at our FDCA Flagship Plant.
By the end of 2025, the utilities and sugar dehydration unit were
started-up, with the weld repair program well underway and the
team focusing on starting up the oxidation and purification units.
We now expect start‑up to be completed by mid‑2026, with sales
under our offtake agreements commencing in the second half of
2026.
In early 2026, we furthermore successfully achieved certification
for ISO 140001, 45001, and 9001 (environmental management
systems, occupational health and safety systems, and quality
management systems, respectively) for the production of
intermediate chemicals used in the production of FDCA at our
FDCA Flagship Plant.
Paving the Way for Circular Plastic
While our fundraising activities and start-up delays slowed our
progress on the commercial activities of Avantium Renewable
Polymers, we were able to take several important steps forward.
Most significantly, we advanced our discussions with potential
technology licensing partners with the potential to build 100-
kilotonne (or more) FDCA production facilities. It is a testament to
our innovative YXY® Technology and revolutionary plant-based
plastic releaf® that interest from potential licensees has remained
strong, both in a difficult year for the chemical industry at large
and at a time when sustainable investment is being scaled back
in many markets.
In September, we announced a key strategic alliance with Tereos
(our feedstock supplier) and LMVH GAÏA (the environmental R&D
division of LVMH Louis Vuitton Moët Hennessy) to scale up
releaf® production across Europe. Building on our longstanding
collaboration within the PEFerence consortium, this new
consortium intends to identify and receive commitment from an
operational partner to build and operate the first industrial-scale
facility in Europe, based on our proprietary YXY® Technology.
This will form an important pillar of Avantium’s licensing strategy
in the region.
Meanwhile, we continued to grow our network of offtake partners
for our FDCA Flagship Plant. In Avantium’s first step into the
construction industry, we signed a five-year conditional
agreement with PLIXXENT, a leading producer of polyurethane
products, that will buy our FDCA for use in insulation foams.
As well as delivering significant environmental benefits over
traditional petrochemical-based foams, FDCA provides the
mechanical strength and dimensional stability needed for building
applications.
We made more agreements with partners in food packaging.
We announced a conditional offtake agreement with fresh juice
producer Hoogesteger, who will purchase PEF to use in bottles to
be sold at Albert Heijn. This marks the third PEF-based
application for the Netherlands’ largest supermarket chain.
Additionally, we signed an offtake agreement with the Bottle
Collective to integrate PEF into its fiber bottles, improving both
barrier performance and sustainability. Supported by partners
such as PA Consulting, PulPac, LogoPlaste, and major global
brands including Diageo, Opella, and Haleon, the Bottle
Collective is advancing the development of next-generation fiber
bottles based on the Dry Molded Fiber technology.
Avantium also signed new capacity reservation agreements in
2025, with partners who will gain preferred access to PEF
produced by future technology licensees:
Amcor Rigid Packaging, with whom Avantium will also partner to
explore the use of releaf® in containers for a range of consumer
products.
BIOVOX, a pioneer in sustainable healthcare plastics.
Royal Hordijk, a leading producer of sustainable plastic
packaging solutions.
Logoplaste Consultores Técnicos, a global packaging
manufacturer.
Avantium JV2025 Other Developments.jpg
In January 2026, we signed a capacity reservation agreement
with Packamama, the UK- and Australia-based innovator in
sustainable wine packaging. At the time of publication, capacity
reservations now exceed 100 kilotonnes, effectively fully booking
a 100‑kilotonne licensed facility and supporting the development
of multiple licensed plants.
Other Developments
In addition to securing more commercial partnerships
in 2025, we celebrated other notable developments all along
our value chain and across a wide range of industries.
This further confirms the market’s readiness for our game-
changing circular plastic.
During the year, we continued our collaboration with a
consortium of leading textile innovators on developing
a PEF-based spacer fabric for Auping mattresses.
In May, Avantium Renewable Polymers was awarded a
€200,000 grant by the EU Horizon Europe program for
participation in the CERISEA consortium for the large-scale
production of the bio-based chemical 5-Hydroxymethylfurfural
(5-HMF), which can be used as an intermediate in producing
FDCA. The goal of CERISEA is to help create an integrated and
sustainable European production ecosystem that reduces
environmental impacts and strengthens the economic
resilience of the region’s chemical industry.
In Japan, FDCA was named as an approved monomer on the so-
called "Positive List", making PEF eligible for use in food-contact
applications. This builds on similar approvals already granted in
Europe and the United States and represents an important step
in bringing a circular and renewable solution to this key market.
Later in the year, the Council for PET Bottle Recycling (CPBR)
approved PEF used in a multilayer PET/PEF bottle for recycling
within Japan’s PET bottle stream.
Similarly, the European non-profit RecyClass also evaluated our
multilayer PET/PEF bottle and found this combination to be
compatible with the PET recycling stream (unlike PET bottles that
use nylon as a barrier material). This means that brand owners
can confidently adopt PEF as a barrier layer without
compromising packaging quality or end-of-life recyclability.
Meanwhile, the European PET Bottle Platform (EPBP) has
extended its interim endorsement for recycling bottles containing
PEF in a designated test market. This assessment covers the use
of PEF in bottles and similar applications, including its role as a
barrier layer in multilayer PET bottles within the European
recycling stream.
Avantium JV2025 Across Avantium.jpg
Across Avantium
Fulfilling the Potential of Our Technologies
In 2025, as we continued to sharpen our strategic focus on FDCA
and PEF, we initiated a comprehensive review of Avantium’s
other business areas and proprietary technologies. During the
year, we held discussions with external parties regarding
strategic options – including full or partial transfer of ownership –
for Volta Technology, Dawn Technology®, Parana Technology
(part of Corporate Technology), and Avantium R&D Solutions.
For more information about our specific strategies, see
“Business Areas” on page 10. Here, we share key developments
from 2025.
Dawn Technology®
With only 1% of the world’s textile waste being recycled, the
industry urgently needs solutions. In 2025, we worked on
creating the business case for our biorefinery platform,
Dawn Technology®, to provide an answer. Having continued to
test and fine-tune the use of blended polycotton textile waste
during the year, it is clear that this platform can solve two
important environmental challenges: converting cotton into
glucose derivatives (a second-generation feedstock for, for
example, FDCA and PEF), and preserving the polyester for true
fiber-to-fiber recycling. New results confirm that the Dawn
Technology® process can remove elastane from PET, including
twisted PET‑elastane yarns, revealing another valuable
application for Dawn Technology®. It is on this basis that we are
exploring options together with financing and strategic partners
on how to best prepare Dawn Technology® for the future.
Volta Technology
With our carbon capture and utilization (CCU) technology
ready for the pilot plant phase, we focused during the year
on strengthening our collaboration with value chain partners,
such as suppliers of Volta Technology’s key feedstock, CO2.
Volta Technology is also supporting the Province of Groningen
in its CCU FWD (Carbon Capture & Utilization – Forward) initiative:
a collaborative effort between industry, university, and
government institutions that aims to create a CCU ecosystem in
which we believe our platform could play a key role. Moreover,
as made clear in the Wennink report released at the end of 2025,
CCU is an important technology for the sustainable economic
growth of the Netherlands. The Wennink report examined
what is needed to strengthen the Netherlands’ industrial
competitiveness, innovation capacity, and sustainable economic
growth, with a strong focus on enabling the transition to
sustainable and circular chemistry.
At the same time, we continued to develop the markets for
Volta Technology products. As a fossil-free, compostable, and
recyclable polymer, PLGA (polylactic co-glycolic acid) can help
brand owners and plastic converters reduce the environmental
impact of raw materials sourcing and the eventual disposal of
plastic products, with little to no compromise on the quality of
their products. Another key product is glycolic acid, which is in
high demand in the personal care industry. This is chemically
identical to the fossil-based variant and does not require
extensive reformulation work, and its higher purity and lower
carbon footprint make it an attractive alternative.
In our WaterProof, HICCUPS, and ICO2NIC programs,
we continued to strengthen our Volta Technology at both
laboratory scale and within container units. The construction
of the next‑generation container unit for the WaterProof project is
nearly complete and will be shipped to its demonstration site in
the first quarter of 2026.
Avantium JV2025 Catalysis_Product.jpg
Parana Technology
In 2025, we saw exciting progress in our early-stage R&D related
to several families of renewable polyesters with desirable
mechanical properties and strong sustainability credentials.
In 2025, the team scaled up its work on these materials and
continued its application testing with LEGO and a major
cosmetics brand.
We use Avantium’s Geleen pilot plant to carry out the first
commercial trials in 2026, while continuing discussions with
potential commercial and investment partners around the world.
At the end of the year, Avantium received a grant for participation
in the NO-REGRET consortium, in which Avantium’s Parana
Technology expertise will contribute to the development of an
AI model that will predict polymer properties, thereby streamlining
the R&D process.
megamenu_icon_07@8x.png
Avantium R&D Solutions
Several factors made 2025 a challenging year for this business
unit. Our contract R&D services were affected by temporary
technical issues, while a key customer also closed down one of
its two dedicated catalysis units. Altogether, Avantium R&D
Solutions’ revenue amounted to €13.4 million in 2025 (2024:
€14.3 million).
With the chemical industry struggling and corporate sustainability
under pressure, demand for sustainable chemistry solutions was
significantly lower than expected. While we continued our
collaboration with Climeworks, including the sale of another direct
air capture (DAC) unit, progress in our other sustainable chemistry
focus areas stalled. Avantium R&D Solutions has decided to stop
investment in green hydrogen in particular, owing to the tough
market environment and the high level of competition.
There were, however, positive signs in our Flowrence® activities,
in terms of both orders and execution. Defying the general trend,
in 2025, 48% of revenue from Flowrence® projects came from
customers’ sustainable chemistry applications. We developed a
version of these proprietary catalyst testing units with parallel
trains of reactors in series. This unit is mechanically complete and
awaiting start-up in 2026. There is already strong interest in these
two-zone hydrocracking units, which could be valuable in oil-
refining applications as well as non-fossil processes.
1 EBITDA (earnings before interest, tax, depreciation, and amortization) is an important measurement of the Company's financial performance. EBITDA margins provide a view of operational efficiency and enable a more accurate and relevant comparison between
peer companies.
2 During the 2024 financial year, management made a reclassification between the employee benefits expenses and raw materials and contract costs line items (refer to note 25). Comparative has been updated accordingly.
3 Please refer to note 12.
Financial Performance 2025
Income Statement
Revenue
in millions of €
2025
2024
% change
R&D Solutions
13.4
14.3
-6%
Renewable Polymers
0.5
6.5
-92%
Corporate allocations
0.7
0.3
133%
Total revenue
14.6
21.1
(31%)
In 2025, Avantium's consolidated revenue decreased by 31% from
€21.1 million in 2024 to €14.6 million in 2025. The decrease in
revenue was mainly driven by Avantium Renewable Polymers,
whose revenues decreased by 92% following the July 2024
decision to pause the revenue recognition under the license
agreement with Origin Materials. Avantium R&D Solutions revenues
decreased by 6%, due to a decrease in machine capacity in the first
half year of 2025. The issues were resolved in the second half of
the year and the machines returned to full capacity.
Other Income: Government Grants
Income from government grants decreased by 26%, from €4.6
million in 2024 to €3.4 million in 2025. This decrease mainly
reflects the accelerated recognition of the awarded PEFerence
grant in 2025, even though the project formally concluded at
year‑end. In addition, the reduction in full-time equivalents (FTEs)
resulting from cost‑saving measures led to fewer hours eligible for
grant recognition and limited the Company’s ability to apply for new
grants.
In 2025, the Company recognized grant income from ICO2NIC, 
a project focused on demonstrating the full value chain of a closed
carbon cycle. Through this project, Avantium will use its proprietary
Volta Technology to convert CO₂ from wastewater purification and
waste incineration into formic acid.
EBITDA 1
in millions of €
2025
2024
% change
R&D Solutions
1.8
2.2
-18%
Renewable Polymers
-22.3
-17.2
-30%
Corporate allocations
-15.6
-18.3
15%
EBITDA
(36.1)
(33.3)
-8%
In Avantium R&D Solutions, the decrease in EBITDA for 2025
reflects lower revenues that were not fully offset by reduced
operating costs.
Avantium Renewable Polymers showed a decrease in EBITDA
in 2025, driven primarily by lower revenue and other income
recognition, as well as higher consumable costs.
For further information on the EBITDA of Avantium's business
segments, please refer to note 23 in the financial statements.
Total EBITDA for Avantium decreased from €-33.3 million in 2024
to €-36.1 million in 2025.
Operating Expenses
in millions of €
2025
2024
% change
Raw materials and contract
costs 2
(4.4)
(4.7)
6%
Employee benefit expenses 3
(34.3)
(35.9)
4%
Office and housing expenses
(3.3)
(4.0)
18%
Patent, license, legal, and
advisory expenses
(4.2)
(5.9)
29%
Laboratory expenses
(6.2)
(4.2)
-48%
Advertising and
representation expenses
(0.8)
(1.8)
56%
Other operating expenses
(0.9)
(2.4)
63%
Net operating expenses
(54.1)
(58.9)
8%
Net operating expenses amounted to €54.1 million in 2025, a
decrease of €4.8 million compared to 2024 (€58.9 million). This
reduction was mainly driven by cost‑saving measures that reduced
expenses incurred in the ordinary course of the Company’s
operations in 2025, including operating and commercial support
costs.
4 For more information, refer to note 10 of the Consolidated Financial Statements.
5 In presenting and discussing Avantium’s financial position, operating results, and cash flows, Avantium (like many other publicly listed companies) uses certain alternative performance measures (APMs) not defined by the International Financial Reporting Standards
(IFRS). These APMs are used because they are an important measure of Avantium’s business development and management performance. Please see note Alternative performance measures.
6 Refer to footnote 7.
7 Other includes non-cash movements related to share-based payments.
Financial Position and Balance Sheet
Cash Position and Cash Flow
The total cash position (including restricted cash4) as at December
31, 2025 was €57.5 million (December 31, 2024: €23.9 million). 
During 2025, Avantium's cash position increased due to the
successful equity raise completed in the summer of 2025. In June,
Avantium secured €10.0  million in short‑term financing from the
Province of Groningen and its senior lender consortium, followed in
July by an additional €10.0  million loan from Invest‑NL. In August,
the Company agreed an amended and extended Debt Financing
Facilities with its lenders. In September, Avantium completed an
€84.8 million equity raise, significantly above the initial €65.0 million
target, supported by a €15.0 million investment from the State of the
Netherlands. Together with strict cost controls and a Company
reorganization impacting approximately 40 positions, this capital
strengthened Avantium’s financial position. The cash outflow for the
year was mainly driven by operating expenses, capital expenditure
relating to the FDCA Flagship Plant and interest payments.
Avantium’s net cash used in operating, investing, and financing
activities in 2025 was €61.4 million, versus €106.1million in 2024,
mainly due to the Group's negative EBITDA.
In 2025, the working capital experienced a positive movement
of €7.4 million, compared to a negative movement of €5.7 million
in 2024. This positive movement was mainly due to a €5.1 million
decrease in trade and other receivables and a €2.0 million increase
in trade and other payables.
The decrease in trade and other receivables primarily reflects lower
outstanding balances from customers of Avantium R&D Solutions.
The increase in trade and other payables mainly relate to
expenditure for the construction of the FDCA Flagship Plant and
the execution of work under the grant programs.
Looking ahead, we are committed to strengthening our solvency
position through disciplined financial management and strategic
initiatives. This includes optimizing our capital structure, cost
management, and, where appropriate, pursuing cost-saving
measures, alongside continued engagement on funding and
financing initiatives. Our main priority remains the safe
commissioning and start-up of the FDCA Flagship Plant in 2026.
The following table provides an overview of the net cash outflow
during the year, excluding extraordinary cash flows:
in millions of €
2025
2024
EBITDA
(36.1)
(33.3)
Lease payments
(2.8)
(2.4)
Working capital movement 5
7.4
(5.7)
Capital expenditures 6
(20.7)
(58.6)
Net interest costs and commitment fees
from borrowings
(9.8)
(7.6)
Other 7
0.6
1.5
Net cash outflow
(61.4)
(106.1)
Balance Sheet
Total assets increased to €356.2 million in 2025 (2024: €288.6
million), mainly as a result of the investment in the FDCA Flagship
Plant and the capitalization of the borrowing cost. Total equity
increased to €149.6 million (2024: €97.8 million) as a result of the
capital raise in 2025. Total borrowings increased to €118.6 million
(2024: €118.0 million), which relates to the debt modifications that
took place in September 2025 resulting in fair value adjustments to
the borrowings.
Financial lease obligations decreased to €8.5 million (2024:
€10.1 million), mainly reflecting lease agreements for offices, plants,
and laboratory facilities. This decrease is driven by lease terms
ending in 2025, largely related to the FDCA Flagship Plant
construction and amendments to the discount rate used.
Non-current assets increased from €246.3 million in 2024 to
€288.1 million in 2025, primarily as a result of the planned
investment in the construction of the FDCA Flagship Plant and
the capitalization of the borrowing cost.
Alternative Performance Measures
In presenting and discussing Avantium's financial position,
operating results, and net results, management uses certain
alternative performance measures (APMs) not defined by the
International Financial Reporting Standards (IFRS). These APMs
should not be viewed in isolation as alternative to equivalent IFRS
measures but should be used as supplementary information in
conjunction with the most directly comparable IFRS measures.
Since APMs do not have standardized meaning under IFRS, they
may not be not be comparable to similar measures presented by
other companies. Nonetheless, management believes that these
APMs provide useful information to assess the Company's
performance and financial position, both when comparing
reporting periods and when benchmarking against a peer group,
particularly considering the current phase of the Company's
business.
To provide clear reporting on the development of the business,
APM adjustments, which represent material items of income or
expenses, are made. The APMs that are disclosed in this report
are listed in the table. No separate reconciliation is provided for
APMs where the inputs are directly derived from their definitions
combined with the information on the face of the Consolidated
Financial Statements. Otherwise, a reconciliation to the most
directly comparable IFRS measures is provided for APMs that
pertain to historical performance.
Significant judgment is required in using APMs, particularly in
identifying material items in the consolidated income statement
as "APM adjustments."
APM
Definition
EBITDA
The sum of the revenue, other income
and net operating expenses.
APM
Definition
EBITDA of business
segments
The sum of the revenue, other income
and net operating expenses for each
business segment. This excludes
overheads and cost allocations for
shared service activities. Refer to note
23 for a reconciliation to the most
directly comparable IFRS measure.
Capital expenditure
The sum of the cash outflow from
investments in property, plant, and
equipment and investments in
intangible asset, as included in the
consolidated statement of cash flows
Working capital
movement
The movement in working capital as
included in the consolidated statement
of cash flows.
Net cash flow used
in operating,
investing, and
financing activities
This is the sum of the cash flows from
operating activities, cash flows from
investing activities, and cash flows from
financing activities as included in the
consolidated statement of cash flows.
Cost increase FDCA
Flagship Plant
The current expected remaining cash
outflow relating to the FDCA Flagship
Plant, insofar this is higher than the
budgeted cash outflow. This is a
measure of expected future
performance that will be reflected in
cash flows from investing activities in
the consolidated statement of cash
flows in future periods.
APM
Definition
Adjusted equity
total
Calculated as equity attributable to
owners of the parent minus intangible
assets.
Adjusted balance
sheet total
Calculated as total assets minus
intangible assets, participating interest,
receivables from shareholders, and
shares held in the own Company.
Adjusted solvency
Calculated as the Adjusted equity total
divided by the Adjusted balance sheet 
total. Refer to note 3.8  for a
reconciliation to the most directly
comparable IFRS measure.
Net cash outflow
This is the sum of the total EBITDA,
lease payments, working capital
movement, capital expenditure, interest
and commitments fees from borrowings
and other movements which includes
non-cash movements related to share-
based payments.
Investor Relations and Share Performance
Investor Relations
Avantium values its strong relationship with shareholders and the
broader investment community. We set high standards for our
communications strategy to ensure that we provide transparent,
accurate, complete, and relevant information to our shareholders
and investors, thereby helping them to make informed investment
decisions. We are committed to providing accurate and complete
information to all stakeholders simultaneously and in a timely way.
To this end, Avantium regularly updates the markets on its
performance, the progress made on the execution of our
strategy, and any other relevant developments within the
Company.
We do this through press releases, webcasts, conference calls,
and other forms of communication, in compliance with Euronext
Amsterdam and the Dutch Authority for the Financial Markets
(AFM) rules and regulations. Additional details about our investor
engagement approach are available on our website.
Shareholder Engagement
To foster ongoing dialogue with investors, Avantium actively
participates in (virtual) roadshows, investor meetings, capital
markets days, and investor conferences. We accommodate
requests for meetings from the financial community whenever
possible, always adhering to regulatory and confidentiality
requirements. When annual or half-year results are published,
or when major strategic updates occur, our CEO and CFO host
conference calls for equity research analysts to discuss recent
business and financial performance. Transcripts of these calls
are made available on our website immediately after each event.
We also leverage dedicated events to inform both institutional
and retail investors about our business and strategy. Our Bilateral
Contact Policy, outlined in the Corporate Governance section of
our website, stipulates that, where feasible, at least two Avantium
representatives should attend each meeting with shareholders
and investors. Bilateral meetings and analyst calls are not
conducted during “closed periods,” which typically begin one
month before the release of annual or half-year results.
General Meetings of Shareholders
Avantium holds an Annual General Meeting of Shareholders
(AGM) each year, and Extraordinary General Meetings (EGMs) are
convened as needed by the Management Board or Supervisory
Board. At least 42 days prior to an AGM or EGM, the meeting
date, agenda, and supporting documents are published on the
Investor Relations section of our website.
On April 23, 2025, ahead of the AGM on May 14, 2025, Avantium
hosted an online Q&A session for retail investors, providing
insights into strategic direction, recent developments, and
future plans. During the AGM, shareholders approved all agenda
items, including the adoption of the 2024 financial statements.
Tom van Aken was re-appointed to the Management Board,
Margret Kleinsman to the Supervisory Board, and
PricewaterhouseCoopers (PwC) was appointed as the external
auditor for 2025. Shareholders also approved a 1:10 share
consolidation and authorized the Management Board to issue
ordinary shares up to the statutory maximum, with the ability to
limit or exclude pre-emption rights for 18 months from the AGM
date. Further details, including minutes, voting outcomes, and
attendance, are available on our website.
Share Consolidation
As previously mentioned, at the 2025 AGM, shareholders
approved a 1:10 share consolidation along with related
amendments to the Company’s Articles of Association. As a result
of the share consolidation, which became effective on May 22,
2025, 10 ordinary shares (ISIN: NL0012047823) were combined
into one ordinary share (ISIN: NL0015002IE0), the nominal value
per ordinary share changed from €0.10 to €1.00, and the total
number of outstanding shares decreased from 86,960,115 to
8,696,012. Consequently, the share price was multiplied by 10.
The primary aim of this consolidation was to increase the market
value per share. Previously, even small changes in the share
price resulted in significant percentage fluctuations.
Capital Raise
On September 4, 2025, Avantium initiated a fully underwritten
rights offering, and by September 18, 2025, the Company had
successfully raised a total of €84.8 million in equity.
Of this amount, €65.4 million was secured through the rights
offering, resulting in the issuance of 12,103,283 new shares.
The subscription period attracted demand for 14,010,507 shares,
representing an oversubscription rate of 115.6%, with a take-up of
10,536,570 shares, or 87.1%. An additional €19.4 million was
raised through an Additional Placement, which included €15.0
million in new shares allocated to the State of the Netherlands,
represented by the Ministry of Climate Policy and Green Growth.
Cornerstone investors VP Capital N.V. and Ambassador
Vermogensbeheer B.V. received €4.8 million in shares (in
addition to their allocation under the rights offering and the rump
offering), while institutional investors were allocated €4.4 million
in shares at a price of €8.16 per share, corresponding to the last
closing price on September 17, 2025.
Avantium JV2025 Listing and Indices.jpg
Listing and Indices
Avantium shares are listed on Euronext Amsterdam and Euronext
Brussels under the ticker AVTX. The company is included in the
Euronext Amsterdam SmallCap Index (AScX), which features the
25 companies ranked 51–75 by market capitalization.
Share Capital and Voting Rights
As of year-end 2025, Avantium had 25,206,719 issued and
outstanding ordinary shares, each conferring one vote.
Major Shareholders
Under the Dutch Financial Markets Supervision Act, investors
holding 3% or more of Avantium’s capital or voting rights must
disclose this to the AFM, which maintains a public register at
At the end of 2025, the State of the Netherlands was Avantium’s
largest shareholder (approximately 11%), Ambassador
Vermogensbeheer (including former Wierda en Partners
Vermogensbeheer) held around 8%, and Pieter Kooi held 5%.
The Company continues to have a broad base of Dutch and
Belgian retail investors.
Share Price Performance and Liquidity
At the end of 2025, Avantium’s share price was €6.84 (end
of 2024: €12.00, adjusted for share consolidation and 2025
rights issue), with a market capitalization of €172 million
(2024: €157 million). The average daily trading volume in
2025 was 163,668 shares (2024: 46,987).
2025_Avantium Shareprice_01.svg
1. 19 March 2025: Publication of 2024 Full Year Results
2. 4 September 2025: Publication of 2025 Half Year Results
3. 4 September 2025: Launch of rights offering
4. 18 September 2025: Completion of €84.8 million equity raise
Analyst Recommendations
Avantium is currently covered by six equity research analysts.
Their target prices and recommendations on December 31, 2025
were as follows:
Bank
Target Price
Recommendation
ABN AMRO – Oddo BHF
€9.20
Outperform
Berenberg
€17.00
Buy
Degroof Petercam
€14.00
Buy
ING
€95.70
Buy
Kepler Cheuvreux
€13.50
Hold
STIFEL
€49.00
Buy
Dividend Policy
Over the next period, Avantium intends to retain any profits,
to support the growth and development of its business.
Therefore, the Company does not anticipate paying dividends
to its shareholders in the foreseeable future.
Avantium JV2025 Going Concern_01.jpg
Going Concern
The financial statements have been prepared on a
going concern basis.
As Avantium continues to transition from a company focused on
technology development to an operational company, the focus is
on the start-up of the FDCA Flagship Plant and the subsequent
entry into the operational and commercial stage. The net cash
inflow for the year ended December 31, 2025 amounted to
€33.6 million (2024: net cash outflow of € 11.3 million).
Avantium’s cash position (including restricted cash of €1.6 million)
was €57.5 million as at December 31, 2025 (December 31, 2024:
€23.9 million). During 2025, Avantium's cash position increased
primarily due to the successful equity raise completed in the
summer of 2025. In June, Avantium secured €10.0  million in
short‑term financing from the Province of Groningen and its
senior lender consortium. In August, the Company agreed an
amended and extended Debt Financing Facilities with its lenders.
In September, Avantium completed an €84.8 million equity raise,
supported by a €15.0 million investment from the State of the
Netherlands. Together with cost controls and a Company
reorganization impacting approximately 40 positions, this capital
strengthened Avantium’s financial position. The cash outflow for
the year was mainly driven by operating expenses, capital
expenditure relating to the FDCA Flagship Plant, and interest
payments.
Until the Company reaches EBITDA break-even, it will depend
on external sources of funding. In this respect, the following
elements are fundamental to its continuity:
Successful completion of commissioning, start-up, and start of
commercial production at the FDCA Flagship Plant as of
mid-2026;
Compliance with conditions and undertakings under the
existing Debt Financing Facilities;
Achievement of FDCA Flagship Plant product sales income
and milestone payments from license agreement engagements
in the second half of 2026;
Securing additional funding from a government-related
investment initiative;
The satisfactory conclusion of the ongoing discussions with
Worley concerning the close‑out of the construction phase of
the FDCA Flagship Plant; and
Successful execution of strategic options for the non-core
technology assets and related cost management.
Avantium JV2025 Going Concern_02.jpg
Overview of the Uncertainties
Successful completion of commissioning, start-up, and start
of commercial production at the FDCA Flagship Plant as of
mid-2026
The successful start-up of the FDCA Flagship Plant and the start
of commercial production are key milestones for the Company
and a prerequisite for its licensing strategy, underpinning
expected future profitability and cash flows. Once commercial
operations have commenced, Avantium Renewable Polymers will
be able to produce FDCA from the FDCA Flagship Plant that can
be converted into PEF and supplied to its customers under
existing offtake agreements. This will result in the Company
starting to generate revenues from the FDCA Flagship Plant.
Avantium completed construction of its FDCA Flagship Plant in
October 2024 and subsequently commenced phased
commissioning and start-up. The commissioning and start-up
phase is inherently complex and subject to technical, operational
and safety-related uncertainties. In such a phase, unforeseen
events may occur that can result in additional capital expenditure
and operating expenditure, including as a result of technical
defects, rework, or delays.
During commissioning, construction-related quality issues were
identified in certain titanium welds, representing a safety risk for
start-up and operations. In the second half of 2025, further expert
assessment identified that the percentage of affected welds was
higher than initially assessed. These issues delayed the overall
start-up schedule. The Company now expects to complete start-
up by mid-2026 and to commence product sales under existing
offtake agreements in the second half of 2026.
Any delay in commencing commercial product sales will extend
the period without product sales income and may delay
milestone payments from technology license agreement
engagements, as well as potentially impacting compliance with
conditions and undertakings under the existing Debt Financing
Facilities.
Compliance with conditions and undertakings under the
existing Debt Financing Facilities
The Company’s Debt Financing Facilities contain conditions,
including milestone-related undertakings linked to achieving
the Production Operation Date, the sale of technology licenses
based on proven technology following the achievement of the
Production Operation Date, minimum liquidity requirements,
and conditions related to additional offtake agreements to cover
the ramp-up of the FDCA Flagship Plant. Meeting these
conditions within the required timeframes depends on the
successful and timely commissioning, start-up, and ramp-up of the
FDCA Flagship Plant.
Certain conditions and undertakings under the Debt Financing
Facilities are operational in nature and may be subject to
interpretation, including those related to insurance coverage,
minimum cash balances and offtake agreements.
Failure to comply with such conditions and undertakings,
including technical or administrative non-compliance, may
constitute a breach under the Debt Financing Facilities.
If any such breaches are not remedied or waived, the lenders
may be entitled to exercise remedies under the Debt Financing
Facilities, which could include acceleration of repayment,
requests for payment of waiver fees, impact on interest or other
enforcement actions. Any such actions would have a material
adverse effect on the Company’s liquidity position.
With respect to compliance with the conditions and undertakings
under the existing Debt Financing Facilities, the Company
acknowledges that, as at December 31, 2025, a technical breach
existed under an insurance related covenant, as further
described in Note 17 to the Consolidated Financial Statements.
This breach resulted from the continued commissioning phase of
the FDCA Flagship Plant and the fact that the transition from
construction all-risk insurance to operational insurance could not
yet be completed within the originally prescribed timeframe.
Achievement of FDCA Flagship Plant product sales income and
milestone payments from technology license agreement
engagements in the second half of 2026
Following the start-up of the FDCA Flagship Plant, the Company’s
short- and mid-term liquidity will be primarily driven by revenues
from product sales under offtake agreements, as well as the
successful and timely execution of YXY® Technology license
agreements and related milestone payments.
The Company’s offtake agreements are generally conditional in
nature and subject to conditions precedent, including the timely
achievement of joint development milestone dates, regulatory
approvals, and the FDCA Flagship Plant's subsequent production
timelines and deadlines. Changes to the anticipated start-up or
ramp-up timeline of the FDCA Flagship Plant may require
amendments to existing offtake agreements. There is a risk that
negotiations on updated timelines or milestones may take longer
than anticipated or fail to reach acceptable terms, which could
lead to delayed, reduced, or lost product sales income.
In certain cases, offtake counterparties may elect to suspend or
terminate agreements if conditions precedent are not met.
Similarly, the timing and amount of license income depend on the
successful negotiation and execution of technology license
agreements and the subsequent achievement of contractual
milestones, upon which a portion of these milestone payments
are anticipated. The successful execution of technology license
agreements is linked to the start-up and initial ramp-up of the
FDCA Flagship Plant and subsequent commencement of
commercial product sales and is furthermore influenced by
factors largely outside the Company’s control, including
counterparties’ investment decisions, financing capabilities and
project planning. Any delays or deviations in license execution or
milestone achievement may result in a mismatch between the
Company’s expected cash inflows and its ongoing operational,
financing and investing requirements during the going concern
period.
Securing additional funding from a government-related
investment initiative
The Company is pursuing additional funding of approximately
€20 million from a government-related investment initiative,
which may take the form of a subsidy, grant, (convertible)
subordinated loan, or equity-type investment. The availability,
timing, form, and amount of this funding are subject to
governmental decision-making processes, procedural
requirements, and approvals outside the Company’s control and
may be subject to unanticipated conditions.
There is a risk that this funding is delayed, approved on terms or
in an amount different from those anticipated, or not approved
at all. In such events, the Company may not have sufficient cash
resources to meet its obligations as they fall due. and the
Company’s ability to continue as a going concern for at least
15 months as of the date of these financial statements is, in part,
dependent on securing this funding, particularly in the event of
delays in the startup or ramp-up of the FDCA Flagship Plant or
delays in the receipt of anticipated near-term milestone payments
under technology license agreements.
Should the Company not secure the anticipated funding from
the government-related investment initiative (in whole or in part),
it would need to consider alternative financing arrangements
or implement mitigating measures, including cost reductions or
the deferral of planned activities; however, the availability or
sufficiency of such measures cannot be guaranteed to ensure
the Company’s ability to continue as a going concern.
The satisfactory conclusion of the ongoing discussions with
Worley concerning the close‑out of the construction phase of
the FDCA Flagship Plant
The Company is engaged in ongoing discussions regarding the
close-out of the engineering and construction phase of the FDCA
Flagship Plant, including the finalization of the determination of
responsibility for outstanding cost overruns, as well as other
matters relating to the period prior to completion and handover
to Avantium Renewable Polymers B.V. There is a risk that these
close-out discussions do not result in an outcome aligned with
the Company’s expectations, in which case the Company may be
required to settle outstanding amounts or pay amounts withheld
as recorded in the trade payables. Any such settlement could
result in a cash outflow and adversely affect the Company’s
liquidity position.
Successful execution of strategic options for the non-core
technology assets and related cost management
As part of its strategy to focus financial and operational resources
on its core activities, the Renewable Polymers business, the
Company is exploring strategic options for certain non-core
assets and technologies, including divestments, partnerships
or other value-creation structures. The successful completion
of these strategic options is subject to market conditions,
counterparty interest, conditions and undertakings under the
Debt Financing Facilities, and external approvals, including
regulatory, and other factors, many of which are outside the
Company’s control.
There is a risk that these processes take longer than anticipated,
resulting in continued operating costs associated with non-core
activities. There is also a risk that such transactions are not
completed at all, which may require the Company to repay
subsidies or grants previously received, decommission and
dismantle related assets, and to shelve, abandon, or otherwise
cease actively maintaining the associated intellectual property or
to implement additional restructuring measures.
All of the above events indicate the existence of a material
uncertainty that may cast significant doubt on Avantium’s ability to
continue as a going concern and, therefore, that it may be unable
to realize its assets and discharge its liabilities in the normal
course of business.
Avantium JV2025 Going Concern_03.jpg
Overview of the Planned Measures
Successful completion of commissioning, start-up, and start of
commercial production at the FDCA Flagship Plant as of
mid-2026
In response to the risks and uncertainties associated with the
commissioning and start-up of the FDCA Flagship Plant,
management has implemented a series of mitigating measures.
A structured and phased commissioning and start-up program is
being executed to enable a safe, controlled transition from
construction to commercial operations, with activities sequenced
to prioritize critical systems and limit operational and safety risks.
Following the identification of a higher than initially assessed
percentage of defective titanium welds, a targeted remediation
program was initiated, including enhanced quality controls,
specialist third-party expertise, and increased independent expert
inspection and testing. Repair activities are closely coordinated
with commissioning, including parallel execution where
technically feasible, to mitigate schedule impact.
Operational governance and oversight have been strengthened
during the commissioning and start-up phase, including increased
management attention, frequent progress reviews, and escalation
mechanisms. A Chief Operating Officer (COO) has been
appointed, with sole responsibility for and full focus on the
commissioning, start-up, and ramp-up of the FDCA Flagship Plant,
bringing dedicated operational leadership and experience
relevant to first-of-a-kind plant start-up activities, and
strengthening coordination across engineering, operations,
safety, and external contractors.
In parallel, management continues to closely monitors capital and
operating expenditures during commissioning and ramp-up, with
a focus on preserving liquidity and aligning cash outflows with
available funding. Discretionary expenditure is deferred where
possible until stable operations can be achieved. Updated
schedules and contingency plans are maintained to reflect
commissioning progress and remaining risks, and are used to
inform liquidity planning and management decision-making
during the going concern assessment period.
Compliance with conditions and undertakings under the
existing Debt Financing Facilities
To mitigate the risk of non-compliance with the conditions and
undertakings under the Debt Financing Facilities, the Company
has implemented, and continues to enhance, a set of integrated
monitoring, planning, and communication measures.
Conditions and undertakings, including those related to the
Production Operations Date, offtake coverage, liquidity
thresholds, minimum cash balances, insurance coverage, and
other operational milestones, are embedded in operational
planning, commissioning timelines, and ramp-up scenarios for the
FDCA Flagship Plant. Compliance is closely monitored through
regular internal reviews and reporting, supported by close
coordination across operations, finance, and legal and treasury
functions to ensure that operational developments,
commissioning progress and commercial arrangements are
promptly reflected in compliance assessments.
To address the technical breach under the insurance covenant,
and to align the insurance-related condition with the revised
project timeline, the Company engaged in December 2025 with
its lenders and requested a deferral of the applicable deadline.
Subsequent to year-end, the lenders agreed to extend the timing
for delivery of the relevant insurance documentation, subject to
conditions relating to approval from relevant stakeholders and
the confirmation and extension of construction-phase insurance
coverage, including the provision of independent expert
confirmation on the timing of the transition to operational
insurance, all of which points the Company is currently
addressing.
The Company maintains an active dialogue with its lenders and
provides periodic compliance reporting in accordance with the
Debt Financing Facilities. The frequency of lender meetings has
been increased to ensure timely and transparent updates on
commissioning progress, operational developments, liquidity
and covenant compliance. Management is further strengthening
the timeliness, structure, and consistency of covenant-related
communications, including early identification and discussion of
potential non-compliance, and, where appropriate, engagement
on remedial actions, waivers, deferrals, or amendments.
Liquidity is closely managed through rolling cash-flow forecasts
and scenario analyses, which are regularly updated to reflect
anticipated ramp-up cash outflows and covenant thresholds, and
are used to inform contingency planning and timely management
decision-making during the going concern assessment period.
Achievement of FDCA Flagship Plant product sales income and
milestone payments from technology license agreement
engagements in the second half of 2026
To support the generation of product sales from the FDCA
Flagship Plant and the receipt of milestone payments under
technology license agreements, the Company has implemented
and continues to enhance a set of commercial and operational
measures. The licensing strategy is closely linked to the
successful commissioning and operation of the FDCA Flagship
Plant as a reference installation for the YXY® Technology,
with management prioritizing the demonstration of stable
and reproducible plant performance as a key prerequisite for
license execution and related milestone payments.
The Company has strengthened its commercial and licensing
capabilities through the expansion and professionalization of the
commercial organization, including dedicated resources for
license negotiations, technical-commercial interactions and
coordination with technology development, engineering, and
operations. In parallel, the Company actively manages a
diversified pipeline of potential licensees across end markets and
geographies, prioritized by technical readiness, strategic fit, and
financing capacity, with the objective of progressing multiple
opportunities in parallel and reducing the reliance on any single
transaction. A significant pool of potential licensing opportunities
has been identified, with over 20 near-term prospects and active
discussions underway with more than 10 potential licensees.
While these discussions are at various stages of maturity, no
resulting binding license agreements have been concluded to
date.
Management is pursuing a phased approach to licensing,
including early-stage agreements, option structures, and capacity
reservation arrangements, enabling counterparties to commit
progressively as operational proof points are achieved. In this
context, the Company is actively securing capacity reservation
agreements to demonstrate market demand for FDCA and PEF
across multiple applications, markets, and geographies. Total
capacity reservations now exceed 100 kilotonnes.
In parallel, the Company remains actively engaged with existing
and prospective offtake partners during the commissioning and
ramp-up phase. Where necessary, offtake agreements are
amended to reflect revised timelines and operational milestones,
subject to agreement with counterparties. Offtake agreements
entered into up to now broadly align with the projected ramp-up
plan for the FDCA Flagship Plant, and the Company is negotiating
additional offtake agreements beyond current management
expectations. Management continues to prioritize transparent
communication and relationship management with customers and
partners to support initial product sales as operations stabilize,
manage expectations during ramp-up, and preserve long-term
commercial relationships to help underpin future product sales
and licensing opportunities.
Securing additional funding from a government-related
investment initiative
The Company has submitted its formal application under this
investment initiative to pursue the additional funding of
approximately €20 million. As part of the customary
governmental procedures, the funding may be accompanied by
certain ancillary requirements, potentially including elements of
shared financial participation. The Company is actively engaged
in ongoing discussions with all stakeholders who have a role in
the decision-making process and governance of the government-
related investment fund, with the aim of gaining further insight
into the fund’s conditions and communicating the Company's
strategic objectives and outcomes that could be supported.
There can be no assurance that this funding will be obtained in
full, on acceptable terms, or within the anticipated timeframe. The
Company continues to explore further measures to improve its
working capital position and create additional liquidity headroom,
although no assurance can be given that such measures will
be successfully implemented.
The satisfactory conclusion of the ongoing discussions with
Worley concerning the close‑out of the construction phase of
the FDCA Flagship Plant
The parties are in active discussion on the close-out topics.
These discussions also encompass construction-related quality
issues identified during commissioning, including titanium
welding, and the related cost impacts and delays.
Successful execution of strategic options for the non-core
technology assets and related cost management
Management continues to assess strategic options for its non-
core technology assets and exercises close oversight of all
related expenditures, including costs associated with non-core
activities and overheads such as staffing and leases. These
actions are intended to reduce ongoing cash outflows and overall
cash burn, thereby supporting the Company’s YXY® Technology
cash flow by allowing management to focus financial and
operational resources on its core Renewable Polymers business.
These measures are not expected to result in material cash
proceeds, but rather to contribute through improved cost
discipline and cash preservation, while capturing potential future
value through its minority shareholdings.
The Company is engaged in advanced discussions with several
third-party investors and industry participants regarding potential
transactions, which may include full or partial divestitures,
the establishment of strategic partnerships, joint-venture
arrangements, or other value-creation structures. The structure,
valuation and timing of any such transactions remain subject to
negotiation, definitive documentation, approvals, and customary
closing conditions.
With respect to Volta Technology, which has been successfully
demonstrated at laboratory scale and in larger container units,
the Company is engaging with strategic and financial partners to
support further scale-up toward pilot plant-development and
eventual commercialization. For Dawn Technology®, the
Company has initiated discussions with partners capable of
providing the requisite capital and expertise to advance the
technology. As a result of increasing market interest in bio-based
polymers and related building blocks, the Company aims to
pursue a spin-out of the Parana Technology, with Avantium
retaining a minority shareholding in the new entity.
The R&D Solutions business unit continues to operate as a
stand-alone entity while strategic alternatives are evaluated.
Should any of these plans not materialize, the Company may
need to consider additional measures, which could include
organizational and cost-reduction initiatives.
Conclusion
In light of all of the above, management has assessed the going
concern assumption, which is the basis on which Avantium’s
Consolidated Financial Statements for the year ended December
31, 2025 have been prepared. The described events indicate the
existence of a material uncertainty that may cast significant doubt
on Avantium’s ability to continue as a going concern and,
therefore, that it may be unable to realize its assets and discharge
its liabilities in the normal course of business.
Based on management’s analyses and assessments, although
this material uncertainty remains with respect to the Company’s
going concern, management believes that it is appropriate to
prepare Avantium’s Consolidated Financial Statements for the
year ended December 31, 2025 using the going concern
assumption.
Sustainability Statement
Avantium JV2025 Double Materiality Assessment.jpg
General Disclosures
As a renewable chemistry company, we consider
sustainability to be a fundamental part of our DNA
and the driving force behind all we do. Avantium’s
aim is to develop and commercialize products and
technologies that accelerate the de-fossilization
of the chemical industry, drive the transition to
a circular economy, and generate long-term,
sustainable value for all our stakeholders.
We also recognize that our work to achieve this
creates further impacts, both positive and negative,
that it is also our responsibility to manage.
As part of our approach to managing material sustainability
topics, we are committed to reporting transparently about our
environmental, social, and governance (ESG) performance.
We have prepared this 2025 Sustainability Statement, including
Supplementary Information, voluntarily and without external
assurance. In doing so, the Company intends to limit the
administrative requirements and financial implications associated
with externally assured reporting. Elements of this statement have
been prepared with reference to the European Sustainability
Reporting Standards (ESRS).
Double Materiality Assessment
To determine the scope of our sustainability focus and ensure
we address the areas that matter most to Avantium’s business
and stakeholders (see page 18 for details of our stakeholder
groups), we carried out a new materiality assessment in 2024
and 2025.
This was our first in-depth materiality assessment since 2022
and our first to be guided by the requirements of the Corporate
Sustainability Reporting Directive (CSRD). Accordingly, we used
the principle of double materiality to identify and prioritize
Avantium’s material sustainability topics: considering both
our impacts on the world around us and financial risks and
opportunities for our business (impacts, risks, and opportunities,
or IROs)
IRO long-list
IRO short-list
ESRS mapping
Financial
materiality
check
Validation
and final
approval
Avantium JV2025 DMA process_02.jpg
Process
We established a Core Stakeholders Team, made up of Avantium
employees representing various teams and stakeholder groups,
to guide the double materiality assessment (DMA) process, which
included the following steps:
IRO long-list: We carried out a comprehensive desk study,
using more than 20 internal and third-party sources, in order to
compile a long-list of hundreds of potential IROs. The Core
Stakeholder Team validated the completeness of the list.
IRO short-list: Subject-matter experts assessed each IRO
based on criteria such as likelihood, scope, scale, irremediable
character, time horizon, and value chain location. IROs were
scored on a scale of zero to nine; in practice, none scored less
than three. The Management Team participated in a workshop
to determine the materiality threshold, concluding that IROs
scoring five or higher should be considered material for
Avantium. This resulted in a short-list of 93 IROs.
ESRS mapping: We mapped these IROs against the ESRS
sub‑topics and sub‑sub‑topics. This analysis revealed several
ESRS areas linked to only a small number of IROs with relatively
low scores, which were therefore considered less significant.
The Core Stakeholder Team then further assessed these
sub‑topics for relevance and materiality. The resulting short-list
of 19 ESRS (sub‑)sub‑topics was presented to Avantium’s
Management Team for discussion and formal approval, and
subsequently served as the basis for external stakeholder
consultation.
Financial materiality check: We compared the short-list of
ESRS topics with Avantium’s risk register, identifying ten that
were also financially material and included in the risk register.
Validation and final approval: We validated the 19 short-list
topics with selected external stakeholders, an external
consultant and the Core Stakeholder Team. The Management
Team then approved the final list, after which the approach of
implementation was defined.
Results and Implementation
A total of 19 topics across the value chain were deemed material.
ESRS Sub-topics
Weighed
IRO score
First priority – focus 2025-2026
Circular Economy: Outflows
106
Climate Change: Mitigation
82
Circular Economy: Inflows
78
Own Workforce: Health and Safety
78
Circular Economy: Waste
63
Second priority – revisit during materiality
assessment in 2027
Own Workforce: Training and Development
35
Pollution: Pollution of Water
33
Climate Change: Adaptation
31
Climate Change: Energy
26
Water: Water Consumption
22
Third priority – on hold until after the
materiality assessment 2027
Biodiversity: Land, Fresh Water and See-use
Change
20
Biodiversity: Direct Exploitation
18
Own Workforce: Diversity
15
Business Conduct: Management of
Relationships with Suppliers
13
Consumers and End-users: Health and Safety
10
Non-ESRS: IP and Data Security
10
Own Workforce: Work-life Balance
9
Pollution: microplastics
7
Own workforce: Adequate wages
6
We will take a phased approach to Avantium’s reporting on
these topics, using a weighted score to determine priorities and
timelines. In 2026 and 2027, we will focus on the five highest-
priority topics, which together address 61% of the weighted score
of the material IROs. We plan to conduct a new DMA in 2027 to
reconfirm these.  For more details on the outcomes of the DMA,
please see the Supplementary Information (page 193).
Avantium JV2025 Sustainability Strategy.jpg
Sustainability Strategy
The outcomes of our Materiality Assessment contributed
to the update of our sustainability strategy, which had guided
Avantium’s ESG approach since 2020. This was also
an opportunity to take into account the significant changes that
have taken place in the past five years, both within Avantium
and in our operating environment.
We launched our new sustainability strategy in early 2026,
and will use it as focus for our sustainability efforts. Our vision –
a fossil-free chemical industry by 2050 – remains unchanged.
The first priority ESRS topics as determined by the Double
Materiality Assessment form bases for the new strategy. As a result
of in-depth discussions at the Management Team some additional
second and third priority topics from the DMA were included.
The majority of these can be closely mapped to the goals of
our previous sustainability strategy, Chain Reaction 2030.
You can find more details about our transition to these new
priorities and goals in the sections about ESG performance.
We have now added an additional layer to the strategy.
Building on our vision of a fossil‑free chemical industry by 2050,
we have defined four strategic categories: Climate Change,
Circularity, Own Workforce and Business Conduct. For each
category, we highlight key focus areas and set mid‑term goals
that are further translated into annual targets and KPIs by the
responsible business units. The Management Team steers the
implementation of this strategy and ESG targets remain part of 
Avantium's Remunerations Policy.
Our updated sustainability strategy remains fully integrated with,
and inseparable from, our corporate strategy and business
model. For further details, see "Making an Impact through Our
Integrated Strategy.
Industry-wide emissions reduction
by deploying our technology
Emissions intensity of our own
FDCA Flagship Plant
  Climate
Change 
Circularity
Circularity of PEF
Sustainable feedstock
Valorization of waste/ by-products
of our technology
Why
We believe
in a fossil-
free world.
Let's go
Advocacy for a circular and fossil-
free chemical industry
Consumer health and safety
Health and safety of our own
operations
Development of human capital
Business
  Conduct
    Own
Workforce
8 https://cefic.org/policy/climate/
Environmental
Reaching net zero carbon emissions by 2050 demands significant
transformation across the chemical sector and beyond.
The European Commission has set an ambitious target 8 of
reducing net GHG emissions by 90% by 2040, pushing the
chemical industry to prioritize enhanced resource efficiency,
circularity, and low-carbon energy.
Still, carbon remains central to many chemical processes and products, making access to
alternative carbon sources essential for progress. Broader change is also needed in how
we use and dispose of plastic products to reduce consumption and waste. At Avantium,
we view our commitments to circularity and efficient production as deliberate steps toward
this net-zero future.
Avantium Energy.svg
Avantium Material topics_Hazardous Materials Management_red.svg
Energy
in MWh
Hazardous waste
in Ton
Non-hazardous waste
in Ton
12764
125
53
Scope 1 emissions
in tCO2 e
Scope 2 emissions
in tCO2 e
Scope 3 emissions
in tCO2 e
544
2985
3060
Material Topics Addressed
Avantium Material topics_Environmental Impact_red.svg
Climate Change Mitigation
Circular Products
Sustainable Feedstocks
Waste Valorization
ESRS
ESRS E1: Climate Change
ESRS E5: Resource Use and Circular Economy
GRI Standards
GRI 102: Climate Change 2025
GRI 103: Energy 2025
GRI 305: Emissions 2016
GRI 306: Waste
SDG Targets
SDG07.svg
SDG-icon-ENG-09.svg
SDG-icon-ENG-11.svg
Avantium's ambition is to be a driving force in achieving an
efficient, sustainable chemical industry. Through our
technologies, we strive to deliver significant CO2 savings,
either by increasing production efficiency or by developing novel
materials with a lower environmental impact than fossil-based
incumbents. We are also mindful for our own emissions.
This commitment is reflected in both our previous and our new
sustainability strategy.
Previous
Sustainability Strategy
New
Sustainability Strategy
Deliver CO2 savings across
the chemical industry
→ Industry-wide emissions
reduction by deploying our
technology
Reduce carbon emissions from
own operations
→ Emissions intensity of our
own FDCA Flagship Plant
Policies and procedures for our environmental impacts include
strict instructions for monitoring, checking, discussing and
reporting our energy consumption and emissions, waste and
other KPIs.
Central to our pursuit of industry-wide emissions reduction by
deploying our technology is the initiation of our licensing strategy
for YXY® Technology. We expect that the launch of industrial-
scale FDCA facilities (more than 100 kilotonnes) will lead to
significant CO2 savings across the industry, as demonstrated in
the findings of our life-cycle assessments (LCAs). The effective
CO2 savings can be assessed based on the scale, ramp-up, and
operation of each licensee, including its supply chain.
Industry-Wide Emissions Reduction by
Deploying Our Technology
OUR GOAL
By 2030, we will optimize the FDCA process to improve
yield by 10% and reduce energy requirements by 5%
Each licensee will benefit from the optimization of the FDCA
production process, which will ultimately lead to less carbon-
intensive products, helping to mitigate the negative climate
change impacts.
We validate the CO2 reduction potential of our technologies
through third-party, peer-reviewed, and ISO-certified LCAs.
We regularly update these LCAs to take into account
improvements to our technologies and use them to track our
progress toward our key sustainability ambitions. For more
information on our work around recycling, see the Advocacy
section (page 61).
In 2024, the sustainability performance of PEF was confirmed by
a LCA conducted by nova‑Institute, an independent research
institute specialized in the bio‑based and CO₂‑based economy.
The LCA focused on the use of PEF in 500 ml bottle applications
and compared its environmental footprint with that of
conventional PET bottles. The assessment concluded that
replacing fossil‑based carbon in PET with 100% renewable carbon
in PEF results in a 73% reduction in greenhouse gas (GHG)
emissions over the full life cycle of a 500 ml bottle. In addition,
emissions released during the incineration of bio‑based PEF
bottles are compensated by the CO₂ uptake during the growth of
renewable feedstocks, ensuring that no net additional CO₂ is
released to the atmosphere. The LCA further showed that only a
PET bottle containing approximately 85% recycled content would
achieve a carbon footprint comparable to that of a PEF bottle.
In 2025, Avantium updated this LCA, with the results expected to
be published in 2026.
Avantium JV2025 Emissions Intensity.jpg
Industry CO2 savings can only occur and be measured once our
licensees begin operations at their commercial plants.
The start-up and stable operation of our own FDCA Flagship Plant
in Delfzijl is a crucial next step toward commercialization.
Although construction challenges in the titanium welds have
delayed the process, approximately half of the FDCA Flagship
Plant was commissioned and started-up in 2025, including our
sugar dehydration unit, which converts sugar into MMF, a key
ingredient for FDCA. We now expect to complete start-up of our
full FDCA Flagship Plant in mid-2026, with sales of product
anticipated to start in the second half of 2026. With the scalability
of our technology proven, Avantium will be well-positioned to
attract more licensees, increasing PEF production and delivering
much-needed CO2 savings across the industry.
As we work to commercialize PEF and deliver significant
downstream emissions reductions for the chemical industry,
we must balance the demands of growth with our responsibility
to minimize GHG emissions from our own operations.
Emissions Intensity of Our Own
FDCA Flagship Plant
OUR GOAL
By 2030, we will improve the emissions intensity of our
FDCA Flagship Plant by 25% compared to start-up
The start-up of our FDCA Flagship Plant in Delfzijl means that our
overall emissions will rise year-on-year as we ramp up production.
We have therefore shifted our focus from decreasing net
emissions to reducing emissions intensity per kilo of FDCA
produced and set the goal, starting from the moment when our
FDCA Flagship Plant will become fully operational.
In pursuing this goal, we are limited by the small scale of our
FDCA Flagship Plant. We expect to use 2026 as the base year
and start measuring progress thereafter. Nevertheless, we take
steps to improve the process efficiency and reduce emissions
where possible.
We track our progress against this goal by assessing our Scope 1,
Scope 2, and Scope 3 emissions in line with the GHG Protocol.
We have reported on our Scope 1 and Scope 2 emissions for
several years; last year, we reported on our Scope 3 emissions
for the first time, using a spend-based method across five
categories: capital goods, business travel, purchased goods and
services, upstream transportation, and waste management.
Our total Scope 1 and Scope 2 emissions in 2025 were more than
10 times higher than in 2024. The primary reason for this increase
is the commissioning and start-up of our FDCA Flagship Plant in
Delfzijl. Other emissions from our own operations remained low
and in line with previous years.
In 2026, we expect our emissions to rise again  following the
completion of the start‑up of the FDCA Flagship Plant.
Thereafter, we aim to optimize the process and stabilize energy
consumption, supporting progress toward our emissions‑intensity
goal.
For more information about the methodology and scope of the
reported energy and emissions, please see the Supplementary
Information section (page 188).
While we continue to pursue performance improvements for PEF,
we also recognize the areas in which we can enhance circularity.
In both our previous and our new sustainability strategies we
have identified areas of focus.
Previous
Sustainability Strategy
New
Sustainability Strategy
Ensure that our plant-based
feedstock comes from
sustainable sources
→ Sustainable feedstock
Become a circular business
→ Circularity of PEF
Send zero non-hazardous
waste to incineration and
landfill
→ Valorization of waste/
by-products of our technology
Avantium currently relies on first‑generation plant‑based
feedstocks, until second‑ and third‑generation (2G and 3G)
alternatives become available. Transitioning to these advanced
feedstocks will further enhance the circularity of PEF.
In 2022, we developed and launched our Sustainable Supplier
Code, which is based on the conventions of the International
Labour Organization (ILO) and the Ethical Trading Initiative, and
on the principles of the Sustainable Agriculture Initiative Platform.
The scope and ambition of this Code reflect Avantium's
commitment to sourcing raw materials and feedstocks in
compliance with international best practices on sustainability and
responsible sourcing.
In particular, the Sustainable Supplier Code sets out the following:
Compliance with national and international laws and
regulations: following regulations; conducting operations with
honesty, integrity, and openness; respecting and following
business integrity laws; and accurately recording all business
transactions with Avantium.
Respect for human rights and labor standards: adhering to ILO
Convention 138 and 182 regarding child labor and ILO
Convention 29 and 105 regarding forced labor; providing at
least a "living wage;" not tolerating discrimination, harassment,
or bullying; respecting the right to form and join trade unions or
collective bargaining; providing adequate employment
contracts; and ensuring relevant training for employees.
A safe working environment: providing relevant safety
instructions, training, and equipment; providing employees with
access to safe drinking water; and assessing health and safety
risks.
Environmental responsibility: ensuring that all necessary
environmental permits are in place; becoming more circular;
and optimizing resource use, including by minimizing impacts
on biodiversity.
Managing bio-based feedstock: not using banned agrochemicals;
registering used agrochemicals; minimizing any adverse effects
on soil fertility, water, and air quality, and biodiversity from
agricultural activities; providing clear traceability of seed origins;
and making positive contributions where possible.
As a company that develops and commercializes technologies to
mitigate climate change, Avantium's main contribution to
circularity is through safe and sustainable design. PEF offers
excellent durability and performance that already facilitates more
efficient material production. For instance, its high gas barrier
offers a 10x better oxygen barrier and 15x better CO2 barrier than
PET, extending shelf life and unlocking mono-material packaging
solutions for our partners.
In a truly circular system, waste and by-products can be fed back
into the production process to maintain efficient and sustainable
operations. We therefore recognize our responsibility to find
valorization technologies for waste and by-products from PEF
production.
Sustainable Feedstock
OUR GOAL
Ensure that feedstock partners for the FDCA Flagship Plant
comply with Avantium’s Sustainable Supplier Code
By 2030, we will demonstrate the process for producing
intermediate chemical (RMF) from second generation
feedstock technologies such as our Dawn Technology® into
FDCA/PEF at pilot scale
Our business model is built on replacing fossil‑based materials
with plant‑based feedstocks to create products with strong
competitive and sustainable performance. Because our input
materials are, by definition, bio‑based and renewable, it is
essential that our suppliers adhere to strict sustainability
principles.
We therefore require our suppliers to agree to the Sustainable
Supplier Code, either through the General Terms and Conditions
as part of our Purchasing Procedure or as explicit agreements in
case of our feedstock suppliers. In 2025, we continued to
engage with two key feedstock suppliers for our YXY®
Technology: India Glycols and Tereos. Both of these "Tier 1"
suppliers have accepted the requirements of our Sustainable
Supplier Code. In the coming years, we aim to begin auditing our
suppliers to verify compliance with the Code.
During the year, we continued to work on strengthening the
pipeline for sustainable feedstocks. In addition to focusing on our
suppliers, we are exploring second‑generation feedstock
technologies, such as our own Dawn Technology®, as future
feedstock sources for our YXY® Technology. These
second‑generation feedstocks differ from first‑generation sugars
because they are derived from residual, non‑food materials rather
than food crops.
Avantium JV2025 Circularity of PEF.jpg
Our Dawn Technology® for instance is now fully focused on
textile waste recycling, converting cotton from textile waste into
the sugars required for, amongst others, FDCA and PEF
production, while preserving the polyester for true fiber-to-fiber
recycling. We are seeking strategic options for our Dawn
Technology® business line, since these developments not only
support increased uptake of sustainable FDCA feedstocks but
also offer a potential solution to the circularity crisis within textiles,
as industry estimates show that less than 1% of all textile waste in
2025 was successfully recycled back into textiles.
Circularity of PEF
OUR GOAL
By 2030, we will ensure that PEF recycling is an accepted
end-of life option in our key markets
By 2030, we will set up a closed loop recycling stream
project for PEF
Avantium takes responsibility for finding sustainable end-of-life
solutions for our materials. As our business focus remains on
commercializing PEF, increasing its recyclability is a cornerstone
of our circularity strategy.
As a polyester, PEF is highly suitable for recycling and circular
packaging solutions, as assessed by multiple independent
organizations. We continuously seek partnerships and
agreements with recycling authorities around the world to
validate the inclusion of PEF within both PET production and
recycling streams.
A 2022 evaluation by PTI Europe Sàrl, conducted in accordance
with the European PET Bottle Platform (EPBP) protocol,
determined the effect of multilayer PET bottles containing 10%
PEF on the PET recycling stream. The results showed that PET/
PEF multilayer bottles have no negative impact on haze and other
properties of the resulting recycled PET products at a market
penetration of 5%, even taking into account potential local
accumulation. Based on this, the EPBP awarded an interim
endorsement to the Company's PEF resin.
Avantium was also granted Critical Guidance Recognition from
the US-based international non-profit APR in 2023, validating
multilayer PET/PEF bottles' compatibility with standard PET
recycling practices and the lack of impact on the physical
properties of the recycled PET.
We secured two landmark recycling confirmations in 2025: first,
from RecyClass, a non-profit, cross-industry European initiative
focusing on promoting the recyclability, traceability, and use of
recycled content in plastics. In June, RecyClass validated
Avantium's PET/PEF multilayer bottle, containing 10% PEF releaf®
RP90N, as fully compatible within the PET recycling stream.
This validation confirms PEF as a more sustainable alternative to
nylon in the production of multilayer PET bottles for enhancing
barrier performance. It also enables our partners to adopt PEF
into PET packaging with confidence, while complying with
Extended Producer Responsibility (EPR) regulations. The second
key approval Avantium received in 2025 was from the Japanese
Council for PET Bottle Recycling. This approval officially validated
multilayer PET bottles containing up to 10% PEF as suitable for
use in Japan's PET bottle recycling system.
In combination with FDCA's inclusion on Japan's "Positive List"
for food-contact plastics, this approval sets the stage for PEF's
adoption within Japan's beverage packaging market.
Avantium JV2025 interview MARCO.jpg
Valorization of Waste/By-products of
our Technology
OUR GOAL
By 2030, we will valorize at least 20% of annual SDH
Flagship Plant waste (humins in ML)
According to the European Environment Agency in 2022
approximately 5 tons of waste per capita were generated in
Europe. Only 40.8% of this waste was recycled. While it is
impossible to completely avoid waste in the manufacturing
process, we are actively pursuing waste valorization methods for
all our key technologies, with a primary focus on FDCA
production at our FDCA Flagship Plant.
2025 saw the sugar dehydration (SDH) unit come online at our
FDCA Flagship plant, enabling the conversion of plant sugars into
methoxymethyl furfural (MMF), an FDCA intermediate.
The successful start-up of the SDH unit was an important
milestone in the phased commissioning of the FDCA Flagship
Plant, as it enables the commercial production of FDCA at a
multi-kilotonne scale. As the process scales up we expect to see
increase in availability of by-products that can be subject to
possible valorization.
Waste and by-product utilization technologies are already in
place for our Volta Technology. By combining the glycolic acid
produced by our Volta Technology with lactic acid, we can
make PLGA, a carbon-neutral, recyclable, home-compostable,
and marine-biodegradable polymer with valuable barrier and
mechanical properties. PLGA is therefore a more sustainable and
cost-effective alternative to fossil-based polymers.
With the phased start-up of the FDCA Flagship Plant operations
we started monitoring different waste streams and continued the
same for other locations of Avantium. In 2025, we observed a
reduction in hazardous waste at our Amsterdam Zekeringstraat
location, largely due to improved awareness on sustainability and
to scaling down laboratory activities following the deprioritization
of Ray Technology® development.
At the same time, hazardous waste volumes at our Geleen site
increased compared to 2024, though they remained similar to
2023. These fluctuations can be explained by variations in the
technology development programs.
We provide more information about the methodology and scope
of the reported waste in the Supplementary Information section
(page 190).
Speak_Icon.png
"After establishing a robust data‑collection framework
in recent years, we now use integrated dashboards
to monitor our energy consumption, emissions
and waste. These insights enhance our data quality
and help us identify opportunities to further reduce
our environmental footprint."
Marco Houben
Pilot Plant Manager and member of the               
Chain Reaction 2030 team
9 CEFIC: People - cefic
Social
Employing just over 1.2 million people, the chemical sector represents around
0.8% of the total EU workforce, highlighting its importance within the
European economy. 9 A sustainable chemical industry relies on a strong and
capable workforce, and ongoing labor shortages make attracting skilled talent
for specialized and technical roles essential for both current operations and
long‑term resilience. Safety also remains a core priority, with a continuously
improving safety culture that protects employees and consumers alike.
Employees
Nationalities
Students engaged
since 2020
274
29
56153
% women overall
% women in leadership
positions
% women in non-
leadership positions
26%
52%
23%
Avantium operates in a highly innovative field where the
Material Topics Addressed
Health and Safety of our Operations
Diversity and Inclusion
Next Generation of Scientists
ESRS
ESRS S1: Own Workforce
GRI Standards
GRI 401: Employment 2016
GRI 403: Occupational Health and Safety 2018
GRI 404: Training and Education 2016
GRI 405: Diversity and Equal Opportunity 2016
SDG Targets
SDG03.svg
SDG04.svg
SDG08.svg
knowledge and dedication of our people are essential.
We greatly value our employees and recognize the central
role they play in our success – now and in the future. Ensuring
a safe and healthy working environment is our highest priority;
we know that investing in the development of our human capital
is an investment in long‑term growth and resilience.
Our strategy for Own Workforce includes two focus points:
development of human capital and health and safety for people
working in our own operations.
This has been addressed in both our previous and our new
sustainability strategies.
Previous Sustainability
Strategy
New Sustainability Strategy
Mobilize our colleagues and the
next generation of scientists to
help solve the climate's most
pressing problems.
→ Development of human
capital
Minimize the impact of
occupational accidents and
work-related health conditions.
→ Health and safety in our
own operations
At Avantium, we respect and encourage different talents and
perspectives (one of our Core Values). We are also committed to
providing equal opportunities to our staff, our contractors, and
agents of and applicants to the Company. We do not discriminate
on the basis of age, gender, race, disability, faith, beliefs, or
sexual orientation. Avantium aims to ensure that employees are
selected, trained, compensated, promoted, or transferred solely
based on abilities, qualifications, and merit. Our overall approach
The policy outlines our targets, including on gender diversity,
and commits us to maintaining a diverse and multinational
workforce and ensuring equal pay for equal work.
At Avantium, we believe that renewable chemistry is not just
essential but exciting. We aim to use our position as a leader in
the field to inspire the next generation of chemists, helping to
build a pipeline of motivated, creative, and talented people who
are keen to make a difference in the chemical industry.
Our approach starts with raising awareness among young people
– including consumers as well as the chemists of tomorrow –
about the need to transition away from a fossil-based, linear
economy toward a sustainable, circular future.
Our Core Values
1
We make a lasting impact
We think big. We understand our customers through
and through. We improve the world around us.
We drive – and thrive on – change. We have an impact
on the environmental footprint of the wider industry.
2
We are determined team players
We embrace challenges. We value complementary
talents and diverse perspectives. We actively engage
with partners. We work in teams to solve problems.
We go the extra mile to deliver results.
3
We do the right things right
We behave ethically. We make bold choices. We take
responsibility for our actions. We operate safely.
4
We are pragmatic idealists
We always find a way. We think outside the box,
but never lose sight of reality. We keep our feet on the
ground. We always sail towards our destination,
adjusting course when necessary.
5
We have fun (and the rest of the world is a little bit
weird)
We appreciate unconventional solutions. We celebrate
success and learn from setbacks. We view things with a
positive eye and an open mind.
We maintain strict policies and management systems of
Occupational Health and Safety (OHS), ensuring that all
onboarding, training, and work practices are properly followed.
Procedures, risk assessments, and monitoring activities are
continuously updated and enforced. Hazardous materials are
managed under stringent guidelines, and our safety policy is
grounded in the Hierarchy of Control, with our first priority being
to eliminate hazardous materials whenever possible.
Avantium’s 274 people work together in service of a common
goal: making a lasting positive impact on people and the planet
by accelerating the transition away from fossil resources.
To maximize this impact, we work hard to attract and retain
talented employees and to foster working environments where
everyone feels that they belong, are able to develop themselves,
and can contribute to our success.
The year 2025 was challenging due to the financial pressures
Avantium faced. As a consequence, Avantium imposed a hiring
freeze and a freeze on non‑essential spending, including learning
and development. To further strengthen our financial position and
manage costs responsibly, we conducted a broad review of our
expenditures. As part of this process, we made the difficult
decision to reorganize the Company and reduce labor costs.
Overall, approximately 40 positions were lapsed, across all
business units and departments but particularly in R&D.
This reflects our transition from a R&D focused company to a
commercial and manufacturing company. We adhered to all
relevant legal requirements and provided support to departing
colleagues via Avantium’s social plan, created in 2024 with the
involvement of our Works Council (“Ondernemingsraad”; see
below).
We recognize the significant impact – both practical and
emotional – of this reorganization, first and foremost on the
people directly affected, but also on their colleagues and on
our organization as a whole. Ensuring the mental well-being of
our people is a key priority at Avantium, and in stressful times,
it is more important than ever that we support people’s health.
Our line managers are trained on managing sick leave,
strengthening resilience, dealing with employment-related
legislative and compliance issues, and having difficult
conversations with employees.
We also aim to promote well-being by encouraging engagement
and a strong community feeling, so everyone is supported to
perform at their best and motivated to drive our success.
This starts with transparent communication, one of our Great
Place to Work (GPtW) focus areas. During this year year, we
aimed to communicate clearly and regularly with our workforce,
being as open as possible about key developments and
challenges. With social activities limited by cost constraints in
2025, revitalizing our community engagement program –
also a GPtW focus – will be one of our top priorities in 2026.
Meanwhile, our Company Values emphasize creating a vibrant
and safe environment for colleagues at all stages of their working
life. We therefore have several initiatives in place to facilitate a
healthy work-life balance for employees, including care leave and
parental leave policies.
Finally, our measures to prevent and address unacceptable
workplace behavior – including bullying, harassment, and
discrimination – also contribute to employee well-being.
Anyone who witnesses or experiences issues like these can
contact one of our Confidants, who act as confidential advisors
and guide employees through Avantium’s complaints procedure.
We also have a robust Speak-Up Policy (whistleblower policy),
which outlines the whistleblowing process and guides employees
in reporting irregularities.
Works Council
Avantium’s Works Council (Ondernemingsraad) continued to
represent employee interests through regular consultations with
management and engagement across business units and sites.
In 2025, the Council issued advice on strategic financing
measures to support the Company’s plans and provided input on
the Company’s reorganization program, emphasizing fair
procedures, transparency, and employee well‑being.
The Works Council also refreshed its internal regulations to
further strengthen governance and election processes, and
maintained dialogue on safety, vitality and policy updates –
building on the 2024 focus areas such as the Speak‑up Policy,
the Preventive Medical Examination, and updates to the
Employee Handbook. Through these activities, the Works
Council aims to contribute constructively to Avantium’s
sustainable growth and to a safe, inclusive workplace.
Performance Management
At Avantium, we are committed to ensuring that all our people
have the opportunity to reach their full potential. In consultation
with their line manager, all employees set annual goals related
both to Avantium’s strategic priorities and to self-development
targets. Progress toward these goals is then monitored in regular
meetings during the year.
Training and Development
While we were not able to make as much progress on our
Avantium Academy learning and development platform as hoped,
employees were able to access the GoodHabitz platform
throughout 2025 and numerous other trainings, completing a
total of 32,986 training hours: an average of 120.4 hours per
employee. This is a significant increase compared to previous
years, a change that can be explained by the start-up of our
FDCA Flagship Plant, which required us to provide extensive
onboarding and training to ensure safe and efficient work.
Avantium JV2025 Development of Human Capital.jpg
We aim to resume work on the Avantium Academy in 2026, as
well as restarting our monthly lunch lecture series. In addition to
serving as tool for social dialogue these sessions highlight certain
teams or projects, helping to foster internal communication,
providing a platform for engagement, and increasing
understanding and appreciation of people's contribution to our
common mission.
At the end of the year, we kicked off a new mentoring program,
matching up 14 pairs of volunteer mentors and mentees within our
Company. The goal is to enable learning and exchange on a
wide range of topics, such as leadership, presentation, or IT skills.
If the three-month pilot is successful, we aim to expand this
initiative to other interested colleagues, fostering valuable
connections and enabling peer-to-peer development.
Development of Human Capital
OUR GOAL
Drive inclusivity initiatives to ensure year-on-year progress
in diversity in line with Avantium's Diversity, Equality and
Inclusion Policy
As part of our commitment to providing equal opportunities, we
take steps to prevent unconscious bias in our people processes.
This includes supplying all line managers with briefing documents
to guide them on avoiding unconscious bias during the annual
performance review cycle. To avoid bias in our recruitment
processes, meanwhile, interviewers use standardized recruitment
scorecards to evaluate candidates on their suitability for the
vacancy. The hiring team then compares these scorecards to
identify the strongest candidate.
In 2025, Avantium was home to people of 29 different
nationalities. The decrease in the total number of employees this
year also resulted in a decrease in the number of nationalities
represented, while the share of employees with non-Dutch
nationality remained the same as last year: 24%.
Home to people
of different
nationalities
29
Avantium JV2025 interview nienke.jpg
Our target for men and women each to represent at least one-
third of our Supervisory Board and Management Team was
reached in 2025, as we had 40% women in the Supervisory
Board and 38% women in the Management Team. 
We also aim for a 2% increase in the number of women across
our overall workforce and in leadership positions each year.
In 2025 we saw no change in the overall workforce: the
representation of women remained at 26%. However, more than
half (52%) of leadership positions were taken by women as of
December 31, 2025, which is a steep increase from 2024 (39%).
When hiring for Management Team positions, we pay particular
attention to including women on the long- and short-lists.
The women-to-men salary ratio for non-Management Team
members was 103.34%. This was also an increase compared to
2024's figure of 100.16% .
We provide more metrics about the employment and diversity in
the Supplementary Information section (page 191).
We were unable to hold a GPtW survey in 2025. We also did not
meet our June deadline for implementing all of the improvement
actions based on the 2024 survey due to the financial challenges
the Company faced.
Nevertheless, we addressed some of the focus areas identified in
the previous survey, particularly those with strong links to work-
life balance and flexible working. We introduced two additional
holidays and a new Working from Abroad Policy that gives
people the chance to work from their home country for four
weeks per year. This joins our well-established Working from
Home Policy, which supports an effective and flexible mix of in-
person collaboration and individual focus time, with the added
benefits of cutting down commuting hours (and emissions) and
promoting well-being through a healthier work-life balance.
We will revisit our review of secondary benefits – which include a
Mobility Plan and bike scheme – in 2026.
OUR GOAL
By 2030, we will engage at least 100,000 students
In 2024, we created a digital chemistry lesson for elementary
schools across the Netherlands in collaboration with C3
classroom experiment using simple everyday materials, this off-
the-shelf lesson enables children to explore the principle of
transforming one object into another, thanks to their similar basic
building blocks. In 2025 this lesson was used in classrooms all
over The Netherlands and reached 8775 children.
As well as once again hosting a Girls Day at our Zekeringstraat
office in Amsterdam, Avantium participated in 2025's annual
Weekend of Science. We also organized another masterclass for
pre-university students about sustainable plastics in collaboration
with Bètapartners.
One of the PhD candidates conducting research at Avantium,
Nienke Leenders, was selected as a finalist for the 2025
Amsterdam Science Innovation Awards for her work on recycling
polycotton waste textiles. Her research forms part of a broader
programme led by Prof. Gert‑Jan Gruter, Avantium’s Chief
Technology Officer and head of the Industrial Sustainable
Chemistry group at the UvA’s Van ’t Hoff Institute for Molecular
Sciences (HIMS).
In total, we have engaged 56153 students since setting ourselves
this goal in 2020.
Health and Safety in Our Own Operations
OUR GOAL
Obtain and maintain ISO 45001 (Health and safety)
certification for the FDCA Flagship Plant
Speak_Icon.png
"I was delighted that the jury’s experts recognize the
potential of our technology to valorize polycotton
waste textiles, and I was truly honored to stand
alongside such pioneering innovators at the
Amsterdam Science Innovation Awards (AMSIA)
2025."
Nienke Leenders,
PhD Candidate at Avantium
Avantium has been able to achieve certification for ISO 14001
(Environmental Management), ISO 45001 (Occupational Health &
Safety Management) and ISO 9001 (Quality Management) for the
production of intermediate chemicals used in the production of
FDCA at its FDCA Flagship Plant in Delfzijl. Many Avantium
colleagues were involved in the audit process, which found only
a handful of minor non-conformities that we will focus on
addressing in 2026.
Avantium JV2025 interview nanda.jpg
Avantium’s FDCA Flagship Plant is subject to the Seveso
Directive (Directive 2012/18/EU). Although the plant is still in its
start‑up phase we must meet all obligations. In 2025, Avantium’s
FDCA Flagship Plant was audited by inspectors from the Safety
Region, the Netherlands Labor Inspectorate, and the Groningen
Environmental Service, and a total of seven minor non-
conformities were reported. The local team is dedicated to
solving these non-conformities and improving the implemented
safety management system.
We also conducted a comprehensive Risk Assessment (RI&E) of
Hazardous Substances across our laboratories at Zekeringstraat
and Science Park. This initiative, led by occupational hygiene
specialists, aimed to evaluate exposure risks, reinforce safety
practices, and ensure regulatory compliance throughout the
organization.
We reviewed the used chemicals and prioritized higher-risk
experiments, with a focus on safe chemical handling, exposure
pathways, and the effectiveness of control measures.
This resulted in a list of improvement actions, including
continuous exposure monitoring, regular updates to safety
procedures, and a sustained commitment to maintaining high
standards of occupational health and safety.
This assessment emphasizes Avantium’s dedication to
maintaining a safe working environment and proactively
managing chemical risk.
QHSE responsibilities were reviewed and clearly (re)structured
across sites, with site managers and local QHSE teams working
closely together. Monthly QHSE community meetings and regular
QHSE manager sessions strengthened knowledge sharing,
alignment, and continuous improvement.
To help prevent accidents and incidents, we begin every
Avantium team meeting with a safety update, giving colleagues
the chance to share cases that provide important learnings.
We follow Golden Safety Rules and other safety protocols,
including mandatory trainings before people can access
operational areas, and provide a comprehensive OHS reading list
to all new joiners. Every three years, a certified OHS service
provider assesses our workplaces and identifies any risks to
mental or physical health.
We encourage all employees to report any situation they
consider unsafe. The QHSE department then discusses and
classifies the report, following up where necessary. We publish a
company-wide safety scorecard monthly.
A recordable process safety incident was reported involving a
solvent bottle that broke in the laboratory and caused a spill.
The incident was handled in full accordance with our safety
procedures. It reinforces the need for ongoing vigilance and
strong process safety management. We saw an increase in small
safety incidents (133 in 2025 compared to 109 in 2024) and near
misses (123 in 2025 compared to 62 in 2024). 12 First Aid cases
were recorded and luckily none of them resulted in medical
treatment cases or serious injuries.
To address broader health and well-being concerns beyond our
manufacturing sites and labs, we provide guidance on ergonomic
best practices, offer voluntary medical assessments, and are
supported by an OHS provider in matters of employee health,
illness, and absence. We also recognize the potential effects of
workplace stress on mental health and well-being.
The overall sick leave rate in 2025 was 6.25%, slightly below the
6.52% recorded in 2024. We view this as a positive outcome
given the challenging circumstances our employees faced during
the year. At the same time, we remain committed to further
reducing absence levels, with a particular focus on prevention
and addressing potential sources of stress.
We provide more information about safety reporting in the
Supplementary Information section (page 190).
"Achieving our ISO Certification confirms for us
that quality isn't a coincidence, but the result of
dedication, collaboration, and continuous
improvement. Our journey has been intensive,
educational, and ultimately rewarded with recognition
that motivates us to live quality as a habit every day."
Speak_Icon.png
Nanda Weitering
QA Manager
Governance
At its core, Avantium is a renewable chemistry company dedicated to
leading the transition from fossil-based to renewable plastics and materials
by using sustainable feedstock.
We therefore recognize our duty not only to strive for sustainable business practices in
our own operations, but also to encourage others across the chemical industry and beyond
to follow our example, to protect our intellectual property, and to ensure that we meet all
relevant compliance requirements. At the same time, it is important to ensure that our materials –
in particular FDCA and PEF – are safe and valid for use in different applications.
Compliance requirements are an integral part in our product journey.
Avantium Publication_icon.svg
Scientific
publications
Articles
18
671
Interviews
28
Material Topics Addressed
Avantium Material topics_03_Stakeholder Engagement.svg
Partnerships and Stakeholder Engagement
Advocacy
Consumers Health and Safety
Icon_dataa protection_MvB_01.svg
IP and Data Management
ESRS
ESRS G1: Business Conduct
ESRS S4: Customers and End-users
GRI Standards
GRI 416: Customer Health and Safety 2016
SDG Targets
SDG-icon-ENG-12.svg
SDG13.svg
SDG-icon-ENG-17.svg
In all our partnerships, we adhere to the responsible business
principles set out in our Code of Business Conduct.
This document includes norms on labor and human rights,
ethics, bribery, fraud, corruption, transparency, governance,
and accountability.
In the coming years, our focus will include ensuring the
responsible application of our products by prioritizing customer
health and safety, and actively advocating for circular and
fossil‑free chemistry.
Previous Sustainability
Strategy
New Sustainability
Strategy
Be the leading advocate
for circular and fossil-free
chemical industry
→ Advocacy for a circular and
fossil-free chemical industry
→ Consumer health and safety
Our advocacy focuses on several key strategies aimed at
advancing technologies for circular and renewable plastics,
removing barriers that hinder their adoption in industry, and
promoting more responsible business practices through policy
developments at both national and EU levels.
We do this firstly by building engagement and educating the
public on the impact of climate change caused by using fossil
feedstock in the chemical industry, in particular for the production
of plastics. We use our voice to advocate for change in the
chemical industry via events, media, blogs, and digital platforms.
We also work closely with stakeholders across the plastic value
chain to fundamentally change the plastic materials industry and
empower our partners to shift to renewable and circular solutions.
Finally, we work with governments and industry associations to
help inform the debate around the material transition and help
shape climate policy through positive lobbying.
Advocacy was an integral part of the sustainability agenda laid
out in our previous sustainability strategy and will continue to play
a key role going forward. We are now also focusing on customer
health and safety to ensure full compliance with the regulatory
requirements for our plant-based and circular polymer material
PEF, branded as releaf®.
While much of the media attention on Avantium in 2025 centered
on the financial challenges the Company faced, significant
coverage was also given to the September equity raise and the
participation of the Dutch State, represented by the Ministry of
Climate Policy & Green Growth. In parallel, we received
substantial media attention for our textile waste recycling
technology, particularly following its publication in Nature
Communications, which highlighted Avantium’s innovative
contribution to advancing circular materials solutions.
Avantium was featured in more than 671 articles and 28
interviews during the year, as well as participating in and
speaking at over 40 conferences and publishing 18 peer-
reviewed papers. We use these opportunities to share our work,
objectives, and motivation with different audiences and to
advocate for a circular, bio-based economy.
Partnerships and Stakeholder Engagement
Avantium secured a number of new corporate partnerships in
2025 to accelerate progress toward our strategic goals.
Some notable milestones included signing a collaboration
agreement with EPC Engineering & Technologies to
commercialize continuous PEF polyester production, targeting
plant capacities larger than 100 kilotonnes. We also signed
notable commercial agreements with leading market players
including Amcor Rigid Packaging and Auping Mattresses, as well
as a Memorandum of Understanding with Tereos and LVMH GAÏA
to collaborate to accelerate industrial-scale production of PEF,
branded as releaf®, in Europe. For more information on our
business partnerships this year, refer to page 25 of the
Performance by Business Area 2025 section.
We believe that continuous stakeholder engagement, in which
we embrace open dialogue and knowledge-sharing, is important
in an innovation-driven industry and helps us to identify areas for
improvement. We communicate with our stakeholders through
various channels and at a variety of levels. Our methods of
engagement vary depending on the stakeholder, the key issues
at hand, and the purpose of engagement. The following table
provides an overview of our main stakeholder groups, the ways
we communicate with them, and the topics most relevant to them.
See more information on how we create value together with our
stakeholder in the How We Create Value section (page 18)
Stakeholder
Form and Frequency of Dialogue
Topics Discussed
Effect of Dialogue on Avantium
Employees
Social intranet (Embrace)
Company meetings with all employees (every two months or when
appropriate)
Leadership Team meetings (every two months or when appropriate)
Business unit town hall meetings (every two months or when
appropriate)
Performance reviews (twice a year)
Training and development programs (when appropriate)
Works Council (at least every two months or when appropriate)
Onboarding program for new employees (when appropriate)
Monthly lunch lectures and interviews
Strategy
Business highlights and performance
Health and safety
HR-related topics, including vitality
Diversity and inclusion
Training and development
Peer-to-peer learning
Career path and development opportunities
ESG topics (when relevant)
Through continuous and open dialogue, we aim to help our
employees embrace our values and fully understand our
strategy and mission. We celebrate our successes and openly
share our challenges and setbacks, fostering transparency,
engagement, and effective communication. We believe that
employee engagement is fundamental to Avantium’s success,
which is built on the commitment, ambition, and expertise of our
people.
(Prospective)
Partners and
Customers
Business meetings and site visits, joint (research and development)
projects, and business development (when appropriate)
Phone and video calls, email exchanges, and virtual tours by
commercial or technical teams (daily)
Conferences, symposia, and special events (when appropriate)
Technologies, lead products, and services
Business development and innovation
Customer support and quality
Technology licenses
ESG targets (e.g., circular business models,
carbon footprint)
Close collaboration with strong partners and customers across
the entire value chain is central to Avantium’s strategy and to our
commercialization and licensing roadmap. We work with
organizations that share our values and our commitment to
creating a better world for future generations. These
partnerships enable us to develop innovative solutions that
deliver meaningful circular and renewable benefits for
customers and other stakeholders.
Shareholders
Direct interaction with Investor Relations, CEO, or CFO in (video and
audio) calls, email exchanges, and site visits (regularly)
Annual General Meeting (annually)
Extraordinary General Meeting (when appropriate)
Capital Markets Day (Technology & Markets Day/Retail Investors Day)
(annually or when appropriate)
Annual or half-year results presentation and press release (bi-annually)
Investor conferences and roadshows (when appropriate)
Strategy, business activities, and performance
Financial results
Funding options
Commercial and operational progress
Company roadmap and technology portfolio
Lead products and end-market
ESG performance and specific ESG-related
topics
Board composition and remuneration
We aim to support current shareholders, potential investors, and
financial analysts in understanding the long‑term investment
opportunities Avantium offers. In our dialogue with shareholders,
we transparently discuss our strategy and business model,
financial performance and outlook, and funding approach and
opportunities, as well as the risks associated with our operations
and the renewable and circular solutions we bring to market.
Stakeholder
Form and Frequency of Dialogue
Topics Discussed
Effect of Dialogue on Avantium
Financial Partners
Direct interaction with consortium of lenders and grant providers in
calls, email exchanges, and virtual meetings (regularly and when
appropriate)
Strategy, business activities, and performance
Financial results
Funding options
Commercial and operational progress
Risks and opportunities
ESG performance and specific ESG-related
topics
Our financial partners – including a consortium of lenders such
as ABN AMRO Bank, ASN Bank, ING Bank, Rabobank, and the
Dutch government‑backed impact fund Invest‑NL, as well as
loan providers like the Province of Groningen and Fonds
Nieuwe Doen, and various subsidy providers – are vital
stakeholders for Avantium. They expect us to effectively
implement our strategy and the projects linked to it. In our
dialogue with these partners, we discuss our strategy and
business model, financial performance and outlook, funding
approach, commercial and operational progress, and the
associated risks and opportunities.
Suppliers and
Contractors
Direct interaction via supplier account teams/procurement in calls,
email exchanges, and virtual meetings (daily)
Site visits at Avantium and/or at the supplier’s office (when
appropriate)
Communications regarding specific interactions, setting up purchase
orders, discussing details of the General Terms and Conditions (as
relevant)
Engagement regarding ESG norms and agreeing with the Avantium
Sustainable Supplier Code (when relevant)
Products and technology
Innovation
Supply chain of renewable feedstock
Supplier performance and risk management
Health and safety
Compliance
Human rights and labor standards
Environmental topics, including biodiversity
IP / information security
Business continuity
We rely heavily on our supplier network, as our suppliers and
contractors are essential partners in the efficient and seamless
scale‑up of our technologies and in meeting our commitments to
customers. We are committed to maintaining a responsible and
sustainable supply chain, as outlined in our Sustainable Supplier
Code.
Stakeholder
Form and Frequency of Dialogue
Topics Discussed
Effect of Dialogue on Avantium
Governments and
authorities
(Pro)Active dialogue with government, regulators, and authorities and
municipalities (when appropriate)
Safety and compliance reporting (when appropriate)
Reporting on diversity, energy efficiency, commuting, and other ESG-
related topics (when appropriate)
Our technologies and lead products
Strengthening innovation in the industry and
society where we operate
Funding
Policies and Regulations
Compliance
Safety
Permitting
Avantium engages in open and constructive dialogue with
relevant government bodies and authorities. We hold regular
meetings with national, regional, and local governments to
discuss our activities, opportunities, and challenges, as well as
new or adjusted regulations related to circular and bio-based
plastic material targets. These interactions aim to strengthen our
license to operate, foster an environment that supports
investment and development, and mitigate regulatory and
political risks. European, Dutch, and local governments also play
a vital role in funding Avantium, making our continued
collaboration with them essential to supporting our innovation
and long‑term growth.
Society
Industry associations
Member conferences, regular meetings, and round tables of relevant
industry associations (when appropriate)
Community, universities, media, NGOs, and others
www.avantium.com (continuously)
Avantium's social media channels (continuously/when appropriate)
Press releases, interviews, and engagement calls/meetings (when
appropriate)
Collaboration with University of Amsterdam (continuously)
Community engagement programs (when appropriate)
Company visits (when appropriate)
Trainings and networks (when appropriate)
Our technologies and lead products
Strengthening innovation in the industry and
society where we operate
Compliance
Circular economy
Community engagement
Our people
Exciting the next generation about renewable
chemistry
Local developments
ESG related topics
We align our business strategy and sustainability ambitions with
the needs of the wider society beyond our direct value chain.
We also actively engage with students at schools and
universities, sharing our expertise and inspiring the next
generation to pursue circular and renewable chemistry.
Meanwhile, we continued to engage with different players on
the climate crisis and the urgent need to de-fossilize the
chemical industry. This forms an important part of our stakeholder
engagement activities. In 2025, we continued to participate
in associations such as Renewable Carbon Initiative, MVO
Nederland, European BioPlastics (EUPB), Industry Table Northern
Netherlands, the Royal Association of the Dutch Chemical
Industry (VNCI), European Chemical Industry Council (CEFIC),
and the Bio-based Industries Consortium (BIC).
We also work closely with other companies in various grant
consortia, such as PEFerence, which aims to replace a significant
share of fossil-based polyesters with 100% plant-based PEF.
The consortium's members include Carlsberg Group, LVMH,
Henkel, LEGO, and Nestlé Waters. The EU‑funded Horizon 2020
PEFerence project officially concluded in early 2026, marked by
a final review meeting at Avantium’s FDCA Flagship Plant in
Delfzijl. Over its duration, the project delivered significant
milestones for the bio-based plastics sector, including the
opening of the world’s first commercial‑scale FDCA Flagship
Plant, the establishment of an integrated value chain from
renewable feedstocks to end‑use products, and the successful
validation of FDCA and PEF applications such as bottles, films,
packaging, adhesives and specialty materials. The project also
achieved food‑contact approvals in the EU, US, and Japan,
confirmed PEF recyclability within existing PET streams, and
demonstrated strong market traction with over 20 offtake
agreements. Robust LCA results further underlined the
greenhouse gas‑reduction potential of PEF compared with
conventional materials. Beyond its technical deliverables,
PEFerence supported EU climate and bioeconomy objectives,
advanced circularity, and helped build the capabilities needed to
scale a new generation of circular and renewable plastics.
The project’s success lays a strong foundation for the
commercialization of FDCA and PEF.
In 2025, we received a €200,000 Horizon Europe grant to join
CERISEA, a 12-partner consortium led by Michelin Engineered
Polymers. The consortium's goal is to design, build, and operate
an HMF Flagship Plant, enabling large-scale production of 5-HMF
(hydroxymethylfurfural), a key bio-based chemical. As part of the
consortium, Avantium will help to evaluate potential synergies
between the planned HMF plant and Avantium’s FDCA Flagship
Plant, including future feedstock integration.
Advocate For a Circular and Fossil-Free
Chemical Industry
OUR GOAL
Advocate for legislative incentives of using bio-based
material
Advocate for the inclusion of innovative bio-based materials
within circular economy legislation frameworks
Our advocacy includes engaging with governments and
authorities to help shape climate policy and plastic regulations
(such as CEA, ESPR, or PPWR). We do this as Avantium and as
part of industry organizations, as partners in grant consortia, and
through engagements with like-minded partners.
A notable example of our positive lobbying occurred on
November 11, 2025, when we welcomed the European
Commissioner for Environment, Water Resilience, and a
Competitive Circular Economy to our FDCA pilot plant in Geleen.
The visit focused on the European bioeconomy and how
innovative technologies can contribute to the continent's green
transition. European Commissioner Jessika Roswall was
accompanied by Dutch State Secretary Thierry Aartsen and was
given an in-depth introduction to our FDCA and PEF technology.
The visit contributed to informing the European Commission as it
prepared its updated Bioeconomy Strategy, which was formally
adopted on November 27, 2025. For more information on this
strategy and its relevance to the chemical industry,
see section The World Around Us (page 16).
Avantium earned recognition from the Dutch government in
2025. When granting Avantium €15 million during our September
equity raise, the Ministry of Climate Policy and Green Growth
justified the investment by highlighting our importance in driving
innovation and retaining knowledge within the Netherlands.
The Ministry also noted that Avantium serves as a key signal for
the investment climate, helping to attract business activity and
foreign investments. For more information on Avantium's
importance to the European chemical sector and the emerging
bioeconomy, see The World Around Us section (page 16).
Consumer Health and Safety
OUR GOAL
Ensure that products from the FDCA Flagship Plant meet
all regulatory requirements for their intended applications
(e.g., fibers, packaging), including compliance with
consumer health and safety standards
Growing regulatory acceptance of PEF in food packaging reflects
a broader industry shift toward more sustainable materials.
The EU, MERCOSUR, and the USA have already authorized
FDCA and PEF for various food‑contact uses, although certain
restrictions remain in place in the US, such as exclusions for
high‑alcohol products and infant formula packaging.
In 2025, Japan introduced its "Positive List" for food‑contact
materials, officially permitting PEF by listing FDCA as an essential
monomer within the polyester category (polymers primarily
composed of ester bonds). China is also reviewing regulatory
updates to allow PEF as a food‑contact resin, recognizing its
strong performance and excellent gas‑barrier properties.
Avantium JV2025 Customer Health and Safety.jpg
These regulatory developments underline a growing global
commitment to safe and sustainable food‑packaging solutions.
Avantium’s Integrated Chemical Compliance and Safety (ICCS)
team ensures that our products meet regulatory requirements
worldwide, manages product registrations, communicates hazard
information, and supports stakeholders across applications
beyond food contact. Over the past year, the ICCS team focused
on building flexible, region‑specific compliance strategies,
particularly for Asian markets, while streamlining dossier
preparation to simplify product registrations and import
processes. These efforts help make PEF more accessible to
customers globally.
Focusing on FDCA production at Avantium’s FDCA Flagship Plant,
the ICCS team updated the FDCA chemical registration
to meet the European Chemicals Agency's compliance‑check
requirements and ensured that the REACH (Registration,
Evaluation, Authorization and Restriction of Chemicals) dossier
contains all necessary documentation. Avantium also initiated
studies into the properties and toxicity of Humins in the ML side
stream: an emerging material with promising potential across
various applications.
Intellectual Property and Data Management
Effective intellectual property (IP) management is essential
to Avantium's success as a developer of innovative, sustainable
materials and technologies. Our goal is to remain at the forefront
of our field by continuously developing our technologies and
ensuring we stay ahead of competitors. Where possible, we secure
protection of these developments.
Business Unit
Current Number of Patent
Familes2 (Incl. Newly Filed
Applications)
New Patent Applications in
2025 3
Patents Granted in Europe
(EPO) or the USA in 20253
Inventions Reported in
20254
Avantium Renewable
Polymers
74
5
3
4
Avantium R&D Solutions
12
1
0
10
Volta Technology
39
2
2
3
Dawn Technology 1
15
1
1
7
Parana Technology 1
18
3
3
1
Ray Technology
19
0
0
0
Corporate Technology
2
0
0
0
Total
179
12
9
25
1.Patents and patent applications on Parana and use of Dawn for waste polycotton textiles were reported previously as part of Corporate Technology.
2.A patent family is a collection of several national and/or regional patents and/or patent applications covering the same invention.
3.A patent application is a request pending at a patent office for the grant of a patent for an invention. Once the patent application complies with the laws of
the country or region concerned, a patent may be granted for the invention.
4.Reported inventions may mature into a publication or patent application or may be kept as a trade secret.
We also regularly and critically review our existing patent portfolio
to ensure that the associated costs remain justified. Our IP
strategy is closely aligned with our technology strategy, enabling
us to capture business opportunities effectively and to support
Avantium’s long‑term growth.
Avantium's data and data management systems are vital assets
for our Company. We therefore aim to uphold a secure
information technology (IT) infrastructure and cybersecurity
practices that evolve in line with emerging threats.
To protect our IT infrastructure, we conduct ongoing assessments
with a particular focus on cybersecurity. Our IT team is partway
through implementing an IT security and governance framework
based on the Center for Internet Security (CIS) Critical Security
Controls. As part of this process, we are developing a complete
set of updated and modernized IT policies, aligned with industry
standards and the NIS2 directive.
Avantium continues to face daily cyberattacks, primarily via email.
The majority of these attempts are automatically mitigated by the
Company’s email protection systems, which are actively
maintained and regularly updated. Most user‑reported suspicious
messages turn out to be internal phishing‑awareness tests,
demonstrating that end‑user training is effective and that
employees remain alert.
Occasionally, endpoint protection software blocks risky user
actions, generating alerts that are handled promptly.
Importantly, no successful or impactful cyberattacks were
identified in 2025, indicating that the layered security controls in
place are functioning as intended.
We recorded 3 IT security incidents in 2025:
Lost iPhone
A company‑issued iPhone was reported lost.
A remote wipe command was issued
immediately. Because the device is
protected with full encryption and requires
user authentication, no additional action is
needed at this time.
Lost Laptop
A laptop was also reported lost. As with
the iPhone, a remote wipe was initiated.
The device is encrypted and requires
sign‑in, so the risk of data exposure is
minimal and no further steps are required.
Phishing
Attempt
Targeting
Trello Access
A sophisticated phishing email designed to
obtain Trello credentials was sent to multiple
team members. The message initially
bypassed security filters but was quickly
reported by several users. The email was
subsequently withdrawn, and there are no
indications of successful compromise or
further related incidents.
Avantium completed an external IT security and NIS2 readiness
quick scan in 2024. Throughout 2025, multiple recommendations
from this assessment were implemented, resulting in significant
improvements across the security landscape.
We implemented a modern security awareness system to replace
the previous solution, offering improved training content, better
tracking, and more engaging learning formats. In line with this, a
refreshed set of security trainings was rolled out to all employees,
ensuring alignment with current threats and NIS2 expectations,
while internal security policies and new instructions were issued
on the proper use of Microsoft Teams, including governance,
data handling, and periodic access reviews.
We recognize the risks of using publicly available (generative)
artificial intelligence (AI) tools, for instance, risks regarding patent
confidentiality and data security. We therefore only allow
employees to use our in-house Microsoft Copilot, and hold
dedicated training sessions to help people adopt this tool and
use it effectively and securely.
These measures ensure the responsible use of AI‑assisted
productivity tools at Avantium:
Endpoint Hardening Enhancements: Updated and strengthened
endpoint security policies to reduce attack surface and improve
device protection.
Enhanced Email Security: Introduced new email security
measures to better detect and block phishing, spoofing, and
other email‑borne threats.
Dark Web Monitoring: Implemented monitoring to detect
potential exposure of company credentials or sensitive
information on dark web platforms.
Microsoft 365 Tenant Hardening: Strengthened the Microsoft
365 environment with improved configuration baselines and
security controls.
Improved Account & User Management: Streamlined identity
lifecycle processes in alignment with HR, reducing risks related
to orphaned or misconfigured accounts.
Phasing Out Uncontrolled File Sharing: The legacy Box
environment was decommissioned. File sharing and
collaboration were migrated to a monitored and governed
Microsoft Teams environment.
Access Reviews Initiated: Regular access reviews began for
Teams and SharePoint to ensure proper authorization and
reduce permission sprawl.
IT Governance Policy Updates: Several governance policies
were updated in line with the CIS security framework. Additional
refinement and expansion of these policies are planned for
2026.
We protect our data in line with the EU’s General Data Protection
Regulation (GDPR) requirements. In 2025, there were no
substantiated complaints concerning breaches of customer
privacy or losses of customer data at Avantium.
In 2026, we will continue to embrace AI as an essential business
tool. This includes developing appropriate policies and controls
to ensure that we can use these new technologies in a safe and
sustainable way.
Corporate
Governance
Risk Management and Internal Control
Enterprise-Wide Risk Management Framework
Risk management is one of the key responsibilities of Avantium’s
Management Team and Supervisory Board. Risks and
uncertainties are highly dynamic and our assessment of and
responses to them are critical to the Company achieving its
strategic objectives. In line with industry best practice, Avantium’s
enterprise-wide risk management ("ERM") process is designed to
comply with the principles set out in the Dutch Corporate
Governance Code unless otherwise stated, while taking into
account that Avantium is a small listed company with limited
resources.
Within Avantium, a Risk and Control Manager is dedicated to the
management of the enterprise-wide risk management process
and has an independent reporting line to the Chief Financial
Officer (CFO) and General Counsel. The CFO ultimately oversees
risk management tasks and directs the work performed by the
Risk and Control Manager.
Risk assessments occur in both a formal and informal manner
according to the needs of the Management Team and external
stakeholders. Throughout 2025, Avantium performed periodic
risk workshops and control assessments with internal subject-
matter experts, reporting the results to process stakeholders.
The results of risk assessments are used to design and
implement adequate risk and control systems across the
Company. Risk and process owners ensure these systems are
embedded into work processes with the guidance of relevant
Risk Management Process
Avantium Risk Management Process_02.svg
leadership.
An update on risk management activities, findings, conclusions,
and actions is provided to the Audit Committee on a regular
basis. This includes reporting any major observed deficiency in
the internal risk management and control systems, changes made
to these systems, any major improvements planned, and
concluding on the efficacy of the ERM process.
Risk Appetite
Avantium manages its risks and internal control environment
through the boundaries defined by the risk appetite.
The Management Team, with support from the Supervisory
Board, determines Avantium’s risk appetite, monitors Avantium’s
risk exposure, and sets the Group-wide targets.
Our risk appetite is broken down into the following risk areas:
Risk Areas
Description of Risk Areas
Appetite for Risk
Strategy
and
Technology
Avantium develops new
technologies through research and
development (R&D) projects, which
are "industry-disruptive." Avantium
seeks to protect its proprietary
technology. We aim to demonstrate
scale-up of these technologies from
laboratory scale via a pilot plant to
a flagship plant, and subsequently
to sell technology licenses. Funding
these technologies is inherently risky.
High
Operations
Avantium’s operational risk is
related to managing its laboratories
and offices, starting up and
operating its pilot plants, and
building and operating the
FDCA Flagship Plant.
Low
(safety and
quality)
Medium
(technology
scale-up)
Finance and
Reporting
Avantium has a conservative
financial strategy and strives to
ensure that there are no reporting
errors.
Low
Legal and
Compliance
Avantium strives to avoid non-
compliance with laws and
regulations, which include health
and safety regulations, competition
laws, and environmental laws, and
aims to limit any liability risk and to
avoid fraud and bribery.
Low
Avantium JV2025 VOR & Key Risks in 2025.jpg
VOR & Key Risks in 2025
Key risks were identified during risk assessments performed
in the 2025 reporting year and presented to, and approved by,
the Disclosure Committee for inclusion in the 2025 Annual
Report. During the assessment, both our internal and external
environment were taken into account.
Key risks were primarily selected based on their ability to
materially affect the achievement of Avantium’s strategic,
operational, compliance, and reporting objectives and do not
represent a comprehensive list of all risks affecting the Company. 
As required by the latest Dutch Corporate Governance Code this
report includes a Risk Management Statement (verklaring omtrent
risicobeheersing – "VOR"). After assessing the effectiveness of
mitigating controls and residual risk exposure related to the key
risks disclosed below the Management Team concluded that
internal risk management and control systems operated
effectively for the past financial year and enabled them to identify
and respond to all key risks (as disclosed below). The Audit
Committee oversees the Company's ERM framework and will
continue to monitor management's adherence thereto in support
of the VOR.
The symbols in the last columns of the risk register represent
management’s assessment of risk exposure changes compared
to 2024. The table below provides explanation for the symbols
used:
Increase
Decrease
Remained the same
Risks
Mitigating controls
Risk Trend
Financial Sustainability
Avantium has accumulated losses from years of R&D activities while operating with limited revenue
streams, and therefore remains heavily reliant on external financing to fund its R&D activities and start-up
of the FDCA Flagship Plant. Avantium’s financing options can be summarized as the following:
Debt with restrictive terms, such as covenants,
Equity financing that results in ownership dilution, and
Grants with stringent requirements.
Avantium may continue to make losses for the foreseeable future and/ or not have access to sufficient
cash reserves to fund day-to-day operations. The financial sustainability of Avantium will largely depend
on its ability to become EBITDA positive through successful commercialization of YXY® Technology in a
timely manner through product sales and licensing deals.
Setting our strategic direction and measuring against key performance indicators (KPIs) in business plans
to ensure Avantium delivers on its licensing and other revenue strategies.
Focusing efforts and resources in ensuring a quick and safe start-up of the FDCA Flagship Plant.
Maintaining relationships with close stakeholders, such as lenders, Avantium Renewable Polymers
shareholders, and the State through constant, proactive communication and relationship-building.
Actively pursuing strategic opportunities to raise funding.
Continuously monitoring the grant landscape for new opportunities.
Strictly managing debt financing according to covenants.
Prudently managing and forecasting cash within the Company.
FDCA Flagship Plant Start-Up and Operation
The commissioning and start-up of the FDCA Flagship Plant has progressed during 2025 but remains a
work in progress and priority for the Company. The additional resources needed due to delays in
commissioning and start-up resulted in material budget overruns and significantly impacted the cash
position of Avantium. The delay in commissioning, start-up and operations (and consequent budget
overruns), can be further exacerbated in the case of:
Machine breakdown,
Plant components experiencing quality issues or not meeting the required performance specifications
(such as the titanium welding issue), or
Other unforeseen operational disruptions.
Dedicated project team to manage and monitor commissioning and start-up activities to ensure a timely
and safe start-up of the plant, including addressing any issues that may arise during this time.
Putting comprehensive assurance in place throughout construction, testing, and operation of the FDCA
Flagship Plant to ensure a safe, compliant, and quality build.
Expanding and continuously training the Flagship Plant workforce to ensure that the FDCA Flagship Plant
is adequately geared for commercial operations to begin.
Obtaining or working to obtain permits to ensure all regulatory requirements are met during testing and
operations.
Using independent service providers to review relevant processes within the Company to ensure
operational excellence and to align with certain International Organization for Standardization (ISO)
standards.
Market Dynamics
Avantium is exposed to geopolitical and macro-economic changes when building its supply chain,
including factors such as global economic growth, price fluctuations, resource scarcity, competition within
the market, etc.
Our revenue-generating unit, Avantium R&D Solutions, delivers niche services for a small number of
customers. Loss of a customer, or even a new competitor in the market, could significantly affect revenue. 
A cut in spending on R&D by its customers could negatively impact its prospects.
As a new player in the polymer materials industry, Avantium is subject to several market forces, such as:
Competing in a well-established market with numerous big players and new technology competitors.
The current economic downturn in the chemical industry, which could negatively affect appetite for
investing in new technology.
The success of our commercialization efforts will rely heavily on market acceptance of FDCA and PEF
(including fulfilling the uptake of our own production capacity, as well as our licensee production
capacity), delivering on our existing agreements, and finding licensees who will commit to investing in our
technology.  If Avantium does not gain market traction fast enough through offtake volumes and
technology licensing, or has a loss in existing market share, financial sustainability may not be achieved.
Actively managing and leveraging customer relationships.
Utilizing pilot plants and the FDCA Flagship Plant to showcase technology to potential clients and
customers.
Establishing and managing sales funnels to enable our business development team to engage with
potential customers and form partnerships.
Actively monitoring and responding to market activity and macro-economic factors that could affect
business plans and dealings.
Regular analyses of market intelligence and trends to inform strategic decision making.
Continuously investing in technology development to maintain competitiveness within the market and
improve our offering.
Maintaining, protecting, and expanding our current intellectual property (IP) portfolio.
Risks
Mitigating controls
Risk Trend
Organizational Change
Previously, Avantium’s operations were focused solely on R&D and major projects. With the start-up of
the FDCA Flagship Plant, Avantium is undergoing a significant organizational change as it transitions to
being a commercial company and licensor in chemical manufacturing. This change necessitates change
management across the Company, which affects Avantium’s people, processes, systems, and planning.
This change also presents unique challenges to the Company, such as:
Maintaining key personnel and minimizing regrettable loss due to the impact on people.
Finding talent and the necessary skills to implement and run new processes and departments within
the company.
Addressing how operations will be run after the change in geographical location.
Not adequately preparing for and dealing with this change could have negative consequences for the
Company, including achieving long-term financial sustainability.
Performing long-term planning and continuously working to meet long-term milestones.
Aligning hiring practices to the Company strategy.
Investing in systems, training, and other tools to facilitate delivery on short-, medium-, and long-term
goals.
Hiring external consultants to temporarily support the team and provide the Company with access to
necessary skills and knowledge that are not available internally.
Creating a culture of transparency and collaboration within the Company by engaging with managers and
employees to determine their current and future needs through our Great Place to Work program.
Continuously improving our existing processes and implementing new tools to ensure that scaling of the
Company is aligned with planned growth.
Technology and Intellectual Property
We continue to invest resources into new technology and improving and de-risking the scale-up of YXY®
Technology. These efforts lead to the creation of IP that needs to be registered with the relevant
authorities (global and local), protected, and commercialized before patent expiry.
Inability to scale up and deploy technology or the loss of patent protection or leakage of trade secrets will
significantly affect Avantium’s ability to sell technology licenses.
Conversely, Avantium can lose its freedom to operate if it inadvertently infringes on the IP rights of third
parties in its technological or commercial operations.  Such an infringement could also lead to costly
litigation or third-party claims against the Company and its partners.
Actively monitoring worldwide trends and technology developments, especially with respect to the patent
landscape.
The Industrialization Committee acts as the Supervisory Board's advisory and risk review forum,
overseeing the Company's technology strategy, industrialization roadmaps, and technology portfolio.
Senior management of each business unit sets an IP strategy to manage the maintenance, protection,
and expansion of Avantium’s IP portfolio.  The strategy includes decisions related to ongoing investment
of resources.
Proactively consulting technical teams and committees when seeking patent protection.
Implementing adequate legal, human resources (HR), and information technology (IT) controls to protect
IP from breach.
Regulations, Permits, and Compliance
Increased regulation within the European Union (EU), coupled with the ever-changing environment of
Avantium’s operations and the expansion of the supply chain into new geographical locations, has added
significant complexity to our operations. This includes elements such as:
Complying with laws and regulations,
Maintaining permits for operations,
Maintaining and obtaining registrations for manufacturing and export,
Complying with international trading sanctions, and
Preventing bribery, money laundering, and fraud in all our dealings.
Managing these risks is resource-intensive. Not adequately managing Avantium’s compliance risks could
result in fines, loss of permits, costly third-party liability claims, loss of trust, or operational disruptions.
Cumbersome regulation in other geographical locations could potentially create a barrier to entry for
business development or expansion of operations.
Registering Avantium products in accordance with applicable regulations and directives, allowing the
manufacturing, distribution, and use of our products locally and globally.
Continuously monitoring the regulatory landscape for changes and applying for prerequisite regulatory
approvals and registrations where applicable.
Establishing and maintaining a dialogue with authorities, where applicable.
Including appropriate liability clauses in contracts, including limitation of liability, liquidated damages, and,
where possible, exclusion of consequential damages.
Establishing strict manufacturing protocols and quality assurance procedures to ensure that our products
are fully in line with specifications according to regulations and customer needs.
Establishing strict manufacturing protocols to ensure that we do not pollute or damage the environment
and comply with permit requirements.
Taking out comprehensive liability and other insurances to cover risks within our operating environment.
Performing due diligence checks (including UBO and KYC scans) on clients and customers.
Implementing strict financial controls to prevent and detect fraud.
Implementing and enforcing several internal policies to protect whistle-blowers and provide employees
with guidance and training on anti-money laundering, anti-bribery, and anti-corruption controls.
Risks
Mitigating controls
Risk Trend
Partnerships
Significant portions of our business are reliant on building and maintaining functional and beneficial
partnerships. These relationships are often affected by external factors, such as geopolitical and
economic changes, which are outside of the Company's control.
A disruption in key partnerships can impact the company in numerous ways, including:
Unforeseen disruptions to operations,
Reputational damage
Interruption of R&D activities,
Increased costs, and/or
Loss of income.
Actively building and maintaining relationships within the industry and supply chain.
Diversifying and growing partnerships to avoid over-reliance on one party.
Following an established contract management process.
Including provisions for right to conduct audits in our contracts.
Sustainable Supplier Code has been implemented.
Collaborating with universities and industry players through grants and other projects.
Using up-to-date sanctions screening software and other onboarding processes when entering into new
business relationships.
Safety
Ongoing R&D activities as well as the start-up and operations of the FDCA Flagship Plant could
potentially lead to safety-related incidents occurring, with the potential being exacerbated by the
presence of hazardous substances on site.
An incident of this nature could potentially cause injuries, loss of life, negative environmental impacts, or
operational disruptions.
Onboarding every employee, student, intern, and hired specialist with adequate safety and process
training at the start of their engagement.
Incidents are logged in a central repository, with root cause analysis performed and learned from by
communicating the incident or changing supporting policies and procedures.
Creating awareness for health, safety, and environment (HSE) issues through leadership engagement,
training procedures, safety systems, internal memos, instructions, and Company Meetings.
Applying strict design criteria for the handling and storing of hazardous substances.
Performing periodic hazard and risk assessments for all planned operational activities to ensure
necessary preventive measures are implemented.
Implementing work methods to prevent incidents and accidents.
Establishing strict manufacturing protocols to ensure there is a safe work environment for all persons on
site.
Maintenance management system in place to maintain assets and to ensure they comply with regulatory
inspections.
Risks
Mitigating controls
Risk Trend
Information and Communications Technology
Avantium’s IT systems and processes support operations within the Company. Protecting and managing
these systems and the information therein are key to ensuring business continuity and preventing data
loss. Cyber security risks remain a concern as the sophistication of these attacks has escalated globally,
often targeting critical infrastructure, corporate data, and supply chains.  Avantium’s public presence and
valuable IP makes us an especially attractive target for cyberattacks. We are therefore challenged to
continually improve our security monitoring and response measures.
Emerging technologies, such as AI, also present the Company with new opportunities and challenges.
The company is continually monitoring the ICT landscape to ensure new technologies are identified and,
where beneficial, incorporated into day-to-day activities in a responsible manner.
Our IT roadmap is reviewed regularly to ensure long-term decision making with respect to technology.
Implementing policies and procedures that are closely aligned with industry best practices to ensure
adequate management of data, systems, and security.
Security measures within hardware and software are continuously evaluated and attuned.
Strict user-management practices applied throughout the company.
Comprehensive insurance policies that cover our IT risks.
Managing risk associated with emerging technologies through robust governance to inform user activities
and prevent unauthorized usage.
Working with specialists and implementing recommendations for Avantium’s IT infrastructure and
security.
Providing compulsory training for employees to build their awareness of cybersecurity.
Sustainability
Avantium aims to improve the sustainability of its products and operations. Overall, the effects of
environmental factors (such as climate change and increased scarcity of resources) and social changes
could significantly affect the Company and its value chain in the short, medium, and long term.
In addition to internal goals and milestones, the Company is subject to regulation, contractual
requirements, and other pressures from outside parties to improve sustainability. Non-compliance with
these rules or expectations could lead to possible fines, reputational damage, or the breakdown of key
relationships.
Integrating sustainability milestones and roadmaps in strategic planning and decision making of the
Company. This includes ESG KPI's which are built into the Remuneration Policy.
Double materiality assessment was completed which informed the environmental impact reporting.
Performing assessments on the supply chain to predict and mitigate any interruptions that may occur.
A Sustainable Supplier Code is implemented.
Maintaining dialogue with internal and external stakeholders on sustainability matters.
Implementing policies and procedures to ensure compliance with our own sustainability roadmap.
Control Environment
The Management Team and Supervisory Board are ultimately
responsible for ensuring that the Company maintains a strong set
of internal controls. Particular attention is  given to observed
weaknesses, process non-compliances, and audit results to
continually improve the organization's control environment.
The continuous transformation of the Company, including the
start-up of the FDCA Flagship Plant, has resulted in a significant
increase in the complexity of control and reporting requirements.
To support the Flagship Plant in its start-up activities and ISO
certification an internal audit function was created to provide
assurance on the operations of the Flagship Plant.  A three-year
audit plan was approved and initiated from Q2 in 2025.
The scope and activities of the internal audit function will continue
to be assessed as the Company's needs and objectives evolve.
In-Control Statement
Our systems and procedures cannot reasonably provide full
assurance that all strategic, operational, compliance, and
reporting objectives will be achieved, nor can they prevent all
control gaps, misstatements, inaccuracies, errors, fraud, and non-
compliance with laws and regulations. To management's
knowledge, there have been no reportable instances of fraud,
bribery, or money laundering during 2025.
On this basis, and in accordance with provision 1.4.3 of the Dutch
Corporate Governance Code, Avantium’s Management Board
states to the best of its knowledge that:
This Annual Report provides sufficient insight into any failings in
the effectiveness of Avantium’s internal risk management and
control systems;
The aforementioned risk management and control systems
provide reasonable assurance that the financial reporting does
not contain any material inaccuracies;
We are not aware that the aforementioned risk and internal
control systems would not provide appropriate comfort that our
main operational and compliance risks (as disclosed), are
effectively managed to an acceptable level considering our risk
appetite, referring as well to the inherent limitations and
disclosures noted earlier.
As allowed by CSRD and as described in the Sustainability
Statement, we have prepared all sustainability information,
and supplementary information, on a voluntary basis and
without external assurance.
Based on the current state of affairs, financial reporting on a
going concern basis is justified (refer to Going Concern on
page 34); and
The Going Concern section in the Annual Report lists those
material risks and uncertainties relevant to expectations
regarding Avantium’s continuity for the period of 12 months
after the preparation of this Report of the Management Board.
In accordance with Article 5:25c of the Financial Markets
Supervision Act, Avantium's Management Team confirms, to the
best of its knowledge, that:
The financial statements in this Annual Report give a true and
fair view of the Company's assets, liabilities, and financial
position as at December 31, 2025 and the results of our
consolidated operations for the financial year 2025; and
The sections in the Report of the Management Board provide a
true and fair view of the situation on the balance sheet date and
the business development during the financial year of Avantium
and of our affiliated Group companies included in the financial
statements, and describe the principal risks that Avantium N.V.
faces.
Amsterdam, March 17, 2026
Tom van Aken
Chief Executive Officer
Corporate Governance Statement
General
Avantium N.V. ("Avantium" or "the Company") is a public limited
liability company incorporated under the laws of the Netherlands,
with its registered seat in Amsterdam and its offices at
Zekeringstraat 29, 1014 BV Amsterdam, the Netherlands,
with chamber of commerce registration number 34138918.
Avantium’s shares are listed on Euronext Amsterdam and
Euronext Brussels (symbol: AVTX).
Avantium’s corporate governance framework is grounded in
the Dutch Civil Code, the Dutch Corporate Governance Code
(“the Dutch Code”), the Company’s Articles of Association (last
amended on May 22, 2025), relevant securities laws, and the
regulations governing the Management and Supervisory Boards.
The Articles of Association, publicly available on the Avantium
website, incorporate the key principles and best‑practice
provisions of the Dutch Code applicable to a two‑tier governance
structure.
Since the 2017 financial year, Avantium has complied with the
2016 Dutch Code, most recently updated in 2025. This Code
outlines the roles and interactions of the Management Board,
the Supervisory Board, and the General Meeting of Shareholders.
As a listed company in the Netherlands, Avantium must report on
its adherence to the Dutch Code. This chapter explains how
Avantium applies the Code in practice.
Governance Structure
Avantium operates under a two‑tier board structure, consisting of
the Management Board and the Supervisory Board.
The Management Board is responsible for the Company’s
day‑to‑day operations, while both Boards jointly oversee the
overall governance framework. Their shared focus is on
sustainable long‑term value creation, taking the interests of all
stakeholders into account when making strategic decisions.
Each Board, together with the Supervisory Board’s committees,
operates under dedicated regulations that define their duties,
responsibilities, composition, and working methods.
These regulations are available on our website. Avantium
also has a third governing body: the General Meeting of
Shareholders (“General Meeting”).
The Works Council, representing employee interests, maintains
an ongoing dialogue with both the Management Board and the
Supervisory Board, offering feedback and fulfilling its advisory
role.
The following sections describe the roles and responsibilities of
each of these governing bodies.
Management Board
Powers, Responsibilities, and Functioning
The Management Board is Avantium’s statutory executive body,
as defined in the Articles of Association. Together with key
appointed employees, it forms the Management Team –
Avantium’s equivalent of an Executive Committee – which
oversees day‑to‑day operations and is responsible for delivering
the Company’s objectives, strategy, policies, and results. This
team develops and implements business strategies and policies
aligned with Avantium’s risk profile and maintains effective
internal control systems.
The Management Board is authorized to take all actions
necessary or beneficial to achieving Avantium’s objectives,
except where such actions are restricted by law or explicitly
assigned to the General Meeting or the Supervisory Board under
the Articles of Association.
In carrying out its duties, the Management Board considers the
interests of all stakeholders, including shareholders, employees,
partners, and customers, as well as relevant sustainability
considerations.
The Management Board is accountable to both the Supervisory
Board and the General Meeting of Shareholders. Certain
decisions require approval from the Supervisory Board and/or the
General Meeting. These requirements are detailed in the Articles
of Association and the Supervisory Board Regulations, both
available Avantium's website.
The Management Board keeps the Supervisory Board informed
and consults with it on all key matters. It reports on the main
elements of the Company’s strategy, the general and financial
risks, and the risk management and internal control systems.
The Management Board must also provide the Supervisory Board
with all information required for the proper performance of its
duties, and must do so in a timely manner.
Composition of the Management Board
The Management Board consists of at least two members. In line
with the Dutch Code, the Supervisory Board designates one
Managing Director as Chief Executive Officer (CEO) and another
as Chief Financial Officer (CFO), with the CFO specifically
responsible for the Company’s financial management.
The Supervisory Board has the authority to make binding
nominations to the General Meeting for the appointment of
Management Board members. Each Management Board member
is appointed for a term of up to four years, ending immediately
after the Annual General Meeting of Shareholders (AGM) held in
the fourth calendar year following their appointment.
The current member of the Management Board is:
Name
Years in
Management
Board
Date of
initial
appointment
Date of
re-appointment
Term
ends in
Tom
van
Aken
20
2005
AGM 2025
AGM
2029
On May 14, 2025, the General Meeting re-appointed Tom van
Aken as member of the Management Board and CEO for a term
of four years.
By the end of March 2025, Boudewijn van Schaïk resigned as
CFO and Management Board member, effective May 9, 2025, to
pursue his career elsewhere. Bert Cornelese assumed the role of
interim CFO on April 1, 2025. In August 2025, René Ploegsma
succeeded him in the role of interim CFO. The Company is close
to finalizing the recruitment of a permanent CFO for nomination
and appointment.
Evaluation
At least once a year, the Management Board conducts a
self‑evaluation, primarily together with the Management Team,
assessing both its collective performance and that of its individual
members. In addition, the Supervisory Board reviews the
Management Board’s performance during the Supervisory
Board's closed sessions, with the Chair of the Supervisory Board
communicating the outcomes to the Management Board.
Remuneration
Information on the Remuneration Policy for Management Board
members and their individual remuneration can be found in the
Remuneration Report 2025 (page 88).
Management Team
The Management Team – Avantium’s equivalent of an Executive
Committee – currently consists of the following members:
Tom van Aken, Chief Executive Officer
René Ploegsma, interim Chief Financial Officer
Carmen Portocarero, General Counsel
Gert-Jan Gruter, Chief Technology Officer
Marco Jansen, Chief Commercial Officer
Hero de Jager, interim Chief Operating Officer
Annelore van Thiel, Director Human Resources
Steven Olivier serves as Managing Director of Avantium R&D
Solutions and Yap Chie Cheung is Managing Director of Volta
Technology.
Supervisory Board
Powers, Responsibilities, and Functioning
The Supervisory Board fulfils three key roles: it supervises and
advises the Management Board, acts as its employer, and has
specific powers including the authority to approve certain
Management Board decisions.
The Supervisory Board oversees the Management Board and the
overall course of affairs of the Company, its subsidiaries, and
related business activities. It is accountable for this oversight to
the General Meeting. In addition, the Supervisory Board provides
guidance to the Management Board, offering advice on matters
related to Avantium’s activities.
In carrying out their duties, the Supervisory Board members act
in the interests of the Company, taking into account the interests
of all stakeholders. They also oversee the effectiveness of
Avantium’s internal risk management and control systems,
as well as the integrity and quality of the financial reporting.
The Supervisory Board is responsible for nominating and
overseeing the external accountant, who audits the Company’s
annual financial statements and reports on them to the General
Meeting.
Composition of the Supervisory Board
Avantium’s Supervisory Board consists of at least three members
and is authorized to make binding nominations for new
appointments to the General Meeting. The Supervisory Board
appoints one of its members as Chair. In line with the Dutch
Code, each member is appointed for a term of up to four years,
ending at the close of the General Meeting held in the fourth
calendar year after their initial appointment. Members may be
reappointed once for an additional term of up to four years.
They may subsequently be reappointed for a further two‑year
term, which may be extended once more by another two years.
Any appointment exceeding eight years must be specifically
justified in the Supervisory Board Report.
On May 14, 2025, the General Meeting re‑appointed Margret
Kleinsman for a third term of two years on the Supervisory Board.
In proposing her re‑appointment, the Supervisory Board
considered the value of retaining her experience, including as
Chair of the Audit Committee, to ensure continuity.
In November 2025, the Dutch Ministry of Climate Policy and
Green Growth (Ministerie van Klimaat en Groene Groei – KGG)
nominated Patrick Polak as observer to its Supervisory Board.
This nomination follows the ministry’s €15 million share
investment in Avantium in September 2025. One of the
conditions of this investment was the right to appoint an observer
to the Supervisory Board. As observer, Patrick Polak will attend
Supervisory Board and Committee meetings and receive the
same information as board members, without rights to vote or
quorum status. This arrangement remains in place as long as the
ministry or its affiliates hold shares in Avantium.
In 2025, the Supervisory Board consisted of the following
members:
Name
Member
since
Year of possible
re-election
End of
final term
Edwin Moses
2019
2027
2031
Michelle Jou
2020
2028
2032
Margret Kleinsman
2017
2027
2029
Nils Björkman
2022
2026
2034
Peter Williams
2023
2027
2035
Evaluation
At least once a year, the Supervisory Board evaluates its own
performance, as well as the performance of its Committees,
performance of the Management Board, and performance of their
individual members. Further details on the 2025 evaluation are
provided in the Report of the Supervisory Board (page 81).
Remuneration
Information on the Remuneration Policy for Supervisory Board
members, as well as their individual remuneration, is provided in
the Remuneration Report 2025 (page 88).
Supervisory Board Committees
The Audit, Industrialization, Remuneration, and Nomination
Committees support the Supervisory Board by providing advice
and informing its decision‑making. The Supervisory Board,
however, remains collectively responsible for all duties delegated
to its Committees. The Committee Regulations are available on
Avantium’s website.
Audit Committee
The Audit Committee supports the Supervisory Board by
overseeing the integrity and quality of the Company’s financial
reporting and the effectiveness of internal risk management and
control systems. Its responsibilities include monitoring compliance
with relevant laws, regulations, and codes of conduct, supervising
the Company’s financing, and evaluating the external audit
process. The Committee also reviews the scope, approach,
progress, and performance of the external auditor, with the
relationship assessed annually. Together with the Management
Board, the Committee reviews the half‑year and full‑year financial
statements, the independent auditor’s reports, and the
Management Letter. In addition, it oversees the Company’s tax
planning policy and the application of information technology (IT),
including the opportunities and risks of artificial intelligence (AI)
and cybersecurity risks.
Industrialization Committee
The Industrialization Committee serves as the Supervisory
Board’s advisory and risk‑review forum, overseeing the
Company’s technology strategy, industrialization roadmaps, and
technology portfolio. These areas are developed and executed
by the Management Board and senior management.
Remuneration Committee
The Remuneration Committee evaluates and drafts the
Remuneration Policy for the Management Board and the
Supervisory Board, which is submitted to the General Meeting for
adoption. The approved policy forms the basis for determining
the Management Board’s fixed and variable remuneration.
Nomination Committee
The Nomination Committee advises on candidates for vacancies
in the Management Board and Supervisory Board, evaluates the
performance of both Boards and their members, oversees the
Management Board’s policy on selection criteria and appointment
procedures for senior management, and ensures long‑term
succession planning.
Independence and Conflicts of Interest
In line with the Supervisory Board Regulations, the Management
Board Regulations, and the Dutch Code, Board members must
immediately report any actual or potential conflict of interest to
the Chair of the Supervisory Board and/or to the other
Management Board members. In 2025, no such situations were
reported for either the Supervisory Board or the Management
Board. The Supervisory Board also performed its duties
independently, in accordance with principles 2.1.7 to 2.1.9 of the
Dutch Code.
Diversity and Inclusion
The Dutch Diversity Act (“Wet evenwichtiger man‑vrouwverhouding
in de top van het bedrijfsleven”) entered into force on January 1,
2022. The Act requires large and/or listed companies to establish
appropriate and ambitious gender balance targets and to report
annually to the Social and Economic Council (SER) on their
composition and progress. In line with this legislation, Avantium
has set targets to achieve a balanced representation of men and
women in the Management Team, the Supervisory Board, and the
sub‑top management level. Avantium aims for diverse
representation of the Management Team and Supervisory Board
and an inclusive and diverse culture in which differences are
recognized, valued, and utilized. Avantium’s Diversity & Inclusion
Policy and targets are published on our corporate website.
The Management Team and Supervisory Board are diverse and
well balanced in terms of educational background and professional
experience. Together, they bring a strong mix of sector expertise,
financial knowledge, and leadership capabilities. The Supervisory
Board reviews the composition of the Supervisory Board, the
Management Board, and the Management Team each year.
The Supervisory Board has established a profile that sets out its
desired size and composition. This includes (i) the number of
members, (ii) the expertise and backgrounds required, (iii) the
desired level of diversity and independence, and (iv) the
qualifications expected of its members. This profile is available
on the corporate website.
At the end of 2025, women represented 40% of the Supervisory
Board, meeting the quota prescribed by Section 2:166 of the
Dutch Civil Code. The Management Team also met its
gender‑balance objective, consisting of five men and three
women (38% women). More broadly, Avantium benefits from a
highly diverse workforce, with employees of different genders,
backgrounds, cultures, and religions. More information on
the impact of our Diversity & Inclusion Policy can be found on
pages 53 and 191.
Shareholders
Annual General Meeting of Shareholders
The Annual General Meeting (AGM) or General Meeting is held
within six months after the end of each financial year. Its primary
purpose is to address matters prescribed by Avantium’s Articles
of Association and Dutch law, including the adoption of the
financial statements and the discharge of the Management Board
and Supervisory Board from their respective duties. Extraordinary
General Meetings (EGMs) may be convened when deemed
necessary by the Management Board and Supervisory Board, or
at the request of one or more shareholders who collectively
represent at least 10% of Avantium’s issued share capital. The
requesting shareholder must also respect the response time
stipulated by the Management Board, in accordance with best
practice provision 4.1.7. If the Management Board sets such a
response time, it must be reasonable and may not exceed 180
days from the moment it is informed of a shareholder’s intention
to place an item on the agenda until the General Meeting at
which the item will be discussed. In 2025, no shareholder
requested agenda items, and therefore no response time was
applicable.
An AGM or EGM is convened by notice from the Management
Board or the Supervisory Board. Shareholders who individually or
collectively represent at least 0.03% of the Company’s issued
share capital may request that items be added to the agenda. All
shareholders have the right to attend, speak, and vote at the
meeting. Unless Dutch law or the Articles of Association require a
higher threshold, resolutions are adopted by a simple majority of
the votes cast. Certain resolutions require a two‑thirds majority of
the votes cast if less than half of the issued share capital is
represented at the meeting.
In line with best practice provision 4.2 of the Dutch Corporate
Governance Code, the Management Board and the Supervisory
Board ensure that the General Meeting is provided with adequate
information. If the Boards decide not to disclose certain
information due to an overriding interest of the Company, they
will explain the reasons for this. In 2025, this did not occur.
The draft minutes must be published on the corporate website
within three months after the AGM or EGM. Shareholders then
have three months to submit any comments. After this period, the
minutes are adopted and signed by the Chair of the Supervisory
Board and the General Counsel, who serves as secretary to the
meeting.
Consultation with Shareholders
Contacts with shareholders are conducted entirely in line with the
policy on fair disclosure and bilateral dialogue, as published on
the Avantium website. The Company's Disclosure Committee
supervises compliance with laws and regulations in relation to the
disclosure of price-sensitive information.
Transactions with Majority Shareholders 
No transactions with majority shareholders, as referred to in best
practice provision 2.7.5 of the Dutch Code, took place in 2025.
Works Council
Avantium’s Works Council (“Ondernemingsraad”) ensures
employee participation in both day‑to‑day operations and the
Company’s strategic decision‑making. It supports constructive
dialogue, strengthens workplace representation, and contributes
to the Company’s continuous improvement. The Works Council
consists of members drawn from various business units and
locations, elected by employees during the Works Council
elections. From its members, the Works Council elects a Chair
and a Deputy Chair, with the Chair preferably having completed
at least one previous term.
The Works Council meets monthly. In addition, every six weeks it
convenes with the CEO and the General Counsel to discuss
general topics such as safety, vitality, and budgeting. Depending
on the agenda, the CFO, HR Director, and/or Communications
Director may also join to provide updates and support broader
discussions. Besides recurring subjects such as health and safety,
business developments, and HR matters, other topics include the
Company’s financing and the Risk Inventory & Evaluation for all
sites. More information on the Works Council can be found on
page 52.
Governance Avantium Renewable Polymers B.V.
Avantium Renewable Polymers B.V., a 77.4%-owned subsidiary of
Avantium N.V., is a Dutch limited liability company based and
registered in Amsterdam. It serves as the holding company for
Avantium RNP Flagship Plant B.V., which is currently starting up
the world’s first commercial FDCA manufacturing facility (the
FDCA Flagship Plant). This plant, located in Delfzijl, the
Netherlands, will be operated by Avantium Renewable Polymers.
Due to the equity participation of Bio Plastics Investment
Groningen Consortium B.V. and Worley Nederland B.V. in
Avantium Renewable Polymers B.V., Avantium N.V. entered into a
shareholders’ agreement (SHA) governing the relationship
between the shareholders of Avantium Renewable Polymers B.V.
In addition to customary governance provisions, the SHA includes
several specific governance mechanisms.
Supervisory Board Avantium N.V.
The Supervisory Board of Avantium N.V., acting in its capacity as
Supervisory Board of Avantium Renewable Polymers’ major
shareholder, also oversees the business of Avantium Renewable
Polymers B.V. This includes supervision of the commissioning and
start‑up of the FDCA Flagship Plant. Avantium ensures that at
least one member of the Supervisory Board possesses specific
expertise in this area.
Project Oversight Board
Avantium Renewable Polymers B.V. has established a Project
Oversight Board, with members appointed and dismissed in
accordance with its Regulations. During the engineering,
construction, commissioning, and start‑up of the FDCA Flagship
Plant, the Board meets at least once every two months. Minutes
of these meetings are shared with the shareholders of Avantium
Renewable Polymers B.V. The Project Oversight Board also
oversees the execution of Avantium Renewable Polymers’
licensing strategy. As required by Sections 3.4, 3.6, and 3.7 of the
Project Oversight Regulations, the Board ensures that the
appropriate experience and expertise are in place for this next
phase.
Shareholders’ Committee
Avantium Renewable Polymers B.V. has a Shareholders’
Committee, with each shareholder appointing its own
representative. The Committee meets at least once every three
months. Avantium’s CEO, together with the COO and CCO,
attends these meetings to update the Committee on the progress
of the FDCA Flagship Plant and other relevant matters concerning
the business of Avantium Renewable Polymers.
Sustainability Governance
Avantium began its sustainability journey in 2000 but formalized
its sustainability strategy in 2019 after engaging internal and
external stakeholders to identify the most material topics for the
Company. This process resulted in our Sustainability Manifesto,
outlining our commitment to addressing the global climate crisis.
In 2021, we published Chain Reaction 2030, our sustainability
strategy that sets clear milestones toward our vision of a
fossil‑free chemical industry by 2050. More than 100
stakeholders contributed to the target‑setting process.
To support the implementation of Chain Reaction 2030, we
established a cross‑functional governance structure:
Sustainability Steering Board – Oversees and steers the
execution of Chain Reaction 2030 and approves related plans
and actions. It is chaired by the Chief Sustainability Officer, who
reports directly to the CEO, and further includes the CFO, the
Managing Director of Avantium R&D Solutions, the HR Director,
and the Communications Director.
Chain Reaction 2030 Task Force – Cross‑departmental teams
responsible for delivering strategic targets and driving the
planning, implementation, and monitoring of policies,
processes, and activities.
Members of both bodies have these responsibilities embedded in
their annual goals and are evaluated on their progress.
In 2025, the Company evaluated and updated its sustainability
strategy to reflect evolving expectations, material impacts, and
business priorities. The updated strategy (See page 43) was
launched in 2026 and will also lead to refinements in Avantium’s
sustainability governance framework. The Management Team
steers the execution of the new strategy.
Corporate Governance Statement
Since its listing on Euronext Amsterdam, Avantium has adhered to
the Dutch Code, recognizing the significance of good corporate
governance. Avantium agrees with the principles of the Dutch
Code and has taken, and will continue to take, appropriate steps
to implement its principles and best practice provisions.
The Code recognizes that a one‑size‑fits‑all approach is not
appropriate for every company and that justified deviations may
occur. Under the “comply‑or‑explain” principle, the Boards are
responsible for the Company’s governance structure and for
adhering to the Dutch Code, providing transparent explanations
for any deviations. The principles and best‑practice provisions
where Avantium deviates from the Dutch Code are outlined
below.
Principle 1.3.6: Absence of Internal Audit Department
Avantium’s internal audit function evaluates the design and
effectiveness of the Company’s internal risk management and
control systems. The Management Board oversees this function,
while the Supervisory Board maintains regular contact with those
involved. In 2025, the responsibilities of the internal audit function
were allocated across several senior support staff roles, including
Legal and Finance. These staff members have direct access to
the Audit Committee and to independent external auditor.
Minutes are recorded to document how the Audit Committee is
informed by the internal audit function. The Supervisory Board
annually assesses whether this distribution of responsibilities
across senior support functions remains appropriate. Senior staff
also draw on external subject‑matter expertise when needed.
More information can be found in the Risk Management and
Internal Control section on page 66.
Best Practice Provision 2.3.4: Composition of the
Committees
According to this provision, the Chair of the Audit Committee or
the Remuneration Committee may not also serve as Chair of the
Supervisory Board or be a former member of the Management
Board. In 2025, however, the Chair of the Supervisory Board also
served as Chair of the Remuneration Committee. The Chair brings
substantial expertise in remuneration matters and is supported by
two Supervisory Board members with relevant experience. When
needed, the Remuneration Committee also engages external
advisors.
Best Practice Provision 3.3.2: Remuneration of
Supervisory Board Members
This provision states that Supervisory Board members may not
receive remuneration in the form of shares or rights to shares.
To attract and retain qualified candidates in a competitive global
market and to support the Supervisory Board in creating
sustainable long‑term value, Avantium’s Remuneration Policy –
adopted by the AGM on May 15, 2024 – includes the option for
Supervisory Board members to receive a one‑off fixed award of
restricted share units (RSUs) upon (re)appointment. These
non‑performance‑based RSUs are intended to align the interests
of the Supervisory Board with those of Avantium's shareholders.
The Chair of the Supervisory Board is eligible for a fixed grant of
55,000 shares upon (re)appointment, while other members are
eligible for a fixed grant of 20,000 shares. Members may decline
the award. The applicable terms are set out in the Supervisory
Board Remuneration Policy published on the Avantium website.
The Company does not grant loans to members of the
Supervisory Board. See the Remuneration Report 2025 for more
information.
Best Practice Provision 4.3.3: Canceling the Binding
Nature of a Nomination or Dismissal
This provision states that, in companies without statutory two‑tier
status (“structuurregime”), the General Meeting may cancel the
binding nature of a nomination for the appointment or dismissal of
a Management Board or Supervisory Board member by an
absolute majority of the votes cast. The Articles of Association
may require that this majority also represent a specified
proportion of the issued share capital (up to one‑third). If this
capital threshold is not met at the General Meeting, but an
absolute majority nevertheless votes to cancel the binding nature
of a nomination or dismissal, a new General Meeting may be
convened. At this subsequent meeting, the resolution can be
adopted by an absolute majority of the votes cast, regardless of
the proportion of the share capital represented.
Avantium’s Articles of Association allow the Supervisory Board to
make binding nominations for appointments to the Management
Board or the Supervisory Board. A candidate nominated on a
binding basis will be appointed, regardless of the voting majority.
The General Meeting may set aside such a binding nomination
with a two‑thirds majority of the votes cast, provided these votes
represent more than half of the issued share capital.
If the Supervisory Board does not submit a binding nomination,
the General Meeting may appoint a member of the Management
Board or Supervisory Board at its discretion with a simple
majority, provided this majority represents at least one‑third of the
issued share capital. Under the Articles of Association, the
General Meeting may dismiss a Management Board or
Supervisory Board member at any time. Such a resolution
requires a two‑thirds majority of the votes cast, representing
more than half of the issued share capital, unless the dismissal is
proposed by the Supervisory Board, in which case a simple
majority is sufficient. Avantium deviates from this Dutch Code
provision to safeguard the continuity of the Company.
Decree Article 10 EU Takeover Directive
The information required under the Decree Article 10 EU
Takeover Directive (“Besluit artikel 10 overnamerichtlijn”), insofar
as applicable to the Company, is included in this Corporate
Governance section.
Anti-Takeover Measures
In accordance with best practice provision 4.2.6 of the Dutch
Corporate Governance Code, the Management Board must
outline any existing or potential anti‑takeover measures and
indicate under what circumstances, and by whom, such measures
may be used. Avantium has not implemented any anti‑takeover
measures. As a result, there are no circumstances under which
such measures could be invoked, nor any parties authorized to
do so.
Trust Office Board
In line with best practice provision 4.2.6 of the Dutch Corporate
Governance Code, companies should report on any Trust Office
Board (Stichting Administratiekantoor) and related measures.
Avantium does not have a Trust Office Board and has not
implemented any form of share certification.
Change of Control Provisions 
The contractual terms of the Company’s key financing
agreements may entitle the banks to demand early repayment of
the amounts borrowed by the Company and its subsidiaries if
there is a change of control over the Company, as defined in the
respective agreements.
Certain government grants and subsidies are subject to
restrictions, such as change of control clauses and other
requirements, that could potentially lead to the amount of such
grants or subsidies being reduced. The debt instruments,
including the Debt Financing Facilities and Fonds Nieuw Doen, 
are subject to change of control clauses and other provisions that
could require a mandatory prepayment.
Avantium JV2025 Management Board_01.jpg
Management Board          Supervisory Board
Tom van Aken
(1970, Dutch)
Chief Executive Officer (CEO) and member of
the Management Board
Joined Avantium: 2002
Appointed CEO: 2005
Current term: 2025–2029
Tom van Aken joined Avantium in 2002 as
Vice President of Business Development.
After becoming Vice President of Global
Marketing and Sales in 2004, he was appointed
CEO the following year. Prior to joining
Avantium, he served as Business Development
Director at DSM Fine Chemicals, Inc. Tom holds
a master’s degree in Chemistry from Utrecht
University.
Ancillary positions
Member of Sector Board Chemicals &
Materials -  Chemistry.NL (SME representative)
Member of the Board of Directors TKI Green
Chemistry & Circularity
Edwin Moses
(1954, British
& Belgian)
Chair of the Supervisory Board
Member of the Supervisory Board since:
2019
Current term: 2023–2027
Background
Edwin Moses has held leadership roles at
several European life science companies,
focusing on high‑value services for the
pharmaceutical industry and drug discovery
and development. With a strong track record
in high‑growth environments and change
management, he brings 25 years of board‑level
experience across more than 15 companies,
primarily as Chair.
Responsibilities
Edwin Moses is Chair of the Nomination
Committee, Chair of the Remuneration
Committee, and a member of the Audit
Committee
Ancillary positions
Chair of the Board of LabGenius Ltd
Chair of the Board of NanoSyrinx
Nils Björkman
(1954, Swedish &
Swiss)
Member of the Supervisory Board since:
2022
Current term: 2022−2026
Background
Nils Björkman spent 33 years with the Tetra Pak
Group, holding senior positions in Sweden,
Canada, the United States, the United Kingdom,
and Switzerland. He retired in March 2015 as
Executive Vice President for Commercial
Operations. He has also served as a
non‑executive board member for several
companies. Nils holds an MBA from the
Stockholm School of Economics.
Responsibilities
Nils Björkman is Chair of the Industrialization
Committee and a member of the Remuneration
Committee and the Nomination Committee
Ancillary positions
None
Avantium JV2025 Management Board_02.jpg
Supervisory Board (continued)
Michelle Jou
(1969, Taiwanese)
Member of the Supervisory Board since:
2020
Current term: 2024−2028
Background
Michelle Jou is the CEO of Castrol (part of the
BP group). She previously spent 19 years at
Covestro in senior leadership roles across Asia
and Europe, including serving as President of
the global Polycarbonates segment in Shanghai.
She holds a BA in French from Fu‑Jen University
in Taiwan and an MBA from EMLYON Business
School in France.
Responsibilities
Michelle Jou is a member of the Nomination
Committee and the Remuneration Committee
Ancillary positions
CEO, Castrol (part of the BP group)
Margret Kleinsman
(1963, Dutch)
Member of the Supervisory Board
since: 2017
Current term: 2025−2027
Background
Margret Kleinsman graduated from the
University of Twente and completed her
post‑doctoral research at the Vrije Universiteit
Amsterdam. From 2020 to 2024, she served as
CFO of Agrifirm. Before that, she was CFO of
Holland Colours N.V. and held various roles at
AkzoNobel, where she worked in the chemicals,
fibres and coatings businesses, including two
long‑term assignments in the United States.
Responsibilities
Margret Kleinsman is Chair of the Audit
Committee
Ancillary positions
Member of the Supervisory Board at Brunel
International N.V.
Member of the Supervisory Board at
Barenbrug Holding B.V.
Member of the Supervisory Board at
Bollegraaf & Lubo Recycling Solutions 
Peter Williams
(1955, British)
Member of the Supervisory Board
since: 2023
Current term: 2023–2027
Background
Peter Williams is Group Technology Director and
Head of Investor Relations at INEOS, and
previously served as CEO of INEOS
Technologies. Earlier in his career, he held
senior positions at BP in the UK. Peter holds a
PhD in Chemistry from the University of York.
Responsibilities
Peter Williams is a member of the
Industrialization Committee
Ancillary positions
Group Technology Director and Head of
Investor Relations at INEOS
Non-executive director at V-Carbon
Chair of the Industrial Biotechnology
Innovation Centre in Scotland
Report of the Supervisory Board
Introduction
This report explains how Avantium’s Supervisory Board fulfilled its responsibilities in 2025.
The Report of the Supervisory Board should be read in conjunction with the Corporate Governance
Statement on page 73, which provides information on the Company’s corporate governance structure.
Composition, Diversity, and Independence
The Supervisory Board currently consists of five members: Edwin Moses (Chair), Nils Björkman,
Michelle Jou, Margret Kleinsman, and Peter Williams. The biographies of the Supervisory Board
members are available on the preceding pages of this report and on the Avantium website.
On May 14, 2025, the General Meeting re‑appointed Margret Kleinsman to the Supervisory Board for
a third two‑year term. In proposing her re‑appointment, the Supervisory Board emphasized the
importance of retaining her experience, particularly as Chair of the Audit Committee, to support
continuity.
In November 2025, the Dutch Ministry of Climate Policy and Green Growth (Ministerie van Klimaat en
Groene Groei – KGG) nominated Patrick Polak as observer to the Supervisory Board. This followed
the ministry’s €15 million equity investment in Avantium in September 2025, which included the right
to appoint an observer. As observer, Patrick Polak, attends Supervisory Board and Committee
meetings and receives the same information as Supervisory Board members, for the avoidance of
doubt, without voting rights or quorum status. This arrangement will continue for as long as the
ministry or its affiliates hold shares in Avantium.
Avantium is committed to fostering an inclusive, diverse, and inspiring working environment, as
outlined in the section about Diversity and Inclusion on page 75. This commitment is also reflected in
the composition of the Supervisory Board, which promotes diversity across dimensions such as age,
gender, nationality, industry experience, background, skills, knowledge, and perspectives. In 2025,
women represented 40% of the Supervisory Board, meeting both the Board’s internal target and the
Dutch legal requirement of a minimum of 33% representation of each gender.
Profile
Name
Year of Birth
Nationality
Expertise and Experience
Gender
E. Moses
1954
British and Belgian
Scaling-up and financing innovative
companies
International executive and non-
executive experience
Male
N. Björkman
1954
Swedish
International expertise in the packaging
innovations business
International industry experience
Male
M.B.B. Jou
1969
Taiwanese
International executive experience,
especially Asian region
Commercial experience from chemical
and plastics industries
Female
M.G.
Kleinsman
1963
Dutch
Financial expertise in chemical and
plastics industries
International experience
Female
P.S. Williams
1956
British
Extensive knowledge and experience
in the chemical sector
Comprehensive finance and general
management experience
Male
Retirement and Re-Election Schedule
Name
(Re-)Appointment Date
Year of Possible Re-election
End of Final Term
E. Moses
May 10, 2023
2027
2031
N. Björkman
January 25, 2022
2026
2034
M.B.B. Jou
May 15, 2024
2028
2032
M.G. Kleinsman
May 19, 2021
2027
2029
P.S. Williams
May 10, 2023
2027
2035
All members of the Supervisory Board are considered independent. The Supervisory Board believes
its composition enables members to act critically and independently from one another and from the
Management Board, in line with the Dutch Corporate Governance Code (principles 2.1.7 to 2.1.9).
This independence supports the Supervisory Board in fulfilling its responsibilities under Avantium’s
Articles of Association, including providing both solicited and unsolicited advice and support to the
Management Board.
In 2025, there were no actual or potential conflicts of interest between Avantium and any Supervisory
Board member. As part of the Company’s key control framework and in compliance with legislation,
members of the Supervisory Board and Management Board are required to annually disclose their
related parties and any transactions with the Company. No related‑party transactions occurred in
2025, other than situations in which Supervisory Board members used a management company to
invoice their directors’ fees to Avantium.
Education and Self-Evaluation
Continuous learning is essential for effective governance. Supervisory Board members regularly visit
Avantium’s offices and plants to meet with senior management and other internal stakeholders,
deepening their understanding of the Company’s operations, opportunities, and challenges.
The Chair of the Supervisory Board and the Chief Executive Officer (CEO) meet frequently, both online
and in person, and similar exchanges take place between Committee Chairs and relevant
Management Team members. In addition, one‑on‑one interactions between Supervisory Board
members and Management Team members often arise from discussions during Supervisory Board
meetings, drawing on the specific expertise of individual board members when advice is needed.
The Company provides an onboarding program for newly appointed Supervisory Board members to
ensure they gain a solid understanding of the business, strategy and key risks. The program includes
meetings with fellow Supervisory Board members, the Management Board and other members of
management; detailed presentations on the Company’s operations and risk profile; Dutch corporate
governance topics; and visits to various Company facilities.
The Supervisory Board is committed to ongoing evaluation to strengthen its effectiveness. Each year,
in accordance with the Dutch Corporate Governance Code Section 2.2 and the Supervisory Board
Regulations of Avantium N.V., the Board assesses its composition, competencies and overall
functioning, as well as that of its Committees. The evaluation also covers the relationship between the
Supervisory Board and the Management Board, the performance of individual members, the Chairs of
the Supervisory Board and its Committees, and the composition and functioning of the Management
Board and its individual members.
The Supervisory Board’s 2025 self‑evaluation was conducted through individual interviews, with the
outcomes discussed in closed sessions of the Supervisory Board without the Management Board
present. The overall assessment was positive. Succession planning for both Supervisory Board and
Management Board members, as well as key leadership positions, was discussed in depth, including
from a diversity perspective.
In this context, the Supervisory Board continuously reflects on its own composition, with particular
attention to continuity, orderly rotation, and succession planning. It assesses in a timely manner the
expertise, competencies, experience, and independence required in the event of replacement or
succession of members, ensuring an appropriate balance between continuity and renewal and a
composition aligned with the Company’s strategy, risk profile, and long‑term value creation.
The appointment of a State‑delegated Supervisory Board observer was received constructively and
openly. At the same time, the potential impact on existing Supervisory Board dynamics was
acknowledged and considered as part of the broader evaluation of the Company’s governance
framework and oversight practices.
The Supervisory Board considers its current size and composition appropriate in terms of
competencies, experience, diversity, and geographical representation. It continues to fulfil its duties
effectively, professionally, and constructively.
The Supervisory Board Committees enable efficient and in‑depth consideration of specialized matters
and provide well‑prepared, comprehensive input to support informed plenary discussions and
decision‑making.
The evaluation further highlighted the Supervisory Board’s high level of engagement and availability
throughout the year, reflected in the frequency of meetings held both with and without the
Management Board. During the challenging circumstances of 2025, the Supervisory Board proactively
supported and guided the Management Board, contributing its expertise while maintaining critical
oversight and constructively challenging management where appropriate.
Members are well prepared for meetings, respect diverse perspectives, and actively challenge views,
fostering high‑quality and constructive debate. Trust, openness, and psychological safety within the
Supervisory Board were identified as key strengths. Members also value personal interaction and aim
to further increase face‑to‑face engagement where possible.
The performance of the Management Board is also evaluated throughout the year.
These assessments take place during the Supervisory Board’s closed sessions and are followed up
as appropriate in writing or through face‑to‑face or video conference meetings with the Management
Board and its individual members. The Remuneration Committee is responsible for evaluating the
performance of the Management Board and its members and reports its findings and
recommendations to the full Supervisory Board.
Supervisory Board Meetings in 2025
Meetings and Attendance
The Supervisory Board meets regularly to review the Company’s performance, strategic progress, and
the functioning of both the Supervisory and Management Boards. In 2025, the Supervisory Board held
five formal face-to-face meetings, all attended by the Management Board, except for closed sessions.
Informal dinners were organized around these meetings. In addition, seventeen video conference
updates were held to address urgent matters. The Management Board also provided the Supervisory
Board with regular written updates on financing and other strategic topics. The Supervisory Board
maintained frequent communication with the Management Board both during and between formal
meetings.
The individual attendance per meeting can be found in the table below.
Name
Supervisory Board
meeting
Audit
Committee
meeting
Industrialization
Committee
meeting
Nomination
Committee
meeting
Remuneration
Committee
meeting
E. Moses
22/22
5/5
n.a.
2/2
5/5
N. Björkman
21/22
n.a.
6/6
2/2
5/5
M.B.B. Jou
15/22
n.a.
n.a.
2/2
5/5
M.G. Kleinsman
22/22
5/5
n.a.
n.a.
n.a.
D. Van Meirvenne
2/22*
n.a.
n.a
n.a.
n.a.
P.S. Williams
22/22
n.a.
6/6
n.a.
n.a.
*Dirk Van Meirvenne resigned as Supervisory Board member, effective March 31, 2025.
Topics Discussed in 2025
The Supervisory Board meets at least five times a year (2025: 22 times), including sessions before the
publication of Avantium’s annual and half-year results. These results, along with related documents
like the draft press release and the independent auditor's report, are discussed with the Management
Board.
The Audit Committee reviews such documents and then makes recommendations on them to the
Supervisory Board. The external independent auditor attended the discussion at the Audit Committee
on the 2025 Annual Report and accounts.
In addition to the standard agenda items for meetings, such as the financials and the business
performance throughout the year, the Supervisory Board and Management Board discussed the
following topics in 2025:
Avantium’s liquidity position and overall funding strategy
The Company’s sustainable value‑creation framework and capital allocation priorities
Progress on the commercialization and licensing strategy for FDCA and PEF
Performance updates and strategic direction of Avantium’s other business activities
Developments in new and emerging technologies
Full-year and half-year financial performance, including audit-related matters
The assessment of strategic, technological, operational, financial, and legal risks, and matters
related to control and compliance
Preparation for, evaluation of, and follow‑up to the General Meetings
Sustainability-related topics, including Corporate Sustainability Reporting Directive (CSRD)
requirements and applicable Omnibus rulings
Analyst and investor sentiment, including changes in the shareholder base and structure
Public relations initiatives and thought‑leadership activities
Review and adjustment of remuneration policies for the Management Board and Supervisory Board
Senior leadership performance, organizational developments, and key management appointments
The 2026 budget
The following topics in particular were discussed extensively by the Supervisory Board:
Liquidity Outlook and Funding Strategy
The Supervisory Board and Management Board devoted significant time to evaluating Avantium’s
funding options and financial scenarios, guided by short‑ and medium‑term cash flow forecasts and
required minimum cash balances. Throughout the year, the Board was kept closely informed of
Avantium’s financial position, liquidity outlook, and overall financial plan.
To address short‑term liquidity needs, Avantium secured €10 million in June. This consisted of a €4
million subordinated loan from the Province of Groningen (the second tranche of the agreed €9.9
million) and a €6 million drawdown from the Senior Debt Financing Facilities provided by the lender
consortium (Invest‑NL, ABN AMRO, ING, ASN and Rabobank). In July, Invest‑NL provided an additional
€10 million in senior debt financing, on the condition that it would be repaid from the proceeds of a
planned equity raise. The Supervisory Board engaged in thorough deliberations on all these
short‑term liquidity measures.
This bridge financing enabled Avantium to continue working on longer‑term funding solutions. In
August, Avantium reached agreement with the consortium of lenders on a comprehensive financing
package that amended the Debt Financing Facilities and extended the repayment date from March
2026 to June 2028. The Supervisory Board held extensive discussions on the amendment and
extension of the Debt Financing Facilities.
In September, Avantium launched a capital increase through a fully committed and underwritten rights
offering. The Company raised €84.8 million in equity – significantly exceeding the initial expectation
of €65 million – supported by a €15.0 million equity investment provided by the State of the
Netherlands, represented by the Ministry of Climate Policy and Green Growth..The Supervisory Board
extensively discussed and endorsed the process, structure, and timelines of this capital raise,
including the conditions attached to the support of the State of the Netherlands. These conditions
comprised the Ministry of Climate Policy and Green Growth’s nomination of an observer to the
Supervisory Board and (temporary) adjustments to the remuneration of both the Management Board
and the Supervisory Board.
The Construction of the FDCA Flagship Plant and Commissioning and Start-Up Plan
The construction of the FDCA Flagship Plant, including associated capital expenditures, timeline,
staffing, and governance, was a recurring topic of in‑depth discussion during Supervisory Board
meetings throughout 2025. These discussions were regularly informed by the reports and
conclusions of the Industrialization Committee. Avantium management also conducted periodic
internal audits of the project and shared the findings with the Supervisory Board.
Avantium began 2025 by initiating start‑up activities at the FDCA Flagship Plant in Delfzijl, with the aim
of delivering PEF to customers by the end of the year. However, as a result of a combination of
technical and operational challenges, the commissioning and start‑up period was delayed, with a
material impact on the Company’s financial position.
In early 2025, the ancillary utilities were brought on stream, and in August 2025 the sugar
dehydration unit was successfully brought into operation. Following this latter milestone, Avantium
focused on commissioning and start-up the oxidation and purification units. During these
commissioning activities, the Company identified construction‑related quality issues in certain titanium
welds in the piping, posing a safety risk for start‑up and operations. Subsequent inspections provided
a clearer picture of the extent of the problem and confirmed that more extensive remediation work
was required than initially anticipated.Avantium now expects to complete the start‑up of the FDCA
Flagship Plant by mid‑2026, with sales under its existing offtake agreements anticipated to begin in
the second half of 2026.
Throughout 2025, the Supervisory Board continued to closely monitor progress at the FDCA Flagship
Plant and remained actively engaged with management on key developments and risks.
In addition to its oversight of Avantium N.V., the Supervisory Board also supervises the activities of
Avantium Renewable Polymers B.V., with a particular focus on the engineering, construction and
commissioning of the FDCA Flagship Plant. For this purpose, the Management Board reviewed the
reports of the Project Oversight Board and the Shareholders’ Committee of Avantium Renewable
Polymers and subsequently shared the relevant insights with the Supervisory Board. Further details on
the governance of Avantium Renewable Polymers B.V. are provided in the Corporate Governance
section on page 76.
Cost-Saving Program and Reorganization
The Supervisory Board held extensive discussions with the Management Board and senior
management on the need to implement a strict cost‑saving program, which regrettably included
significant redundancies as part of Avantium’s transition from an organization focused on research
and development (R&D) to a commercial enterprise. In early summer, the Supervisory Board endorsed
the decision to reorganize the Company and reduce labor costs. In total, approximately 40 positions
were terminated across all business units and departments, with the greatest impact in R&D.
Commercial Pipeline and Licensing Strategy
The Supervisory Board actively reviewed and monitored the pipeline of prospective YXY®
Technology licensees. It also closely oversaw the development of conditional offtake agreements for
FDCA and PEF from the FDCA Flagship Plant, as well as capacity reservation agreements for future
licensed plants. Where required, the Supervisory Board assessed and approved the key terms of
these agreements.
Strategic Portfolio Review
The Supervisory Board devoted significant attention to reviewing Avantium’s technology portfolio and
the strategic decisions associated with each platform. It endorsed the decision to prioritize the
commercialization of FDCA and PEF, and to accelerate the related licensing strategy, reflecting their
strong near‑term, high‑growth, and high‑margin potential of the Renewable Polymers business unit.
In line with this strategic focus, Avantium is also exploring strategic options for its other business
activities.
The Supervisory Board supported management’s decision to operate Avantium R&D Solutions as an
independent business unit with its own dedicated leadership team, while actively pursuing strategic
opportunities. It also endorsed the approach to seek strategic or financial partnerships for the Volta
Technology, Dawn Technology®, and Parana Technology, enabling these technologies to be
potentially spun out to partners who will lead further investment while Avantium retains a minority
shareholding. In addition, the Supervisory Board closely monitored the process relating to the sale
process for intellectual property associated with Ray Technology®.
Safety
The Supervisory Board devoted significant attention to safety across Avantium, overseeing the
integration of ISO standards and the further strengthening of a robust safety culture throughout the
Company.
Stakeholder Management
The Supervisory Board actively sought to understand Avantium’s stakeholders, their perspectives,
and their positions on key business matters. Throughout 2025, the Board received regular updates
on stakeholder views from the Management Board, while individual Supervisory Board members also
gathered insights through their own professional networks.
Supervisory Board Committee Activities in 2025
The Supervisory Board delegates detailed discussions on specific topics to four Committees: the
Audit Committee, the Industrialization Committee, the Remuneration Committee, and the Nomination
Committee. These Committees make recommendations on specific topics before the Supervisory
Board makes final decisions in its meetings.
At the end of 2025, the composition of the Supervisory Board committees was as follows:
Audit Committee
Industrialization
Committee
Remuneration Committee
Nomination Committee
Margret Kleinsman (Chair)
Nils Björkman (Chair)
Edwin Moses (Chair)
Edwin Moses (Chair)
Edwin Moses
Peter Williams
Michelle Jou
Michelle Jou
Nils Björkman
Nils Björkman
Report of the Audit Committee
The Audit Committee assists the Supervisory Board in overseeing Avantium’s financing initiatives,
financial reporting, and financial statements, as well as its internal controls, risk management, and
audit systems.
In 2025, the Audit Committee met five times (2024: four) and held two additional calls to approve the
annual and half‑year results. Meetings were attended by the CEO, (interim) Chief Financial Officer
(CFO), General Counsel, Compliance Officer, and the Head of Accounting and Reporting, and, when
relevant, the external auditor, PricewaterhouseCoopers (PwC). Minutes of all sessions were submitted
to the Supervisory Board.
At each meeting, the Audit Committee reviewed key financial, liquidity, and treasury reporting and
accounting matters, as well as internal control and risk management topics, incidents, and any
identified fraud or irregularities. The Committee also considered the Going Concern note included in
the 2025 Annual Report. The Committee monitored the Company’s progress in identifying risks and
implementing mitigation measures, and approved the 2026 Risk Management Plan. It also dedicated
significant attention to business‑ethics matters, including potential bribery, fraud, and corruption, with
regular updates from the Compliance Officer, including on whistleblowing cases. In 2025, there were
no confirmed incidents of fraud or corruption, no legal actions related to anti‑competitive or anti‑trust
behavior, and no reported incidents of discrimination..
In addition, the Audit Committee considered the implications of the forthcoming Corporate
Sustainability Reporting Directive (CSRD). Under the Omnibus Regulation, Avantium is exempt from
CSRD reporting requirements for this year. Nonetheless, in line with the Dutch Corporate Governance
Code, the Company continues to disclose environmental, social, and governance (ESG) information
and applies the European Sustainability Reporting Standards (ESRS), the standards underpinning
CSRD, to guide and structure its ESG reporting.
The Audit Committee also advised the Supervisory Board to nominate PwC for re‑appointment as
external auditor for the 2025 financial year.
Report of the Industrialization Committee
The Industrialization Committee acts as the Supervisory Board's advisory and risk review forum,
overseeing the Company's technology strategy, industrialization roadmaps, and technology portfolio
as determined by the Management Board and senior management. It addresses strategic and
technology portfolio topics through deep-dive sessions, leveraging the expertise of its members and
other Supervisory Board members. The Industrialization Committee met six times in 2025 (2024: nine).
In 2025, the Committee’s primary focus was the progress of the FDCA Flagship Plant construction,
including the costs and the construction schedule. Committee members conducted site visits to the
FDCA Flagship Plant to oversee progress and to engage in detailed discussions with the operations
teams on commissioning and start‑up activities. As part of its oversight, the Committee also monitored
the identification and remediation of the titanium welding issue discovered during commissioning,
reviewing management’s assessment of the safety risks, the scope of the required repairs and the
resulting implications for the commissioning timeline and capital expenditure.
In addition, the Committee reviewed the updated Commissioning and Start‑Up Plan, leveraging the
specialized knowledge of individual Committee members in this area. Beyond the FDCA Flagship
Plant, the Industrialization Committee oversaw the development and execution of Avantium’s broader
technology portfolio and roadmap, dedicating significant time to individual business cases,
intellectual‑property positions, the competitive landscape and long‑term technology roadmaps.
Report of the Remuneration Committee
The Remuneration Committee is responsible for advising the Supervisory Board and preparing its
resolutions on the remuneration of both the Management Board and the Supervisory Board. A key
part of its mandate is to assess whether the performance targets of the Management Board have
been achieved. The Committee met five times in 2025 (2024: three) to review and develop proposals
for the remuneration of individual Management Board members. It presented its findings and
recommendations to the Supervisory Board, which subsequently confirmed the performance
assessments and related remuneration outcomes.
The Committee was closely and intensively involved in the ongoing dialogue on the conditions
attached to the Dutch State Remuneration Measures, including the (temporary) adjustments to the
remuneration of both the Management Board and the Supervisory Board.
Report of the Nomination Committee
The Nomination Committee prepares and reviews proposals for senior nominations, appointments
and re‑appointments. At least once a year, it evaluates the size and composition of the Supervisory
Board and Management Board, as well as the performance of individual members, and discusses
these evaluations with the Supervisory Board. The CEO attends Nomination Committee meetings,
except when his own performance and remuneration are addressed. The Nomination Committee and
the Supervisory Board also continuously review succession planning for both Boards. In 2025, the
Nomination Committee met twice (2024: two). The Chair held regular update calls with the CEO to
stay informed of relevant related developments.
A key topic in 2025 was the search for a Chief Financial Officer. At the end of March 2025, Boudewijn
van Schaïk resigned as CFO and Management Board member, effective May 9, 2025, to pursue his
career elsewhere. Bert Cornelese assumed the role of interim CFO on April 1, 2025, and in August
2025, René Ploegsma succeeded him as interim CFO. The Company is in the final stages of recruiting
a permanent CFO for nomination and appointment, with the Nomination Committee closely involved in
and overseeing this process.
To ensure continuity and support for Avantium’s strategic direction, the Nomination Committee
advised the Supervisory Board to nominate Tom van Aken for re‑appointment as CEO and
Management Board member for an additional four‑year term, ending at the close of the 2029 Annual
General Meeting (AGM). The Supervisory Board highlighted the importance of his expertise and
network for Avantium’s future progress. Shareholders approved his re‑appointment at the AGM on
May 14, 2025.
The Nomination Committee also reviewed the composition of the Supervisory Board and
recommended the re‑appointment of Margret Kleinsman for a two‑year term, from the close of the
2025 AGM until the close of the 2027 AGM. In supporting her re‑appointment, the Supervisory Board
emphasized the value of her experience, including as Chair of the Audit Committee, to safeguard
continuity. Her nomination was approved by shareholders at the AGM on May 14, 2025.
General Meetings of Shareholders in 2025
On May 14, 2025, the AGM took place at the Wicked Grounds venue in Amsterdam. Avantium’s
shareholders approved all items on the agenda at the 2025 AGM. This included the adoption of the
2024 financial statements. Additionally, Tom van Aken was re-appointed as a member of the
Management Board, and Margret Kleinsman was re-appointed as a member of the Supervisory Board.
PwC was appointed as the external auditor for the financial year 2025. Furthermore, the shareholders
approved a 1:10 share consolidation and designated the Management Board to issue ordinary shares
up to the statutory maximum of the authorized share capital, and to limit or exclude pre-emptive rights
in respect thereof, for a period of 18 months from the date of this AGM.
As in previous years, the Chair of the Audit Committee outlined the Committee's work in 2024,
including the Company's collaboration with PwC, and other relevant items from that year. The lead
partner from PwC discussed the audit procedure and the independent auditor's report for 2024. More
information about the 2025 AGM, including minutes, voting results, and attendance, can be found on
Avantium's website.
Financial Statements 2025 and Profit Appropriation
The financial statements for the financial year 2025 were prepared by the Management Board in
compliance with Articles 20 and 21 of the Articles of Association. Attached to these statements is the
unqualified report from the independent auditor, PwC, with a paragraph indicating a material
uncertainty related to going concern. The financial statements and the outcome of the external audit
were discussed by the Audit Committee with the Management Board in the presence of the external
independent auditor.
The 2025 financial statements were endorsed by all Management Board and Supervisory Board
members and are, together with PwC’s independent auditor’s report, included in this Annual Report.
The Management Board will present the 2025 financial statements at the AGM on May 12, 2026.
The Supervisory Board requests that the AGM grants discharge to the members of the Management
Board and to the members of the Supervisory Board for their respective duties in 2025.
Gratitude
The Supervisory Board expresses its deep appreciation to all Avantium employees for their
exceptional dedication during a year of significant transition. Despite the challenges of 2025, the
Supervisory Board is confident that the Company has established a solid foundation for meaningful
commercial progress in the years ahead. The Supervisory Board further expresses its appreciation to
the Management Board and senior leadership for their perseverance, steadfast commitment, and their
continued open and constructive dialogue with the Supervisory Board during a demanding year.
Finally, the Supervisory Board is grateful to shareholders, lenders, the Dutch government, the
Province of Groningen, partners, and customers for their continued trust and support of Avantium’s
strategy and long‑term ambitions.
Amsterdam, March 17, 2026
On behalf of the Supervisory Board,
Edwin Moses, Chair
Nils Björkman
Michelle Jou
Margret Kleinsman
Peter Williams
Remuneration Report 2025
Letter from the Chair of the Remuneration Committee
On behalf of the Remuneration Committee, I am pleased to present the 2025 Remuneration Report.
This report outlines the remuneration policies for the Management Board and the Supervisory Board
and describes how these policies were applied in 2025.
In the following sections, I reflect on the Company’s performance in 2025 and the resulting
remuneration outcomes, as well as the Committee’s key activities during the year and our outlook for
2026.
2025 Company Performance and Remuneration Outcomes
Looking back at 2025, the year was unlike any other in Avantium’s history. The Company achieved
the partial start‑up of the 5‑kilotonne Flagship Plant for the production of FDCA in Delfzijl, the
Netherlands, which marked an important milestone on the path to commercializing its plant‑based,
circular plastic PEF, marketed under the brand name releaf®. At the same time, construction‑related
challenges led to delays in fully starting up the Flagship Plant, which had a significant impact on
Avantium’s financial position. To support the business through this period, Avantium secured a
comprehensive financing package. The Company also had to implement strict cost‑saving measures
and make substantial organizational changes as it transitioned from an R&D‑focused organization to a
commercial company.
Strategic Progress
Not all parts of the FDCA Flagship Plant were started up as planned in 2025. While the
sugar‑dehydration unit and utility systems were successfully started up during the year,
construction‑related quality deficiencies in the titanium welding were identified in the summer of
2025. To ensure a safe and reliable start‑up, an extensive weld remediation program was initiated.
As a result, the start‑up of the oxidation and purification units was delayed.
Avantium has sharpened its strategic focus by prioritizing the commercialization of its FDCA and
PEF technology and accelerating its licensing strategy. In line with this direction, the Company is
exploring strategic options for its other business activities.
Commercial Progress
Avantium secured new offtake agreements in 2025 with partners such as PLIXXENT (construction
materials), and Hoogesteger (Albert Heijn fresh juice bottles).
To further accelerate the market adoption of PEF, the Company also entered into capacity
reservation agreements for future licensed plants with companies including Amcor (bottles), Biovox
(pharmaceutical packaging), Hordijk (Albert Heijn food packaging) and Logoplaste (packaging).
Avantium announced a strategic alliance with its feedstock supplier Tereos and commercial partner
LVMH GAÏA to scale up PEF production across Europe. Building on the long‑standing collaboration
within the PEFerence consortium, the new partnership aims to identify and secure an operational
partner to build and operate the first industrial‑scale facility in Europe based on Avantium’s YXY®
Technology, an important pillar of the Company’s licensing strategy. Additional licensing
agreements are expected once the Flagship Plant is fully operational, as potential partners wish to
see successful start‑up before committing.
Due to the delayed start‑up of the FDCA Flagship Plant, the Company did not realize the planned
revenues from Flagship Plant product sales and from licensing activities in 2025. 
Financial Progress
Avantium reached an agreement with lenders to amend the terms of the Debt Financing Facilities
that extended the loan maturity to June 2028 and introduced lower interest rates, partly payable in
kind.
Avantium launched an equity raise in September despite challenging market conditions. While the
initial target was €65 million, new investors together with the existing shareholder base ultimately
contributed nearly €85 million.
As part of the Company’s comprehensive financing plan, Avantium implemented a strict cost‑saving
program and a reorganization to support its transition from an R&D‑focused organization to a
commercial company.
Organizational Progress
Regretted turnover refers to employees that the Company would have preferred to avoid. In 2025,
regretted turnover amounted to 4.5% in 2025 against a target of 10%.
In 2025, training participation reached 77.2% across the courses offered, meeting the target.
The Chief Financial Officer (CFO) and Chief Operating Officer (COO) positions were filled through
interim appointments.
Safety
No work-related safety accidents, fatalities, or serious injuries were recorded in 2025.
Avantium successfully achieved certification for ISO 140001, 45001, and 9001 (environmental
management systems, occupational health and safety systems, and quality management systems,
respectively).
Environmental, Social, and Governance (ESG)
Avantium updated the Life Cycle Assessment (LCA) for PEF in 2025, but the Company has not yet
quantified circularity parameters, such as waste avoided.
Due to budget constraints, Avantium did not implement improvements to its Scope 3 monitoring and
management system.
In 2025, the Double Materiality Assessment was finalized and published, action plans and policies
for the prioritized European Sustainability Reporting Standards (ESRS) – Environmental and Social
Risks, meaning the material sustainability topics identified through the Double Materiality
Assessment – were drafted and initial action plans implemented, and structural ESG data monitoring
and reporting were established.
A new proposed ESG strategy has been developed, presented to, and approved by the
Management Team.
The Remuneration Committee carefully considered all relevant events in 2025 and ensured that their
impact was appropriately reflected in the application of the Remuneration Policy and the assessment
of the achievement of the targets.
After careful consideration and following the assessment made by the Remuneration Committee on
the level of achievement for each of the goals for 2025, the Supervisory Board made the following
decisions:
There was an average total Company achievement of approximately 50% of the 2025 goals.
The achievement assessment of the Company’s 2025 goals together with the assessment of
individual goals and business unit goals will form the basis for the cash incentive bonus payment to
all staff and senior management's annual performance-related cash bonus component (short-term
incentive) and the non-cash long-term annual variable incentive component (long-term incentive),
excluding the Management Board (see below).
There was an achievement of 37% of the Management Board's goals.
Conditions of the State of the Netherlands’ support in the September 2025 Equity Raise
As part of the conditions attached to the State of the Netherlands’ support in the September 2025
equity raise, Avantium and the Ministry of Climate Policy and Green Growth (KGG) agreed to
temporary remuneration measures ("the Dutch State Remuneration Measures"). These apply as of
September 22, 2025, until the earlier of: the Company achieving a positive EBITDA and maintaining a
positive EBITDA outlook for the immediately succeeding six‑month period; KGG ceasing to be a
shareholder; or December 31, 2027. During this period, the fixed remuneration of the Chief Executive
Officer (CEO) and Chief Financial Officer (CFO) will be capped at €350,000 and €320,000
respectively, with no variable remuneration (including short- and long-term incentives) to be awarded.
Supervisory Board remuneration will be reduced by 25%.
2025 Remuneration Committee Focus Areas
In 2025, the Remuneration Committee met five times (2024: three times) to review and develop
remuneration proposals for individual Management Board members. The Committee held extensive
discussions about the Management and Supervisory Boards' remuneration conditions attached to the
Dutch State Remuneration Measures. In addition, the Remuneration Committee discussed the
achievement of the Company’s targets and strategic objectives, senior management remuneration
(including short‑term and long‑term incentives), and remuneration‑related matters concerning the
Company’s employees. It presented its findings and recommendations to the Supervisory Board,
which subsequently confirmed the performance assessments and related remuneration outcomes.
I look forward to discussing the remuneration practices in the 2026 Annual General Meeting (AGM),
and will be happy to answer any questions you may have.
Edwin Moses
Chair of the Remuneration Committee
Introduction
This Remuneration Report outlines the remuneration policies for Avantium’s Management Board and
Supervisory Board and provides an overview of the remuneration paid to their members in the 2025
financial year. It has been prepared in accordance with the relevant provisions of Section 135, Book 2
of the Dutch Civil Code and the EU guidelines under the Shareholders’ Rights Directive. Remuneration
has been determined in line with the Remuneration Policy adopted at the AGM on May 15, 2024,
effective as of January 1, 2024 and the Dutch State's Remuneration Measures imposed on the
Management and Supervisory Boards. This Remuneration Report for the 2025 financial year will be
submitted to the AGM on May 12, 2026 for an advisory vote, in accordance with Section 135b(2), Book
2 of the Dutch Civil Code.
The Remuneration Report for the 2024 financial year was submitted to the 2025 AGM and received a
positive advisory vote (96.1%).
Remuneration Policies
Introduction and Governance of the Remuneration Policies
The Remuneration Policies for the Management Board and for the Supervisory Board were adopted at
the AGM of May 15, 2024 and are effective as per January 1, 2024. The Management Board
Policy with respect to the Management Board and Supervisory Board, adopted by the General
Meeting on May 14, 2020, and effective as per January 1, 2020.
The Supervisory Board is responsible for establishing and implementing the Remuneration Policies.
The Remuneration Committee regularly reviews these policies, consults key internal and external
stakeholders, and advises the Supervisory Board on any necessary updates
i) Management Board Remuneration Policy
The Remuneration Policy for the Management Board supports Avantium’s purpose, long‑term
strategy, and stakeholder expectations while maintaining an appropriate risk profile. The Supervisory
Board ensures its alignment with Avantium’s strategic objectives. The remuneration structure balances
short‑ and long‑term performance, promoting long‑term value creation, integrity, and good corporate
governance. It motivates strong performance through a mix of financial and non‑financial measures.
As sustainability is central to Avantium’s strategy, its sustainability objectives are embedded in the
remuneration framework.
The Supervisory Board aims to remunerate the Management Board fairly within the relevant labor
market. In formulating the 2024 Management Board Remuneration Policy, the Supervisory Board took
into account the remuneration and employment conditions of the wider organization – including the
Management Team, senior management, and other employees – supported by internal pay‑ratio
disclosures in the annual Remuneration Report. Stakeholder and societal expectations were also
considered, alongside the external environment, statutory requirements and codes, market practice,
and input from Avantium’s major shareholders. The Supervisory Board further sought advice from an
external remuneration expert and consulted Avantium’s Works Council.
External Perspective: Reference Group and Market Positioning
In 2024, the Supervisory Board conducted a remuneration benchmark to assess the market
competitiveness of the Management Board’s remuneration. The benchmark was based on a
reference group of peer companies selected to reflect Avantium’s size, profile and international
scope, comprising companies across several industries, including chemicals, paper and forest
products, electrical equipment, containers and packaging, and automobile components.
The benchmark covered base salary, target short‑term incentive, total cash compensation, long‑term
incentive (as a percentage of base salary) and total direct compensation. The Supervisory Board
intends to conduct the next full remuneration benchmark following the conclusion of the Dutch State
Remuneration Measures as per below, or in any event in 2028.
Conditions of the State of the Netherlands’ support in the September 2025 Equity Raise
As part of the conditions attached to the State of the Netherlands’ support in the September 2025
equity raise, Avantium and the Ministry of Climate Policy and Green Growth (KGG) agreed to
temporary remuneration measures ("the Dutch State Remuneration Measures"). These apply as of
September 22, 2025 until the earlier of: the Company achieving a positive EBITDA and maintaining a
positive EBITDA outlook for the immediately succeeding six‑month period; KGG ceasing to be a
shareholder; or December 31, 2027. During this period, the fixed annual remuneration of the CEO and
CFO will be capped at €350,000 and €320,000 respectively, with no variable remuneration
(including short- and long-term incentives).
ii) Supervisory Board Remuneration Policy
The Remuneration Policy for the Supervisory Board supports the Company’s long‑term development
in a dynamic environment while meeting stakeholder expectations and maintaining an appropriate risk
profile. To attract and retain high‑caliber talent and support sustainable value creation, the
Remuneration Committee upholds the principle of a one‑off share‑based award in the form of
restricted share units for Supervisory Board members upon appointment and reappointment.
Conditions of the State of the Netherlands’ Support in the September 2025 Equity Raise
The Dutch State Remuneration Measures applicable during the relevant period, including a mandatory
reduction of Supervisory Board remuneration by 25%, have been taken into account and may affect
the Company’s ability to attract and retain Supervisory Board members of the desired profile.
For compliance with, and any deviations from, the Dutch Code, reference is made to page 77.
Remuneration 2025
The remuneration paid to the members of the Management Board in 2025 was based on Avantium’s
For 2025, prior to September 22, 2025, the remuneration for members of the Management Board
included the following key
components:
I. Fixed annual base salary;
II. Short-term annual variable remuneration (STI) (not applicable as of September 22, 2025);
III. Long-term annual variable remuneration (LTI) (not applicable as of September 22, 2025);
IV. Company contributions for pension and social security premiums and fringe benefits.
As of September 22, 2025, the remuneration of the members of the Management Board was
adjusted, in accordance with the Dutch State Remuneration Measures, to a fixed capped
remuneration, inclusive of Company contributions for pension and social security premiums.
Avantium does not grant any personal loans, guarantees, or advance payments to members of the
Management Board.
i) Fixed Annual Base Salary
The fixed annual base salary aims to reward Management Board members for their daily
responsibilities and overall performance. It is determined based on their level of responsibility and
performance, and is set around the median of the remuneration levels within the reference group.
However, there is flexibility to deviate up to 20% above or below this median.
In years without a benchmark, the Supervisory Board evaluates the need for base salary adjustments
based on market trends and salary changes for other Avantium employees. Any adjustments should
not exceed the median of the reference group by more than 20%, although purchasing power
adjustments are permitted.
In 2025, the CEO’s full‑year base salary was set at €342,000 (2024: €342,500). The CFO resigned
effective May 9, 2025; accordingly, a pro‑rated portion of his base salary was paid (92,000) (2024:
255,000). As of September 22, 2025, in light of the Dutch State Remuneration Measures, the CEO’s
full‑year base salary was adjusted on a pro rata basis to ensure compliance with the €350,000 cap
on fixed annual remuneration.
ii) Short-Term Annual Variable Remuneration (STI)
The objective of the STI is to ensure that Management Board members remain focused on achieving
short‑term operational goals that support long‑term value creation. The STI is an annual
performance‑related cash bonus, set at 60% of base salary for the CEO and 45% for the CFO.
These on‑target percentages significantly exceed the market median, underscoring the emphasis on
pay‑for‑performance during the transition from a pre‑revenue company to profitability.
The maximum bonus – payable in the event of above‑target performance – is 150% of the on‑target
bonus. No bonus is paid if performance falls below the predefined threshold. For performance
between the threshold and the maximum, the bonus is determined on a sliding scale ranging from
50% to 150% of the on‑target bonus.
At the beginning of each financial year, the Supervisory Board sets specific performance targets,
including a threshold level that triggers a 50% payout of the on‑target STI and an over‑performance
level that qualifies for the maximum 150% payout. Performance below the threshold results in no
award.
The Supervisory Board may exercise discretion to adjust the incentive pay‑out upwards or
downwards if the calculated outcome is deemed unreasonable or inappropriate in light of
circumstances during the performance period, including the long‑term interests and sustainable
success of the Company. Scenario analyses of the potential outcomes of the variable remuneration
components and their impact on Management Board remuneration are performed.
Although the Management Board achieved 37% of its targets in 2025, no STI variable remuneration
will be awarded, in accordance with the Dutch State Remuneration Measures.
The Supervisory Board did not use its power to recover any remuneration from present or former
Management Board members.
Performance Goals
Bonus pay‑outs are prorated based on the achievement of defined performance criteria. These
criteria comprise a balanced mix of ESG, strategic, commercial, financial, and operational targets,
ensuring focus on both the Company’s short‑term financial performance and its long‑term strategic
objectives.
The Supervisory Board sets targets for each performance measure that are both ambitious and
achievable. These targets are reviewed annually, with semi‑annual reviews conducted if deemed
appropriate. Once set, performance measures generally remain unchanged throughout the
performance period, although the Supervisory Board may adjust targets or weightings in response to
significant shifts in strategic priorities. To ensure alignment across the organization, a subset of the
bonus performance measures, target‑setting approach, and pay‑out structure in the Management
Board Remuneration Policy is also applied to Avantium employees.
Performance goals are also specific and measurable and are set and communicated at the start of
each financial year, unless the Supervisory Board determines that semi‑annual target‑setting is more
appropriate. Targets and their weightings may be adjusted during the year if circumstances warrant it.
Following a presentation by the Management Board, the Supervisory Board establishes the targets
based on progress in sustainability, commercial, financial and operational performance, in line with
Avantium’s strategy and long‑term objectives, as set out in the Management Board Remuneration
In setting the performance goals, the interests of all stakeholders, internal and external, are
considered.
Strategic progress targets support long‑term value creation and may include securing financing,
forming strategic partnerships, and achieving key strategic milestones. Commercial targets focus on
advancing the commercialization of technology programs, including securing partnerships and
progressing from laboratory to demonstration, commercial, and ultimately industrial scale through
licensing. Operational and financial targets relate to delivering the operational milestones of the
various technology programs and meeting financial and organizational performance goals. ESG
targets are derived from the Company’s roadmap for executing its sustainability plan and ESG
reporting, including health and safety.
While Avantium believes that detailed targets are strategically and commercially sensitive, it
recognizes the need for transparency with external stakeholders. The Company will continue to
carefully consider this matter, both in advance of setting targets and retrospectively.
For the annual bonus in 2025, the performance targets and their relative weighting were set as
follows:
Performance Targets Weighting 2025
Name
Weight factor
Target
T.B. van Aken
35%
Strategic
20%
Commercial
20%
Financial
15%
Operational
10%
ESG
The Remuneration Committee carefully considered all relevant events in 2025 and ensured that their
impact was appropriately reflected in the application of the Remuneration Policy and the assessment
of target achievement.
After careful consideration and following the assessment made by the Remuneration Committee on
the level of achievement for each of the goals for 2025, the Supervisory Board made the following
decisions:
There was an average total Company achievement of approximately 50% of the 2025 goals.
The achievement assessment of the Company’s 2025 goals together with the assessment of
individual goals and business unit goals will form the basis for the cash incentive bonus payment to
all staff and senior management's annual performance-related cash bonus component (short-term
incentive) and the non-cash long-term annual variable incentive component (long-term incentive).
There was an achievement of 37.3% of the Management Board's goals.
In accordance with the Dutch State Remuneration Measures, no STI variable remuneration will be
awarded to the Management Board in the applicable period.
For the assessment of the goal achievements in 2025, the following considerations were made:
The Company placed the greatest weight on strategic targets. These targets related primarily to the
start‑up of the FDCA Flagship Plant. While the sugar‑dehydration unit and utility systems were
successfully started up during the year, construction‑related quality deficiencies in the titanium
welding were identified in the summer of 2025. To ensure a safe and reliable start‑up, an extensive
weld‑remediation program was initiated, resulting in a delay of the start‑up of the oxidation and
purification units.
Additional strategic targets related to the exploration of strategic options for Avantium R&D
Solutions and Volta Technology, following the Company’s sharpened strategic focus on
commercializing FDCA and PEF. These efforts had not come to a conclusion by year‑end 2025.
The commercial targets were assessed as partly achieved. Avantium secured several new
commercial partnerships, although not at the planned target level. Despite progress in advancing its
licensing strategy – through new capacity reservations, expansion of the IP portfolio, and the
formation of a strategic alliance with feedstock supplier Tereos and commercial partner LVMH GAÏA
– the Company did not sign an additional technology licensing agreement in 2025. Due to the
delayed start‑up of the FDCA Flagship Plant, the Company also did not realize the budgeted
revenues from product sales from the FDCA Flagship Plant and from licensing activities.
The financial targets for the Company were achieved in 2025. Avantium reached an agreement with
its lenders to amend the terms of the Debt Financing Facilities, with an extension of the loan
maturity to June 2028 and lower, partly payment‑in‑kind, interest rates. In addition, Avantium
launched an equity raise in September despite challenging market conditions. Although the initial
target was €65 million, new investors together with the existing shareholder base ultimately
contributed nearly €85 million. As part of the comprehensive financing plan, Avantium also
implemented a strict cost‑saving program and a reorganization to support its transition from an
R&D‑focused organization to a commercial company.
The operational targets were partially achieved. Regretted turnover – defined as the percentage of
employees who leave the Company and whose departure the organization would have preferred to
avoid – amounted to 4.5% in 2025 against a target of 10%, resulting in full target achievement.
Training participation reached 77.2% across the courses offered, meeting the target. The CFO and
COO positions were filled through interim appointments rather than permanent appointments, and
this target was therefore not achieved.
With respect to the ESG targets, Avantium extended its positive safety record with zero safety
accidents. Avantium updated the LCA for PEF in 2025; however, the Company has not yet
quantified circularity parameters such as waste avoided. Due to budget constraints, improvements
to the Scope 3 monitoring and management system were not implemented. In 2025, the Double
Materiality Assessment was finalized and published, action plans and policies for the prioritized
ESRS – Environmental and Social Risks, meaning the material sustainability topics identified through
the Double Materiality Assessment – were drafted, and initial actions were implemented. Structural
ESG data monitoring and reporting processes were also established. In addition, a new proposed
ESG strategy was developed, presented to, and approved by the Management Team.
The overall achievement of the Management Board for the performance year 2025 amounts to 37%.
Reference is made to the table below. Although the Management Board achieved 37% of its targets in
2025, no STI variable remuneration may be awarded in accordance with the Dutch State
Remuneration Measures in the applicable period.
Total Performance 2025
Name
Weight Factor
Target
Measured
Performance
Total Performance
in 2025
T.B. van Aken
35%
Strategic
—%
37%
20%
Commercial
3%
20%
Financial
20%
15%
Operational
5%
10%
ESG
9%
Performance Targets and Outcome 2025
Performance Measure
Objective
Target
Performance
ESG
Safety and health
1. Zero accidents as per Avantium’s incident classification system
1. Achieved
ESG
Chain Reaction 2030
implementation
1. Achieve ecological, operational, supplier, and people targets related to related to CO₂ reduction, circularity, waste reduction, Scope 1, 2
and 3 emissions, and CSRD
1. Partly achieved
Strategic
Achieve strategic milestones
1. Safe and timely start-up of FDCA Flagship Plant
2. Achieve strategic focus in the Company's technology portfolio
1. Not achieved
2. Not achieved
Commercial
Drive commercial performance
1. Drive licensing business as long-term commercialization business model by signing new licensing deals
2. Ensure commercial loading of FDCA Flagship Plant
3. Record planned revenues from FDCA Flagship Plant and licensing business
1. Not achieved
2. Partly achieved
3. Not achieved
Financial
Drive financial performance
1. Ensure the Company has access to sufficient funding to operate with 12-months runway
2. Ensure extension of Debt Financing Facilities package until 2027
3. Implement Company efficiencies and cost reductions
1. Achieved
2.Achieved
3.Achieved
Operational
Drive organizational performance
1. Staff retention: manage regretted loss percentage below 10%
2. Invest in training and development of employees
1. Achieved
2. Achieved
iii) Long-Term Annual Variable Remuneration (LTI)
To create direct alignment with long-term shareholder value, members of the Management Board may
receive conditional awards of performance share units (PSUs) on an annual basis.
In accordance with the Dutch State Remuneration Measures, no long-term variable remuneration will
be awarded to the Management Board during the relevant period.
iii.a) Performance Share Units
The number of PSUs granted corresponds to 70% of the CEO’s fixed annual base salary and 55% of
the CFO’s. This LTI percentage – above the reference‑market median of 60% – reinforces the
pay‑for‑performance principle and ensures that Management Board compensation is aligned with the
Company’s long‑term objectives and shareholders’ interests.
The number of PSUs granted each year is determined as follows: for 2025, using a one‑year
volume‑weighted average share price (VWAP) as of the publication date of the 2024 Annual Report;
and thereafter, using a two‑year VWAP as of the publication date of the Annual Report. Subject to the
Supervisory Board’s underpin assessment, the PSUs will vest three years after the grant date and will
be subject to a five‑year lock‑up period from the date of award, except for customary sell‑to‑cover
transactions to meet applicable tax obligations. The Supervisory Board will conduct an underpin
assessment at vesting. This assessment will evaluate long‑term value creation over the vesting period
and determine whether vesting is justified, taking into account the overall performance of the
Management Board member during that period.
The Supervisory Board will assess (i) the long‑term value created by the Management Board over the
vesting period and (ii) whether any significant financial or non‑financial events occurred in the years
preceding vesting. As input for this overall assessment, the Supervisory Board conducts regular
interim evaluations of points (i) and (ii) throughout the vesting period as part of its annual review of
goal achievements.
Based on this evaluation, the Supervisory Board will, at its sole discretion, determine the extent to
which Management Board members are entitled to the shares corresponding to the PSUs and
whether any portion of the PSUs will be forfeited. The annual remuneration report for the relevant
vesting year will disclose the outcome of the underpin assessment for awards whose vesting period
ended during that reporting year, including the number of vested and forfeited PSUs and the
corresponding shares delivered.
Any awards to members of the Management Board are subject to customary leaver provisions, which
are interpreted and applied by the Supervisory Board at its sole and absolute discretion. For a good
leaver, the Supervisory Board may, at its discretion, decide whether (i) a prorated number of PSUs will
vest, (ii) the standard vesting schedule will continue to apply, or (iii) alternative vesting conditions will
apply as deemed appropriate.
iii.b) Share Ownership Guidelines
Members of the Management Board are required to build and maintain a personal shareholding in
Avantium within five years of their appointment, with additional time granted if the requirement
increases materially. This obligation underscores their commitment to the Company’s strategy and
long‑term success.
The current shareholding requirement is 150% of the CEO’s fixed annual gross base salary and 100%
of the CFO’s. The value of the shareholding is assessed annually, with the Supervisory Board aiming
to apply a consistent calculation methodology. The requirement can be met by retaining all after‑tax
shares from the LTI plan and does not require personal share purchases.
The Supervisory Board allows a five‑year period for Management Board members to build the
required shareholding, taking into account the LTI plan’s three‑year vesting period. Members may sell
shares to cover taxes arising from the LTI plan or previous incentive plans. The Supervisory Board
may temporarily waive the shareholding requirement in exceptional circumstances, such as significant
share‑price fluctuations and for the relevant period, the Dutch State Remuneration Measures.
iii.c) Adjustments to Variable Remuneration
In line with Dutch law, the variable remuneration of Management Board members may be reduced or
reclaimed if any of the circumstances described in Section 4.2 (Management Board Remuneration:
Adjustments to Variable Remuneration) of the Remuneration Policy apply.
iv) Allowance for Pension and Fringe Benefits
Members of the Management Board may participate in the Company’s pension plan, which is available to all
Avantium employees. Avantium pays the employer contribution to this defined‑contribution plan.
The pension contribution for Management Board members is currently capped at a pensionable salary of
€137,800 (2025), and they are not compensated for the difference between this pensionable salary and
their base salary. There are no arrangements for early retirement.
If revisions are made to the Dutch Pension Act, the Supervisory Board reserves the right to make
reasonable accommodations.
Additionally, Management Board members receive expense reimbursements, such as travel
expenses, social security costs, and contributions to health and disability insurance, all in accordance
with Avantium's policies, plans, and arrangements.
The table on page 96 provides a breakdown of the aggregate remuneration of the members of the
Management Board in 2025.
Management Board Agreements and Severance Payments
Each member of the Management Board provides services based on a services agreement with the
Company ("overeenkomst van opdracht") according to Article 7:400 of the Dutch Civil Code.
The term of the services agreement is for a definite period, typically matching the term for which each
member is appointed by the General Meeting. The Company's notice period is four months, unless
the Supervisory Board decides to extend it to six months. Each agreement includes customary
provisions on protective covenants and confidentiality.
The Supervisory Board may determine that a member of the Management Board is entitled to a
severance payment for loss of income resulting from termination of their position as a Management
Board member. Any severance payment is limited to one year’s base salary, in line with the Code, and
any severance or compensation awarded by a court in relation to the termination of the management
agreement will be deducted from this amount.
10 Other benefits mainly include contributions to social security plans and benefits in kind such as mobility allowance, medical expenses, legal expenses, CFO educational costs, and an annual fixed allowance as compensation for the loss of certain expense
reimbursements received from the former CFO's previous employer.
11 Including the awarded bonus for the specific performance year.
12 Including the value of the various performance share-based plans that vested during the year. The value of the long-term investment plan (LTIP) reward is calculated based on the number of matching shares that have vested and of the share price at the date of
vesting. The value of the employee stock option plan (ESOP) reward is calculated based on the number of share options that have vested during the year and the net of the share price at vesting date less the exercise price. The value of the performance share
units (PSU) reward is calculated based on the number of PSUs that have vested and of the share price at the date of vesting represents the estimated fair value of the awards, or any changes in such estimates until grant date is achieved, which are reflected in
the expenses recognized for the awards during the three-year cliff-vesting period.
13 Employer costs refer to the total expenses incurred by an employer in relation to employing staff. These costs include social security contributions, pension premiums, insurance, taxes, and other employee-related benefits and overheads.
Total Remuneration Received by Members of the Management Board
(In €1,000)
Fixed Remuneration
Variable
Management Board Member
Salary
Other
Benefits 10
Short-Term
Bonus 11
Long-Term Award 12
Post-Employee Benefits
Total Remuneration
% of Fixed
Remuneration
% of Variable
Remuneration
Employer
Cost 13
T.B. van Aken
2025
342
18
2
16
378
100%
0%
13
2024
343
28
82
107
30
590
68%
32%
13
B.W. van Schaïk (former CFO)
2025
92
7
2
101
100%
0%
7
2024
255
88
46
22
18
429
84%
16%
16
B.J.J.V. Welten (former CFO)
2025
1
1
0%
100%
2024
19
19
0%
100%
Total – 2025
434
26
3
18
480
99%
1%
20
Total – 2024
598
116
128
147
48
1,038
73%
27%
29
CEO-CFO Remuneration pie charts.svg
The total remuneration based on the International Financial Reporting Standards (IFRS) in 2025 for
Tom van Aken amounted to €428,000 (2024: €699,000) due to the share-based payment expenses
of €50,000 recognized during the year (2024: €216,000). The total remuneration based on IFRS in
2025 for Boudewijn van Schaïk amounted to €103,000 (2024: €478,000) due to the share-based
payment expenses of €2,000 recognized during the year (2024:€70,000). In 2025, no severance
payment was awarded to the CFO, who resigned effective May 9, 2025. In accordance with the Dutch
State Remuneration Measures, base salary and other cash based elements have been adjusted
accordingly and short-term and long-term variable remuneration will not be awarded to the
Management Board during the relevant period (as of September 22, 2025).
14 Starting as of January 1, 2021, the value of the share-based component of the remuneration is determined at the time of assignment in accordance with the applicable rules under IFRS. Before January 1, 2021, the value of the share-based component of the
remuneration was determined based on the value of the options that vested during the year and the net of the share price at vesting date less the exercise price.
Internal Pay Ratio
In setting the Remuneration Policy for the Management Board, the Supervisory Board also considers
the internal pay ratio. This ratio compares the average remuneration of all Avantium employees with
the CEO’s average remuneration for 2025. Since 2020, the calculation has also included pension
contributions and long‑term incentive components.
The 2025 pay ratio is 5:1 (2024: 6:1; 2023: 6:1; 2022: 6:1 2021: 6:1 2020: 5:1) for the CEO.
The 2025 pay ratio is based on the specific guidance on the calculation methodology of the pay ratio
effective as of January 1, 2023, as provided in the Dutch Code. 14 The following table provides an
overview of the remuneration of the members of the Management Board compared with the average
total remuneration of an Avantium employee (defined as gross wages, holiday allowance, other
benefits, pension, bonus, and long-term awards) and Company performance.
The table includes information on a five-year period, as of 2020.
(In €1,000)
2025
% change
2024
% change
2023
% change
2022
% change
2021
% change
2020
Management Board Member
T.B. van Aken
378
-36%
590
-4%
615
11%
553
-6%
589
34%
440
B.W. van Schaïk (former CFO)
101
-77%
429
-7%
460
0%
0%
0%
B.J.J.V. Welten (former CFO)
1
-96%
19
-61%
47
-87%
364
-12%
411
35%
304
Average employee salary
105
18%
88
-9%
97
0%
96
5%
91
12%
81
15 The Company’s performance and achievement of the performance measures for 2020 was set to zero percent herein; as the Management Board and senior management decided to forfeit their respective annual cash bonus, the Company elected not to
disclose the realized achievement of the 2020 performance targets.
The average total Company performance for 2025 was approximately 50%. This score reflects the
weighted achievement of performance targets, as  employees are remunerated based on
Company‑wide performance (strategic, commercial, financial, operational, and ESG targets) and
business unit-specific performance. Depending on the business unit, the weighting between
Company-wide and business unit performance is set at either 50%/50% or 30%/70%, Business unit
performance is assessed against more granular financial, commercial, operational, and organizational
targets relevant to that unit.
2025
% change
2024
% change
2023
% change
2022
% change
2021
% change
2020 15
Total Company Performance
50%
12%
45%
-43%
78%
-6%
83%
-1%
84%
100%
—%
Number of Shares Outstanding relating to Performance Share Units
The main conditions of share option plans
Information Regarding the Reported Financial Year
Management Board
Member
Specification
of Plan
Award Date
Vesting Date
Number of Vested PSU's
as at January 1
Number of Unvested
PSU's Outstanding as at
January 1
PSU's Granted
During the
Year
PSU's
Forfeited
During the
Year
Share
Consolidation
PSU's Vested
During the
Year
PSU's Vested
as at
December 31
Number of
Unvested PSU's as at
December 31
T.B. van Aken, CEO
PSU
1/1/2024
12/31/2027
85,320
(76,788)
8,532
5/15/2025
12/31/2027
10,858
10,858
B.W. van Schaïk, former
CFO
PSU
1/1/2024
12/31/2027
49,911
(49,911)
Total Management Board members
10,858
(49,911)
19,390
16 The value of Matching Shares vested during the year is expressed in EUR and is determined by the share price at vesting date.
Number of Investment Shares and Matching Shares Outstanding and Awarded to the Management Board
The main conditions of share plans
Information regarding the reported financial year
T.B. van
Aken,
CEO
Management
Board
Member
LTIP –
Investment
Shares
Specification
of Plan
Performance
Period
Award Date
Vesting Sate
End of
Eetention
Period
Number of
Awards
Outstanding
January 1
Shares
Allocated
During the
year
Shares
Forfeited
During the
Year
Share
Consolidatio
n
Shares
Vested
During the
Year
Value of
Matching
Shares Vested
During the
Year in EUR 16
Matching
Shares
Unvested as
at December
31
Shares
Subject to
Retention
Period as at
December 31
Matching
Shares
Vested as at
December 31
2019-2020
5/14/2020
5/14/2023
5/14/2025
15,365
(13,829)
2021-2022
5/18/2022
5/18/2025
5/18/2027
24,323
(21,891)
2,432
2022-2023
5/10/2023
5/10/2026
5/10/2028
17,220
(15,498)
1,722
n/a
5/14/2020
5/14/2023
5/14/2025
18,115
(16,304)
1,812
n/a
5/18/2022
5/18/2025
5/18/2027
24,323
(21,891)
270
386
2,432
n/a
5/10/2023
5/10/2026
5/10/2028
17,220
(15,498)
1,385
1,457
191
B.J.J.V.
Welten, 
former CFO
LTIP –
Investment
Shares
2021-2022
5/18/2022
5/18/2025
5/18/2027
11,728
(10,555)
1,173
LTIP – Matching
Shares
n/a
5/18/2022
5/18/2025
5/18/2027
11,728
(10,555)
130
698
130
Total Management Board members
116,566
(104,911)
1,656
1,843
191
4,154
4,244
Total former Management Board members
23,456
(21,110)
130
698
1,173
130
Under the Remuneration Policy effective from January 1, 2020, to January 1, 2024, the Management
Board was eligible for long-term variable remuneration in the form of shares (long-term incentive plan;
LTIP). Members of the Management Board were required to invest the entire non-cash component of
their net bonus in shares provided by the Company (Investment Shares). This non-cash component
constituted 50% of the bonus. Additionally, the cash component of the bonus could also be invested
in Investment Shares at the discretion of the Board member.
Investment Shares are subject to a five-year retention period. After this period, Avantium will match
the Investment Shares on a 1:1 basis (Matching Shares), granting one Matching Share for each
Investment Share. These Matching Shares are delivered at the end of the five-year retention period.
If a Board member is no longer with the Company at the end of the retention period, the number of
Matching Shares will be reduced according to the LTIP. The reduction is based on the termination
date and reason for departure, with a pro-rata reduction based on the number of full months the
Board member was not engaged.
At the AGM on May 15, 2024, shareholders approved a 17.9% increase in LTIP shares to compensate
for the value reduction from not receiving claim rights for entitlements to shares and being unable to
exercise or sell them, following the €70 million capital raise, including through a rights issue in
February 2024, which resulted in the dilution of LTIP participants' rights.There is no change in the
vesting period.
On May 14, 2025, the Annual General Meeting adopted the 1:10 share consolidation. Effective on
May 22, 2025, the share consolidation has resulted in 10 ordinary shares being consolidated into
one ordinary share. The share-based compensation plans provide the Supervisory Board with the
right to adjust the number of units accordingly upon the occurrence of a share consolidation. After the
consolidation, the total intrinsic and fair value of share units and options remains unchanged.
Therefore, as the economic value of the grants under the share-based compensation plans has
been preserved after the consolidation and the consolidation is not beneficial to the counterparties,
this modification to the existing share-based compensation plans has not had an impact.
17 The exercise price is the modified price after the 1:10 share consolidation as approved by the shareholders during the AGM held on May 14, 2025. The exercise price is the modified price after the 17,9% decrease in the exercise price as approved by the
shareholders during the AGM held on May 15, 2024.
18 The value of share options vested during the year is expressed in EUR and is determined by the average share price at vesting date less the exercise price.
Number of Options Outstanding and Awarded to the Management Board
The main conditions of share option plans
Information regarding the reported financial year
Management Board
Member
Specification
of Plan
Award Date
Vesting Date
Exercise
Period
Exercise Price of
the Option in
EUR 17
Number of
Options
Outstanding
as at
January 1
Share
Options
Granted
During the
Year
Share
Options
Forfeited
During the
Year
Share
Consolidation
Share
Options
Vested
During the
Year
Value of
Share
Options
Vested
During the
Year 18
Share Options
Unvested as
at December
31
Share Options
Vested as at
December 31
T.B. van Aken, CEO
ESOP
5/17/2017
5/17/2020
8 years
86.90
50,000
(45,000)
5,000
3/28/2018
3/28/2021
8 years
43.84
50,000
(45,000)
5,000
5/16/2019
5/16/2022
8 years
21.35
100,000
(90,000)
10,000
5/14/2020
5/14/2023
8 years
29.47
50,000
(45,000)
5,000
5/19/2021
5/19/2024
8 years
37.44
50,000
(45,000)
5,000
5/18/2022
5/19/2025
8 years
25.20
50,000
(45,000)
556
5,000
5/10/2023
5/10/2026
8 years
28.74
50,000
(45,000)
1,667
556
4,444
B.W. van Schaïk, CFO
ESOP
12/30/2022
12/30/2025
8 years
29.97
50,000
(417)
(45,000)
1,528
4,583
5/10/2023
5/10/2026
8 years
28.74
20,000
(444)
(18,000)
667
1,333
Total Management Board members
470,000
(861)
(423,000)
4,417
556
45,361
Until January 1, 2024, when the current Management Board Remuneration Policy came into effect,
share options under the employee stock option plan (ESOP) were awarded annually to members of
the Management Board based on performance parameters pre-determined by the Supervisory Board.
The Options fully vest on the third anniversary following the date of the award. The exercise period of
the Options is up to five years after the date of vesting. The Options vest at the end of a three-year
vesting term and not on an annual pro-rata basis during this period. Only if a member of the
Management Board is no longer employed by the Company at the date of vesting would the number
of options be decreased as provided for in the ESOP. This reduction depends on the cause of
departure and termination date, with a pro-rata decrease based on the number of full months the
Board member was not engaged during the three-year vesting period.
At the AGM held on May 15, 2024, the shareholders approved the decrease of the exercise price of
the Options granted under the ESOP by 17.9% to compensate for the value reduction from not
receiving claim rights for share options and being unable to exercise or sell them, following the
€70 million capital raise, including through a rights issue in February 2024, which resulted in
the dilution of ESOP participants' rights. There is no change in the vesting period.
On May 14, 2025, the AGM adopted the 1:10 share consolidation. Effective on May 22, 2025, the share
consolidation has resulted in 10 ordinary shares being consolidated into one ordinary share. The
share-based compensation plans provide the Supervisory Board with the right to adjust the number of
units accordingly upon the occurrence of a share consolidation. After the consolidation, the total
intrinsic and fair value of share units and options remains unchanged. Therefore, as the economic
value of the grants under the share-based compensation plans has been preserved after the
consolidation and the consolidation is not beneficial to the counterparties, this modification to the
existing share-based compensation plans has not had an impact.
In 2025, 0 additional share options under the ESOP plan were granted to the Management Board.
The share-based payment expenses of the Management Board of €52,000 comprise the part of the
share-based compensation attributable to the share options granted in previous years and PSUs
(note 14).
19 The exercise price is the modified price after the 17,9% decrease in the exercise price as approved by the shareholders during the AGM held on 15 May 2024.
20 The value of share options exercised during the year is expressed in EUR and is determined by the share price at exercise date less the exercise price.
Number of Options Outstanding and Awarded to Former Management Board Member
The main conditions of share option plans
Information regarding the reported financial year
Management
Board member
Specification
of plan
Award date
Vesting date
Exercise period
Exercise price
of the option in
EUR 19
Number
of options
outstanding as
at January 1
Share options
exercised
during the
year
Share options
forfeited
during the
year
Share
consolidation
Share options
vested during
the year
Value of
share options
vested during
the year 20
Share options
unvested as at
December 31
Share options
vested as at
December 31
B.J.J.V Welten,
former CFO
ESOP
5/14/20
5/14/23
8 years
29.50
44,444
(40,000)
4,444
5/19/21
5/19/24
8 years
37.40
16,667
(15,000)
1,667
5/18/22
5/19/25
8 years
25.20
6,667
(6,000)
667
Total former Management Board members
67,778
(40,000)
6,778
Management Board Remuneration 2026
The 2026 goals are only being disclosed to the extent that they are not share-price or competition
sensitive. For this reason, some of these goals are described generically.
As per the current Management Board Remuneration Policy of 2024, the on-target bonus for
the CEO is 60% of his annual base salary. The on-target bonus for the CFO is 45% of his annual base
salary. In accordance with the Dutch State Remuneration Measures, no short-term or long-term
variable remuneration will be awarded to the Management Board during the relevant period (as of
September 22, 2025). The Management Board's performance will, however, continue to be
measured. 
Performance Targets Weighting 2026
Performance Measures 2026
CEO
CFO
Strategic
30%
30%
Commercial
25%
25%
Operational – financial performance
20%
20%
Operational – organizational performance
15%
15%
ESG
10%
10%
Total performance
100%
100%
Performance Targets and Weighting 2026
Performance
Measure
Objective
Target
Weight
Management
Board
Financial
Non-financial
ESG
Safety and health
1. Zero accidents as per Avantium’s incident classification system
5.0%
0.0%
5.0%
ESG
Sustainability Strategy
1. Achieve ecological, operational, supplier, and people targets related to rolling out the updated sustainability strategy, establishing
policies and governance for the new priorities, reporting in line with these priorities and goals, and strengthening Avantium’s positioning
in ESG ratings
5.0%
0.0%
5.0%
Strategic
Achieve strategic
milestones
1. Safe and timely start-up of FDCA Flagship Plant
2. Achieve strategic focus in the Company's technology portfolio
30.0%
10.0%
20.0%
Commercial
Drive commercial
performance
1. Drive licensing business as long-term commercialization business model by signing new licensing deals and record planned revenues
from licensing business
2. Drive market adoption of PEF and FDCA by signing new offtake agreements and capacity reservations
25.0%
25.0%
0.0%
Operational
Drive financial
performance
1. Improve EBITDA in order to reach EBITDA break-even in 2027
2. Ensure the Company remains well capitalized
20.0%
20.0%
0.0%
Operational
Drive organizational
performance
1. Staff retention: manage regretted loss percentage below 10%
2. Ensure that at least 85% of employees complete structured and documented goal‑setting and mid‑year and year‑end performance
reviews.
15.0%
0.0%
15.0%
Total
100.0%
55.0%
45.0%
Supervisory Board Remuneration 2025
Remuneration Policy for the Supervisory Board
The remuneration of the members of the Supervisory Board consists of the following components:
i. annual fee;
ii. restricted share units (RSUs); and
iii. travel and other expenses. 
i) Annual Fee
The Supervisory Board Remuneration Policy, effective from January 1, 2024, determines the annual
(gross) fees for each position of the Supervisory Board, separated into membership and chairship of
the Supervisory Board and membership and chairship of a Committee.
In line with the Supervisory Board Remuneration Policy, the members of the Supervisory Board
received the following annual (gross) fees:
Membership of the Supervisory Board: €45,000;
Chairship of the Supervisory Board: €40,000 (additional);
Membership of a Committee of the Supervisory Board: €6,000 (per Committee); and
Chairship of the Audit Committee of the Supervisory Board: €10,000 (additional).
A mandatory 25% reduction in Supervisory Board remuneration was applied in line with the Dutch
State Remuneration Measures in force as of September 22, 2025.
The table hereafter provides a breakdown of the Supervisory Board members’ remuneration in 2025.
Avantium does not grant any personal loans, guarantees, or advance payments to members of the
Supervisory Board.
ii) Restricted Share Units (RSUs)
Effective as of January 1, 2024, a new equity-based incentive plan in the form of RSUs was introduced.
Upon (re-)appointment, shares are awarded to members of the Supervisory Board in the form of RSUs,
which are non-performance-based instruments.
Based on an appointment or re-appointment term of four (4) years, the number of RSUs to be granted
to Supervisory Board members is:
1. A fixed grant of 55,000 shares upon (re-)appointment of the Chair of the Supervisory Board; and
2. A fixed grant of 20,000 shares upon (re-)appointment of other members of the Supervisory Board.
Vesting of RSUs takes place on an annual pro-rata basis during a period of four years as of the date of
the grant, therefore fully vesting on the fourth anniversary following the date of the grant.
If the membership of a member of the Supervisory Board is terminated or ends prior to the date of
vesting, the number of shares will be decreased depending on the Supervisory Board member’s end
date, on an annual pro-rata basis during the period of four years. Settlement of RSUs takes place in
ordinary shares.
A lock-up period of one year applies from the date that the shares have fully vested. Members of the
Supervisory Board are not entitled to any dividend equivalents during the period that the RSUs have
not vested.
Customary sell-to-cover and net settlement clauses apply, based on which the members of the
Supervisory Board are entitled to dispose of shares or RSUs as soon as they have become
unconditional, in deviation from the applicable holding period and other conditions, to meet
applicable tax obligations.
Any awards to members of the Supervisory Board under the RSU plan are subject to customary leaver
provisions, which are to be interpreted and applied by the Supervisory Board in its sole and absolute
discretion.
With respect to compliance with and deviations from the Dutch Code, reference is made to page 73.
In accordance with the Dutch State Remuneration Measures, RSUs will not be awarded to a
Supervisory Board member upon (re-)appointment during the relevant period (as of September 22,
2025).
iii) Travel Expenses and Other Expenses
Supervisory Board members shall be reimbursed for all reasonable costs incurred in connection with
their attendance of meetings. Travel costs will be reimbursed in line with Avantium’s Travel Policy.
Any other expenses shall only be reimbursed, either in whole or in part, if incurred with the prior
consent of the Chair. In addition, Supervisory Board members may be granted a fixed net cost
allowance covering certain predefined out-of-pocket expenses.
21 Other compensation includes expenditures related to travel.
22 Long-term award includes the value of the ESOP plan and RSU plan. The value of the ESOP reward is calculated based on the number of share options that have vested during the year and the net of the share price at vesting date less the exercise price. The
value of the RSU award is calculated based on the number of RSUs that vested during the year and of the share price at the date of vesting.
Total Overview of Supervisory Board Remuneration 2025
(In €1,000)
Fixed remuneration
Variable remuneration
Membership
Committees
Other compensation 21
Long-term award 22
Total remuneration
% of fixed remuneration
% of variable remuneration
E. Moses
79
17
2
98
98%
2%
M.B.B. Jou
42
11
3
20
76
70%
30%
D. Van Meirvenne
11
2
13
100%
%
M.G. Kleinsman
42
9
51
100%
%
P.S. Williams
42
6
48
100%
%
N. Björkman
42
17
3
61
97%
5%
Total – 2025
258
62
8
20
347
92%
8%
Detail on the Total Remuneration Received by Each Supervisory Board Member in 2025
(In €1,000)
2025
2024
2023
2022
2021
2020
E. Moses
98
106
98
123
121
133
M.G. Kleinsman
51
55
50
50
50
50
M.B.B. Jou
76
66
55
67
70
47
N. Björkman
61
71
60
57
P.S. Williams
48
51
29
Total Supervisory Board members
334
349
292
297
241
230
Remuneration of former Supervisory Board members
C.A. Arnold (member until March 31, 2022)
17
53
14
G.E. Schoolenberg (member until September 1, 2022)
25
44
13
D.J. Lucquin (member until September 30, 2020)
44
D. Van Meirvenne (member till 31 March 2025)
13
53
30
Total former Supervisory Board members
13
53
30
42
97
71
Total remuneration
347
402
322
339
338
301
The total remuneration based on IFRS in 2025 for Edwin Moses amounted to €124,000 (2024:
195,000) due to the share-based payment expenses of €26,000 recognized during the year (2024:
90,000). The total remuneration based on IFRS in 2025 for Michelle Jou amounted to €77,000
(2024: €76,000) due to the share-based payment expenses of €20,000 recognized during the year
(2024: €16,000). The total remuneration based on IFRS in 2025 for Nils Björkman amounted to
63,000 (2024: €79,000) due to the share-based payment expenses of €2,000 recognized during
the year (2024: €11,000). The total remuneration based on IFRS in 2025 for Dirk Van Meirvenne
amounted to €23,000 (2024: €77,000) due to the share-based payment expenses of €10,000
recognized during the year (2024: €25,000). The total remuneration based on IFRS in 2025 for Peter
23 The value of share options vested during the year is expressed in EUR and is determined by the share price at vesting date less the exercise price.
24 The value of share options exercised during the year is expressed in EUR and is determined by the share price at exercise date less the exercise price.
Williams amounted to €57,000 (2024: €76,000) due to the share-based payment expenses of
10,000 recognized during the year (2024: €25,000).
Number of Options Supervisory Board
The main conditions of share option plans
Specification of plan
Award date
Vesting date
Exercise period
Exercise price of the option in EUR
E. Moses
ESOP
May 10, 2023
May 10, 2026
8 years
28.74
M.B.B. Jou
ESOP
May 14, 2020
May 14, 2023
8 years
29.47
N. Björkman
ESOP
May 18, 2022
May 19, 2025
8 years
25.20
D. Van Meirvenne
ESOP
May 10, 2023
May 10, 2026
8 years
28.74
P.S. Williams
ESOP
May 10, 2023
May 10, 2026
8 years
28.74
Information regarding the reported financial year
Specification
of plan
Number of
options
outstanding
January 1
Share options
granted during
the year
Share options
exercised
during the year
Share options
forfeited
during the year
Share
consolidation
Share options
vested during
the year
Value of share
options vested
during the year 23
Value of share
options
exercised during
the year 24
Share options
unvested as at
December 31
Share options
vested as at
December 31
E. Moses
ESOP
85,000
(76,500)
2,833
944
7,556
M.B.B. Jou
ESOP
30,000
(27,000)
3,000
N. Björkman
ESOP
30,000
(27,000)
333
3,000
P.S. Williams
ESOP
30,000
(27,000)
1,000
333
2,667
Total Supervisory Board members
175,000
(157,500)
4,167
1,278
16,222
The main conditions of share option plans
Information regarding the reported financial year
Management Board
member
Specification
of plan
Award date
Vesting date
Number of
vested shares
as at
January 1
Number of
unvested shares
outstanding as at
January 1
Share options
granted during
the year
Share options
forfeited during
the year
Share
consolidation
Share options
vested during the
year
Shares vested as
at December 31
Number of
unvested
shares as at
December 31
M.B.B. Jou
RSU
5/15/2024
5/14/2028
20,000
(18,000)
2,000
Total Management Board members
2,000
Until January 1, 2024, when the new Supervisory Board Remuneration Policy took effect, share
options under the ESOP were awarded to Supervisory Board members upon (re-)appointment.
Each member received 30,000 Options, while the Chair received 85,000 Options.
Members could choose to decline the award.
Margret Kleinsman chose not to receive the Options award. With respect to compliance with and
deviations from the Dutch Code, reference is made to page 77.
At the AGM held on May 15, 2024, the shareholders approved the decrease of the exercise price of
the Options granted under the ESOP by 17.9% to compensate for the value reduction from not
receiving claim rights for share options and being unable to exercise or sell them, following the
€70 million capital raise, including through a rights issue in February 2024, which resulted in the
dilution of ESOP participants' rights. There is no change in the vesting period.
On May 14, 2025 the Annual General Meeting adopted the 1:10 share consolidation. Effective on
May 22, 2025, the share consolidation has resulted in 10 ordinary shares being consolidated into
one ordinary share. The share-based compensation plans provide the Supervisory Board with the
right to adjust the number of units accordingly upon the occurrence of a share consolidation. After the
consolidation, the total intrinsic and fair value of share units and options remains unchanged.
Therefore, as the economic value of the grants under the share-based compensation plans has been
preserved after the consolidation and the consolidation is not beneficial to the counterparties,
this modification to the existing share-based compensation plans has not had an impact.
Financial Statements 2025
Consolidated Financial Statements 2025
Consolidated Statement of Financial Position
As at December 31
in Euro x 1,000
Notes
2025
2024
ASSETS
 
Non-current assets
Property, plant and equipment
5
278,771
234,971
Intangible assets
6
2,942
3,271
Right-of-use assets
7
6,157
7,820
Other non-current assets
9
188
189
Total non-current assets
288,058
246,251
Current assets
Inventories
8
1,419
1,317
Trade and other receivables
9
9,225
14,244
Cash and cash equivalents
10
57,466
23,898
Assets held for sale
11
2,916
Total current assets
68,110
42,375
Total assets
356,168
288,626
EQUITY
Equity attributable to owners of the parent
Ordinary shares
12
25,195
8,611
Share premium
411,213
341,761
Other reserves
12
1,339
8,392
Accumulated losses
(285,228)
(262,910)
Total equity attributable to the owners of the parent
152,519
95,854
Non-controlling interests
13
(2,922)
1,931
Total equity
149,597
97,785
in Euro x 1,000
Notes
2025
2024
LIABILITIES
Non-current liabilities
Borrowings
17
12,806
7,523
Financial liability
20
10,485
Shareholder loan
18
27,431
Trade and other payables
16
709
859
Prepayment liabilities
16
360
600
Lease liabilities
7
5,269
7,708
Provisions
19
2,880
3,022
Total non-current liabilities
59,940
19,712
Current liabilities
Borrowings
17
105,805
110,511
Financial liability
20
7,593
Shareholder loan
18
13,436
Lease liabilities
7
3,262
2,409
Trade and other payables
16
36,990
37,020
Provisions
19
574
123
Liabilities associated with asset held for sale
11
37
Total current liabilities
146,631
171,129
Total liabilities
206,571
190,841
Total equity and liabilities
356,168
288,626
The accompanying notes are an integral part of these Consolidated Financial Statements.
25EBITDA is an important measurement of the Company's financial performance before taking the cost of capital, depreciation and taxes into consideration. EBITDA margins provide a view of operational efficiency and enable a more accurate and relevant
comparison between peer companies. In presenting and discussing Avantium’s financial position, operating results and cash flows, Avantium (like many other publicly listed  companies) uses certain Alternative performance measures (APMs) not defined by IFRS.
These APMs are used because they are an important measure of Avantium’s business development and Avantium’s management performance. Please see Alternative performance measures as included under Financial performance 2025
Consolidated Statement of Profit or Loss and Comprehensive Income
For the year ended December 31
in Euro x 1,000
Notes
2025
2024
Revenues
21
14,593
21,036
Other income
22
3,404
4,596
Total revenues and other income
17,997
25,632
Operating expenses
Raw materials and contract costs
24
(4,408)
(4,669)
Employee benefit expenses
23; 24; 25
(34,281)
(35,890)
Office and housing expenses
24
(3,332)
(3,981)
Patent, license, legal and advisory expenses
24
(4,220)
(5,903)
Laboratory expenses
24
(6,151)
(4,232)
Advertising and representation expenses
24
(764)
(1,826)
Other operating expenses
24
(907)
(2,411)
Net operating expenses
(54,063)
(58,912)
EBITDA 25
(36,066)
(33,280)
Depreciation, amortization and impairment charge
24
(6,968)
(5,230)
Operating loss
(43,034)
(38,510)
Finance income
26
379
1,475
Finance costs
26
(2,720)
(2,946)
Fair value remeasurement
20 ; 38
18,242
7,354
Loss before income tax
(27,133)
(32,627)
Income tax expense
27
Loss for the year
(27,133)
(32,627)
Other comprehensive income
Total comprehensive loss for the year
(27,133)
(32,627)
in Euro x 1,000
Notes
2025
2024
Loss attributable to:
Owners of the parent
(22,518)
(26,868)
Owners of the non-controlling interests
13
(4,615)
(5,759)
(27,133)
(32,627)
Total comprehensive loss attributable to:
Owners of the parent
(22,518)
(26,868)
Owners of the non-controlling interests
13
(4,615)
(5,759)
(27,133)
(32,627)
in Euro
Notes
2025
2024
Loss per share attributable to the ordinary equity holders of the
company
Basic earnings per share
15
(1.70)
(3.56)
Diluted earnings per share
15
(1.70)
(3.56)
The accompanying notes are an integral part of these Consolidated Financial Statements.
Consolidated Statement of Changes in Equity
For the year ended December 31
in Euro x 1,000
Ordinary shares
Share premium
Other reserves
Accumulated losses
Non-controlling interest
Total Equity
Balance at January 1, 2024
4,321
271,006
6,924
(236,078)
7,690
53,863
Loss for the year
(26,868)
(5,759)
(32,627)
Total Comprehensive expense for the year
(26,868)
(5,759)
(32,627)
Transactions with owners
Share based payments
1,512
1,512
Issue of ordinary shares due to capital raise
4,284
70,755
75,039
Transfer value share scheme to accumulated losses
(38)
38
Issue of ordinary shares from share option plan
6
(6)
Total transactions with owners
4,290
70,755
1,468
38
76,551
Balance at December 31, 2024
8,611
341,761
8,392
(262,910)
1,931
97,785
Balance at January 1, 2025
8,611
341,761
8,392
(262,910)
1,931
97,785
Loss for the year
(22,518)
(4,615)
(27,133)
Total Comprehensive expense for the year
(22,518)
(4,615)
(27,133)
Transactions with owners
Employee share schemes - value of Employee services
594
594
Transfer value share scheme to accumulated losses
(200)
200
Issue of ordinary shares due to capital raise
15,423
64,666
80,089
Cost relating to equity raise
(2,110)
(2,110)
Informal capital distribution - shareholder loan
(7,446)
(1,301)
(8,747)
Informal capital contribution - shareholder loan
1,063
1,063
Warrants exercised
189
2,622
2,811
Issue of ordinary shares upon conversion of convertible
loan
972
4,274
5,246
Total transactions with owners
16,584
69,452
(7,052)
200
(238)
78,946
Balance at December 31, 2025
25,195
411,213
1,339
(285,228)
(2,922)
149,597
The accompanying notes are an integral part of these Consolidated Financial Statements.
26 Interest paid consist of the following: Interest paid on borrowings 10.0 million (2024 :7.7 million) (refer to note 17); interest paid on leases 0.4 million ( 2024: 0.5 million); commitment fees 0.3 million (2024: 0.2 million); other interest on bank accounts and
charges 0.1 million (2024: 0.7 million) and other interest income 0.6 million
Consolidated Statement of Cash Flows
For the year ended December 31
in Euro x 1,000
Notes
2025
2024
Cash flows from operating activities
Loss for the year
(27,133)
(32,627)
Adjustments for:
Depreciation of property, plant and equipment
5
1,313
2,395
Amortization
6
341
230
Depreciation of right of use assets
7
2,483
2,578
Share-based payment
14
594
1,454
Finance income - net
26
2,341
1,471
Fair value remeasurement
20
(18,242)
(7,354)
Impairment of property, plant and equipment
5
2,831
27
Changes in working capital:
(Increase)/ Decrease in inventories
8
(102)
51
Decrease/(Increase) in trade and other receivables
9
5,079
(1,258)
Increase/(Decrease) in trade and other payables
16
1,990
(4,447)
Increase in provisions
19
419
3
Cash flows from operations
(28,088)
(37,476)
Interest received on current accounts
26
380
1,475
Net cash used in operating activities
(27,708)
(36,001)
Cash flows from investing activities
Purchases of property, plant and equipment
5
(20,651)
(58,325)
Purchases of intangible assets
6
(12)
(310)
Net cash used in investing activities
(20,663)
(58,635)
in Euro x 1,000
Notes
2025
2024
Cash flows from financing activities
Proceeds from convertible loan
17
5,000
Net proceeds from capital raise
12
77,978
75,039
Proceeds from borrowings
17
21,883
14,775
Repayment of borrowings
17
(10,000)
Proceeds from shareholder loan
18
5,033
Interest paid 26
(10,178)
(9,060)
Principal elements of lease payments
7
(2,789)
(2,394)
Net cash generated from financing activities
81,927
83,360
Net increase/(decrease) in cash and cash equivalents
33,556
(11,277)
Cash and cash equivalents at beginning of the year
10
23,898
35,216
Effect of exchange rate changes
26
12
(41)
Cash and cash equivalents at end of financial year
10
57,466
23,898
The accompanying notes are an integral part of these Consolidated Financial Statements.
Main Notes to the Consolidated Financial Statements
1.  General Information
Avantium N.V . (‘the Company’) is a company incorporated and domiciled in the Netherlands , with its
statutory seat at Zekeringstraat 29-31, 1014 BV in Amsterdam . The Company is listed on Euronext
Amsterdam and Brussels. Chamber of Commerce number: 34138918.
The Consolidated Financial Statements of the Company for the year ended December 31, 2025
comprise the Company and its subsidiaries (together referred to as 'the Group'). The Company is also
the ultimate parent of the Group.
These Consolidated Financial Statements are part of the Company's statutory financial statements for
the year ended December 31, 2025, which also include the company financial statements.
The Company is primarily involved in developing and commercializing next generation bio-based
plastics and chemicals based on our unique technological capabilities in advanced catalysis research
& development . The Company also provides R&D solutions in the field of sustainable chemistry and is
the leading provider of advanced catalyst testing technology and services to accelerate catalyst R&D.
These Consolidated Financial Statements were authorized for issue by both the Management Board
and the Supervisory Board on March 17, 2026.
2.  Summary of Material Accounting Policies
The material accounting policies applied in the preparation of these Consolidated Financial
Statements are set out below. These policies have been consistently applied to all the years
presented, unless otherwise stated.
2.1  Basis of Preparation
The Consolidated Financial Statements have been prepared in accordance with IFRS Accounting
Standards as adopted by the European Union and section 2:362 sub 9 of the Netherlands Civil Code.
The Consolidated Financial Statements have been prepared under the historical cost convention,
except for derivatives which are stated at fair value.
2.1.1  Going Concern
The financial statements have been prepared on a going concern basis.
As Avantium continues to transition from a company focused on technology development to an
operational company, the focus is on the start-up of the FDCA Flagship Plant and the subsequent
entry into the operational and commercial stage. The net cash inflow for the year ended December 31,
2025 amounted to €33.6 million (2024: net cash outflow of € 11.3 million).
Avantium’s cash position (including restricted cash of €1.6 million) was €57.5 million as at December
31, 2025 (December 31, 2024: €23.9 million). During 2025, Avantium's cash position increased
primarily due to the successful equity raise completed in the summer of 2025. In June, Avantium
secured €10.0  million in short‑term financing from the Province of Groningen and its senior lender
consortium. In August, the Company agreed an amended and extended Debt Financing Facilities with
its lenders. In September, Avantium completed an €84.8 million equity raise, supported by a €15.0
million investment from the State of the Netherlands. Together with cost controls and a Company
reorganization impacting approximately 40 positions, this capital strengthened Avantium’s financial
position. The cash outflow for the year was mainly driven by operating expenses, capital expenditure
relating to the FDCA Flagship Plant, and interest payments.
Until the Company reaches EBITDA break-even, it will depend on external sources of funding. In this
respect, the following elements are fundamental to its continuity:
Successful completion of commissioning, start-up, and start of commercial production at the FDCA
Flagship Plant as of mid-2026;
Compliance with conditions and undertakings under the existing Debt Financing Facilities;
Achievement of FDCA Flagship Plant product sales income
and milestone payments from license agreement engagements in the second half of 2026;
Securing additional funding from a government-related investment initiative;
The satisfactory conclusion of the ongoing discussions with Worley concerning the close‑out of the
construction phase of the FDCA Flagship Plant; and
Successful execution of strategic options for the non-core technology assets and related cost
management.
Overview of the Uncertainties
Successful completion of commissioning, start-up, and start of commercial production at the FDCA
Flagship Plant as of mid-2026
The successful start-up of the FDCA Flagship Plant and the start of commercial production are key
milestones for the Company and a prerequisite for its licensing strategy, underpinning expected future
profitability and cash flows. Once commercial operations have commenced, Avantium Renewable
Polymers will be able to produce FDCA from the FDCA Flagship Plant that can be converted into PEF
and supplied to its customers under existing offtake agreements. This will result in the Company
starting to generate revenues from the FDCA Flagship Plant.
Avantium completed construction of its FDCA Flagship Plant in October 2024 and subsequently
commenced phased commissioning and start-up. The commissioning and start-up phase is inherently
complex and subject to technical, operational and safety-related uncertainties. In such a phase,
unforeseen events may occur that can result in additional capital expenditure and operating
expenditure, including as a result of technical defects, rework or delays.
During commissioning, construction-related quality issues were identified in certain titanium welds,
representing a safety risk for start-up and operations. In the second half of 2025, further expert
assessment identified that the percentage of affected welds was higher than initially assessed.
These issues delayed the overall start-up schedule. The Company now expects to complete start-up
by mid-2026 and to commence product sales under existing offtake agreements in the second half of
2026.
Any delay in commencing commercial product sales will extend the period without product sales
income and may delay milestone payments from technology license agreement engagements, as well
as potentially impacting compliance with conditions and undertakings under the existing Debt
Financing Facilities.
Compliance with conditions and undertakings under the existing Debt Financing Facilities
The Company’s Debt Financing Facilities contain conditions, including milestone-related undertakings
linked to achieving the Production Operation Date, the sale of technology licenses based on proven
technology following the achievement of the Production Operation Date, minimum liquidity
requirements, and conditions related to additional offtake agreements to cover the ramp-up of the
FDCA Flagship Plant. Meeting these conditions within the required timeframes depends on the
successful and timely commissioning, start-up and ramp-up of the FDCA Flagship Plant.
Certain conditions and undertakings under the Debt Financing Facilities are operational in nature and
may be subject to interpretation, including those related to insurance coverage, minimum cash
balances and offtake agreements. Failure to comply with such conditions and undertakings, including
technical or administrative non-compliance, may constitute a breach under the Debt Financing
Facilities.
If any such breaches are not remedied or waived, the lenders may be entitled to exercise remedies
under the Debt Financing Facilities, which could include acceleration of repayment, requests for
payment of waiver fees, impact on interest or other enforcement actions. Any such actions would
have a material adverse effect on the Company’s liquidity position.
With respect to compliance with the conditions and undertakings under the existing Debt Financing
Facilities, the Company acknowledges that, as at December 31, 2025, a technical breach existed
under an insurance related covenant, as further described in Note 17 to the Consolidated Financial
Statements.
This breach resulted from the continued commissioning phase of the FDCA Flagship Plant and the
fact that the transition from construction all-risk insurance to operational insurance could not yet be
completed within the originally prescribed timeframe.
Achievement of FDCA Flagship Plant product sales income and milestone payments from
technology license agreement engagements in the second half of 2026
Following the start-up of the FDCA Flagship Plant, the Company’s short- and mid-term liquidity will be
primarily driven by revenues from product sales under offtake agreements, as well as the successful
and timely execution of YXY® Technology license agreements and related milestone payments.
The Company’s offtake agreements are generally conditional in nature and subject to conditions
precedent, including the timely achievement of joint development milestone dates, regulatory
approvals, and the FDCA Flagship Plant's subsequent production timelines and deadlines. Changes to
the anticipated start-up or ramp-up timeline of the FDCA Flagship Plant may require amendments to
existing offtake agreements. There is a risk that negotiations on updated timelines or milestones may
take longer than anticipated or fail to reach acceptable terms, which could lead to delayed, reduced
or lost product sales income. In certain cases, offtake counterparties may elect to suspend or
terminate agreements if conditions precedent are not met.
Similarly, the timing and amount of license income depend on the successful negotiation and
execution of technology license agreements and the subsequent achievement of contractual
milestones, upon which a portion of these milestone payments are anticipated. The successful
execution of technology license agreements is linked to the start-up and initial ramp-up of the FDCA
Flagship Plant and subsequent commencement of commercial product sales and is furthermore
influenced by factors largely outside the Company’s control, including counterparties’ investment
decisions, financing capabilities and project planning. Any delays or deviations in license execution or
milestone achievement may result in a mismatch between the Company’s expected cash inflows and
its ongoing operational, financing and investing requirements during the going concern period.
Securing additional funding from a government-related investment initiative
The Company is pursuing additional funding of approximately €20 million from a government-related
investment initiative, which may take the form of a subsidy, grant, (convertible) subordinated loan or
equity-type investment. The availability, timing, form and amount of this funding are subject to
governmental decision-making processes, procedural requirements and approvals outside the
Company’s control and may be subject to unanticipated conditions.
There is a risk that this funding is delayed, approved on terms or in an amount different from those
anticipated, or not approved at all. In such events, the Company may not have sufficient cash
resources to meet its obligations as they fall due. and the Company’s ability to continue as a going
concern for at least 15 months as of the date of these financial statements is, in part, dependent on
securing this funding, particularly in the event of delays in the startup or ramp-up of the FDCA Flagship
Plant or delays in the receipt of anticipated near-term milestone payments under technology license
agreements.
Should the Company not secure the anticipated funding from the government-related investment
initiative (in whole or in part), it would need to consider alternative financing arrangements
or implement mitigating measures, including cost reductions or the deferral of planned activities;
however, the availability or sufficiency of such measures cannot be guaranteed to ensure
the Company’s ability to continue as a going concern.
The satisfactory conclusion of the ongoing discussions with Worley concerning the close‑out of
the construction phase of the FDCA Flagship Plant
The Company is engaged in ongoing discussions regarding the close-out of the engineering and
construction phase of the FDCA Flagship Plant, including the finalization of the determination of
responsibility for outstanding cost overruns, as well as other matters relating to the period prior to
completion and handover to Avantium Renewable Polymers B.V. There is a risk that these close-out
discussions do not result in an outcome aligned with the Company’s expectations, in which case the
Company may be required to settle outstanding amounts or pay amounts withheld as recorded in the
trade payables. Any such settlement could result in a cash outflow and adversely affect the
Company’s liquidity position.
Successful execution of strategic options for the non-core technology assets and related cost
management
As part of its strategy to focus financial and operational resources on its core activities, the Renewable
Polymers business, the Company is exploring strategic options for certain non-core assets and
technologies, including divestments, partnerships or other value-creation structures. The successful
completion of these strategic options is subject to market conditions, counterparty interest, conditions
and undertakings under the Debt Financing Facilities, and external approvals, including regulatory,
and other factors, many of which are outside the Company’s control.
There is a risk that these processes take longer than anticipated, resulting in continued operating
costs associated with non-core activities. There is also a risk that such transactions are not completed
at all, which may require the Company to repay subsidies or grants previously received,
decommission and dismantle related assets, and to shelve, abandon or otherwise cease actively
maintaining the associated intellectual property or to implement additional restructuring measures.
All of the above events indicate the existence of a material uncertainty that may cast significant doubt
on Avantium’s ability to continue as a going concern and, therefore, that it may be unable to realize its
assets and discharge its liabilities in the normal course of business.
Overview of the Planned Measures
Successful completion of commissioning, start-up, and start of commercial production at the FDCA
Flagship Plant as of mid-2026
In response to the risks and uncertainties associated with the commissioning and start-up of the FDCA
Flagship Plant, management has implemented a series of mitigating measures. A structured and
phased commissioning and start-up program is being executed to enable a safe, controlled transition
from construction to commercial operations, with activities sequenced to prioritize critical systems and
limit operational and safety risks.
Following the identification of a higher than initially assessed percentage of defective titanium welds,
a targeted remediation program was initiated, including enhanced quality controls, specialist third-
party expertise and increased independent expert inspection and testing. Repair activities are closely
coordinated with commissioning, including parallel execution where technically feasible, to mitigate
schedule impact.
Operational governance and oversight have been strengthened during the commissioning and start-
up phase, including increased management attention, frequent progress reviews and escalation
mechanisms. A Chief Operating Officer (COO) has been appointed, with sole responsibility for and full
focus on the commissioning, start-up and ramp-up of the FDCA Flagship Plant, bringing dedicated
operational leadership and experience relevant to first-of-a-kind plant start-up activities, and
strengthening coordination across engineering, operations,
safety and external contractors.
In parallel, management continues to closely monitors capital and operating expenditures during
commissioning and ramp-up, with a focus on preserving liquidity and aligning cash outflows with
available funding. Discretionary expenditure is deferred where possible until stable operations can be
achieved. Updated schedules and contingency plans are maintained to reflect commissioning
progress and remaining risks, and are used to inform liquidity planning and management decision-
making during the going concern assessment period.
Compliance with conditions and undertakings under the existing Debt Financing Facilities
To mitigate the risk of non-compliance with the conditions and undertakings under the Debt Financing
Facilities, the Company has implemented, and continues to enhance, a set of integrated monitoring,
planning and communication measures. Conditions and undertakings, including those related to the
Production Operations Date, offtake coverage, liquidity thresholds, minimum cash balances, insurance
coverage and other operational milestones, are embedded in operational planning, commissioning
timelines and ramp-up scenarios for the FDCA Flagship Plant. Compliance is closely monitored
through regular internal reviews and reporting, supported by close coordination across operations,
finance, and legal and treasury functions to ensure that operational developments, commissioning
progress and commercial arrangements are promptly reflected in compliance assessments.
To address the technical breach under the insurance covenant, and to align the insurance-related
condition with the revised project timeline, the Company engaged in December 2025 with its lenders
and requested a deferral of the applicable deadline.
Subsequent to year-end, the lenders agreed to extend the timing for delivery of the relevant
insurance documentation, subject to conditions relating to approval from relevant stakeholders and
the confirmation and extension of construction-phase insurance coverage, including the provision of
independent expert confirmation on the timing of the transition to operational insurance, all of which
points the Company is currently addressing.
The Company maintains an active dialogue with its lenders and provides periodic compliance
reporting in accordance with the Debt Financing Facilities. The frequency of lender meetings has
been increased to ensure timely and transparent updates on commissioning progress, operational
developments, liquidity and covenant compliance. Management is further strengthening the
timeliness, structure and consistency of covenant-related communications, including early
identification and discussion of potential non-compliance, and, where appropriate, engagement on
remedial actions, waivers, deferrals or amendments.
Liquidity is closely managed through rolling cash-flow forecasts and scenario analyses, which are
regularly updated to reflect anticipated ramp-up cash outflows and covenant thresholds, and are used
to inform contingency planning and timely management decision-making during the going concern
assessment period.
Achievement of FDCA Flagship Plant product sales income and milestone payments from
technology license agreement engagements in the second half of 2026
To support the generation of product sales from the FDCA Flagship Plant and the receipt of milestone
payments under technology license agreements, the Company has implemented and continues to
enhance a set of commercial and operational measures. The licensing strategy is closely linked to the
successful commissioning and operation of the FDCA Flagship Plant as a reference installation for the
YXY® Technology, with management prioritizing the demonstration of stable and reproducible plant
performance as a key prerequisite for license execution and related milestone payments.
The Company has strengthened its commercial and licensing capabilities through the expansion and
professionalization of the commercial organization, including dedicated resources for license
negotiations, technical-commercial interactions and coordination with technology development,
engineering and operations. In parallel, the Company actively manages a diversified pipeline of
potential licensees across end markets and geographies, prioritized by technical readiness, strategic
fit and financing capacity, with the objective of progressing multiple opportunities in parallel and
reducing the reliance on any single transaction. A significant pool of potential licensing opportunities
has been identified, with over 20 near term prospects and active discussions underway with more
than 10 potential licensees. While these discussions are at various stages of maturity, no resulting
binding license agreements have been concluded to date.
Management is pursuing a phased approach to licensing, including early-stage agreements, option
structures and capacity reservation arrangements, enabling counterparties to commit progressively as
operational proof points are achieved. In this context, the Company is actively securing capacity
reservation agreements to demonstrate market demand for FDCA and PEF across multiple
applications, markets and geographies. Total capacity reservations now exceed 100 kilotonnes.
In parallel, the Company remains actively engaged with existing and prospective offtake partners
during the commissioning and ramp-up phase. Where necessary, offtake agreements are amended to
reflect revised timelines and operational milestones, subject to agreement with counterparties.
Offtake agreements entered into up to now broadly align with the projected ramp-up plan for the
FDCA Flagship Plant, and the Company is negotiating additional offtake agreements beyond current
management expectations. Management continues to prioritize transparent communication and
relationship management with customers and partners to support initial product sales as operations
stabilize, manage expectations during ramp-up and preserve long-term commercial relationships to
help underpin future product sales and licensing opportunities.
Securing additional funding from a government-related investment initiative
The Company has submitted its formal application under this investment initiative to pursue the
additional funding of approximately €20 million. As part of the customary governmental procedures,
the funding may be accompanied by certain ancillary requirements, potentially including elements of
shared financial participation. The Company is actively engaged in ongoing discussions with all
stakeholders who have a role in the decision-making process and governance of the government-
related investment fund, with the aim of gaining further insight into the fund’s conditions and
communicating the Company's strategic objectives and outcomes that could be supported. There can
be no assurance that this funding will be obtained in full, on acceptable terms, or within the
anticipated timeframe. The Company continues to explore further measures to improve its working
capital position and create additional liquidity headroom, although no assurance can be given that
such measures will be successfully implemented.
The satisfactory conclusion of the ongoing discussions with Worley concerning the close‑out of
the construction phase of the FDCA Flagship Plant
The parties are in active discussion on the close-out topics. These discussions also encompass
construction-related quality issues identified during commissioning, including titanium welding, and
the related cost impacts and delays.
Successful execution of strategic options for the non-core technology assets and related cost
management
Management continues to assess strategic options for its non-core technology assets and exercises
close oversight of all related expenditures, including costs associated with non-core activities and
overheads such as staffing and leases. These actions are intended to reduce ongoing cash outflows
and overall cash burn, thereby supporting the Company’s YXY® Technology cash flow by allowing
management to focus financial and operational resources on its core Renewable Polymers business.
These measures are not expected to result in material cash proceeds, but rather to contribute through
improved cost discipline and cash preservation, while capturing potential future value through its
minority shareholdings.
The Company is engaged in advanced discussions with several third-party investors and industry
participants regarding potential transactions, which may include full or partial divestitures,
the establishment of strategic partnerships, joint-venture arrangements, or other value-creation
structures. The structure, valuation and timing of any such transactions remain subject to negotiation,
definitive documentation, approvals, and customary closing conditions.
With respect to Volta Technology, which has been successfully demonstrated at laboratory scale and
in larger container units, the Company is engaging with strategic and financial partners to support
further scale-up toward pilot plant-development and eventual commercialization. For Dawn
Technology®, the Company has initiated discussions with partners capable of providing the requisite
capital and expertise to advance the technology. As a result of increasing market interest in bio-based
polymers and related building blocks, the Company aims to pursue a spin-out of the Parana
Technology, with Avantium retaining a minority shareholding in the new entity. The R&D Solutions
business unit continues to operate as a stand-alone entity while strategic alternatives are evaluated.
Should any of these plans not materialize, the Company may need to consider additional measures,
which could include organizational and cost-reduction initiatives.
Conclusion
In light of all of the above, management has assessed the going concern assumption, which is the
basis on which Avantium’s Consolidated Financial Statements for the year ended December 31, 2025
have been prepared. The described events indicate the existence of a material uncertainty that may
cast significant doubt on Avantium’s ability to continue as a going concern and, therefore, that it may
be unable to realize its assets and discharge its liabilities in the normal course of business.
Based on management’s analyses and assessments, although this material uncertainty remains with
respect to the Company’s going concern, management believes that it is appropriate to prepare
Avantium’s Consolidated Financial Statements for the year ended December 31, 2025 using the going
concern assumption.
2.1.2  Changes in Accounting Policy and Disclosures
New Standards, Amendments and Interpretations Adopted
The following amendment applies for annual reporting periods beginning on or after January 1, 2025 :
Amendments to IAS 21 – Lack of Exchangeability, which provides guidance and additional
disclosure requirements when transactions are done in currencies that cannot be exchanged into
another currency.
The entities of the Group do not transact in currencies that cannot be exchanged into the functional
currency. Accordingly, the amendments to IAS 21 do not have an effect on the Group.
New Standards, Amendments and Interpretations not yet Adopted
A number of new standards and amendments to standards and interpretations have been published
that are not mandatory for December 31, 2025 reporting periods and have not been early adopted by
the Company.
The following amendments are already adopted by the European Union:
Annual Improvements Volume 11 (effective date January 1, 2026);
Amendments to IFRS 9 and IFRS 7 – Contracts Referencing Nature-dependent Electricity (effective
date 1 January 2026);
Amendments to IFRS 7 and 9 – Amendments to the Classification and Measurement of Financial
Instruments (effective date January 1, 2026)
The following amendments and new standards are not yet adopted by the European Union:
IFRS 18 Presentation and Disclosure in Financial Statements (effective date January 1, 2027);
IFRS 19 Subsidiaries without Public Accountability – Disclosures (effective date  January 1, 2027);
Amendments to IAS 21 – Translation to a Hyperinflationary Presentation Currency (effective date
January 1, 2027);
Amendments to IFRS 19 Subsidiaries without Public Accountability (effective date January 1, 2027).
These standards are not expected to have a material impact on the Company in the current or future
reporting periods and on foreseeable future transactions, with the exception of IFRS 18, Presentation
and Disclosure in Financial Statements. This new standard will impact the Company's presentation in
the Statement of Profit or Loss and disclosures around management performance measures. It is
expected to become effective for annual reporting periods beginning on or after January 1, 2027, at
which point the Company plans to apply the standard, subject to adoption by the European Union.
The Company has yet to determine the full impact of this new standard.
Changes in presentation or classification of comparative figures
In 2023 an informal capital distribution was made by a subsidiary of the Group to one of the minority
shareholders. The informal capital distribution should have been attributed to the non-controlling
interest for the amount of €0.5 million. A reclassification was made in 2025 between the non-
controlling interest and other reserves to reflect the correct attribution.
In 2024 general borrowing costs incurred on the construction of the FDCA Flagship Plant, for the
amount of €2.5 million should have been capitalized. These borrowing costs now have been
capitalized in 2025, ensuring that the book amount of 'Construction in progress' for the period-ended
June 30, 2025 includes the total amount of incurred and capitalized borrowing cost. Refer to note 3.
Other changes in accounting policies
The Company adopted a new accounting policy on spare parts, as detailed in note 2.12. This has not
had an impact on comparative figures. The Company has also updated the accounting policy on
borrowing cost, as detailed in note 2.24
2.2  Consolidation
2.2.1  Subsidiaries
Subsidiaries are all entities over which the Company has control. The Company controls an entity
when the Company is exposed to, or has rights to, variable returns from its involvement with the entity
and has the ability to affect those returns through its power over the entity. Subsidiaries are
consolidated from the date on which control is obtained by the Company. They are de-consolidated
from the date that control ceases.
The principal consolidated companies are listed below (indicating the ownership percentage):
Avantium Technologies B.V., Amsterdam (100%)
Avantium Support B.V., Amsterdam (100%)
Renewable Technologies B.V., Amsterdam (100%)
Avantium Chemicals B.V., Amsterdam (100%)
Avantium Knowledge Centre B.V., Amsterdam (100%)
Synvina C.V., Amsterdam (100%)
YXY Technologies B.V., Amsterdam (100%)
Stichting Administratiekantoor Avantium, Amsterdam (100%)
Stichting Stock Options Avantium, Amsterdam (100%)
Feedstock Technologies B.V., Amsterdam (100%)
Avantium Renewable Polymers B.V., Amsterdam (77.4%)
Avantium RNP Flagship Plant B.V., Amsterdam (77.4%)
Furanix Technologies B.V., Amsterdam (77.4%)
Avantium Japan K.K., Tokyo (77.4% )
Inter-company transactions, balances and unrealized gains on transactions between group companies
are eliminated. Unrealized losses are also eliminated. When necessary, amounts reported by
subsidiaries have been adjusted to conform to the Company’s accounting policies.
2.2.2  Disposal of Subsidiaries
When the Company ceases to have control, any retained interest in the entity is remeasured to its fair
value at the date when control is lost with the change in carrying amount recognized in profit or loss.
The fair value is the initial carrying amount for the purposes of subsequently accounting for the
retained interest as an associate, joint venture or financial asset.
In addition, any amounts previously recognized in other comprehensive income in respect of that
entity are accounted for as if the group had directly disposed of the related assets or liabilities. This
may mean that amounts previously recognized in other comprehensive income are reclassified to
profit or loss.
2.2.3  Non-Controlling interests
Non-controlling interests are measured at the proportionate share of non-controlling interests in the
carrying value of identifiable net assets of the subsidiaries concerned at the reporting date. The
Group treats transactions with non-controlling interests that do not result in the loss of control as
transactions with equity owners of the Company. A change in ownership interest results in an
adjustment between the carrying amounts of the controlling and non-controlling interests to reflect
their relative interests in the subsidiary. Any difference between the amount of the adjustment to non-
controlling interests and any consideration paid or received is recognized in equity attributable to
owners of the Company.
2.2.4  Segment Reporting
Operating segments are reported in a manner consistent with the business responsibilities and
internal reporting.
The Management Board has appointed the Management Team which assesses the financial
performance and position of the group, and makes strategic decisions. For the 2025 financial year the
Management Team consists of the Chief Executive Officer, the Interim Chief Financial Officer, the
Chief Technology Officer, the interim Chief Commercial Officer, the Chief Operating Officer, the Group
Legal Counsel, the Director Human Resources, the Managing Director of Volta Technology and the
Managing Director of Avantium R&D Solutions.
2.3  Foreign Currency Translation
Functional and Presentation Currency
Items included in the financial statements of each of the Group’s entities are measured using the
currency of the primary economic environment in which the entity operates (‘the functional currency’).
The Consolidated Financial Statements are presented in euros, which is the Company’s functional
currency.
Transactions and Balances
Foreign currency transactions are translated into the functional currency using the exchange rates
prevailing at the dates of the transactions or valuations where items are remeasured. Foreign
exchange gains and losses resulting from the settlement of such transactions and from the translation
at year-end exchange rates of monetary assets and liabilities denominated in foreign currencies are
recognized in profit or loss.
Foreign exchange gains and losses that relate to borrowings and cash and cash equivalents are
presented in profit or loss within ‘finance income or cost’.
Foreign operations
The results and financial position of foreign subsidiaries that have a functional currency different from
the Company's presentation currency are translated into the presentation currency as follows:
Assets and liabilities for each balance sheet presented are translated at the closing rate at the date
of that balance sheet.
Income and expenses for each statement of comprehensive income are translated at the average
exchange rates.
All resulting exchange differences are recognized as a separate component of other
comprehensive income.
2.4  Use of Estimates
The preparation of Consolidated Financial Statements requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities, disclosure of contingencies at
the date of the financial statements and the reported amounts of revenues and expenses during the
reporting period. The use of estimates is or could be a significant factor affecting the reported
carrying values of property, plant and equipment, intangibles, trade and other receivables and trade
and other payables. Despite management’s best efforts to accurately estimate such amounts, future
results could materially differ from those estimates. Refer to note 4 for Critical Accounting Estimates
and Judgments as applied in the preparation of the financial statements.
2.5  Property, Plant and Equipment
Property, plant and equipment comprise mainly of assets under construction, laboratory equipment,
hardware and leasehold improvements. Leasehold improvements include machinery that is located in
at the pilot plant sites and FDCA Flagship Plant. All property, plant and equipment is stated at
historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost
includes capitalized borrowings costs (refer to note 2.24) and expenditures that are directly
attributable to the acquisition of the items and includes capitalization of decommissioning and
restoration costs associated with provisions decommissioning and restoration costs (refer to note
2.19 ). Where an item of property, plant and equipment has been obtained by exchange for a non-
monetary asset, and the exchange lacks commercial substance, the acquired item is not measured at
fair value, but at the carrying amount of the asset given up. If significant parts of an item of property,
plant and equipment have different useful lives, then they are accounted for as separate items (major
components) of property, plant and equipment. The carrying amount of any component accounted for
as a separate asset is derecognized when replaced.
Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as
appropriate, only when it is probable that future economic benefits associated with the item will flow
to the Group and the cost of the item can be measured reliably. All other repairs and maintenance
charges are expensed in the period in which they are incurred.
Depreciation commences when an asset is available for use and is calculated using the straight-line
method to allocate the cost of the assets to their residual values over their estimated useful lives as
follows:
Leasehold improvements
5-20 years
Laboratory equipment, machinery and vehicles
5-10 years
Computer hardware
3-5 years
Office furniture and equipment
3-5 years
Residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate,
at the end of each reporting period.
Gains and losses on disposals are determined by comparing the proceeds with the carrying amount.
Gains and losses are included in profit or loss.
Expenditures incurred for the acquisition of items of property, plant and equipment under construction
are initially recorded as ‘under construction’ until the asset is completed and ready for use. Upon
completion of the assets, the recognized costs are reclassified from ‘under construction’ to the
relevant category of property, plant and equipment. Assets under construction are not depreciated
and are measured at cost less any impairment losses.
2.6  Intangible Assets
Research and Development
Research expenditures are recognized as expenses as incurred. Development costs that are directly
attributable to the design and testing of identifiable and unique products controlled by the group are
recognized as intangible assets when the following criteria are fulfilled:
It is technically feasible to complete the intangible asset so that it will be available for use or sale.
Management intends to complete the intangible asset and use or sell it.
There is an ability to use or sell the intangible asset.
It can be demonstrated how the intangible asset will generate probable future economic benefits.
Adequate technical, financial and other resources to complete the development and to use or sell
the intangible asset are available.
The expenditure attributable to the intangible asset during its development can be reliably
measured.
Other development expenditures that do not meet these criteria are recognized as an expense as
incurred. Development costs previously recognized as an expense are not recognized as an asset in
a subsequent period.
Residual values, useful lives and depreciation methods are reviewed, and adjusted if appropriate, at
the end of each reporting period
Amortization of development costs is included in depreciation, amortization and impairment charge in
the statement of profit or loss. All development costs arose from internal development. Intangible
assets not ready for use are tested for impairment at least on an annual basis.
Development costs
Capitalized development costs are recorded as intangible assets and amortized from the point at
which the asset is ready for use on a straight-line basis over its estimated useful life of:
Development costs
5 years
Computer Software and Other Intangibles
Acquired computer software licenses are capitalized on the basis of the costs incurred to acquire and
use the specific software.
Costs associated with developing or maintaining computer software programs are recognized as
expenses as incurred. Development costs that are directly attributable to the design and testing of
identifiable and unique software products controlled by the group, that will probably generate
economic benefits exceeding costs beyond one year, are recognized as intangible assets.
Other intangibles consisting of an in-kind contribution of a shareholder for their software at the
foundation of the Group and compensation paid to a third party to exclusively use parts of their
technology.
Amortization is calculated using the straight-line method over the estimated useful life of:
Computer software and other intangibles
3 years
Intellectual Property
Intellectual property is stated at historical cost; less accumulated amortization and any accumulated
impairment losses. Intellectual property is amortized over the period until the moment that the
technology on which the intellectual property is filed is ready to be deployed commercially.
Subsequent costs are included in the asset’s carrying amount or recognized as a separate asset, as
appropriate, only when it is probable that future economic benefits associated with the item will flow
to the group and the cost of the item can be measured reliably.
Amortization is calculated using the straight-line method to allocate their cost of the assets to their
residual values over their estimated useful lives (average lifetime of patent portfolio) as follows:
Intellectual property
5-20 years
License rights
Acquired licenses that grant the right to use technologies not owned/developed by the Company are
recorded at historical cost, less accumulated amortization and impairment losses.
License rights contain variable royalty fee payment terms that are linked to production of the License
Products once the FDCA Flagship Plant starts production. The fees will equal to $20 USD per metric
ton of Licensed Products produced from the FDCA Flagship Plant. Variable royalty fee payments that
depend on the volume of production of the Licensed Products are recognized in profit or loss when
products are produced.
Where an intangible asset is obtained in exchange for consideration payable on deferred credit
terms, the asset is initially recognized at its cost price equivalent, being the present value of the
consideration payable over the credit term.
Where an intangible asset is obtained in exchange for variable consideration, such variable
consideration is not included in the carrying amount of the asset at acquisition and no liability is
recognized for the variable consideration. Subsequent payments of variable consideration are
recognized in profit and loss as and when incurred.
Amortization is calculated using the straight-line method to allocate their cost of the assets to their
residual values over their estimated useful lives (average lifetime of license rights) as follows:
License rights
5-20 years
2.7  Impairment of Non-Financial Assets
Non-financial assets (other than deferred tax assets, inventories and contract assets) are reviewed at
each reporting date for possible impairment whenever an impairment trigger is identified. Any events
or changes in circumstances which could indicate that the carrying amount of the assets may not be
recoverable are considered impairment triggers. If any such impairment triggers are identified, the
asset's recoverable amount is estimated. The recoverable amount is determined to be the higher of
an asset’s fair value less costs to sell and value in use. Value in use is based on the estimated future
cash flows, discounted to their present value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to the asset. An impairment loss is
recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount.
Impairment losses are recognized in profit or loss. For the purposes of assessing impairment, assets
are grouped at the lowest levels for which there are separately identifiable cash flows (cash-
generating units). Each reporting segment is considered a cash-generating unit. An annual
assessment is performed on all cash-generating units to identify potential impairment triggers.
Non-financial assets which are impaired, are tested periodically to determine whether the recoverable
amount has increased and the impairment be (partially) reversed. Impairment losses on goodwill are
not reversed. For other assets, an impairment loss is reversed only to the extent that the asset’s
carrying amount does not exceed the carrying amount that would have been determined, net of
depreciation or amortization, if no impairment loss had been recognized. Reversal of impairments is
only permitted if, in a subsequent period after an impairment loss has been recognized, the amount of
the impairment loss decreases and the decrease can be related objectively to an event after the
impairment loss was recognized.
2.8  Non-Current Assets (or Disposal Groups) Held for Sale
Non-current assets (or disposal groups) are classified as assets held for sale when their carrying
amount is to be recovered principally through a sale transaction and a sale is considered highly
probable. They are stated at the lower of carrying amount and fair value less costs to sell. Upon
designation as held for sale the Group ceases to depreciate these assets. Non-current assets (or
disposal groups) are reclassified out of assets held for sale when they no longer meet the
requirements to be classified as such. Upon reclassification, they are measured at the lower of their
book value as if they had not been classified as held for sale, or their recoverable amount.
2.9  Financial Assets
2.9.1  Classification
The Company determines the classification of its financial assets at initial recognition. The
classification depends on the Company’s business model for managing the financial assets and the
contractual terms of the cash flows. The contractual cash flows solely comprise principal and interest.
The financial assets are held to collect the contractual cash flows, and are classified as subsequently
measured at amortized cost.
2.9.2  Recognition and Measurement
Regular purchases and sales of financial assets are recognized on the trade-date, the date on which
the group commits to purchase or sell the asset. Financial assets are initially recognized at fair value,
which for trade receivables in general is the transaction price. Subsequently they are stated at
amortized cost using the effective interest method, less allowance for impairment. Financial assets are
derecognized when the rights to receive cash flows from the financial assets expire or if the Company
transfers the financial asset to another party and does not retain control or substantially all risks and
rewards of the asset. Any gain or loss arising on derecognition is recognized in profit or loss as other
gains/(losses).
2.9.3  Interest income
Interest income from financial assets is included in finance income using the effective interest method.
When a loan or receivable is impaired, the Group reduces the carrying amount to its recoverable
amount, being the estimated future cash flows discounted at the original effective interest rate of the
instrument and continues unwinding the discount as interest income. Interest income on impaired
loans and receivables is recognized using the original effective interest rate.
2.10  Offsetting Financial Instruments
Financial assets and liabilities are offset and the net amount reported in the balance sheet when there
is a legally enforceable right to offset the recognized amounts and there is an intention to settle on a
net basis or realize the asset and settle the liability simultaneously. The legally enforceable right must
not be contingent on future events and must be enforceable in the normal course of business and in
the event of default, insolvency or bankruptcy of the Company or the counterparty.
2.11  Impairment of Financial Assets
Impairment allowances for trade receivables are recognized based on the simplified approach within
IFRS 9 to measure expected credit losses which uses a lifetime expected loss allowance for all trade
receivables and contract assets.
To measure the expected credit losses, trade receivables and contract assets have been grouped
based on shared credit risk characteristics and the days past due. The contract assets relate to
unbilled work in progress and have substantially the same risk characteristics as the trade receivables
for the same types of contracts. The Group has therefore concluded that the expected loss rates for
trade receivables are a reasonable approximation of the loss rates for the contract assets. Allowances
for expected credit losses are deducted from the carrying amount of the financial assets. Additions to
the allowance for expected credit losses are recognized in profit or loss.If, in a subsequent period, the
amount of the impairment loss decreases and the decrease can be related objectively to an event
occurring after the impairment was recognized (such as an improvement in the debtor’s credit rating),
the reversal of the previously recognized impairment loss is recognized in profit or loss.
2.12  Inventories
Inventories are stated at the lower of cost and net realizable value. Cost is determined using the first-
in, first-out (FIFO) method. The cost of raw materials, finished goods and work in progress comprises
all purchase costs including charges incurred to bring inventories to their current location and into
their current state. It excludes borrowing costs. Net realizable value is the estimated selling price in
the ordinary course of business, less applicable variable selling expenses.
Spare parts with a useful life of more than 1 year are capitalized as property, plant and equipment.
Spare parts with a useful life of less than 12 months are treated as inventories, and recognized in profit
or loss as raw materials and contract costs when they are consumed.
2.13  Trade Receivables
Trade receivables are amounts due from customers for products sold or services performed in the
ordinary course of business. If collection is expected in one year or less (or in the normal operating
cycle of the business if longer), they are classified as current assets. If not, they are presented as non-
current assets.
Trade receivables are recognized initially at fair value and subsequently measured at amortized cost
using the effective interest method, less allowance for impairment. Refer to note 2.11 for further
information about the group’s impairment policy on financial assets.
2.14  Cash and Cash Equivalents
Cash and cash equivalents includes cash in hand, deposits held at call with banks, other short-term
highly liquid investments with original maturities of three months or less.
Restricted Cash
Restricted cash includes cash deposits, which are measured at an amount equal to the current
outstanding bank guarantees issued to third parties and/or cash deposits held in designated accounts
for an equity reserve as agreed with lenders. The restricted cash is not available for use by the
Company to meet the short-term cash obligations. In the consolidated statement of financial position
the restricted cash is shown within cash and cash equivalents as current assets.
2.15  Share Capital
Ordinary Shares
Ordinary shares are classified as equity. Incremental costs directly attributable to the issue of new
ordinary shares or options are shown in equity as a deduction, net of tax, from the proceeds.
The difference between the proceeds of issued shares and the nominal value of the issued shares is
recognized as share premium. Costs incurred in anticipation of an issuance of equity instruments are
recognized as prepaid expenses at the reporting date. When the equity instruments are issued and
recognized as equity, the directly attributable transaction costs are deducted from equity.
2.16  Trade and Other Payables
Trade payables are obligations to pay for goods or services that have been acquired in the ordinary
course of business from suppliers. Accounts payable are classified as current liabilities if payment is
due within one year or less (or in the normal operating cycle of the business if longer). If not, they are
presented as non-current liabilities.
Trade payables are recognized initially at fair value and subsequently measured at amortized cost
using the effective interest method.
2.17  Current and Deferred Income Tax
The tax expense for the year comprises current and deferred tax. Tax is recognized in profit or loss,
except to the extent that it relates to items recognized in other comprehensive income or directly in
equity. In this case, the tax is also recognized in other comprehensive income or directly in equity,
respectively.
The current income tax charge is calculated on the basis of the tax laws enacted or substantively
enacted at the balance sheet date. Management periodically evaluates positions taken in tax returns
with respect to situations in which applicable tax regulation is subject to interpretation. It establishes
provisions where appropriate on the basis of amounts expected to be paid to the tax authorities.
Deferred income tax is recognized, using the liability method, on temporary differences arising
between the tax bases of assets and liabilities and their carrying amounts in the Consolidated
Financial Statements and for unused tax losses and credits carried forward. However, the deferred
income tax is not accounted for if it arises from initial recognition of an asset or liability in a transaction
other than a business combination that at the time of the transaction affects neither accounting nor
taxable profit or loss and does not give rise to equal taxable and deductible temporary differences.
Deferred income tax is determined using tax rates (and laws) that have been enacted or substantially
enacted at the balance sheet date and are expected to apply when the related deferred income tax
asset is realized or the deferred income tax liability is settled.
Deferred income tax assets are recognized only to the extent that it is probable that future taxable
profit will be available against which the temporary differences, unused tax losses and the tax credits
carried forward can be utilized. Unrecognized deferred tax assets are reassessed at each reporting
date and recognized to the extent that it has become probable that future taxable profits will be
available against which they can be used.
Income tax assets and liabilities are presented separately, except when there is a legally enforceable
right to offset and (for current tax) an intention to settle the balances on a net basis with the same
taxation authority and (for deferred tax) the balances relate to taxes levied by the same taxation
authority on the same taxable entity or fiscal group that intends to settle the current tax on a net basis.
2.18  Employee Benefits
Pension Obligations
The Group operates a defined contribution pension plan for all employees funded through payments
to an insurance company. The Group has no legal or constructive obligations to pay further
contributions if the plan does not hold sufficient assets to pay all employees the benefits relating to
employee service in the current and prior years. The contributions are recognized as employee
benefit expense when they are due. Prepaid contributions are recognized as an asset to the extent
that a cash refund or a reduction in the future payments is available.
Share-Based Payments
The Group operates share-based compensation plans for its employees, which consist of an
Employee Stock Option Plan (ESOP), a Long-Term Incentive Plan (LTIP) and since 2024 a new Long-
Term Incentive Plan (New LTIP). Under the New LTIP, Performance Share Units (PSUs) to members of
the Management Board and Restricted Share Units (RSUs) to other employees and Supervisory Board
members. These PSUs and RSUs are settled in ordinary shares upon vesting, through the issuance of
new shares. Also refer to note 14. These plans are classified as an equity-settled share-based
payment plans.
Share options granted to employees are measured at the fair value of the equity instruments granted
under the indirect method of measurement. Fair value is determined through the use of an option-
pricing model considering, amongst others, the following variables:
a) The exercise price of the option
b) The expected life of the option
c) The current value of the underlying shares
d) The expected volatility of the share price
e) The dividends expected on the shares
f) The risk-free interest rate for the life of the option
For the ESOP, management’s judgment is that the Black-Scholes valuation model is most appropriate
for determining fair values as this model allows accounting for non-transferability and early exercise.
Since the Company became listed in March 2017, there is published share price information available
to determine the fair value of its shares and the expected volatility of that value. These assumptions
and estimates are further discussed in note 14 to the Consolidated Financial Statements. The result of
the share option valuations and the related compensation expense is dependent on the model and
input parameters used.
For the equity-settled schemes, the fair value of the grant is determined at the grant date. For the LTIP
and new LTIP, the fair value is determined by the share price of the award at the grant date. Where
the grant date is not yet achieved, the fair value is estimated by reference to the closing share price
as at the balance sheet date.
The fair value of the employee services received in exchange for the grant of the awards is
recognized as an expense in profit or loss, with a corresponding adjustment to equity. For share-
based payments that do not vest until the employees have completed a specified period of service,
the group recognizes the cost of services received as the employees render service during that
period.
At each balance sheet date, the Company revises its estimates of the number of awards that are
expected to become exercisable. It recognizes the impact of the revision of original estimates, if any,
in profit or loss and a corresponding adjustment to equity.
The proceeds received from exercised options net of any directly attributable transaction costs are
credited to share capital (nominal value) and share premium. While PSUs are settled in ordinary shares
upon vesting, hence the reserve attributable to the allocated shares is transferred to share capital and
share premium.
Profit-sharing and Bonus Plans
The Group recognizes a liability and an expense for bonuses and profit-sharing where contractually
obliged or where there is a past practice that has created a constructive obligation.
Termination Benefits
Termination benefits are payable when employment is terminated by the Group before the normal
retirement date, or when an employee accepts voluntary redundancy in exchange for these benefits.
The group recognizes termination benefits at the earlier of the following dates: (a) when the group can
no longer withdraw the offer of those benefits; and (b) when the entity recognizes costs for a
restructuring that involves the payment of termination benefits. In the case of an offer made to
encourage voluntary redundancy, the termination benefits are measured based on the number of
employees expected to accept the offer. Benefits falling due more than 12 months after the end of the
reporting period are discounted to present value.
2.19  Provisions
Provisions are recognized when the group has a present legal or constructive obligation as a result of
past events; it is probable that an outflow of resources will be required to settle the obligation; and the
amount can be reliably estimated.
A provision for restructuring is recognized after the group has approved a detailed and formal
restructuring plan and the restructuring has either commenced or been announced publicly.
The Group provides for the estimated cost of product warranties that do not represent a separate
performance obligation under contracts with customers at the time revenue is recognized and the
group has a constructive obligation. The warranty provision is established based on the group’s best
estimates of the amounts necessary to settle future and existing claims on products sold as of the
balance sheet date.
A provision for decommissioning and restoration costs is recognized (together with a corresponding
amount as part of the related property, plant and equipment) for legal or constructive obligations to
dismantle an item of property, plant and equipment and to restore the site on which it is located.
Provisions for decommissioning and restoration costs are measured on the basis of the current
requirements, technology and price levels; the present value is calculated using amounts discounted
over the useful economic life of the assets. The effects of changes resulting from revisions to the
timing or the amount of the original estimate of the provision are reflected on a prospective basis,
generally by adjustment to the carrying amount of the related property, plant and equipment.
Provisions are measured at the present value of the expenditures expected to be required to settle
the obligation using a pre-tax discount rate that reflects current market assessments of the time value
of money and the risks specific to the obligation.
2.20  Revenue Recognition
Revenue from contracts with customers is recognized in accordance with the five step process
outlined in IFRS 15. Revenue is recognized at the transaction price to which it expects to be entitled.
The transaction price is generally stipulated in the contract. For contracts that contain separate
performance obligations, the transaction price is allocated to those separate performance obligations
by reference to their relative stand-alone selling prices.
Revenue is recognized as and when the group satisfies a performance obligation by transferring
control over a promised good or service to a customer. Control can transfer to a customer either “at a
point in time” or “over time”. Revenue is shown net of value-added tax, returns, rebates, and
discounts, and after eliminating sales within the group. As the group generally does not extend credit
terms to customers exceeding 12 months, it applies the practical expedient in IFRS 15 regarding
significant financing components.
Where incremental costs of obtaining a contract with a customer are incurred, an asset is recognized
for these costs if it is expected that these costs shall be recovered. Such costs are recognized directly
in profit and loss in the case that no expectation to recover such costs exists.
Discounts or credits provided to customers are considered consideration payable to a customer for
goods/services which are not distinct and therefore are deducted from the transaction price in
determining the amount of revenue to be recognized.
Main Revenue Streams
Work in Progress Projects
Services
Sale of Goods
Sale of Licenses
The information provided below reflects additional details over the groups revenue streams.
Work in Progress Projects
The Group specializes in engineering and constructing various mechanical systems for customers
used in R&D, as well as providing contractual R&D services. Given the custom and individually
engineered nature of these contracts, customers are consulted on the input of varying components
and actively involved in directing the specifics of expected results. Therefore, at contract inception, it
is determined that the Group's performance does not create an asset with an alternative use outside
of the contracted purpose.
As work over the project progresses, control is transferred to the customer incrementally based on
the stage of completion. The stage of completion is measured by comparing the proportion of costs
incurred to the total expected costs, ensuring that the costs incurred accurately reflect the progress
made in transferring goods and services to the customer.
Services
Revenue from the provision of services, primarily servicing and maintenance activities, is recognized
based on the stage of completion of the work performed. This method is used because the client
receives the benefits from and has use of the services at the same rate as the work is performed.
There are two primary types of servicing and maintenance contracts, stand-ready agreements and
maintenance work in progress projects. Where such services are provided as part of a larger contract,
they are considered separate performance obligations.
Stand-ready: Service level agreements for the provision of maintenance and support services within
a specified timeframe. The stage of completion is determined by the percentage of the period
within the stand-ready agreement that has been fulfilled, over the contracted period of time.
Maintenance Work in Progress: Servicing and maintenance projects conducted over a period of
time to customers specifications. Refer to ‘Work in Progress Projects’ for more information on the
determination of the stage of completion.
Sale of Goods
The Group sells customized spare parts and research & development samples to its customers.
Revenue from these sales is recognized at the point in time when control of the goods is transferred
to the customer, and the Group has a present right to receive payment.
This transfer of control is measured using the commercial shipment terms specified within each
contract, assessed on a contract-by-contract basis.
Sale of Licenses
The Group issues licenses to its intellectual property in conjunction with design and engineering
services. Generally, these licenses are not distinct from the associated services and are therefore
accounted for as a single performance obligation. License contracts typically include a combination of
fixed (including upfront non-refundable payments) and variable consideration. An estimate of variable
consideration is included in the transaction price to the extent that it is highly probable that a
significant reversal in the amount of cumulative revenue recognized will not occur when the
uncertainty associated with the variable consideration is resolved.
Revenue is generally recognized over time, as the Company's performance does not create an asset
with an alternative use and the company has an enforceable right to payment for performance
completed to date. Management measures progress towards the performance obligation in a manner
that most faithfully depicts the Company's performance, typically using an input measure of costs
incurred compared to total expected costs.
License contracts may also include additional elements such as usage/sale-based royalties, support
services, and the sale of goods. Usage/sale-based royalties are considered variable consideration
and recognized at the earlier of when the related performance obligation is satisfied or when the
sales or usage occurs. Support services and the sale of goods are treated as separate performance
obligations, as they are distinct promises that the customer can benefit from independently. Refer to
the respective sections above, which describe the accounting treatment applied to these
performance obligations.
Contract Assets and Liabilities
The timing of payment of consideration for the supply of goods and services to the customer is based
on contractually agreed installment terms.
Contract assets are unbilled revenues, where the Group has recognized revenue to date in line with
satisfaction of performance obligations as detailed above. Contract assets are transferred to trade
receivables when the contractually identified installment term is met.
Contract liabilities are obligations to transfer goods or services to a customer for which the Group has
received consideration or has recognized a receivable asset in line with the contractually identified
installment term. These amounts are reported as contract liabilities on the balance sheet under trade
and other payables. Contract liabilities are recognized as revenue when performance obligations are
satisfied.
2.21  Grants
Grants and subsidies from third parties are recognized at their fair value when there is a reasonable
assurance that the grant will be received, and the Group will comply with all attached conditions. Any
outstanding receivables related to these grants are recorded as other receivables under current
receivables.
Advances received for grants related to income are deferred and recognized in profit or loss over the
period necessary to match them with the costs that they are intended to compensate. Grants relating
to costs are deducted from the relevant costs to be compensated in the same period.
Grants relating to property, plant and equipment are included in non-current liabilities as deferred
government grants and are credited to profit or loss on a straight-line basis over the expected lives of
the related assets.
Subsidies are recognized as a reduction in Employee benefit expenses over time.
The Group treats the benefit of a government loan at a below-market rate of interest as a government
grant, even where there are no conditions specifically relating to the operating activities of the Group
other than the requirement to operate in a certain region or sector. The grant is recognized in profit or
loss systematically over the period in which the related costs are incurred, that is until maturity of the
loan, as a reduction of finance costs.
2.22  Leases
The Group leases various offices and a vehicle. Short-term leases (less than 12 months) or low-value
leases (less than EUR 5,000) are expensed in profit or loss as incurred. Lease contracts are generally
entered into for fixed periods of 3 to 10 years but may have extension options. Lease terms are
negotiated on an individual basis and contain a wide range of different terms and conditions. The
lease agreements do not impose any covenants other than the security deposits in the leased assets
that are held by the lessor. Leased assets may not be used as security for borrowing purposes.
Management considers extension options and the reasonable certainty with which such options might
be exercised in determining the non-cancellable lease period over which the value of the lease
liability and related right-of-use asset is to be calculated. Management reassesses extension options
on an annual basis and revises the lease terms accordingly.
Contracts may contain both lease and non-lease components. The consideration in the contract is
allocated to the lease and non-lease components based on their relative stand-alone prices.
Leases are recognized as right-of-use asset and a corresponding liability at the date at which the
leased asset is available for use by the Group. Each lease payment is allocated between the lease
liability and finance cost. The finance cost is charged to profit or loss over the lease period so as to
produce a constant periodic rate of interest on the remaining balance of the liability for each period.
Lease Liability
Lease liabilities are initially measured at the net present value of the following lease payments:
fixed payments (including in-substance fixed payments), less any lease incentives receivable;
variable lease payments are based on an index or a rate;
decommissioning costs; and
payments of penalties for terminating the lease, if the lease term reflects the lessee exercising that
option.
The lease payments are discounted using the interest rate implicit in the lease. If that rate cannot be
determined, the lessee's incremental borrowing rate is used, being the rate that the lessee would
have to pay to borrow the funds necessary to obtain an asset of similar value in a similar economic
environment with similar terms and conditions.
The Group is exposed to potential future increases in variable lease payments based on an index or
rate, which are not included in the lease liability until they take effect. When adjustments to lease
payments based on an index or rate take effect, the lease liability is reassessed and adjusted against
the right-of-use asset.
Right-of-Use Assets
Right-of-use assets are initially measured at cost comprising the following:
the amount of the initial measurement of the lease liability;
any lease payments made at or before the commencement date less any lease incentives received
– any initial direct costs; and
onerous contract provisions.
Right-of-use assets are generally depreciated over the shorter of the asset's useful life and the lease
term on a straight-line basis over the remaining term of the lease or over the remaining economic life
of the asset, if this is judged to be shorter than the lease term. If the Group is reasonably certain to
exercise a purchase option, or the ownership of the underlying asset is transferred to the Group at the
end of the lease, the right-of-use asset is depreciated over the underlying asset's useful life.
2.23  Financial Liability
2.23.1  Classification
The Group classifies all financial liabilities as subsequently measured at amortized cost, except for
derivatives, which are classified as subsequently measured at fair value through profit or loss.
Financial liabilities are classified as current liabilities unless the Group has the right to defer settlement
of the liability for at least 12 months after the balance sheet date.
Warrants
The Company has issued warrants under financing arrangements. Under the terms of the respective
contracts, such warrants are derivative financial instruments that will be settled by the Company in its
own equity instruments. Where a warrant holder is entitled to anything other than a fixed amount of
ordinary shares in exchange for a fixed amount of cash upon exercise, such warrants are classified as
financial liabilities.
2.23.2  Recognition and Measurement
Financial liabilities are initially recognized when the Group becomes a party to the contractual
provision of a financial instrument. They are recognized initially at fair value and, in the case of loans
and borrowings, net of directly attributable transaction costs.
Subsequent to initial recognition of financial liabilities measured at amortized cost, any difference
between the proceeds and redemption value is recognized in profit or loss, using the effective
interest method. Financial liabilities are derecognized when the Group's obligations specified in the
contract expire or are discharged or cancelled.
Derivatives (including warrants) are subsequently measured at fair value through profit or loss at each
reporting date. Gains and losses resulting from the fair value remeasurement are recognized in profit
or loss as fair value gains/(losses) on financial instruments.
Where the terms of a financial liability measured at amortized cost are modified, the Group determines
whether the modification results in derecognition; the Group derecognizes a liability when the
modified terms are substantially different, which is typically evidenced when the discounted present
value of the revised cash flows differs by 10% or more from that of the original liability using the
original effective interest rate. If the modification does not result in derecognition, the liability’s
carrying amount is recalculated as the present value of the modified cash flows discounted at the
original effective interest rate, and any resulting gain or loss is recognized immediately in profit or
loss. The liability continues to be accounted for based using the original effective interest rate,
adjusted for any incremental and direct transaction costs related to the modification. If the liability is
derecognized, the original liability is removed and a new liability is recognized at its fair value, with
any difference recognized in profit or loss.
2.23.3  Interest Expense
Interest expense is recognized in profit or loss using the effective interest rate method, except when
capitalized as borrowing costs. Refer to note 2.24.
2.24  Borrowing Costs
General and specific borrowing costs that are directly attributable to the acquisition, construction or
production of a qualifying asset are capitalized as part of the cost of the asset. Borrowing costs
include interest expenses calculated as based on the effective interest method as well as interest in
respect of lease liabilities. Borrowing costs include modification gains or loss on borrowings, except
any gains or losses on derecognition. Qualifying assets are assets that necessarily take a substantial
period of time to get ready for their intended use or sale.
The commencement date for capitalization is the date at which both expenditures for the qualifying
asset and borrowing costs are incurred and the activities necessary to prepare the asset for its
intended use have been undertaken. The capitalization of borrowing costs will cease when
substantially all activities necessary to prepare the qualifying asset for its intended use or sale is
complete. An asset is normally ready for its intended use or sale when the physical construction of the
asset is complete even though routine administrative work or minor modifications might still continue.
Management applies judgment in determining whether any activities required post completion of
physical construction constitutes administrative work or minor modifications based on the nature of
these activities and the associated cost in proportion to total cost of acquisition, construction or
production.
2.25  Earnings per Share
Basic earnings per share is calculated by dividing:
The profit/(loss) attributable to owners of the Company
By the weighted average number of ordinary shares outstanding during the year, excluding treasury
shares (note 15 ).
Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to
take into account:
The after-tax effect of interest and other financing costs associated with dilutive potential ordinary
shares
The additional weighted average number of additional ordinary shares that would have been
outstanding assuming the conversion of all dilutive potential ordinary shares.
2.26  Cash Flow Statement
The Statement of Cash Flows is presented using the indirect method. Cash flow in foreign currencies
are converted at the exchange rate on the date of the cash flow, or based on the average rate.
Changes in balance sheet items that have not resulted in cash flows such as amortization and
depreciation, deferred taxes, translation differences, leases, fair value changes, share-based
payments, conversions of debt to equity, accounting policy changes, etc., have been eliminated for
the purpose of preparing this statement.
Interest received is included in operating activities. Any interest paid (including interest on lease
liabilities and interest capitalized as borrowing costs) during the year is presented as cash flows from
financing activities.
2.27  Climate Risk
Management has disclosed climate related targets and progress made during the 2025 financial year
in the Sustainability performance section of the Management Report. Transformational risk related to
the achievement of such climate related targets have been disclosed in the Governance section of
this report (refer to page 67).
3.  Financial Risk Management
3.1  Financial Risk Factors
The Group’s activities expose it to a variety of financial risks: market risk (including currency risk,
interest rate risk and other price risk, credit risk and liquidity risk). The Group’s risk management
program focuses on the unpredictable nature of financial markets and seeks to limit any potential
adverse effects on financial performance.
Risk management is carried out by the central Finance & Accounting department (Group F&A) under
policies approved by the Management Board. Group F&A identifies, evaluates and covers financial
risks in close cooperation with the Group’s operating units. The Management Board provides
principles for overall risk management, as well as written policies covering specific areas such as
foreign-exchange risk, interest rate risk, credit risk, use of non-derivative financial instruments, and
investment of excess liquidity.
3.2  Financial Instruments
Non-Current Financial assets as at December 31:
in Euro x 1,000
Notes
2025
2024
Other non-current assets
9
188
189
Non-Current Financial liabilities as at December 31:
in Euro x 1,000
Notes
2025
2024
Borrowings
17
12,806
7,523
Financial liability
20
10,485
Shareholder loan
18
27,431
TNO License Agreement
16
709
859
Lease liabilities
7
5,269
7,708
Current Financial assets as at December 31:
in Euro x 1,000
Notes
2025
2024
Trade receivables
9
3,557
5,124
Other receivables
9
4,897
8,866
Cash and cash equivalents
10
57,466
23,898
Current Financial liabilities as at December 31:
in Euro x 1,000
Notes
2025
2024
Borrowings
17
105,805
110,511
Financial liability
20
7,593
Shareholder loan
18
13,436
Lease liabilities
7
3,262
2,409
Trade payables
16
15,612
14,767
Other liabilities
16
9,686
13,309
All financial assets and liabilities are classified as measured at amortized cost, except for the financial
liability related to the warrants, which is classified as measured at fair value through profit or loss.
The carrying amounts of financial assets and current financial liabilities are assumed to approximate
their fair values due to their short-term nature. Also refer to note 16 for an overview of trade and other
payables. Refer to note 17 for an overview of the borrowings.
3.3  Interest Rate Risk
The most significant interest rate risk for the Company relates to borrowings (refer to note 17).
As at December 31, 2025 the borrowings of the Company consisted of a three-year Debt Financing
Facilities agreement amounting to €111.0 million (2024: €105.0 million), the Fonds Nieuwe Doen loan
of €2.5 million (2024: €2.5 million) and the Province Groningen loan of €9.9 million (2024: €0 million).
The interest payable under the Debt Financing Facilities agreement is variable and based on
EURIBOR. The accrued cash and PIK interest expense at December 31, 2025 amounted to €10.7
million (2024: €9.4 million).
Interest rate risk is the risk that changes in the market interest rates affect the fair value or cash flows
of a financial instrument. If market interest rates had been 50 basis points higher on average during
2025, with all other variables held constant, the capitalized interest for the year would have been
€0.6 million higher (2024: €0.6 million). The opposite applies in the case of a 50 basis points
decrease in the interest rates. There was no impact on equity due to interest rate risk.
3.4  Currency Risk
The Group operates internationally and is exposed to foreign exchange risk primarily in relation to the
US dollar. Foreign exchange risk arises from future commercial transactions, recognized assets and
liabilities. Management has set up a policy that requires Group companies to manage their foreign
exchange risk against their functional currency. The Group companies are required to close
commercial transactions in euros. Certain US-based customers negotiate US-dollar contracts. There
are a limited number of these contracts, and the group companies can only close these with
management’s written approval. The Group’s operations are therefore not subject to significant
foreign exchange rate risks.
The Group does not have receivables or payables in foreign currencies in excess of €0.1 million
(2024: €0.1 million).
Exchange rates:
Currency (from EUR):
Average rate for 2025 financial year
Closing rate as at December 31, 2025
CHF
0.94
0.93
CNY
8.08
8.23
GBP
0.85
0.87
JPY
170.41
183.71
NOK
11.68
11.82
USD
1.13
1.18
Currency (from EUR):
Average rate for 2024 financial year
Closing rate as at December 31, 2024
CHF
0.95
0.94
CNY
7.84
7.59
GBP
0.85
0.83
JPY
163.74
162.69
NOK
11.52
11.79
USD
1.10
1.04
The average exchange rates presented in the table represent the quarterly averages based on
publicly available market data.
3.5  Credit Risk
Credit risk is managed on a Group basis. The Group does have a significant concentration of credit
risk. On December 31, 2025, the largest single client exposure consisted of 37% (2024: 41%) of the
outstanding trade receivables, having received the amount in January 2026. The Group's customers
are subject to creditworthiness tests. Sales are subject to payment conditions varying between
payments in advance and 30 days after invoice date. For certain projects, deviations to this rule may
apply only after approval of Group F&A, in which case additional security, including guarantees and
documentary credits, may be required. Management does not expect any losses from non-
performance by its clients nor from concentration of this risk.
In 2025, €0 (2024: €0 million) of trade or other receivables was written off; €0.3 million (2024: €2.0
million) was past due, of which 85% had been paid before January 31, 2026 (as at January 31, 2025:
62%).
Trade and other receivables past due as at December 31, were as follows:
in Euro x 1,000
2025
2024
Less than 3 months past due
290
1,119
Between 3 and 6 months past due
16
812
More than 6 months past due
2
59
308
1,990
The Group determines any significant increase in credit risk since initial recognition in accordance
with the aging profile of receivables (typically when a contractual payment is more than 30 days past
due, which is also considered to be a default). Expected credit losses on trade receivables are
recognized based on the simplified approach within IFRS 9, measuring expected credit losses based
on the lifetime expected loss allowance for all trade receivables and contract assets. This is
determined in accordance with the aging profile of receivables.
At year end 2025, management has applied the following rates for the calculation of the allowance for
expected credit losses:
Aging bucket
2025
2024
0 - 30 days post due
1%
2%
31 - 90 days post due
7%
9%
> 91 days post due
—%
30%
Management monitors any extended default (instances where a debtor continues to not meet its
payment obligations) and determines on an individual basis whether such receivables are considered
credit-impaired. Trade receivables and contract assets are written off where there is no reasonable
expectation of recovery. Indicators that there is no reasonable expectation of recovery include,
amongst others, the failure of a customer to engage in a repayment plan with the group, and a failure
to make contractual payment for a period of greater than 6 months past due. Management has
recognized an allowance for expected credit losses of €0.1 million (2024: €0.2 million) on the trade
receivables as at December 31, 2025.
The maximum exposure to credit risk at the reporting date is the carrying value of each class of
financial asset mentioned above. The Group does not hold any collateral as security. The long-term
credit ratings of banks used by the Group, as at December 31, 2025 at Moody’s and S&P
subsequently, are as follows. Group funds are held at Rabobank with a long-term credit rating of Aa2
and A+, ABN AMRO Bank with a long-term credit rating of between Aa3 and A, and at ING Bank with a
long-term credit rating between A1 and A+.
3.6  Liquidity Risk
Prudent liquidity risk management implies maintaining sufficient cash and marketable securities, the
availability of funding through an adequate amount of committed credit facilities and the ability to
close out market positions.
The table below analyses the Group’s financial liabilities into relevant maturity groupings based on the
remaining period at the balance sheet to the contractual maturity. The amounts disclosed in the table
are the contractual cash flows for continuing operations. The specific time buckets are not mandated
by the standard but are based on a choice of management. The tables includes only the principal
cash flows:
As at December 31, 2025:
in Euro x 1,000
Less than 1
year
Between 1
and 2 years
Between 2
and 5 year
Over 5 years
Total
Borrowings
(124,781)
(19,469)
(2,093)
(146,343)
Shareholder loan
(37,189)
(37,189)
Interest payable
(5,700)
(5,700)
Lease liabilities
(3,614)
(2,496)
(2,369)
(1,140)
(9,619)
Financial liability
(10,485)
(10,485)
Trade payables
(15,612)
(15,612)
Other current liabilities
(9,686)
(9,686)
Other non-current liabilities
(125)
(100)
(300)
(400)
(925)
(159,518)
(2,597)
(69,812)
(3,633)
(235,560)
As at December 31, 2024:
in Euro x 1,000
Less than 1
year
Between 1
and 2 years
Between 2
and 5 year
Over 5 years
Total
Borrowings
(114,384)
(2,500)
(5,998)
(122,882)
Shareholder loan
(13,877)
(13,877)
Interest payable
(2,124)
(10)
(2,134)
Lease liabilities
(2,893)
(3,234)
(4,476)
(1,196)
(11,799)
Financial liability
(7,593)
(7,593)
Trade payables
(14,767)
(14,767)
Other current liabilities
(13,309)
(13,309)
Other non-current liabilities
(100)
(100)
(300)
(500)
(1,000)
(169,047)
(5,844)
(10,774)
(1,696)
(187,361)
The line "Borrowings" includes capital repayments and payment in kind interest. Cash interest payable
until maturity is included on the line "Interest payable".
1In presenting and discussing Avantium’s financial position, operating results and cash flows, Avantium (like many other publicly listed companies) uses certain Alternative performance measures (APMs) not defined by IFRS. These APMs are used because they
are an important measure of Avantium’s business development and Avantium’s management performance. Please see Alternative performance measures disclosure under the section Financial Performance in 2025.
3.7  Fair Value
The Group applies the following hierarchy for determining and disclosing the fair value of the financial
instruments by valuation technique:
Level 1: Quoted (unadjusted) prices in active markets for identical assets or liabilities;
Level 2: Valuation techniques whereby the lowest-level input as significant for valuation at fair value is
directly or indirectly observable;
Level 3: Valuation techniques whereby the lowest level input as significant for valuation at fair value is
not observable.
Trade and other receivables, payables to suppliers, and other liabilities due to expire within one year
are measured at amortized cost. The amortized cost is considered to be a reflection of fair value due
to the short duration.
The fair value measurement for borrowings is categorized within level 3 of the fair value hierarchy.
The fair value is determined based on the discounted cash flow method. This interest rate is
calculated using the market interest rate with company specific adjustments.
The financial liability (warrants) are categorized within level 2 of the fair value hierarchy as this is not a
trading instrument.
During the year, there were no transfers of assets and liabilities between level 1 and 2 classification of
the fair value hierarchy.
3.8  Capital Management
The Group’s objective when managing capital is to safeguard its ability to continue as a going
concern (also refer to 2.1.1) in order to provide returns for shareholders and benefits for other
stakeholders, and to maintain an optimal capital structure to reduce the cost of capital. To maintain
or adjust the capital structure, the Group monitors capital on the basis of its adjusted solvency ratio.
This ratio is calculated as adjusted equity divided by the adjusted balance sheet total.
The adjusted equity is calculated as equity:
Minus the intangible assets, participating interests and receivables from shareholders
The adjusted balance sheet total is calculated as total assets:
Minus the intangible assets, participating interest, receivables from shareholders and shares held in
the own Company
The adjusted solvency ratios as at December 31, were as follows:
in Euro x 1,000
2025
2024
Equity attributable to owners of the parent
152,519
95,854
Intangible assets
(2,942)
(3,271)
Adjusted equity total
149,577
92,583
Total assets
356,168
288,625
Intangible assets
(2,942)
(3,271)
Adjusted balance sheet total 1
353,257
285,354
Adjusted solvency ratio
42%
32%
4.  Critical Accounting Estimates and Judgments
The preparation of financial statements in accordance with IFRS requires the use of certain accounting
estimates. It also requires management to exercise its judgment in the process of applying the
Group's accounting policies. Estimates and judgments are continually evaluated, and are based on
historical experience and other factors, including expectations of future events that are believed to be
reasonable under the circumstances. The resulting accounting estimates will, by definition, seldom
equal the related actual results.
Judgments made in applying accounting policies that have the most significant effects on amounts
recognized in the Consolidated Financial Statements relate to:
Revenue Recognition
The Group recognizes revenue over time or at point in time depending on the agreed contract
performance obligations.
For Flowrence® systems and services contracts the Group recognizes revenue over time as
performance of the contract progresses. The performance on a contract relates to fixed-price
contracts to construct tailor-made Flowrence® systems which the customers control and cannot be of
alternative use to the Company. For the Flowrence® systems, the stage of completion is measured by
reference to the total contract costs incurred up to the end of the reporting period as a percentage of
total estimated costs for each contract. Value is delivered to customers up to each of these points.
For services, in order to recognize revenue over time, the Group is required to estimate the series of
distinct services performed to date as a proportion of the total services to be performed, where also
stage gates are present, and value is added up to that point. To define the recognized revenues, the
Group estimates the required total costs (Flowrence®) or man-hours (services) to complete each
project. On a regular basis a review of the total costs or man-hours is performed.
The Group recognizes license revenue over time. The Group measures its performance toward
completion of the performance obligation based on an output measure of surveys of work performed
compared to the overall project timeline. This measure is deemed to represent the pattern of transfer
of control to the customer since the work performed is of a technical nature. The Group assesses on
an ongoing basis whether the estimated project timeline is still in line with expectations and will make
adjustments should there be a delay or faster progression than initially estimated.
Cessation of capitalization of borrowing costs and activation of Flagship Plant
In determining the date at which the FDCA Flagship Plant is to be activated and the capitalization of
borrowing costs is to be ceased, management is required to determine when the FDCA Flagship Plant
is ready for its intended use. As the process of preparing the plant for start-up is dynamic in nature,
determining the exact moment at which the plant is ready for its intended use requires both
estimations and judgments to be made by management. Management has considered the possible
implications of the completion of physical construction, performance testing and regulatory approval
in estimating the date at which the plant is expected to be ready for its intended use. Management
has determined this to be the date of commercial operations of the plant, which is expected to occur
in 2026. This is the date at which the plant is able to commence with commercial production of FDCA.
Government Grants
The Group accounts for income government grants over time. The Group accounts for asset
government grants by deducting the grant amount from the carrying value of the related asset.
For grant programs, this requires the Group to estimate the services/actions performed to date
as a proportion of the total services or actions to be performed. For further considerations and
assumptions with regard to the critical accounting estimate in relation to government grants,
see note 2.21.
Share-based Payments
Share options granted to employees are measured at the fair value of the options granted (indirect
method of measurement). For the Company’s share option plan, management’s judgment is that the
Black-Scholes valuation method is most appropriate for determining fair values. The assumptions and
estimates used in the valuation are further discussed in note 14 to the Consolidated Financial
Statements.
The result of the share option valuations and the related compensation expense is dependent on the
model and input parameters used. Even though management considers the fair values reasonable
and defensible based on the methodologies applied and the information available, others might
derive at a different fair value for the options granted under the Company’s share option plan.
Research and Development Expenditures
The project stage forms the basis in the decision of whether costs made for the Group’s product
development programs should be capitalized or not. Management judgment is required in
determining when the Group should start capitalizing development costs as intangible assets.
Management determined that for a system, commercial feasibility is, in general, probable when the
Group has built a successful prototype and has interested customers for the commercial product.
Management determined that for product development, (refer to note 2.6) commercial feasibility is, in
general, probable when the Group has successfully completed essential testing phases and is in a
late stage of discussions with potential partners for commercialization opportunities.
The estimates and assumptions that could have a significant risk of causing a material adjustment to
the carrying amounts of assets and liabilities within the next financial year are addressed below.
Initial recognition of borrowings, including shareholder loans
The Group measures its financial liabilities initially at fair value. In determining fair value, management
is required to determine the market interest rate, which represents the rate that would be charged by
market participants for a similar financial instrument with comparable terms, cash flow profile,
currency, credit risk and maturity. The Group has entered into several lending arrangements as
referenced in notes 17, 18 and 20. Determining such a market rate involves significant judgment,
particularly when the Group enters into financing arrangements include complex terms (such as
issuance of warrants), or are negotiated with a limited number of lenders. The interest rate for most
lending agreements was derived based on the yield on corporate bonds with a similar credit rating,
taking into account certain company-specific adjustments and the fact that such market has limited
liquidity. For the senior debt facilities particularly, an implicit interest rate was determined taking into
account the fair value of warrants issued to the lenders. For shareholder loans, where these are
agreed at a rate of interest that is below the market rate, the resulting difference between the fair
value at initial recognition and the nominal amount received is accounted for in equity as a capital
contribution received from the non-controlling shareholder.
Going Concern
For the critical accounting judgment with regard to the going concern situation and assumptions that
are applied, refer to note 2.1.1.
Impairment
Judgments and estimates are required, not only to determine whether there is an indication that an
asset may be impaired, but also whether indications exist that impairment losses previously
recognized may no longer exist or may have decreased (impairment reversal). After indications of
impairment have been identified, judgments and estimates are also involved in the determination of
the recoverable amount of a non-current asset. The recoverable amount is determined based on the
higher of the fair value less cost to sell and the value-in-use. These involve estimates of expected
future cash flows (based on future growth rates and remaining useful life) and residual value
assumptions, as well as discount rates to calculate the present value of the future cash flows. For
more information on managements key assumptions and estimates in relation to impairment
assessments performed for the financial year, see note 5.
2  In the Statement of Cash flows the additions paid in 2025 amounted to €20.7 million. To reconcile this to the additions above of €45.1 million (additions and borrowing cost) the following needs to be excluded: the additions reduction of  €1.3 million invoice
accruals,  €0.2 million capitalized estimated decommissioning costs reduction  (see note 19), non-cash borrowing cost  as mentioned below of €20.5 million, and prior year borrowing cost correction of €2.5 million.
3  The borrowing cost includes non-cash borrowing costs amounting to €20.5 million (2024: €12.0 million) and cash borrowing cost paid of €10.0 million (2024: €7.6 million).
Notes to the Consolidated Statement of Financial Position
5.  Property, Plant and Equipment
in Euro x 1,000
Leasehold improvements
Laboratory equipment
Hardware
Office furniture and equipment
Construction in progress
Total
At January 1, 2024
Cost
17,540
34,624
3,424
2,192
159,506
217,286
Accumulated depreciation
(15,655)
(32,242)
(3,123)
(2,145)
(53,166)
Net book amount
1,885
2,382
301
47
159,506
164,121
Year ended December 31, 2024
Opening net book amount
1,885
2,382
301
47
159,506
164,121
Additions
22
(10)
49
53,645
53,706
Borrowing costs
19,538
19,538
Transfers
123
2,297
10
(2,430)
Impairment losses
(26)
(1)
(27)
Depreciation
(536)
(1,739)
(105)
(15)
(2,395)
Reclassification from asset held for sale - book value
28
28
Closing net book amount
1,494
2,904
282
32
230,259
234,971
At December 31, 2024
Cost
17,685
36,885
3,483
2,192
230,259
290,503
Accumulated depreciation
(16,191)
(33,981)
(3,201)
(2,160)
(55,532)
Net book amount
1,494
2,904
282
32
230,259
234,971
Year ended December 31, 2025
Opening net book amount
1,494
2,904
282
32
230,259
234,971
Additions
48
474
41
17,797
18,360 2
Borrowing costs incurred in prior year
2,523
2,523
Borrowing costs
24,187
24,187 3
Transfers
147
157
18
(322)
Impairment losses
(2,450)
(369)
(2)
(2,821)
Depreciation
(420)
(772)
(107)
(14)
(1,313)
Reclassification from asset held for sale - cost
8,937
868
6
9,811
Reclassification from asset held for sale - accumulated depreciation
(6,487)
(458)
(2)
(6,947)
Closing net book amount
1,269
2,804
236
18
274,444
278,771
At December 31, 2025
Cost
24,367
38,015
3,546
2,192
274,444
342,564
Accumulated depreciation
(23,098)
(35,211)
(3,310)
(2,174)
(63,793)
Net book amount
1,269
2,804
236
18
274,444
278,771
The additions in property, plant and equipment during 2025 predominantly related to investments
made by the Avantium Renewable Polymers segment in the construction of the FDCA Flagship Plant.
The Avantium R&D Solutions segment invested mainly in revenue-generating project machinery.
Capitalized borrowing costs include the interest on leases of the FDCA Flagship Plant, Payment in
Kind Interest, Cash interest, Effective interest, and Agency fees on the Debt Financing facility, interest
on the loans from Fonds Nieuwe Doen, Province Groningen Loan, Convertible Loan, Bridge Loan and
Shareholder Loan, as well as gains and losses on any non-substantial modifications of any of these
borrowings. All of these borrowings are related specifically to the FDCA Flagship Plant. The
capitalized general borrowing costs of 2025 includes borrowing costs incurred in 2024 of €2.5 million
which should have been capitalized in 2024.
The property, plant and equipment of €278.8 million are pledged under the Debt Financing Facilities
(refer to note 17).
Impairment Renewable Polymers
At the end of the reporting period, management identified an additional delay of the FDCA Flagship
Plant, with start-up now expected to be completed by mid-2026 and sales under existing offtake
agreements anticipated to begin in the second half of 2026. This is a key development in key
assumptions of Avantium strategic plan and considered a triggering event for impairment. As a result,
management performed an impairment assessment as at December 31, 2025.
In September Avantium initiated and fully implemented a reorganization and cost saving initiative.
The resulting cost savings have been fully incorporated in the 2026 budget and throughout the
forecast period. In October 2024 mechanical completion of the FDCA Flagship Plant was realized.
By December 31, 2025 total CAPEX was at €280.0 million, which was €50.0 million higher than the
previously communicated forecast of total CAPEX per December 31, 2024 (€230.0 million).
Furthermore, the commissioning, testing, and start-up phase is still ongoing and will proceed
expectedly until mid-2026. Sale of commercial products from the plant will commence later than
communicated in the 2024 Full Year Results Press Release and Annual Report per December 31,
2024, and is expected to commence in the second half of 2026.
In line with the IAS 36 guidance, management has identified the following cash generating units
(CGUs) for both internal and external reporting  requirements:
Renewable Polymers Group ("RNP")
R & D Solutions ("RDS")
To assess the need for an impairment, the carrying amount of a CGU is compared to the recoverable
amount of the CGU. The recoverable amount of the CGU is based on the higher of the fair value less
costs of disposal (FVLCD) and value in use (VIU) calculation. VIU is determined by discounting the
future cash flows generated from the continuing use of the CGU using a pre-tax discount rate.
The carrying amount of the CGU of €264.96 million includes the FDCA Flagship Plant, related leases,
working capital and allocation of the relevant corporate assets.
Following the start-up of the FDCA Flagship Plant, a fundamental driver of the long-term funding of
the Group will be the successful sale of technology licenses for Avantium’s YXY® Technology that
enables the large-scale production of FDCA and PEF. Without a timely and successful start-up of the
FDCA Flagship Plant, Avantium may not be successful in selling sufficient technology licenses, in a
timely fashion, to secure the necessary liquidity for the Company. As a result, any material delays or
deviations in relation to the sale of technology licenses and their related income would have a
significant negative impact on the Company’s future cash flows and potentially its viability.
In view of the above, and given that the FDCA Flagship Plant is the first of its kind and most future
license sales have yet to occur, management opted for a VIU calculation based on finite forecast
period (i.e. without a terminal value). The VIU is prepared based on the 6 year forecast for the output
of the FDCA Flagship Plant, extrapolated to the end of the life of the FDCA Flagship Plant in 2035 and
the forecasted license income from the expected sale of licenses in the coming 6 years, extrapolated
to the end date of these licenses (which is forecasted to be 2049). The potential sale of licenses after
the 6-year forecast is not taken into consideration.
Key estimates and assumptions:
The key estimates and assumptions in the model are the timing of the start of commercial product
sales, license income expected to be generated through the sale of licenses which include receipt of
milestone payments and actual license revenue from products and the Weighted Average Cost of
Capital (WACC).
Key estimates and assumptions
2025
2024
Timing of the start of commercial
product sales
H2 2026
H2 2025
License income expected to be
generated through the sale of
licenses
The license income from the
licenses to be sold during the first 6
years after the period end  and
related future income
The license income from the
licenses to be sold during the first 6
years and related future income
WACC
12%
12%
There are three key developments in applied assumptions compared to the impairment test in the
2024 Annual Report:
An additional delay of the FDCA Flagship Plant, with start-up now expected to be completed by
mid-2026 and sales under existing offtake agreements anticipated to begin in the second half of
2026 (previously expected in H2 2025). This is due to both welding progress and an updated
startup planning, resulting in the delay of 1 year to realize sales, combined with a more conservative
estimation of Raw Materials & Utilities costs.
A revised timeline on licensing projections, driven by the delay in the FDCA Flagship Plant, but
offset by advances in the discussions with prospects. Although all revenues associated with the
Origin Materials license have been removed from the licensing model, reflecting the decision to halt
Origin Materials revenues, additional potential licenses have been added resulting in a 17% increase
in the number of licenses forecasted. Avantium is currently engaged in advanced discussions with
10+ potential licensees, and strives to have 4 license agreements in place by the end of 2027.
While these discussions are at various stages of maturity, no binding license agreements have been
concluded to date.
Pre-tax WACC calculated from the model is 15.0% (2024: 14.9%).
In 2025, no impairment loss was recognized in relation to the trigger-based impairment test.
As part of the impairment test, sensitivity tests were performed to assess the impact in changes of the
key assumptions:
Sale of commercial product: a 6-month delay would result in the VIU to be at the same level as the
carrying value;
Timing of license income: if all licenses were shifted by 6 months, this would result in the VIU to be
at the same level as the carrying value;
License income: a reduction in the cumulative license income until 2049 of 7% would result in the
VIU to be at the same level as the carrying value;
WACC: in case of a change of 1.2% (i.e. 13.2% post-tax WACC / 16.2% pre-tax WACC), the VIU would
be at the same level as the carrying value
The recoverable amount of the CGU is significantly dependent on the success of the future licensing
business and thereby any significant deviations and/or delays in the timing of the start of commercial
product sales or the license income expected to be generated through the sale of licenses will have a
material impact on this valuation.
Impairment of Ray Technology® pilot plant
In 2025, management concluded that the Ray Technology® pilot plant (refer to note 11) will no longer
be used in the Company’s operations and will not generate future economic benefits. As no active
market exists for the assets and scrap value is negligible, the pilot plant was fully impaired during the
year.
4  In the Consolidated Statement of Cash Flows the additions paid in 2025 amounted to €12.000 (2024: €0.3 million). In 2024 the additions include €0.8 million non-cash addition relating to the TNO license (refer to note 16).
6.  Intangible Assets
in Euro x 1,000
Development costs
Software
Intellectual Property
License rights
Other
Total
At January 1, 2024
Cost
2,159
7,715
433
1,326
1,138
12,771
Accumulated amortization and impairment losses
(2,159)
(7,301)
(987)
(10,447)
Net book amount
413
433
1,326
151
2,323
Year ended December 31, 2024
Opening net book amount
413
433
1,326
151
2,323
Additions
841
337
1,178
Amortization
(173)
(57)
(230)
Closing net book amount
240
433
2,110
488
3,271
At December 31, 2024
Cost
2,159
7,715
433
2,167
1,475
13,948
Accumulated amortization and impairment losses
(2,159)
(7,475)
(57)
(987)
(10,678)
Net book amount
240
433
2,110
488
3,271
Y
e
a
r
e
n
d
e
d
3
1
D
e
c
e
m
b
e
r
2
0
2
4
Year ended December 31, 2025
Opening net book amount
240
433
2,110
488
3,271
Additions
12
12 4
Disposals acquisition cost
(987)
(987)
Disposals accumulated amortization
987
987
Transfers
415
26
(441)
Impairment
(10)
(10)
Amortization
(251)
(91)
(342)
Reclassification from asset held for sale - cost
34
34
Reclassification from asset held for sale - accumulated
amortization
(23)
(23)
Closing net book amount
405
433
2,045
59
2,942
At December 31, 2025
Cost
2,159
8,154
433
2,192
59
12,997
Accumulated amortization and impairment losses
(2,159)
(7,749)
(147)
(10,055)
Net book amount
405
433
2,045
59
2,942
The Intellectual Property of €0.4 million is pledged under the Debt Financing Facilities (refer to note 17).
Development Costs
The development costs consist of the development and prototype expenses of the Flowrence ®
system and are all fully amortized.
Research expenditures recognized as an expense in profit or loss amounted to €0.2 million (2024:
€1.2 million) and mainly constitute of early stage research trials.
Software and Other Intangibles
Software mainly comprises purchased general laboratory and office-related software.
Other intangibles are the in-kind contribution of a shareholder relating to software at the foundation of
the Group and compensation paid to a third party to exclusively use parts of their technology, as well
as software being developed.
Intellectual Property
Following the Liquid Light acquisition in 2016, the Company records intellectual property (patent
portfolio acquired) on its consolidated balance sheet, which will subsequently be lowered with
accumulated amortization the following years, when the technology on which the intellectual property
is filed, is ready to deploy commercially. As at December 31, 2025, the recoverable amount of the
intellectual property exceeds the carrying amount.
License Rights
The license rights consists of the licenses acquired for technologies not owned or developed by the
Company. Included in the license rights is the Eastman license acquired by Avantium Renewable
Polymers during 2021. As part of the license agreement, royalty fees will be payable to Eastman.
The fees will equal to $20 USD per metric ton of Licensed Products produced from the FDCA
Flagship Plant. The commencement of the operations will be in 2026. Avantium may decide how it
proposes to settle the royalty fees. The foregoing running royalty will be payable by the Company in
cash or in shares of Avantium N.V. (in equivalent value) on a semi-annual basis for the first two years
of operation of the FDCA Flagship Plant, after which all such payments will be paid in cash.
Effective April 2024, Avantium Chemicals B.V. has entered into a non-transferrable, exclusive, non-
sublicensable license with Nederlandse Organisatie voor toegepast-natuurwetenschappelijk
onderzoek TNO. The license provides Avantium Chemicals B.V. with the right to manufacture, sell,
market and further develop Proton Exchange Membrane (PEM) electrolyzer test units. The initial
agreement is valid for a period of seven years, with a possible extension of another three years.
Avantium has obtained the license in exchange for a fixed consideration of € 100,000 per year and
variable consideration in the form of royalties when Avantium realizes future sales under this license.
A liability was recognized for the fixed consideration (refer to note 16), and any variable consideration
payable is recognized in profit or loss as and when incurred. An intangible asset has been recognized
for the License obtained under the agreement.
7.  Leases
This note provides information for leases where the Group is a lessee.
Amounts Recognized in the Statement of Financial Position
The balance sheet shows the following amounts relating to leases:
in Euro x 1,000
December 31, 2025
December 31, 2024
Properties
6,157
7,819
Motor vehicles
1
Total right-of-use assets
6,157
7,820
in Euro x 1,000
December 31, 2025
December 31, 2024
Non-current lease liabilities
5,269
7,708
Current lease liabilities
3,262
2,409
Total lease liabilities
8,531
10,117
Movement schedule for the right-of-use assets
in Euro x 1,000
2025
2024
Balance at January 1
7,820
8,090
New lease contracts
2,023
Depreciation
(2,483)
(2,578)
Modifications
820
286
Balance at December 31
6,157
7,820
Movement schedule for the lease liability
in Euro x 1,000
2025
2024
Balance at January 1
10,117
9,616
New lease contracts
1,771
Repayment of lease liabilities
(2,563)
(2,405)
Modifications
978
286
Reclassification (to)/from liabilities associated with asset held for sale
849
Balance at December 31
8,531
10,117
Additions to the right-of-use assets during 2025 were €0 (2024: €2.1 million). The 2024 additions
pertain to lease agreements for temporary offices and laboratory spaces installed at the FDCA
Flagship Plan t.
Amounts Recognized in the Statement of Profit or Loss and Comprehensive Income
The statement of profit or loss and comprehensive income shows the following amounts relating to
leases:
in Euro x 1,000
2025
2024
Properties
2,480
2,567
Motor vehicles
3
11
Total depreciation charge of right-of-use assets
2,483
2,578
in Euro x 1,000
2025
2024
Interest expense included in finance cost
179
220
Total interest charge on lease liabilities
179
220
Repayment of lease liabilities consists of invoices received of €3.0 million (2024: €2.9 million) related
to the period in question less interest charge of €0.4 million (2024: €0.5 million).
The cash flow related to principal elements of the lease payments made during the period amounted
to €2.8 million (2024: €2.4 million).
Some of the lease agreements contain variable lease elements that are linked to the usage of the
lease, which is not included in the measurement of the lease liability. The variable lease expense for
the year not included in the measurement of the lease liability amounted to €0.4 million (2024:
€0.4 million). The short term and low value lease expenses for 2025 amounted to €0.2 million
(2024: €0.5 million).
8.  Inventories
in Euro x 1,000
December
31, 2025
December
31, 2024
Raw materials
1,256
1,317
Spare parts
163
Total inventories
1,419
1,317
The costs of inventories recognized as an expense and included in raw materials and contract costs,
amounted to €0.3 million (2024: €0.3 million).
9.  Trade and Other Receivables
in Euro x 1,000
December
31, 2025
December
31, 2024
Non-Current
Other non-current assets
188
189
Total other non-current assets
188
189
Current
Trade receivables
3,557
5,124
Less: Allowance for doubtful debts
(63)
(205)
Social security and other taxes
338
1,426
Prepayments
835
459
Contract assets
1,639
3,808
Other receivables
2,919
3,677
Reclassification to asset held for sale
(45)
Total current trade and other receivables
9,225
14,244
Total trade and other receivables
9,413
14,433
Other non-current assets of €0.2 million relate to refundable deposits paid on two leases by Avantium
RNP Flagship B.V. These leases commenced in April 2024 and October 2024 and have been entered
into for terms of 65 and 61 months.
In 2025, €0 (2024: €0 million) of trade or other receivables was written off; €0.3 million (2024: €2.0
million) was past due, of which 85% had been paid before January 31, 2026 (as at January 31, 2025:
62%).
Trade receivables and contract assets are written off where there is no reasonable expectation of
recovery. The Company assessed the trade receivables balance as at December 31, 2025, including
an allowance for expected credit losses of €0.1 million (2024: €0.2 million) (refer to note 3.1).
The carrying amounts of these financial assets are assumed to approximate their fair values.
Trade receivables of €3.6 million (2024: €5.1 million) are pledged under the Debt Financing Facilities
Agreement (refer to note 17).
Contract assets relating to systems and services contracts are unbilled revenues, where the Company
has recognized revenue to date in accordance with its progress towards completion of its
performance obligations, however is not yet in the position to bill these revenues to customers as the
invoicing milestone has not yet been reached.
Other receivables primarily comprise funding to be received in relation to government grants where
the Company has already complied with the attached conditions under the specific grant program
amounting to €2.6 million (2024: €3.3 million) and deposits held at third parties amounting to €0.3
million (2024: €0.3 million).
10.  Cash and Cash Equivalents
in Euro x 1,000
December
31, 2025
December
31, 2024
Cash at bank and on hand
55,834
20,699
Restricted cash
1,632
3,199
Cash and cash equivalents for cash flow purposes
57,466
23,898
The carrying amounts of these financial assets are assumed to approximate their fair values. A
notional cash pool agreement is in place for all Rabobank accounts where balances are netted on a
daily basis. Within the cash pool, there are €0 overdrafts.
The cash and cash equivalents presented in the Consolidated Statement of Financial Position and
Consolidated Statement of Cash Flows include restricted cash of €1.6 million (2024: €3.2 million).
The restricted cash represents short term cash-collateralised guarantee facilities. The guarantee
facilities consists of a facility with Rabobank, which has a maximum capacity of €3.0 million
(2024: €3.0 million) and a facility with ABN AMRO with no maximum capacity. Of the utilized capacity,
€0.9 million (2024: €2.9 million) relates to Rabobank and €0.7 million (2024: €0.3 million) relates to
ABN AMRO.
For further information on commitments issued to third parties, refer to note 30.
11.  Assets Held for Sale
At the end of the 2023 financial year, the Company decided to pause its investments in Ray
Technology® for the production of plant-based glycols, specifically plantMEG and plantMPG.
As a result, the associated assets and liabilities were reclassified and presented as held for sale.
In September 2024, management reconsidered the strategy in relation to the Ray Technology®.
As a result, the scope of the sale was reduced from that of a business to purely IP assets and the
related pilot plant, and leased assets were reclassified out of assets held for sale.
As no sale occurred in 2025, at the end of 2025, management shifted its focus solely on the sale of
the IP assets (which are not recognized on the Statement of Financial Position). As a result, the assets
related to the pilot plant were reclassified out of assets held for sale to property, plant and equipment
and tested for impairment. Refer to note 5.
The carrying value of the major classes of assets and liabilities of the disposal group as at December
31, 2025 are as follows:
in Euro x 1,000
December
31, 2025
December
31, 2024
Property, plant and equipment
2,861
Intangible assets
10
Right of use asset
Trade receivables
Other receivables
45
Total assets held for sale
2,916
Lease liabilities
Trade and other payables
(7)
Other liabilities
(30)
Total liabilities associated with asset held for sale
(37)
12.  Share Capital and Other Reserves
12.1  Ordinary Shares
The authorized share capital as at December 31, 2025 amounted to €43,480,060 (2024:
€10.0 million) consisting of 43,480,060 (2024: 100,000,000) ordinary shares, with a nominal value
each of €1.00 (2024: €0.10).
On March 31, 2025 and May 29, 2025 respectively, 827,103 and 106,376 ordinary shares (adjusted for
the share consolidation) were issued to warrant holders as a result of an exercise on both March 20,
2025 and May 19, 2025. This has resulted in an increase in share premium of €2.6 million (refer to
note 20).
On May 14, 2025 the Annual General Meeting adopted the 1:10 share consolidation and the
amendment of the Articles of Association of the Company. Effective on May 22, 2025 the share
consolidation has resulted in 10 ordinary shares being consolidated into 1 ordinary share, the nominal
value per ordinary shares changing from €0.10 to €1.00 and the number of shares outstanding
changing from 86,960,115 to 8,696,012. Where applicable, comparatives have been adjusted.
On September 18, 2025, the Company announced it successfully increased its equity by €84.8 million
by means of a fully underwritten and committed rights offering of €65.4 million resulting in the issue of
12,103,283 new ordinary shares and the completion of a €19.4 million Additional Placement which
resulted in the issue of 3,319,384 new ordinary shares. This resulted in an increase in share premium
of €64.7 million. The gross proceeds of the equity raise amounted to €84.8 million and the transaction
cost directly relating to the capital raise amounted to €6.8 million.
Additionally, upon the successful minimum equity, 971.664 ordinary shares of the Company were
issued as part of the conversion of the P.Kooi loan. See note 17.
On December 19, 2025, the Company requested the issuance and delivery of 10,000 shares related
in view of satisfying certain obligations under its employee incentive plans (delivery of shares to
employees).
The issued share capital as at December 31, 2025 comprises 25,206,719 ordinary shares (2024:
86,133,012). In 2025, no options were exercised by employees. At December 31, 2025, zero (2024:
zero) shares were held by Stichting Administratiekantoor Avantium (the Foundation) and nil employee
shares were repurchased. All shares issued are fully paid.
12.2  Other Reserves
The costs of equity settled share-based payments to employees are recognized in profit or loss,
together with a corresponding increase in equity during the vesting period. The accumulated expense
of the share incentive plan recognized in profit or loss is shown as part of the equity category ‘other
reserves’ in the Consolidated Statement of Changes in Equity.
Additionally, included in the ‘other reserves’ category is the share-based payment for the Eastman
license acquired in 2021. The settlement of the share-based payment will be in three equal
installments. The first installment was made in 2022 at 8 months after the Final Investment Decision.
The second installment was paid in 2023, 24 months after the Final Investment decision. The third
installment is payable and awaiting transaction details to execute in 2026. Avantium has the option to
settle the outstanding amount in shares or cash.
13.  Non-Controlling Interests
The tables summarize the consolidated information relating to the Company's subsidiary, Avantium
Renewable Polymers B.V., that has Non-Controlling Interests amounting to 22.6%.
On March 31, 2022, there was a change in ownership of Avantium Renewable Polymers B.V., whereby
Worley Nederland B.V. and Bio Plastics Investment Groningen B.V. together have acquired a 22.6%
shareholding. Avantium continues to hold 77.4% of the equity.
Summarized Statement of Financial Position
in Euro x 1,000
December
31, 2025
December
31, 2024
Non-current assets
287,470
236,992
Non-current liabilities
(189,654)
(50,556)
Net non-current assets
97,816
186,436
Current assets
7,326
4,539
Current liabilities
(120,345)
(188,338)
Net current (liabilities)
(113,019)
(183,799)
Net total (liabilities)/ assets
(15,203)
2,637
Accumulated Non-Controlling Interests
(2,922)
1,931
5 In presenting and discussing Avantium’s financial position, operating results and cash flows, Avantium (like many other publicly listed  companies) uses certain Alternative performance measures (APMs) not defined by IFRS’.
These APMs are used because they are an important measure of Avantium’s business development and Avantium’s management performance. Please see Alternative performance measures as included under Financial performance 2025.
Summarized Statement of Profit or Loss and Comprehensive Income 
in Euro x 1,000
2025
2024
Revenue
526
6,478
Other Income
1,520
2,654
Net operating expenses
(24,428)
(26,316)
EBITDA 5
(22,382)
(17,184)
Loss for the year
(20,385)
(25,436)
Loss allocated to Non-Controlling Interests
(4,615)
(5,759)
The loss allocated to Non-Controlling Interests constitutes to 22.6% (2024: 22.6%) of the loss for the
year for Avantium Renewable Polymers B.V.
Summarized Statement of Cash Flows
in Euro x 1,000
2025
2024
Cash flows from operating activities
(22,575)
(4,435)
Cash flows from investing activities
(20,257)
(57,810)
Cash flows from financing activities
45,165
53,761
Net increase/(decrease) in cash and cash equivalents
2,333
(8,484)
14.  Share-based Payment
The Group operates share-based compensation plans for its employees, which consist of an
Employee Share Option Plan (ESOP) and a Long-term Incentive Plan (LTIP). These plans are classified
as equity-settled share-based payment plans. These concern the Company legacy employee
incentive programs.
On May 14, 2025 the Annual General Meeting adopted the 1:10 share consolidation. Effective on May
22, 2025 the share consolidation has resulted in 10 ordinary shares being consolidated into 1 ordinary
share. The share-based compensation plans provide the Supervisory Board with the right to adjust the
number of units accordingly upon the occurrence of a share consolidation. After the consolidation,
the total intrinsic and fair value of share units and options remains unchanged. Therefore, as the
economic value of the grants under the share-based compensation plans has been preserved after
the consolidation and the consolidation is not beneficial to the counterparties, this modification to the
existing share-based compensation plans has not had an impact.
Long-term Investment Plan
The members of the Management Team are obligated to invest a percentage of their (net) cash bonus
in (depository receipts for) shares to be delivered by the Company under the LTIP. Each Investment
share relates to one share. The cash component of the bonus may, at the discretion of the relevant
member of the Management Team, also be invested in Investment shares. The Investment shares are
subject to a retention period of five years, during which the Investment shares cannot be sold. After
the end of the retention period, the Company will match the (depository receipts for) shares granted
under the LTIP at a 1:1 ratio, i.e. one Matching share is granted for each Investment share.
The entitlement to receive Matching shares will be reduced as follows in the case of termination:
100% if the termination date is prior to the first anniversary of the date of the Award; 66.67% if the
termination date is prior to the second anniversary but after the first anniversary of the date of the
Award; 33.33% if the termination date is prior to the third anniversary but after the second anniversary
of the date of the Award.
In 2025, nil (2024: 87,967) shares were granted under the LTIP.
The movements in outstanding LTIP awards with the Management Board and senior management can
be summarized as follows:
Long-term Investment Plan
2025
Number of
awards
Weighted
Average
share price
at grant date
(in Euro)
Number of awards outstanding January 1
584,147
3.51
Impact of share consolidation
(525,732)
Number of options outstanding after share consolidation
58,415
35.14
Number of matching shares forfeited
(26,199)
35.18
Number of awards outstanding December 31
32,216
35.11
Long-term Investment Plan
2024
Number of
awards
Weighted
Average
share price
at grant date
(in Euro)
Number of awards outstanding January 1
424,281
3.78
Number of awards granted (including matching shares)
87,967
2.81
Modification
71,899
2.81
Number of awards outstanding December 31
584,147
3.51
LTIP awards outstanding at the end of the year had the following share price at grant date:
Grant date
Share price at grant date in Euro
Number of awards
March 16, 2018
5.36
7,236
March 21, 2019
2.64
1,967
May 14, 2020
3.59
10,434
May 18, 2022
3.07
16,342
May 10, 2023
3.50
13,263
May 15, 2024
2.81
8,797
At December 31, 2025
58,039
At the Annual General Meeting held on May 15, 2024 the shareholders approved the increase of the
number of Long Term Incentive Plan shares by 17.9%. There is no change in the vesting period.
The fair value of the additional shares is the determined as the share price on date of approval,
being €2.81. The number of additional shares amount to 72,000. The expense recognized during
2025  due to the modification amounted to €6,800 (2024: €0.2 million), with the remaining amount to
be expensed over the remaining vesting periods. The number of awards reflected in the table above
includes the modified number of awards.
The fair value of awards under the LTIP is determined by the share price at grant date and the
weighted average fair value of LTIP awards granted during 2024 was €2.81 per award.
Performance Share Units
In the Annual General Meeting held on May 15, 2024 an update to the Management Board
Remuneration Policy was approved, which included the introduction of the New LTIP. Effective as of
January 1, 2024, a new equity-based long-term incentive plan (the New LTIP) was put in place which
allows for the granting of Performance Share Units (“PSUs”) to Management Board members based on
long-term stakeholder value creation. The PSU provides the participant with a conditional right to
receive a share, following vesting and settlement in accordance with the provisions of this PSU Plan.
Under the New LTIP members of the Management Board will be granted PSUs annually, for a value
equal to a predefined percentage of their fixed annual gross base salary. The number of PSUs
granted each year is determined with reference to the share price. In 2025 10,860 (2024: 135,231)
PSUs were granted under the plan.
PSUs will vest after a three-year cliff vesting period at which point all the granted PSUs will vest in full
or in part subject to the satisfaction of the performance conditions. The vesting of PSUs is contingent
on an underpin assessment which evaluates the long-term value creation by the Management Board
and considers specific financial and non-financial events that could threaten the Company’s long-term
continuity and value. The underpin assessment is conducted by the Supervisory Board at vesting.
Therefore at year end the grant date has not yet been achieved and accordingly the grant date fair
value has been estimated using the closing share price as at the reporting date. The movements in
outstanding PSUs with the Management Board can be summarized as follows:
Long-term Investment Plan (PSU)
2025
2024
Number of
awards
Share price
at grant date
(in Euro)
Number of
awards
Share price
at grant date 
(in Euro)
Number of awards outstanding January 1
135,231
Impact of share consolidation
(121,708)
Number of options outstanding after share
consolidation
13,523
Number of awards granted
10,860
6.84
135,231
1.82
Number of forfeitures
(4,991)
Number of awards outstanding December 31
19,392
135,231
Restricted Share Units
In the Annual General Meeting held on May 15, 2024 an update to the Supervisory Board
Remuneration Policy was approved, which included the introduction of a new equity-based incentive
plan for the Supervisory Board members. Restricted Share Units (RSUs) provide participants with
conditional rights to receive ordinary shares in the capital of the Company. Based on an appointment
or re-appointment term of four (4) years, the number of RSUs to be granted to Supervisory Board
members is:
A fixed grant of 55,000 shares upon re-appointment of the Chair of the Supervisory Board; and
A fixed grant of 20,000 shares upon re-appointment of other members of the Supervisory Board.
In 2025, RSUs were also granted to employees.
These RSUs are non-performance-based instruments. In 2025, 115,250 (2024: 20,000) RSUs were
granted under the plan.
For the grant in 2025, no grant date was achieved yet as the employees were informed late
December. The grant date fair value has been estimated using the closing share price as at the
reporting date.
The movements in outstanding RSUs can be summarized as follows:
Long-term Investment Plan (RSU)
2025
2024
Number of
awards
Share price
at grant date
(in Euro)
Number of
awards
Share price
at grant date
(in Euro)
Number of awards outstanding January 1
20,000
Impact of share consolidation
-18000
0
0
Number of options outstanding after share
consolidation
2,000
Number of awards granted
115,250
6.84
20,000
2.81
Number of awards outstanding December 31
117,250
20,000
Employee Share Option Plan
On an annual basis and on certain other occasions set out in the plan rules, options under the
Employee Share Option Plan (ESOP) may be conditionally granted to eligible employees of the
Company. The options will vest yearly over a three-year vesting period. The vested options have an
exercise period of five years after vesting, after which the option expires.
In 2025, no share options were granted (2024: 371,250 options). 
The movements in outstanding options under the ESOP with the Management Board, senior
management and certain other employees can be summarized as follows:
Employee Share Option Plan (ESOP)
2025
Number of
options
Weighted
Average
exercise 
price (in
Euro)
Number of options outstanding January 1
2,950,103
2.01
Impact of share consolidation
(2,655,092)
Number of options outstanding after share consolidation
295,011
20.15
Number of options forfeited
(135,411)
31.41
Number of options outstanding December 31
159,600
17.43
Employee Share Option Plan (ESOP)
2024
Number of
options
Weighted
Average
exercise 
price (in
Euro)
Number of options outstanding January 1
2,654,599
1.94
Number of options forfeited
(75,746)
3.28
Number of options granted
371,250
2.79
Modification
0.13
Number of options outstanding December 31
2,950,103
2.02
Further details on the grants in can be found in the table below.
Grant date
Plan
Exercise price in Euro per option
Number of ESOP options granted
December 31, 2023
ESOP
28.90
1,100
May 15, 2024
ESOP
28.10
32,525
November 1, 2024
ESOP
24.10
3,500
At December 31, 2025
37,125
At the Annual General Meeting held on May 15, 2024 the shareholders approved the decrease of the
strike price of the options granted under the Employee Stock Option Plan by 17.9%.
There is no change in the vesting period. The fair value is determined based on the Black-Scholes
valuation model as at May 15, 2024 using the strike price grant date and the new strike price.
The expense recognized during 2025 due to the modification amounted to €10,000 (2024: €0.3
million), with the remaining amount to be expensed over the remaining vesting periods.
Share options outstanding at December 31, 2025, amounted to 159,600 (2024: 2,950,102).
The exercise prices range from €0.10 to €47.50. The weighted average remaining contractual term
for options outstanding at December 31, 2025, was 3.74 years.
Avantium N.V. has issued shares resulting from the exercise of options to the Stichting
Administratiekantoor Avantium (the Foundation).
The Foundation has issued depository receipts to members of the Management Board, senior
management and certain other employees. The Foundation is a consolidated special purpose entity
set up by Avantium N.V. The shares held by the Foundation, however, only represent the voting rights
associated with the issued shares and depository receipts representing all economic benefits issued
by the Foundation to members of the Management Board, senior management and certain other
employees, and consequently the shares held by the Foundation are not considered treasury shares.
The number of options which are exercisable at the end of the period (i.e. vested, but not yet
exercised) amounted to 1,381,011 (2024: 1,641,456).The fair value of options under the equity-settled
share-based payment plans is determined using the Black-Scholes valuation model and the weighted
average fair value of options granted during 2024: €2.02. No options were granted in 2025.
The significant inputs into this model were as follows:
May 15, 2024
November 1, 2024
December 31, 2023
Exercise price
€2.81
€2.41
€2.89
Volatility
51%
52%
55%
Risk free interest rate
2.43%
2.38%
1.97%
Dividend yield
Expected life
7.6 years
7.6 years
7.6 years
Early exercise rate
5%
5%
5%
The historical volatility used is based on the volatility of the Company’s own shares in combination
with the historical volatility of a peer group (five companies in total which are considered to be
comparable listed companies), of which the daily stock returns over a period equal to the maturities
of each plan related to the valuation dates was used.
15.  Earnings per Share
Earnings per share for the years 2025 and 2024 are derived below:
In Euro
December
31, 2025
December
31, 2024
Loss for the year attributable to owners of the Company - basic
(22,518,029)
(26,868,173)
Loss for the year attributable to owners of the Company - diluted
(22,518,029)
(26,868,173)
Weighted average number of ordinary shares - basic
13,278,607
7,549,382
Number
Options per end of the year
159,600
295,010
LTIP awards per end of the year
32,216
58,415
Effect of anti-dilutive securities
191,816
353,425
Weighted average number of ordinary shares - diluted
13,278,607
7,549,382
In Euro
Earnings per share - basic
(1.70)
(3.56)
Earnings per share - diluted
(1.70)
(3.56)
As the Company is in a loss-making position, the options and LTIP awards have an anti-dilutive impact
on the diluted earnings per share, for this reason the options and LTIP awards for the year are not
considered in the calculation of diluted earnings per share.
On March 31, 2022, Avantium N.V. issued 2.84 million warrants to the consortium of banks as part of
the Debt Financing Facilities for the FDCA Flagship Plant. Refer to note 20. The warrants issued on
March 31, 2022 had an anti-dilution protection for the equity raise that took place in April 2022. As a
result, on April 14, 2022, 1.02 million additional warrants were issued to the warrant holders, to
compensate for the dilutive effect of the equity offering. There is no further anti-dilution protection
applicable to these warrants. The warrants became exercisable on January 30, 2023, but because
Avantium is loss making there is no dilutive impact on the earnings per share. A number of these
warrants have been exercised by warrant holders on March 20, 2025. Refer to note 20.
Effective July 31, 2024, the Management Board had resolved to grant 559,085 additional warrants
to the consortium of banks upon the receipt of an additional €15.0 million based on an amendment to
the original Debt Financing Facilities Agreement. The warrants became exercisable on October 12,
2024, but because Avantium is loss making there is no dilutive impact on the earnings per share. A
number of these warrants have been exercised by warrant holders on March 20, 2025. Refer to note
20.
On March 18, 2025 Avantium N.V issued 11.4 million extension warrants and 2.4 million first set
increase warrants to the consortium of banks as part of the third amendment to the Debt Financing
Facilities Agreement. 50% of the extension warrants became exercisable on May 14, 2025 and the
remaining 50% of the extension warrants will become exercisable from March 31, 2026. 60% of the
first set increase warrants became exercisable on June 25, 2025 at the first utilization of the
increased commitment and the remaining 40% will become exercisable upon the earlier of any
repayment of the loans outstanding under the increased facility and March 31, 2026. As Avantium is
loss making there is no dilutive impact on the earnings per share. A number of these warrants have
been exercised by warrant holders on May 19, 2025. Refer to note 20.
Under the third warrant agreement above, the issuance of a second set of increase warrants were
contingent upon meeting the conditions precedent to the extension of the Debt Financing Facilities.
On August 12, 2025, this clause has been replaced by the Agreement for Lock-up, Extension and
Transfer of Warrants (the "Fourth Warrant agreement"). In accordance with this agreement, 0.02 million
warrants were issued to the consortium of banks on the fourth amendment to the Debt Financing
Facilities agreement (refer to note 20). In accordance with the revised terms, 50% of the Second Set
Increase Warrants became exercisable immediately upon issuance, with the remaining 50% becoming
exercisable from 31 March 2027. This agreement also provides for a lock-up period on all existing
warrants of 180 days and extended the Warrant Exercise Period up and until December 31, 2028.
The calculation of basic and diluted earnings per share was adjusted retrospectively for the impact of
the share consolidation. The comparative period's number of shares in issue was adjusted in the ratio
of 1:10 as approved by the Annual General Meeting on May 14, 2025.
For further detail on movements in issued ordinary shares, refer to note 12.1.
16.  Trade and Other Payables
In Euro x 1,000
December
31, 2025
December
31, 2024
Non-Current
Prepayment liabilities
360
600
TNO license Agreement
709
859
Total Non-Current Prepayment Liabilities
1,069
1,459
Current
Trade payables
15,612
14,767
TNO license Agreement
76
Interest payable on borrowings
38
1,295
Social security and other taxes
2,192
Holiday pay and holiday days
1,938
1,805
Contract liabilities
840
1,910
Deferred government grants
11,616
8,981
Other current liabilities
4,678
8,299
Reclassification of liabilities associated with asset held for sale
(37)
Total Current Trade and other payables
36,990
37,020
Total Trade and other payables
38,059
38,479
Non-current prepayment liabilities include advance amounts received for costs to be incurred under
collaboration agreements.
Effective April 2024, Avantium R&D Solutions has entered into a non-transferrable, exclusive, non-
sublicensable license with Nederlandse Organisatie voor toegepast- natuurwetenschappelijk
onderzoek TNO (TNO). The license provides Avantium R&D Solutions with the right to manufacture,
sell, market and further develop the Proton Exchange Membrane (PEM) electrolyser test units.
Avantium R&D Solutions has obtained the license in exchange for a minimum fixed consideration of
€0.1 million per year and variable consideration contingent upon future sales. An 'other non-current
financial liability' was recognized at the cost price equivalent of €0.8 million. The cost price equivalent
has been calculated as the present value of the annual minimum €0.1 million payable over the
contract term of 10 years. An intangible asset has been recognized for the License obtained under the
agreement (refer to note 6).
In Euro x 1,000
2025
2024
Balance as at January 1
859
Additions
841
Interest expense
26
18
Payments
(100)
Balance as at December 31
785
859
The increase in ‘social security and other taxes’ to €2.2 million reflects the shift from a net receivable
position in the prior year, driven by WTS and WBSO balances, to a liability position in the current year
due to higher December wage taxes payable (2024: €0.8 million vs 2025: €1.6 million) following the
bonus payout and the movement of the WBSO balance from a €1.0 million receivable to a €0.7 million
payable at year‑end.
Contract liabilities relating to systems and services contracts are deferred revenues, for which the
Company has received payment per invoicing milestones where to date, in accordance with its
progress towards completion of its performance obligations, it has not yet recognized those revenues.
Decrease in contract liabilities compared to the prior period is a result of a decrease in total projects
underway which are in a deferred revenue position (2025: 14, 2024: 29).
The following table shows how much of the revenue recognized in the current reporting period
relates to carried-forward contract liabilities:
In Euro x 1,000
2025
2024
Revenue recognized that was included in the contract liability balance at the
beginning of the period:
- Systems contracts
1,112
1,108
- Services contracts
428
3,292
- Other
5
3,000
1,545
7,400
The contract liability related to the Origin Materials' License Agreement (refer to note 21) remains
suspended along with all activities under the licensing agreement (2025: €0.2 million, 2024: €0.2
million).
Deferred government grants comprise advances received in relation to government grants. The
carrying amounts of these financial liabilities are assumed to approximate their fair values. This
amount also includes the deferred modification gain of €0.3 million (2024: nil) on the Fonds Nieuwe
Doen loan recognized as a government grant.
Other current liabilities comprise primarily other staff pay related accruals of €1.4 million
(2024: €1.6 million) and accrued expenses of €2.7 million (2024: €6.1 million).
Liabilities associated with asset held for sale were reclassified in the current period (refer to note 11).
6 As the March 2025 amendments had no impact on profit or loss, only the modification effects of the August 2025 amendments are presented in the table above.
7 As the March 2025 amendments had no impact on profit or loss, only the modification effects of the August 2025 amendments are presented in the table above .
17.  Borrowings
In Euro x 1,000
Debt Facility
Fonds Nieuwe Doen
Provincie Groningen
Loan
Convertible Loan
Bridge Loan
Borrowings
Balance as at January 1, 2024
84,102
2,500
86,602
Drawdowns
13,436
5,000
18,436
Effective Interest and Payment in Kind interest
12,973
23
12,996
Balance as at December 31, 2024
110,511
2,500
5,023
118,034
Drawdowns
3,595
9,891
10,000
23,486
Warrants issued
(17,957)
(17,957)
Transaction costs on third amendment
(1,876)
(1,876)
Extinguishment on modification 6
(105,488)
(2,500)
(107,988)
Recognition on modification 7
104,818
2,234
107,052
Transaction costs on fourth amendment
(759)
(17)
(68)
(844)
Modification gain or loss
(338)
(338)
Effective Interest and Payment in Kind Interest
12,961
109
995
223
14,288
Conversion of loan to equity
(5,246)
(5,246)
Repayment
(10,000)
(10,000)
Balance as at December 31, 2025
105,805
2,326
10,480
118,611
In Euro x 1,000
December
31, 2025
December
31, 2024
Non-current Borrowings
12,806
7,523
Current Borrowings
105,805
110,511
Total Borrowings
118,611
118,034
The changes in the borrowings during the financial year have resulted in the following proceeds from
borrowings net of transaction costs in financing cash flows:
In Euro x 1,000
2025
2024
Proceeds from Debt Facility drawdowns
2,077
14,755
Proceeds from Province Groningen drawdown
9,823
Proceeds from Bridge Loan drawdown
10,000
Proceeds from Fonds Nieuwe Doen
(17)
Proceeds from Convertible loan
5,000
Proceeds from borrowings
21,883
19,755
Borrowings as at December 31, 2025:
Borrowing company
In Euro x 1,000
Type of loan
Issue date / Latest
amendment date
Principal
amount at
Year End
Interest rate
Date of maturity
Carrying
amount
Fair value
Long term
Short term
Avantium N.V.
Debt Facility A
August 12, 2025
47,500
Euribor + margin
June 30, 2028
44,207
44,207
44,207
Avantium Renewable Polymers B.V.
Debt Facility B1
August 12, 2025
45,000
Euribor + margin
June 30, 2028
41,907
41,907
41,907
Avantium Renewable Polymers B.V.
Debt Facility B2
August 12, 2025
18,500
Euribor + margin
June 30, 2028
19,691
19,691
19,691
Avantium RNP Flagship Plant B.V.
Fonds Nieuwe Doen
September 1, 2025
2,500
10.21% fixed
July 1, 2028
2,326
2,326
2,326
Avantium Renewable Polymers B.V.
Provincie Groningen
March 18, 2025
9,900
12.38% fixed
June 30, 2029
10,480
10,480
10,480
Total Borrowings
118,611
118,611
12,806
105,805
Borrowings as at December 31, 2024:
Borrowing company
In Euro x 1,000
Type of loan
Issue date
Principal
amount at
Year End
Interest rate
Date of maturity
Carrying
amount
Fair value
Long term
Short term
Avantium N.V.
Debt Facility A
2022 and 2024
42,500
Euribor + margin
March31, 2025
44,880
44,880
44,880
Avantium Renewable Polymers B.V.
Debt Facility B1
2023
45,000
Euribor + margin
March31, 2025
47,188
47,188
47,188
Avantium Renewable Polymers B.V.
Debt Facility B2
2023 and 2024
17,500
Euribor + margin
March31, 2025
18,443
18,443
18,443
Avantium RNP Flagship Plant B.V.
Fonds Nieuwe Doen
2023
2,500
4.75% fixed
February 1, 2026
2,500
2,500
2,500
Avantium N.V.
Convertible loan
2024
5,000
6% fixed
December 4,  2027
5,023
5,023
5,023
Total Borrowings
118,034
118,034
7,523
110,511
The fair value measurement for all borrowings are categorized within level 3 of the fair value
hierarchy. The fair value is determined based on the discounted cash flow method.
Debt Financing Facilities
A three-year Debt Financing Facilities agreement of €90.0 million was signed with a consortium of
lenders in March 2022 and was increased in January 2024 by €15.0 million, which was drawn in
August 2024. In March 2025, a third amendment was agreed, extending the repayment of the loan
including accrued interest to March 2026, while also increasing the debt facility by €20.1 million upon
meeting certain conditions. Of this, €5.0 million and €1.0 million were drawn in June 2025 on facility A
and facility B2, respectively. Management had assessed that the third amendment resulted in an
extinguishment and as such the liabilities were derecognized. However, the derecognition did not
result in the recognition of any gain or loss on the debt amendment as the carrying amount of the
original loan (which had only 13 days remaining) equalled the fair value of the new loan as at March
2025 and the warrants issued. As a result, derecognition had no impact on profit or loss and did not
involve any cash outflow.
Upon the March 2025 increase in the facility, the Company issued warrants to the lenders. The fair
value of the warrants issued was included in the amortized cost of the loans and is presented on the
line 'Warrants issued', along with incremental direct legal costs incurred.
In August 2025, the Debt Financing Facilities agreement was amended for the fourth time, cancelling
the unused portions of the March 2025 increase, and extending the maturity of the debt facilities to
June 2028. Management has assessed the fourth amendment to constitute an extinguishment.
Consequently, the amended loan was recognized at its fair value at the date of modification, being
€104.8 million, based on the future cash flows discounted at a market rate of interest of 13.2%. Upon
the August 2025 amendment, the Company issued additional warrants to €2.2 million to the lenders.
The fair value of the warrants issued in August 2025 is recognized separately as a financial liability –
refer to note 20. The extinguishment resulted in a loss on derecognition of €1.5 million which was
recognized in profit or loss (this loss reflects a €0.7 million gain being the difference between the
carrying value of the loan derecognized and the fair value of the loan recognized on amendment,
offset by €2.2 million relating to the fair value of the warrants).
Transaction costs amounting to €0.8 million have been incurred in relation to the modifications of the
debt financing facilities. These transaction costs are considered incremental and directly attributable
to the amendment and drawdowns and are therefore considered as part of the effective interest on
the facilities. The warrants and transactions costs in relation to the cancelled commitments of the
undrawn facility of €14.0 million amounting to €3.0 million have been recognized as a finance cost in
profit or loss.
The Debt Financing Facilities contain customary technical and commercial conditions precedent and a
customary security package including amongst others security on: all material assets, IP rights,
receivables of Avantium, Avantium Renewable Polymers B.V., the holding entity of the FDCA Flagship
Plant, and of several other Group companies, the shares in Avantium Renewable Polymers B.V. and
other group entities, the loan(s) from Avantium N.V. and Avantium Renewable Polymers B.V. to
Avantium RNP Flagship B.V. and the FDCA Flagship Plant itself and the FDCA Pilot Plant.
Under the Debt Financing Facilities, the Group is required to comply with various covenants, including
an insurance covenant requiring the maintenance of adequate insurance coverage for the FDCA
Flagship Plant and the timely delivery of related insurance documentation. As at December 31, 2025,
the Group was not in compliance with this insurance covenant, as the required documentation could
not be delivered within the prescribed remediation period. This resulted from the fact that the FDCA
Flagship Plant remained in the construction and commissioning phase at year‑end and the transition
to operational insurance could not yet be completed, as this will occur upon commencement of
commercial production.
As a consequence of this covenant breach, the consortium of lenders technically had the right to
demand immediate repayment, and the Group’s borrowings have therefore been classified as current
liabilities as at December 31, 2025.
The Group engaged with the lenders in December 2025 and requested a deferral of the applicable
deadline. Following a further assessment of the operational start‑up sequence in early 2026, the
lenders agreed, subsequent to December 31, 2025, to extend the timing for delivery of the relevant
insurance report, with retroactive effect as of December 31, 2025, subject to conditions relating to the
confirmation and extension of the existing construction all‑risk (“CAR”) insurance coverage. The Group
is in the process of addressing these conditions. As this deferral was agreed after the reporting date,
it is treated as a non‑adjusting post‑balance‑sheet event and does not affect the classification of the
Group’s borrowings as at December 31, 2025.
Fonds Nieuwe Doen Loan
In 2023, a loan of €2.5 million was provided by Stichting Fonds Leefbaarheid, Zorg en Energie
Groningen (Fonds Nieuwe Doen). On September 1, 2025, an amendment to the loan agreement was
signed. As a result of the amendment the re-payment of the loan has been extended from February 1,
2026 to July 1, 2028. Management has assessed this amendment to qualify as an extinguishment.
Consequently, the existing loan was derecognized, and a new, modified loan was recognized at its
fair value as of the date of modification. A modification gain of €0.3 million has been recognized in
profit or loss. The fair value of the modified loan was determined based on a market rate of interest of
15.2% as at September 1, 2025. The extinguishment of the loan has not resulted in any cash outflow.
Province Groningen Loan
On March 18, 2025, Province Groningen granted Avantium Renewable Polymers B.V. a subordinated
loan of €9.9 million. The first tranche of €5.9 million was received on March 24, 2025, and the second
tranche of €4.0 million was drawn on June 23, 2025. The principal amount, including capitalized
interest, will be repaid in twelve equal quarterly installments starting April 1, 2027. The final installment
will include an additional €0.1 million and a bonus payment of €0.8 million.
On September 18, 2025, the loan was amended, deferring the commencement of the twelve quarterly
installments from April 1, 2027 to June 30, 2028. The amendment was assessed as a non-substantial
modification, resulting in a modification gain of €0.3 million recognized in profit or loss. Transaction
costs of €0.1 million were incurred in connection with the amendment, and no cash outflow occurred
as part of this modification.
Convertible Loan
Upon the successful minimum equity raise on September 18, 2025, the convertible loan with Pieter
Kooi (€5.0 million) was automatically converted into equity. On this date, the carrying amount of the
loan was derecognized and 971,664 ordinary shares of the Company were issued, at a conversion
rate of €5.40 per share. The conversion has not resulted in the recognition of any gain or loss.
InvestNL Bridge Loan
As part of the fourth amendment to the debt facility, InvestNL provided the Company with a bridge
loan of €10.0 million. On July 25, 2025 the Company withdrew the first €5.0 million and on August 14,
2025, the second €5.0 million. As per the terms of the agreement, the upfront fee of €0.5 million and
the arrangement fee of €0.5 million, together with the outstanding principal of €10.0 million, were
repaid in full on October 1, 2025. No interest was charged on the loan.
Other Disclosures
During the period ended on December 31, 2025, interest on the loans of €24.3 million
(2024: €19.2 million) were capitalized.
During the period ended on December 31, 2025, interest paid on borrowings amounted to €10.0
million (2024: €7.8 million)
In Euro x 1,000
2025
2024
Cash interest paid capitalized
9,974
7,381
Cash interest paid not capitalized
394
Interest paid on borrowings
9,974
7,775
Bank Overdrafts
As at December 31, 2025, the Group had no overdraft facilities with any bank.
18.  Shareholder Loans
In Euro x 1,000
Shareholder Loan
Balance as at January 1, 2024
12,603
Accrued interest on shareholder loans
448
Accrued interest on shareholder compensation liability
385
Balance as at December 31, 2024
13,436
Shareholder loans drawdown
5,033
Modifications on Shareholder loans
(290)
Informal capital contribution on receipt of Shareholder loans
(1,063)
Accrued interest on shareholder loans
937
Shareholder compensation liability
8,747
Modifications on compensation liability
(571)
Accrued interest on shareholder compensation liability
1,202
Balance as at December 31, 2025
27,431
On December 14, 2023, Avantium Renewable Polymers B.V. entered into a Shareholders Loan
Agreement with Avantium N.V. and the non-controlling shareholders.
On January 22, 2025, a second Shareholders Loan Agreement was signed, and the first loan was
amended. Based on the amendment, the repayment of the first shareholders loan has been extended
and becomes payable ultimately on June 30, 2027. On September 18, 2025, the first and second
shareholder loans were amended, extending the repayment term to September 30, 2028. These
amendments did not constitute a substantial modification and therefore did not result in derecognition
of the loans. A total modification gain on these amendments of €0.8 million reduced the capitalized
borrowing costs. The amendments to the loans have not resulted in any cash outflows.
Transaction costs of €0.6 million have been incurred in relation to the modifications. The effective
interest rate on the first and second shareholders loan has been determined at 6.8% and 15.5%,
respectively.
Further, on September 1, 2025, Avantium Renewable Polymers B.V. entered into a third Shareholders
Loan Agreement with Avantium N.V. and the non-controlling shareholders. The issued third
subordinated loans are additional funding to support the Company’s FDCA Flagship Plant. The
maturity date of the third shareholder loan is September 30, 2028.
These loans are subordinated and bear interest at 6.5% per annum, payable in arrears upon
repayment. On initial recognition of the third shareholder loan, the difference between the contractual
rate of interest and the market rate of interest (the latter determined to be 15.2%) on the fair value of
the loan, has been accounted for in equity as an informal capital contribution received. The loans
include a conversion option allowing lenders to convert the outstanding balance into shares of
Avantium Renewable Polymers B.V. at a fixed price. The conversion feature meets the definition of an
equity instrument (fixed-for-fixed), but its fair value was assessed as immaterial; therefore, no amounts
were recognized in equity.
Additionally, all the shareholder loans contain an anti-dilution protection clause, under which the
lenders agreed to compensate the non-controlling shareholder that did not contribute to the loans to
the extent of its shareholding percentage. This compensation to that non-controlling shareholder has
been recognized as a financial liability with a corresponding entry in equity as the nature of the
transaction represents an informal capital distribution to a shareholder.
Management has determined the fair value of the shareholder loans using observable market data
(level 3 of the fair value hierarchy). The market interest rate as at December 31, 2025 has been
determined at 15.2%. This interest rate includes company specific adjustments. As at period ended
December 31, 2025 and 2024 the fair value of the loans approximates the carrying amount of the
shareholder loans.
Other Disclosures
During the period ended on December 31, 2025, interest on the loans of €9.1 million (2024: €0)
were capitalized.
During the period ended on December 31, 2025, interest paid on borrowings amounted to €0
(2024: €0).
19.  Provisions
In Euro x 1,000
Warranty
Restructuring
Decom-
missioning
Total
Balance at January 1, 2024
210
113
1,581
1,904
Additional provision
61
70
95
226
Unwinding of discount
62
62
Unused amounts reversed
(57)
(57)
(114)
Modifications
1,133
1,133
Used during the year
(11)
(56)
(67)
At Balance at December 31, 2024
203
71
2,871
3,145
Balance at January 1, 2025
203
71
2,871
3,145
Additional provision
78
499
577
Unwinding of discount
74
74
Unused amounts reversed
(76)
(4)
1
(80)
Modifications
(183)
(183)
Used during the year
(11)
(66)
(77)
Balance at December 31, 2025
194
499
2,763
3,454
In Euro x 1,000
December 31, 2025
December 31, 2024
Non-current Provisions
2,880
3,022
Current Provisions
574
123
Total Provisions
3,454
3,145
Warranty
The provision for warranty consists of estimated costs for repairs of installed products which may arise
during the warranty period. This estimate is based on historical experience of warranty claims and the
costs associated with that. Unused amounts are reversed after expiration of the warranty period.
As at December 31, 2025, warranty provisions expected to be settled or expire within one year
(current) is €0.1 million (2024: €0.1 million), and amounts expected to be settled or which expire
outside of one year (non-current) is €0.1 million (2024: €0.2 million).
Restructuring
On December 13, 2023 the Group announced it is prioritizing the commercialization of its FDCA
and PEF technology. A decision to halt investments in Ray Technology® resulted in workforce
reductions, for which the Group raised a provision of €0.1 million for the restructuring cost. As at
December 31, 2025 all amounts related to the Ray Technology® restructuring provision were either
utilized, or reversed where unused.
On September 4, 2025 the Group announced its prospectus to raise additional funding to address a
working capital shortfall. This included seeking strategic alternatives for its non-core activities,
including Avantium R&D Solutions, Volta Technology, Ray Technology® and a workforce reduction of
40 seats. An additional €0.5 million was raised as a provision in 2025 for restructuring costs. The
provision is expected to be settled in 2026.
Decommissioning
The decommissioning liability consists of the estimated costs to restore the leased land for the FDCA
Flagship Plant at the end of the lease term (expected after 10 years) to the condition agreed in the
lease agreement. As at year end 2025 the decommissioning liability has decreased. The value of the
expenditure expected to settled the liability in future has increased due to the delay of the completion
of the start-up of the FDCA Flagship Plant, which is on foreseen for mid-2026. As at December 31,
2025, the risk free rate of 3.0% (2024: 2.6%) was used to discount the estimated cost.
20.  Financial Liability
In Euro x 1,000
Financial Liability
Number of outstanding
warrants (x1000)
Balance as at January 1, 2024
13,609
3,861
Warrants issued
1,338
559
Fair value remeasurement
(7,354)
Balance as at December 31, 2024
7,593
4,420
Warrants issued
23,919
13,996
Warrants exercised
(2,811)
(2,028)
Fair value remeasurement
(18,215)
Share consolidation adjustment
(14,594)
Balance as at December 31, 2025
10,485
1,794
Avantium N.V. has issued warrants to the consortium of banks under the Debt Financing Facilities and
subsequent amendments thereto (refer to note 17). In 2025, an additional 13.8 million warrants with a
fair value of €21.7 million were issued as part of the third amendment to the debt facility in March, and
an additional 0.2 million warrants with a fair value of €2.2 million were issued as part of the fourth
amendment in August. The fourth amendment to the debt facility provides for a lock-up period of 180
days on all existing warrants.
The warrants were convertible into the Company's ordinary shares with a 1:1 conversion ratio for an
exercise price of €0.10 per share. On May 14, 2025 the AGM adopted a 1:10 share consolidation. As a
result of the share consolidation, every 10 outstanding warrants have been consolidated into one and
the exercise price per warrant has been adjusted accordingly from €0.10 to €1.00, with effect on May
22, 2025. A warrant holder may elect to exercise the warrant option cashless resulting in the number
of warrants being variable.
During 2025, 0.9 million warrants were exercised on March 20, 2025, resulting in the issuance of
0.8 million ordinary shares (as a result of cashless exercise). On May 19, 2025, 1.1 million warrants (not
adjusted for the share consolidation) were exercised, resulting in the issuance of 0.1 million ordinary
shares (adjusted for the share consolidation).
The exercise period of outstanding warrants was extended during the year and ends on
December 31, 2028.
The fair value remeasurement of all warrants has been calculated as the difference between the
period end fair value and the share price as at December 31, 2025 minus a €1.0 exercise price
(adjusted for the share consolidation). The closing share price as at December 31, 2024 was at €1.8.
When adjusted for the share consolidation, the decrease in the share price when comparing to the
closing share price as at December 31, 2025 of €6.8, amounted to €11.3. This resulted in a decrease
in the fair value of the warrants. The warrants are categorized within level 2 of the fair value hierarchy
(2024: level 2).
Notes to the Consolidated Statement of Profit or Loss and Comprehensive Income
21.  Revenues
Revenue decreased by 31% from € 21.0 million in 2024 to € 14.6 million in 2025, largely attributable to
decreased revenues in the Renewable Polymers business unit, €6.0 million, and the R&D Solutions
business unit, €0.9 million, year on year.
All revenue is recognized at either a point in time, or over time (Refer to note 2.20 ).
The 6% decrease in revenue generated by Avantium R&D Solutions is primarily related to a decrease
in machine capacity in the first half of the year from technical issues incurred on machines used in the
provision of solution services. These issues were resolved In the second half of 2025 and machines
are again running at full capacity.
The decrease in Avantium Renewable Polymers' revenue compared to the prior year is the result of
Origin Materials' announced change in its current strategic focus. Avantium, as of July 2024
suspended all activities under the licensing agreement and decided to take a prudent approach in
pausing the recognition of revenues under this technology license agreement. Avantium continues to
work with Origin Materials on the development of the market for FDCA and PEF applications.
Up to December 31, 2024, Avantium Renewable Polymers recognized €2.7 million as revenue from
the Origin Materials technology license agreement (over time). Revenue recognition under the
technology license agreement with Origin Materials is related to the first milestone payment of
€7.5 million which was received in 2023, and the second milestone payment of €7.0 million which is
due upon delivery of the Process Design Package ('PDP') to Origin Materials.
The full consideration of the Origin contract amounts to €28.5 million. At year-end 2025, management
has re-assessed the transaction price and concluded that the second milestone payment of €7.0
million remains unconstrained. The remaining installments of €14.0 million will be due at various
stages after delivery of the PDP by Avantium Renewable Polymers and constitute variable
consideration depending on whether Origin will terminate the contract at any stage, and is considered
constrained at year-end 2025. Management assessed this contract and concluded that it does not
contain a significant financing component.
To the extent that revenue has not yet been recognized in relation to the Origin Materials' license
consideration received, a contract liability has been recognized (refer to note 16).
All revenue reported originates in the Netherlands for both years presented.
The following table depicts the disaggregation of revenue from contracts with customers:
2025 in Euro x 1,000
R&D
Solutions
services
revenue
R&D
Solutions
systems
revenue
Renewable
Chemistry
development
agreements
Renewable
Polymers
agreements
Un-allocated
revenue
Total
Segment revenue
2,814
10,598
526
654
14,593
Revenue from external
customers
2,814
10,598
526
654
14,593
Timing of revenue
recognition
At a point in time
655
526
654
1,835
Over time
2,814
9,944
12,758
Total
2,814
10,598
526
654
14,593
2024 in Euro x 1,000
R&D
Solutions
services
revenue
R&D
Solutions
systems
revenue
Renewable
Chemistry
development
agreements
Renewable
Polymers 
agreements
Un-allocated
revenue
Total
Segment revenue
5,067
9,214
100
6,478
177
21,036
Revenue from external
customers
5,067
9,214
100
6,478
177
21,036
Timing of revenue
recognition
At a point in time
876
100
3,779
177
4,932
Over time
5,067
8,338
2,699
16,104
Total
5,067
9,214
100
6,478
177
21,036
As of December 31, 2025, the aggregate amount of the transaction price in Avantium R&D Solutions
allocated to the remaining performance obligations is €6.8 million and in Avantium Renewable
Polymers €7.2 million, totaling €14.0 million (2024: €12.2 million and €7.2 million, respectively, totaling
€19.4 million) and the Group will recognize this revenue as the progress on each contract is
completed, which is estimated to occur over 1 to 15 months (2024: 1 to 36 months).
22.  Other Income
in Euro x 1,000
2025
2024
Grants recognized
3,404
4,596
3,404
4,596
The Group recognized government grants of €3.4 million (2024: €4.6 million) that contribute to
Avantium’s development programs, where efforts are focused on developing a new catalytic process
for making plant-based mono-ethylene glycol and for developing an economical viable chemical
process to convert ligno-cellulosic biomass into high quality glucose as feedstock for bio-based
chemicals. In Avantium Renewable Polymers efforts are focussed on its plant-to-plastics YXY®
Technology and on starting-up the FDCA Flagship Plant and to develop a wide range of FDCA and
PEF applications.
EU grants attributable to the Volta Technology support Avantium’s research and development
activities aimed at advancing the electrochemical conversion of CO₂ into higher-value chemicals.
These grants enable the Group to accelerate the development of processes that convert CO₂ into
intermediates suitable for the production of sustainable CO₂‑based polymers.
23.  Segment Information
Description of the Segments and Principal Activities
Business segments are reported consistently with internal reporting provided to the Management
Team, which is considered to be the Company's Chief Operating Decision-Maker.
It has identified two separate business segments:
Avantium R&D Solutions provides R&D solutions in the field of sustainable chemistry and is the
leading provider of advanced catalyst testing technology and services to accelerate catalyst R&D.
The scalable catalyst testing system, Flowrence®, helps customers reach their sustainability, profit
and growth targets.
Avantium Renewable Polymers aims to commercialize our YXY® plants-to-plastics Technology.
This technology catalytically converts plant-based sugars into FDCA (furandicarboxylic acid) and
materials such as the new plant-based packaging material PEF (polyethylene furanoate).
PEF is a plant-based, recyclable plastic with superior performance properties compared to today’s
widely used petroleum-based packaging materials.
Corporate allocations include activities that cannot be allocated to reportable segments. Avantium
Renewable Chemistries does not meet the criteria of IFRS 8 for a reportable segment and is
included in corporate allocations, as well as the Volta Technology and Dawn Technology®.
Revenues per Segment
in Euro x 1,000
2025
2024
R&D Solutions
13,412
14,281
Renewable Polymers
526
6,478
Corporate allocations
655
277
Total segment revenue
14,593
21,036
Revenue is only generated from external customers and no transactions with other segments have
taken place.
During 2025, revenues from transactions with one major customer, amounted to 17% of the Group's
total revenue. These revenues are attributable to the reportable segment Avantium R&D Solutions.
In 2024 two major customers made up 39% of the Groups total revenue. These revenues were
attributable to the reportable segments R&D Solutions (12% related to one customer) and Renewable
Polymers Agreements (27% other major customer).
8In presenting and discussing Avantium’s financial position, operating results and cash flows, Avantium (like many other publicly listed companies) uses certain Alternative performance measures (APMs) not defined by IFRS.
These APMs are used because they are an important measure of Avantium’s business development and Avantium’s management performance. Please see Alternative performance measures as included under Financial performance 2025.
9 In presenting and discussing Avantium’s financial position, operating results and cash flows, Avantium (like many other publicly listed  companies) uses certain Alternative performance measures (APMs) not defined by IFRS’.
These APMs are used because they are an important measure of Avantium’s business development and Avantium’s management performance. Please see Alternative performance measures as included under Financial performance 2025.
Other Income per Segment
in Euro x 1,000
2025
2024
R&D Solutions
121
60
Renewable Polymers
1,520
2,654
Corporate allocations
1,763
1,882
Total segment other income
3,404
4,596
Employee Benefits Expenses per Segment
in Euro x 1,000
2025
2024
R&D Solutions
(6,431)
(6,267)
Renewable Polymers
(15,563)
(15,680)
Corporate allocations
(12,286)
(14,098)
Total segment employee benefits expenses
(34,281)
(36,045)
The average number of full time equivalent employees ("FTE") of the Group per business segment
and other departments is as follows:
(in full time equivalent employees)
2025
2024
R&D Solutions
61
61
Renewable Polymers
135
133
Corporate allocations
82
93
Total average number of FTE during the year
278
287
EBITDA 8
EBITDA is an important measurement of the Company's financial performance before taking the cost
of capital, depreciation and taxes into consideration. EBITDA margins provide a view of operational
efficiency and enable a more accurate and relevant comparison between peer companies.
EBITDA is calculated in the following manner: Profit/loss for the period plus Finance costs-net plus
depreciation, amortization and impairment charge.
EBITDA figures of the business segments are as follows.
in Euro x 1,000
2025
2024
R&D Solutions
1,829
2,192
Renewable Polymers
(22,331)
(17,173)
Corporate allocations
(15,564)
(18,299)
Total EBITDA 9
(36,066)
(33,280)
Assets per Segment
in Euro x 1,000
2025
2024
Renewable Polymers
294,796
241,531
Corporate allocations
61,372
47,095
Total segment assets
356,168
288,626
The impairment loss recognized relating to Ray Technology® as per note 11,  is allocated to the
Corporate allocations for reporting purposes.
Liabilities per Segment
in Euro x 1,000
2025
2024
Renewable Polymers
(309,999)
(238,894)
Corporate allocations
103,428
48,053
Total segment liabilities
(206,571)
(190,841)
Corporate allocations disclosed in the table above include the elimination of intercompany loans to
the Renewable Polymers segment
Depreciation and Amortization per Segment
in Euro x 1,000
2025
2024
R&D Solutions
(325)
(274)
Renewable Polymers
(1,723)
(2,884)
Corporate allocations
(4,919)
(2,072)
Total depreciation, amortization and impairment charge
(6,968)
(5,230)
24.  Expenses by Nature
Net operating expenses in 2025 amounted to €54.1 million (2024 : € 58.9 million). The decrease is
predominantly the result of lower employee benefit expenses and overall savings throughout the
Company.
Raw materials and contract costs in 2025 amounted to €4.4 million (2024: €4.7 million) and comprise
cost of goods sold, costs of laboratory consumables directly attributable to revenue projects, and
other costs incurred in relation to revenue generating activities. The decrease is mainly the result of
decreased business activities in R&D Business Unit.
Employee benefit expenses in 2025 amounted to €34.3 million (2024: €35.9 million) and includes
wages and salaries, social security costs, share options granted to directors and employees, pension
costs, less government grants received. The decrease predominantly relates to a reduction in
average FTE, temporary staffing and external recruitment services, due to the cost saving efforts of
the Company and the reduction in external staffing in the FDCA Flagship Plant.
Office and housing expenses in 2025 amounted to €3.3 million (2024: €4.0 million) and comprises
short-term rentals, other facility related costs, telephony and other IT related office materials and
costs. The decrease is predominantly related to the termination of construction related costs
associated with the scale up of the FDCA Flagship Plant.
Patent, license, legal and advisory costs in 2025 amounted to €4.2 million (2024: €5.9 million).
The decrease is predominantly related to the reduction of external consultancy contracts, along with a
decrease in legal costs in the year. The board expenses are included as part of advisory cost. Refer to
the Remuneration Report for the detail breakdown.
Laboratory expenses in 2025 amounted to €6.2 million (2024: €4.2 million) and comprise laboratory
consumables, utilities in the FDCA Flagship Plant, spare parts, maintenance and repair work in the
laboratory, and small laboratory projects. The increase is predominantly related to the scale up in
operations of the FDCA Flagship Plant.
Advertising and representation expenses in 2025 amounted to €0.8 million (2024: €1.8 million) and
comprise external and internal marketing, communications, and business development efforts,
including travel. Wages for internal business development staff is excluded, as this is included under
employee benefit expenses. The decrease is predominantly related to travel restrictions implemented
by the Company as part of the cost saving initiative.
Other operating expenses in 2025 amounted to €0.9 million (2024: €2.4 million) and comprise
external development costs, such as trials, and other general costs.
In 2024, the Company has made additional one-off efforts related to higher compliance assessments
of PEF and FDCA needed for the use as food contact material and its registration in jurisdictions of
interest, which predominantly explain the decrease in 2025.
Depreciation, amortization and impairment charges increased to €7.0 million (2024: €5.2 million).
The depreciation of fixed assets increased in 2025 mainly due to the reversal and related impairment
of the Renewable Chemistries entity held for sale (see note 11). The depreciation of right of use assets
slightly decreased in 2025 and is mainly the result of an decrease and/or modification in the lease
portfolio of the Company during the year.
25.  Employee Benefit Expenses
in Euro x 1,000
2025
2024
Wages and salaries
(30,002)
(31,256)
Government grants R&D (WBSO)
1,190
1,617
Social security costs
(3,403)
(3,346)
Share-based payments (note 14)
(552)
(1,454)
Pension costs - defined contribution plans
(1,514)
(1,451)
Total employee benefit expenses
(34,281)
(35,890)
Number of full time equivalent employees at the end of the year
251
284
At year end, all employees are working in the Netherlands. The average number of FTEs during 2025
was 278 ( 2024 : 287 ).
In 2025, €1.2 million (2024: €1.6 million ) government grants in the form of WBSO were recognized
directly as an offset of employee benefit expenses.
During 2025, there was a modification to the exercise price of options granted under the ESOP plan
(refer to note 14) .
26.  Finance Income and Costs
in Euro x 1,000
2025
2024
Finance costs:
Net foreign exchange (gains) loss
(12)
(41)
Financing component of lease payments
(179)
(220)
Interest on borrowings
(2,015)
(2,461)
Other bank and commitment fees
(488)
(206)
Effective interest: Prepaid interest
(26)
(18)
Other finance costs
Finance costs
(2,720)
(2,946)
Finance income:
Interest current accounts
379
1,475
Finance income
379
1,475
Finance costs - net
(2,341)
(1,471)
Interest on borrowings includes €nil (2024: €1.6 million) relating to the Debt Facility (note 17 ),
€nil (2024: €0.8 million) relating to the shareholders loans (note 18), €5.2 million ( 2024: €0) relating to
the derecognition of warrants and other costs incurred on the undrawn loan capacity and
modifications at the time of the Debt Facility amendments, €0.7 million (2024: €nil) relating to
modification gains on the borrowings amendments. The interest on borrowings for 2025 include the
effect of the capitalization of borrowing costs incurred in prior years of €2.5 million. Refer to note 2.24
27.  Income Tax Expense
The Company forms a tax group with its subsidiaries (excluding Avantium Renewable Polymers B.V.
and its subsidiaries, which form a separate tax group) for corporate income tax purposes (fiscal unity).
Under the standard conditions, the members of a tax group are jointly and severally liable for income
taxes payable by the group.
The Group does not recognize any deferred tax asset in relation to the losses carried forward as it is
not considered probable that there will be sufficient taxable profit against which the unused tax losses
can be utilized in the following year(s).
Both fiscal unities have carry-forward losses. The total tax losses carry-forward for the Avantium N.V.
fiscal unity as at December 31, 2025 is approximately €187.7 million (December 31, 2024: €164.3
million). The total tax losses carry-forward for the Avantium Renewable Polymers B.V fiscal unity as at
December 31, 2025 is approximately €131.5 million (December 31, 2024: €111.0 million). The carry-
forward tax losses up to December 31, 2021 of €163.1 million have been confirmed by the Dutch tax
authorities.
No tax charge or tax benefit was recognized in 2025, since the Avantium N.V. fiscal unity and the
Avantium Renewable Polymers B.V. fiscal unity are expected to record a net loss (approximately
€17.4 million for Avantium N.V. fiscal unity and approximately €26.7 million for the Avantium
Renewable Polymers B.V. fiscal unity).
The losses of both fiscal unities are subject to the new tax loss utilization rules which apply as of 1
January 2022. An indefinite carry-forward period will apply (previously 9 years) whilst the carry-back
period will remain one year. However, tax losses will only be fully available for carry-forward and
carry-back set off up to an amount of €1.0 million of taxable profit per year. In the case of a profit
which is higher than €1.0 million, the amount above €1.0 million can only be set off up to 50% of that
higher taxable profit.
The Company does not use contrived or abnormal tax structures that are intended for tax avoidance. 
The calculation for 2025 is not based on an official Tax filing.
in Euro x 1,000
2025
2024
Loss before income tax
(27,133)
(32,627)
Tax at applicable tax rate in the Netherlands of 25.8% (2024: 25.8%)
7,000
8,418
Non-deductible expenses
104
715
Subtotal
7,104
9,133
Unrecognized deferred tax assets
(7,104)
(9,133)
Tax profit as a result from revaluation of certain assets
Utilization of previously unrecognized deferred tax assets
Tax charge
The nominal tax rate in 2025 is 19% up to €0.2 million and 25.8% over €0.2 million (2024: 19% up to
€0.2 million and 25.8% over €0.2 million).
Deferred taxes
in Euro x 1,000
2025
2024
Category of temporary differences
Lease liabilities
1,588
2,018
Decommissioning liabilities
Total gross deferred tax assets
1,588
2,018
Offset against deferred tax liabilities
(1,588)
(2,018)
Total net deferred tax assets
Right-of-use assets
(1,588)
(2,018)
Property, plant and equipment
Total gross deferred tax liabilities
(1,588)
(2,018)
Offset against deferred tax assets
1,588
2,018
Total net deferred tax liabilities
Total deferred tax positions (net)
Deferred tax assets related to temporary differences have been recognized only to the extent that
there are reversing deferred tax liabilities. The Company does not recognize any deferred tax asset in
relation to the losses carried forward as it is not considered probable that there will be sufficient
taxable profit against which the unused tax losses can be utilized in the following year(s).
28.  Dividends
The Company declared no dividends for any of the years presented in these Consolidated Financial
Statements.
Other Notes to the Consolidated Financial Statements
29.  Contingencies
As at December 31, 2025, the Company had no contingencies to report.
30.  Commitments & Guarantees
Commitments
Purchase commitments for property, plant and equipment amounted to €2.0 million ( 2024: €3.3
million).
Guarantees
The Company has a cash-collateralised guarantee facility in place. These guarantees are
predominantly issued in relation to payments from customers for systems contracts. Refer to note 10.
31.  Related-party Transactions
Related party transactions entered into at arm's length are conducted in a fair and unbiased manner,
ensuring equitable terms and conditions comparable to those of transactions with unrelated parties,
thereby upholding transparency, integrity, and the best interests of all involved stakeholders.
Identification of Related Parties
Key management is defined as those persons having legal authority and responsibility for planning,
directing and controlling the activities of the entity, directly or indirectly, including any director
(whether executive or otherwise) of that entity. Our key management comprises the members of the
Management Board and the Supervisory Board.
Key Management Changes 2025
On May 15, 2024, the Annual General Meeting re-appointed Michelle Jou as Supervisory Board
member for a term of four years.
The following persons were members of the Supervisory Board on December 31, 2025:
Edwin Moses, Chairperson
Nils Björkman
Michelle Jou
Margret Kleinsman
Peter Williams
Key Management Remuneration Policy
Avantium does not grant its key management with any personal loans, guarantees or advance
payments. For further information on the Remuneration Policy refer to the Remuneration Report.
Key Management Remuneration 2025
Details of the remuneration of the members of the Management Board and the Supervisory Board
pursuant to section 2:383c, 383d and 383e of the Netherlands Civil Code are included in the
Remuneration Report (page 88).
32.  Proposed Appropriation of Result
In anticipation of the Annual General Meeting’s adoption of the annual accounts, the net loss for the
year of € 22.5 million has been added to accumulated losses.
33.  Events After the Balance Sheet Date
In January 2026, Avantium provided an update on the start-up of its FDCA Flagship Plant in Delfzijl.
This followed the identification of construction-related quality issues in certain titanium welds during
commissioning of the oxidation and purification units, representing an unacceptable safety risk for
start-up and operations. These issues, prompting additional inspections and requiring additional
remediation work, resulted in approximately €7.0 million in additional capital expenditure. In
December 2025, these inspections had clarified the scope of the required remediation work. The
implications for the project schedule were assessed thereafter and finalized in January 2026,
resulting in a revised expectation that start‑up will be completed by mid‑2026, with sales under the
existing offtake agreements commencing in the second half of 2026.
As disclosed in note 17, the Company classified its borrowings under the Debt Financing Facilities as
current liabilities as at December 31, 2025 following a breach of an insurance covenant.
The matter had already been raised with the lenders in December 2025, and subsequent to the
reporting date, in early 2026, the Group obtained a deferral of the applicable insurance covenant
deadline, with retroactive effect, subject to certain conditions. As this deferral was agreed after the
reporting date, it constitutes a non‑adjusting post‑balance‑sheet event and therefore does not affect
the classification of the borrowings as at December 31, 2025.
Company Financial Statements 2025
Company Balance Sheet
As at December 31
The balance sheet has been prepared after the proposed appropriation of current year result.
in Euro x 1,000
Note
2025
2024
ASSETS
Non-current assets
Right-of-use assets
40
2,089
3,188
Intangible assets
12
Financial fixed assets
35
208,201
117,055
Total non-current assets
210,302
120,243
Current assets
Financial fixed assets
35
64,017
Other receivables
418
22
Cash and cash equivalents
36
52,267
22,778
Total current assets
52,685
86,817
Total assets
262,987
207,060
LIABILITIES
EQUITY
Ordinary shares
12
25,195
8,611
Share premium
411,213
341,761
Other reserves
12
1,339
8,392
Accumulated losses
(285,228)
(262,910)
Total equity
152,519
95,854
in Euro x 1,000
Note
2025
2024
Provisions
39
3,670
Non-current liabilities
Borrowings
37
5,023
Financial liability
38
10,485
Lease liabilities
40
1,868
3,198
Payables to group companies
41
52,267
52,250
Total non-current liabilities
64,620
60,471
Current liabilities
Borrowings
37
39,812
41,197
Financial liability
38
7,593
Lease liabilities
40
1,190
1,127
Trade payables
823
288
Other current liabilities
353
530
Total current liabilities
42,178
50,735
Total liabilities
106,798
111,206
Total equity and liabilities
262,987
207,060
The accompanying notes are an integral part of these Company Financial Statements.
10 Employee benefit expenses relate to share based compensation awarded to employees, management team – and Supervisory Board – members of group entities. Please refer to note 25 of the Consolidated Financial Statements.
Company Income Statement
For the year ended December 31
in Euro x 1,000
Notes
2025
2024
Operating expenses
Employee benefit expenses 10
(552)
(1,455)
Office and housing expenses
(4)
(6)
Patent, license, legal and advisory expenses
(546)
(280)
Other operating expenses
(545)
(382)
Depreciation, amortization and impairment charge
(964)
(1,007)
Operating loss
(2,611)
(3,130)
Fair value remeasurement
38
18,242
7,354
Finance income
42
4,129
4,091
Finance costs
42
(3,001)
(125)
Profit/(Loss) before income tax
16,759
8,190
Income tax expense
Result from subsidiaries
(39,277)
(35,058)
Loss for the year
(22,518)
(26,868)
The accompanying notes are an integral part of these Company Financial Statements.
Notes to the Company Financial Statements
34.  General Information
The Company financial statements are part of the 2025 statutory financial statements of Avantium
N.V., which also include the Consolidated Financial Statements.
The Company Financial Statements are prepared in accordance with the provisions of Part 9, Book 2
of the Dutch Civil Code. For setting the principles for the recognition and measurement of assets and
liabilities and determination of the result of its Company financial statements, Avantium N.V. makes
use of the option provided in Section 2:362 (8) of the Dutch Civil Code. These principles also include
the classification and presentation of financial instruments, being equity instruments or financial
liabilities. This means that the principles for the recognition and measurements of assets and liabilities
and determination of the result (hereinafter referred to as accounting policies) in the Company
Financial Statements of Avantium N.V. are the same as those applied in the Consolidated Financial
Statements under IFRS (refer to note 2 ). By applying this option, reconciliation is maintained between
the Group’s equity and the Company’s equity.
In the Company Financial Statements, investments in subsidiaries (or group companies) are stated at
net asset value, determined on the basis of the accounting principles applied by the Company in its
Consolidated Financial Statements. Under the application of the net asset value method, the
Company recognizes its share in the result of group companies in the income statement. This is
determined on the basis of the the respective group companies' net result, taking into account
elimination of results on intercompany transactions. In case the net asset value of an investment in a
group company is reduced to nil, the Company's share in losses is recognized to reduce existing
loans to group companies that are considered to be part of the net investment in the group company.
A provision for any remaining equity deficit is recognized when an outflow of resources is probable
and can be reliably estimated.
Expected credit losses are recognized on all financial assets in line with the accounting policy on
impairment of financial assets as included in the Consolidated Financial Statements. This includes any
intercompany receivables. However, such expected credit losses on intercompany receivables are
eliminated in these company financial statements against the carrying value of the intercompany
receivables. In addition, the company recognizes a liability for financial guarantees issued to third
parties in regard of the financial liabilities of any of its subsidiaries. Where no guarantee fee is charged
to a subsidiary, this is accounted for as an informal capital contribution to that subsidiary to the extent
of the Company's ownership in the subsidiary. Such informal capital contribution is eliminated against
the carrying value of the financial guarantee liability. As a result, the financial liability is recognized to
the extent of the ownership of non-controlling shareholders, with a corresponding gain or loss
recognized in the income statement.
Reclassification of Informal Capital Distribution
In 2023 an informal capital distribution was made by a subsidiary of the Group to one of the minority
shareholders. The informal capital distribution should have been attributed to the non-controlling
interest for the amount of €0.5 million. A reclassification was made in 2025 between the non-
controlling interest and other reserves to reflect the correct attribution.
35.  Financial Fixed Assets
The Company directly held interests in the following subsidiaries on December 31, 2025 and 2024:
Avantium Technologies B.V., Amsterdam (100%)
Renewable Technologies B.V., Amsterdam (100%)
Avantium Support B.V., Amsterdam (100%)
Avantium Knowledge Centre B.V., Amsterdam (100%)
Feedstock Technologies B.V., Amsterdam (100%)
Avantium Renewable Polymers B.V., Amsterdam (77.4%)
Synvina C.V., Amsterdam (100%)
in Euro x 1,000
December
31, 2025
December
31, 2024
Participations in group companies
158
991
Receivables from group companies
111,524
116,064
Shareholder loan
96,519
64,017
Total of Financial Fixed Assets
208,201
181,072
in Euro x 1,000
December
31, 2025
December
31, 2024
Non-Current Financial Fixed Assets
208,201
117,055
Current loan to group company
64,017
Total of Financial Fixed Assets
208,201
181,072
The movements in financial fixed assets can be summarized as follows:
in Euro x 1,000
December
31, 2025
December
31, 2024
Balance as at January 1
991
22,779
Share of loss in group companies
(833)
(21,788)
Balance as at December 31
158
991
in Euro x 1,000
December
31, 2025
December
31, 2024
Group receivables outstanding January 1
116,064
94,339
Share of loss of group companies
(39,276)
(13,322)
Informal capital contribution
10,251
Increase in receivables from group companies
24,485
35,047
Group receivables outstanding December 31
111,524
116,064
in Euro x 1,000
December
31, 2025
December
31, 2024
Shareholder Loan balance as at January 1
64,017
21,470
Shareholder loan issued
28,646
39,471
Modification gains/losses
(2,966)
Accrued interest income on shareholder loans
6,822
3,076
Shareholder Loan balance as at December 31
96,519
64,017
On December 14, 2023, Avantium Renewable Polymers B.V. entered into a Shareholders Loan
Agreement with Avantium N.V. and the non-controlling shareholders.
On January 22, 2025, a second Shareholders Loan Agreement was signed, and the first loan was
amended. Based on the amendment, the repayment of the first shareholders loan has been extended
and becomes payable ultimately on June 30, 2027. On September 18, 2025, the first and second
shareholder loans were amended, extending the repayment term to September 30, 2028.
These amendments did not constitute substantial modifications and therefore did not result in
derecognition of the loans. A total modification loss on these amendments of €3.0 million was
recognized in profit or loss. The amendments to the loans have not resulted in any cash outflows.
Further, on September 1, 2025, Avantium Renewable Polymers B.V. entered into a third Shareholders
Loan Agreement with Avantium N.V. and the non-controlling shareholders. The issued third
subordinated loans are additional funding to support the Company’s FDCA flagship plant.
The maturity date of the third shareholder loan is September 30, 2028 (refer to note 3.6).
The shareholder loans are subordinated and bear interest at 6.5% per annum, payable in arrears upon
repayment. Refer to note 18. On initial recognition of the third subordinated loan, the effect of the
difference between the contractual rate of interest and the market rate of interest (the latter
determined to be 15.2%) on the fair value of the receivable, has been accounted for in the Group
Receivables which forms part of the net investment, as an informal capital contribution to the
subsidiary.
The receivables from group companies have no repayment term. No interest is charged.
The fair value of the receivables and shareholder loans approximates the book value.
36.  Cash and Cash equivalents
in Euro x 1,000
December 31, 2025
December 31, 2024
Cash at bank and on hand
51,702
19,778
Restricted cash
565
3,000
Cash and cash equivalents
52,267
22,778
Cash and cash equivalents include restricted cash of €0.6 million (2024: €3.0 million) which
represents short term cash-collateralised guarantee facilities that is used for guarantees issued to
third parties. At year end 2025 the Company had a maximum guarantee capacity of €3.0 million with
Rabobank.
37.  Borrowings
in Euro x 1,000
Debt Facility
Convertible
Loan
Total
Borrowings
Balance as at January 1, 2024
26,774
26,774
Drawdown
10,936
5,000
15,936
Effective Interest
3,487
23
3,510
Balance as at December 31, 2024
41,197
5,023
46,220
Drawdown
2,809
2,809
Warrants issued
(9,182)
(9,182)
Transaction costs on third amendment
(765)
(765)
Transaction costs on fourth ammendment
(325)
(325)
Extinguishment on modification
(43,133)
(43,133)
Recognition on modification
43,835
43,835
Effective Interest
5,376
223
5,599
Conversion of loan to equity
(5,246)
(5,246)
Balance as at December 31, 2025
39,812
39,812
in Euro x 1,000
December 31, 2025
December 31, 2024
Non-current Borrowings
5,023
Current Borrowings
39,812
41,197
Total Borrowings
39,812
46,220
in Euro x 1,000
Less than 1
year
Between 1 and
2 years
Between 2
and 5 year
Over 5 years
Total
Borrowings
39,812
39,812
39,812
39,812
The fair value of the borrowings approximates the book value.
Debt Financing Facilities
In 2025, debt facility A was modified twice. Reference is made to note 17 in the Consolidated Financial
Statements for further details.
For the carrying amounts of the PPE, intangible assets and trade receivables pledged as security for
current and non-current borrowings, refer to the Consolidated Financial Statements.
Convertible loan
On December 4, 2024, Avantium N.V. entered into a convertible loan agreement of €5.0 million with
Pieter Kooi. Upon the successful minimum equity raise on 18th of September 2025, the loan has
automatically been converted into ordinary shares of the Company. On this date, the carrying amount
of the loan was derecognized and 971.664 ordinary shares were issued at a conversion rate of €5.4
per share. The derecognition has not resulted in the recognition of any gain or loss.
11 During the fiscal year of 2025, Management has identified that the 2024 Standalone carrying amount for Debt Financing Facility A incorrectly included PIK interest, which is recognized in Avantium Renewable Polymers B.V.
Borrowings as at December 31, 2025:
in Euro x 1,000
Borrowing company
Type of loan
Issue date
Principle amount at Year End
Interest rate
Date of maturity
Carrying amount
Long term
Short term
Avantium NV
Debt Facility A
2022 and 2024
47,500
Euribor +
margin
June 30, 2028
39,812
39,812
Borrowings as at December 31, 2024:
in Euro x 1,000
Borrowing company
Type of loan
Issue date
Principle amount at Year End
Interest rate
Date of maturity
Carrying amount
Long term
Short term
Avantium NV
Debt Facility A
2022 and 2024
42,500
Euribor +
margin
March 31, 2025
41,197 11
41,197
Avantium NV
Convertible loan
2024
5,000
6% fixed
December 4,2027
5,023
5,023
38.  Financial Liability
For the breakdown and movement of the financial liability refer to note 20.
The fair value remeasurement amount includes €18.2 million (2024: €7.4 million) relating to the
warrant remeasurement (refer to note 20).
39.  Provisions
Provisions for the year were as follows:
in Euro x 1,000
Provisions
On January 1, 2025
Addition of provision
(3,670)
On December 31, 2025
(3,670)
in Euro x 1,000
Provisions
On January 1, 2024
25
Reversal of provision
(25)
On December 31, 2024
At year end December 31, 2023 management incorrectly provided for the equity deficit of Feedstock
Technologies B.V. (2023: €25.000), a financial fixed assets with a negative net equity. During the
2024 financial year management has corrected this by reversing the provision. Management has
assessed the prior period impact to be immaterial and therefore prior period values have not been
restated.
At year end December 31, 2025 the Company has recognized a provision of €3.7 million in its
subsidiary Avantium Renewable Technologies B.V., mainly due to the loss recognized as part of the
reversal of Entity Held for Sale. Refer to note 11.
40.  Leases
This note provides information for leases where the Company is a lessee.
Amounts Recognized in the Balance Sheet
The bala nce sheet shows the following amounts relating to leases:
in Euro x 1,000
December
31, 2025
December
31, 2024
Properties
2,089
3,188
Total right-of-use assets
2,089
3,188
in Euro x 1,000
December
31, 2025
December
31, 2024
Non-current lease liabilities
1,868
3,198
Current lease liabilities
1,190
1,127
Total Lease liabilities
3,058
4,325
Current liability amounts are due within 12 months.
Movement schedule for the right-of-use assets
in Euro x 1,000
2025
2024
Balance at January 1
3,188
4,034
Depreciation
(964)
(1,007)
Modifications
(135)
161
Balance at December 31
2,089
3,188
Movement schedule for the lease liabilities
in Euro x 1,000
2025
2024
Balance at January 1
4,325
5,232
Repayment of lease liabilities
(1,133)
(1,068)
Modifications
(134)
161
Balance at December 31
3,058
4,325
The maturity of lease liabilities does not exceed 5 years.
Amounts Recognized in the Income Statement
The income statement includes the following amounts relating to leases:
in Euro x 1,000
2025
2024
Properties
964
1,007
Total depreciation charge of right-of-use assets
964
1,007
in Euro x 1,000
2025
2024
Interest expense included in finance cost
71
95
Total interest charge on lease liabilities
71
95
41.  Payables to Group Companies
in Euro x 1,000
2025
2024
Group payables outstanding January 1
(52,250)
(73,717)
Movements in payables to group companies
(17)
21,467
Group payables outstanding December 31
(52,267)
(52,250)
The fair value of the intercompany amounts in Avantium N.V. to Group companies approximates their
book values. The payables to group companies have no repayment term. No interest is charged.
The movement in 2024 relates to the redistribution of VAT received on behalf of Avantium
Renewable Polymers B.V.
42.  Finance Income and Costs
in Euro x 1,000
2025
2024
Finance costs
Net foreign exchange (gains) loss
(2)
Financing component of lease payments
71
95
Interest on borrowings
2,917
23
Other bank and commitment fees
12
9
Other finance costs
1
Finance costs
3,001
125
Finance income
Interest on shareholder loans
(3,855)
(3,076)
Interest current accounts
(274)
(1,015)
Finance income
(4,129)
(4,091)
Finance (income) - net
(1,128)
(3,966)
Interest on borrowings includes €2.9 million (2024: €nil) relating to the derecognition of Warrants and
other costs incurred on the undrawn loan capacity at the time of the Debt Financing Facilities
addendum. Additionally, it also includes the effect of the capitalization of borrowing costs incurred in
prior years for the amount of €23,000. Refer to note 2.1.2.
43.  Commitment and Contingencies
The Company is part of a fiscal unity for corporate income tax and value added tax. As a
consequence, the Company bears joint and several liability for the debts with respect to corporate
income tax and value added tax. The Company settles corporate income tax, in principle, based on
the results before taxes of the subsidiaries belonging to the fiscal unity (refer to note 27).
Avantium has issued joint and several liability declarations for the debts arising out of the legal
acts of these subsidiaries, in accordance with Section 403 Part 9, Book 2 of the Dutch Civil Code.
Each of these subsidiaries has filed Avantium’s 403 declaration with the Dutch trade register:
Avantium Support B.V.
Avantium Technologies B.V.
Avantium Chemicals B.V.
As at 31 December 2025, the Company has committed to fund Avantium Renewable Polymers BV
with the remaining portion of the third Shareholder Loan agreement to the amount of €7.5 million.
44.  Audit Fees
The fees listed below relate to services rendered to the Company and its consolidated group entities
by PricewaterhouseCoopers Accountants N.V., the Netherlands, the independent external auditor as
referred to in section 1(1) of the Dutch Audit Firms Oversight Act (Dutch acronym: Wta), as well as by
other members of the PwC-network. Except for the non-audit services, all fees were charged by
PricewaterhouseCoopers Accountants N.V. Fees include work performed on the audit of the annual
financial statements, until the date of issue of the financial statements, as well as services performed
in connection with the equity raise completed in September 2025.
in Euro x 1,000
2025
2024
Audit of the financial statements
577
626
Other audit procedures
830
Tax services
Other non-audit services
1
1
Total
1,408
627
45.  Employee Information
The Company had no employees in 2025 (2024 : nil ).
46.  Events After the Balance Sheet Date
On January 16, 2026, the Company paid the remaining  €7.5 million of the third Shareholder Loan
agreement to Avantium Renewable Polymers B.V.
Signing
Amsterdam, March 17, 2026
Avantium N.V.
Management Board
Tom van Aken, Chief Executive Officer
Supervisory Board
Edwin Moses, Chairperson
Nils Bjorkman
Michelle Jou
Margret Kleinsman
Peter Williams
The financial statements are authorized for issue by the Management Board and the Supervisory
Board on March 17, 2026.
T.B. van Aken
Chief Executive Officer 
Other Information
Articles of Association Governing Profit Appropriation
According to article 31 of the Company’s Articles of Association, the Annual General Meeting
determines the appropriation of the Company’s net result for the year.
Independent Auditor’s Report
To: the General Meeting and the Supervisory Board of Avantium N.V.
Report on the audit of the financial statements 2025
Our opinion
In our opinion:
the consolidated financial statements of Avantium N.V. together with its subsidiaries (‘the Group’)
give a true and fair view of the financial position of the Group as at 31 December 2025, and of its
result and its cash flows for the year then ended in accordance with IFRS Accounting Standards as
adopted by the European Union (‘EU’) and with Part 9 of Book 2 of the Dutch Civil Code;
the company financial statements of Avantium N.V. (‘the Company’) give a true and fair view of the
financial position of the Company as at 31 December 2025 and of its result for the year then ended
in accordance with Part 9 of Book 2 of the Dutch Civil Code.
What we have audited
We have audited the accompanying financial statements 2025 of Avantium N.V., Amsterdam. The
financial statements comprise the consolidated financial statements of the Group and the company
financial statements.
The consolidated financial statements comprise:
the consolidated statement of financial position as at 31 December 2025;
the following statements for 2025: the consolidated statements of profit or loss and comprehensive
income, changes in equity and cash flows; and
the notes to the financial statements, including material accounting policy information and other
explanatory information.
The Company financial statements comprise:
the company balance sheet as at 31 December 2025;
the company income statement for the year then ended; and
the notes, comprising a summary of the accounting policies applied and other explanatory
information.
The financial reporting framework applied in the preparation of the financial statements is IFRS
Accounting Standards as adopted by the EU and the relevant provisions of Part 9 of Book 2 of the
Dutch Civil Codefor the consolidated financial statements and Part 9 of Book 2 of the Dutch Civil
Code for the company financial statements. 
The basis for our opinion
We conducted our audit in accordance with Dutch law, including the Dutch Standards
on Auditing. We have further described our responsibilities under those standards in the section
‘Our responsibilities for the audit of the financial statements’ of our report.
We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis
for our opinion.
Independence
We are independent of Avantium N.V. in accordance with the European Union Regulation on specific
requirements regarding statutory audit of public-interest entities, the ‘Wet toezicht
accountantsorganisaties’ (Wta, Audit firms supervision act), the ‘Verordening inzake de
onafhankelijkheid van accountants bij assuranceopdrachten’ (ViO, Code of Ethics for Professional
Accountants, a regulation with respect to independence) and other relevant independence
regulations in the Netherlands. Furthermore, we have complied with the ‘Verordening gedrags- en
beroepsregels accountants’ (VGBA, Dutch Code of Ethics).
Material uncertainty related to going concern
We draw attention to the going concern paragraph in the note 2.1.1 Going concern of the financial
statements which indicates that the Company remains dependent on additional external funding and
which states that the following elements are fundamental to Avantium’s continuity:
Successful completion of commissioning, start-up and start of commercial production at the FDCA
Flagship Plant;
Compliance with conditions and undertakings under the existing Debt Financing Facilities;
Achievement of FDCA Flagship Plant product sales income and milestone payments from license
agreement engagements in the second half of 2026;
Securing additional funding from a government-related investment initiative;
The satisfactory conclusion of tfhe ongoing discussions with Worley concerning the close‑out of the
construction phase of the FDCA Flagship Plant; and
Successful execution of strategic options for the non-core technology assets and related cost
management.
These conditions indicate the existence of a material uncertainty which may cast significant doubt
about the Company’s ability to continue as a going concern. Our opinion is not modified in respect of
this matter.
We refer to section ‘Audit approach going concern’ for further information on our audit procedures
regarding the going-concern assumption.
Our audit approach
We designed our audit procedures with respect to the key audit matters, fraud and going concern,
and the matters resulting from that, in the context of our audit of the financial statements as a whole
and in forming our opinion thereon. Therefore, we do not provide separate opinions or conclusions
on information in support of our opinion, such as our findings and observations related to individual
key audit matters and the audit approach to address fraud risk and going concern.
Overview and context
Avantium N.V. is a chemical technology company, developing and commercialising innovative
renewable chemistry solutions. As of 31 December 2025, the company consisted of two business
units (Renewable Polymers and R&D Solutions), which were subject to our audit procedures as
set out in the section ‘The scope of our group audit’.
As indicated in the CEO letter, the financial year 2025 was characterised by the partial start-up of the
Flagship Plant, construction-related challenges that resulted in delays in fully starting up the Flagship
Plant, implementing a cost-saving program, securing additional funding and changing existing funding
agreements and an equity raise in September 2025.
In preparing the financial statements, management identified the additional delay of the start up of the
FDCA flagship plant and start of sales under existing off take agreements of products from the FDCA
flagship plant as a potential indicator for impairment and performed an impairment test to estimate the
recoverable amount of the Avantium Renewable Polymers Cash Generating Unit per the end of the
year.
As part of designing our audit, we determined materiality and assessed the risks of material
misstatement in the financial statements. In particular, we considered where the Management Board
made important judgements, for example, in respect of significant accounting estimates that involved
making assumptions and considering future events that are inherently uncertain. In these
considerations, we paid attention to, amongst others, the assumptions underlying the physical and
transition risk related to climate change. In note 4 Critical Accounting Estimates and Judgments of the
financial statements, the Company describes the areas of judgement in applying accounting policies
and the key sources of estimation uncertainty.
We considered the impairment assessment of the Avantium Renewable Polymers Cash Generating
Unit and the accounting and presentation of the loan modifications and extinguishments to be key
audit matters as set out in the section “Key audit matters” of this report, given the significant
estimation uncertainty, the judgmental nature, the magnitude of the balances involved and the related
higher inherent risk of material misstatement.
Avantium N.V. assessed the possible effects of climate change and its plans to meet the net zero
commitments on its financial position, refer to the section 'The World Around Us' of the Management
Board Report. We discussed Avantium N.V.’s assessment and governance thereof with the
management board and evaluated the potential impact on the financial position including underlying
assumptions and estimates. Avantium's management has concluded that climate change does not
negatively impact the financial position of the company. The expected effects of climate change are
not considered a key audit matter.
Other areas of focus, that were not considered as key audit matters, were accounting of additional
warrants issued, and accounting for the proceeds from the equity raise.
We ensured that the audit team included the appropriate skills and competences which are needed
for the audit of a listed chemical technology company. We therefore included experts and specialists
in the areas of amongst others IT, financial instruments, share based payments, valuations and
restructuring and financing in our team.
The outline of our audit approach was as follows:
Auditor Report_Visual_2025.png
Overall materiality: €2.850.000.
All group components were in scope. For all
components, the group engagement team performed
the audit procedures
Impairment assessment of the Avantium Renewable
Polymers Cash Generating Unit.; and
Accounting for modifications and extinguishments of
the loans resulting from the refinancing.
Materiality
The scope of our audit was influenced by the application of materiality, which is further explained in
the section ‘Our responsibilities for the audit of the financial statements’.
Based on our professional judgement we determined certain quantitative thresholds for materiality,
including the overall materiality for the financial statements as a whole as set out in the table below.
These, together with qualitative considerations, helped us to determine the nature, timing and extent
of our audit procedures on the individual financial statement line items and disclosures and to
evaluate the effect of identified misstatements, both individually and in aggregate, on the financial
statements as a whole and on our opinion.
Overall group materiality
€2.850.000 (2024: €2.300.000), rounded
Basis for determining
materiality
We used our professional judgement to determine overall materiality.
As a basis for our judgement, we used 0,8% of total assets.
Rationale for benchmark
applied
We used total assets as the primary benchmark, a generally accepted
auditing practice, based on our analysis of the common information
needs of the users of the financial statements. On this basis, we
believe that total assets is the most relevant metric for the financial
performance of the Company based on the current phase of the
company and the fact that the results before income tax is still
negative and volatile.
We also take misstatements and/or possible misstatements into account that, in our judgement,
are material for qualitative reasons.
We agreed with the Audit Committee that we would report to them any misstatement identified
during our audit above €142.500 (2024: €115.000) as well as misstatements below that amount that,
in our view, warranted reporting for qualitative reasons.
The scope of our group audit
Avantium N.V. is the parent company of a group of entities. The financial information of this group is
included in the consolidated financial statements of Avantium N.V.
The group engagement team performed the audit work on all components, the group consolidation
and financial statement disclosures. By performing these procedures, we have been able to obtain
sufficient and appropriate audit evidence on the Group’s financial information, as a whole, to provide a
basis for our opinion on the financial statements.
Audit approach fraud risks
We identified and assessed the risks of material misstatements in the financial statements due to
fraud. During our audit we obtained an understanding of Avantium N.V. and its environment and the
components of the internal control system. This included the Management Board’s risk assessment
process, the Management Board’s process for responding to the risks of fraud and monitoring the
internal control system and how the Supervisory Board exercised oversight, as well as the outcomes.
We evaluated the design and implementation of relevant aspects of the internal control system with
respect to the risks of material misstatements due to fraud and in particular the informal fraud risk
assessment, as well as the code of conduct, whistleblower procedures, policies around agents and
confidant policies, amongst other things. We evaluated the design and the implementation and, where
considered appropriate, tested the operating effectiveness of internal controls designed to mitigate
fraud risks.
We performed inquiries with a selection of members of the Management Board and senior
management to evaluate their fraud awareness, the internal control environment in relation to fraud,
the ‘tone at the top’ and entity-level controls. As part of these procedures, we have requested the
CEO, interim CFO, General council and Risk and Internal Control manager to fill in our fraud
questionnaire and discussed the outcomes of this questionnaire.
We asked members of the Management Board as well as the Audit Committee and other members of
management whether they were aware of any actual or suspected fraud. This did not result in signals
of actual or suspected fraud that may lead to a material misstatement.
As part of our process of identifying fraud risks, we evaluated fraud risk factors with respect to
financial reporting fraud, misappropriation of assets and bribery and corruption. We evaluated
whether these factors indicate that a risk of material misstatement due to fraud is present.
We identified the following fraud risks and performed the following specific procedures:
Identified fraud risk
Our audit work and observations
Risk of management override
of controls
Management is in a unique
position to perpetrate fraud
because of management’s
ability to manipulate
accounting records and
prepare fraudulent financial
statements by overriding
controls that otherwise appear
to be operating effectively.
That is why, in all our audits,
we pay attention to the risk of
management override of
controls in:
The appropriateness of
journal entries and other
adjustments made in the
preparation of the financial
statements;
Estimates; and
Significant transactions, if
any, outside the normal
course of business for the
Company.
We evaluated the design and implementation of the internal
control system in the processes of generating and processing
journal entries and making estimates. We also paid specific
attention to the access safeguards in the IT system and the
possibility that these lead to violations of the segregation of
duties.
We selected journal entries based on risk criteria such as
unexpected account combinations and journal entries recorded
by unexpected users, and conducted specific audit procedures
for these entries. These procedures include, amongst others,
inspection of the entries to source documentation and verifying
the business nature of the entries recorded. We also paid
particular attention to consolidation and elimination entries.
We also performed audit procedures related to the important
estimates and judgments made by management, including,
but not limited to the going concern assessment, impairment
assessment of property, plant and equipment, revenue
recognition, valuation of warrants, provisions as well as
sharebased payments related estimates. We refer to the key
audit matter for the Impairment assessment of the Avantium
Renewable Polymers Cash Generating Unit. We specifically
paid attention to the inherent risk of bias of management in
estimates.
Our audit procedures did not lead to specific indications of fraud
or suspicions of fraud with respect to management override of
controls.
Identified fraud risk
Our audit work and observations
Risk of fraud in revenue
recognition
As part of our risk assessment
and based on a presumption
that there are risks of fraud in
revenue recognition, we
evaluated which types of
revenue give rise to risk of
material misstatement due
to fraud.
Management receives
bonuses, of which the size
partly depends on the financial
results achieved. This could
lead to pressure on
management to overstate
revenue by entering fictitious
turnover in RDS.
We evaluated the design and implementation of internal controls
covering the initiation and processing of revenue transactions.
We performed substantive audit procedures, on a sample basis,
on the contract revenue based on the sales contract, the hours
made on the project, purchase invoices and progress
confirmation of the project leaders.
We performed specific audit procedures at the end of the
year related to cut-off procedures to identify potential shifts
in revenue from products delivered in the next financial year to
the revenue reported in the current financial year.
In addition we performed specific audit procedures at the end
of the year related to cut-off procedures to identify potential shifts
in revenue from products delivered in the next financial year to
the revenue reported in the current financial year. In addition, we
performed audit procedures to determine whether credit invoices
were registered in the next financial year that indicate incorrectly
registered revenue in the current financial year.
We selected journal entries based on risk criteria such as
unexpected account combinations and journal entries recorded
by unexpected users, and conducted specific audit procedures
for these entries. These procedures include, amongst others,
inspection of the entries to source documentation and verifying
the business nature of the entries recorded. We also paid
particular attention to consolidation and elimination entries.
Our audit procedures did not lead to indications of fraud or
suspicions of fraud with respect to revenue recognition.
We incorporated an element of unpredictability in our audit. We reviewed lawyer’s letters and
correspondence with regulators. During the audit, we remained alert to indications of fraud.
Furthermore, we considered the outcome of our other audit procedures and evaluated whether any
findings were indicative of fraud or non-compliance with laws and regulations.
Audit approach going concern
In the going-concern paragraph in the note 2.1.1. Going concern of the financial statements, the
Management Board disclosed conditions that indicate the existence of a material uncertainty which
may cast significant doubt about the entity’s ability to continue as a going concern.
The Management Board’s most significant assumptions underlying its plans/actions to address these
conditions that indicate the existence of a material uncertainty which may cast significant doubt about
the entity’s ability to continue as a going concern (hereafter: going-concern risks) are:
Successful completion of commissioning, start-up and start of commercial production at the FDCA
Flagship Plant;
Compliance with conditions and undertakings under the existing Debt Financing Facilities;
Achievement of FDCA Flagship Plant product sales income and milestone payments from license
agreement engagements in the second half of 2026;
Securing additional funding from a government-related investment initiative;
The satisfactory conclusion of the ongoing discussions with Worley concerning the close-out of the
construction phase of the FDCA Flagship Plant; and
Successful execution of strategic options for the non-core technology assets and related cost
management.
In order to evaluate the appropriateness of the Management Board’s use of the going-concern basis
of accounting, including the Management Board’s expectation that their plans sufficiently address the
identified going-concern risks and the adequacy of the related disclosures, we, with support of
restructuring and finance specialists amongst others, performed the following procedures.
Regarding the assumptions underlying the Management Board’s plans/actions, we:
inquired with management on the progress of the start-up of the FDCA Flagship Plant for Avantium
Renewable Polymers in H2 2026 and on the commercial process to consider whether there is
adequate support for those assumptions.
analysed the loan agreements, including the conditions precedent in the Debt Financing Facilities
agreements and the December compliance reporting to the lenders.
analysed signed agreements to support potential future license revenue (i.e. license agreement,
letter of intent and non-disclosure agreements) to consider whether there is adequate support for
those assumptions.
assessed reasonability of their forecast of the sale of licenses and product sales against
independent scenarios based on available market research and off take of the plant (i.e. off take
agreements) and alignment with public announcements made to consider whether there is
adequate support for those assumptions.
verified that the application for the funding from a government-related investment initiative has been
filed.
read minutes of the meetings of those charged with governance, presentations from the project
oversight board and information provided to the lenders to evaluate the consistency of these
assumptions with assumptions made by the Management Board.
inquired with management on the progress made with execution of strategic options for the non-
core Technology Assets and related Cost Management and ongoing discussions regarding the
close-out of the engineering and construction phase of the FDCA Flagship Plant.
evaluated the consistency of these assumptions with assumptions made by the Management Board
in other significant estimates such as impairment assessment of the Avantium Renewable Polymers
Cash Generating Unit.
Regarding the Management Board’s plans/actions, we:
read minutes of the meetings of those charged with governance and relevant committees with the
approval of the Management Board’s plan/actions to evaluate the consistency of the assumptions
included in the cash flow forecast.
read Management Board’s presentation to the lenders with the plan to start-up the FDCA Flagship
plant, reach Commercial and Product Operation Date and the status of the licensing strategy and
performed inquiry with management, Chief Operation Officer and Commercial Director to evaluate
the consistency with the Management Board's plan/actions and the cash flow forecast.
analysed whether the current and the required financing has been secured and/or the process to
secure this has started, to enable the continuation of the entirety of the entity’s operations, the
communications with the lenders to extend the insurance condition in the Debt Financing Facility
breached per the end of the year and future conditions required from the lenders to evaluated
whether the Management Board can realise their plans/actions timely.
inquired with management about their knowledge of going-concern risks beyond the period of
management’s assessment to assess whether the expected outcome of the Management Board’s
plans/actions has been adequately included in the cash flow forecast.
assessed if the disclosure of the uncertainties and the measures taken by the Management Board in
the financial statements are consistent with the Management Board’s plan/actions, and cash flow
forecast.
Regarding the cash flow forecast, we:
evaluated the sufficiency of the liquidity headroom as included in the forecast and performed
sensitivity analysis, specifically with regard to achieving Commercial Operating date, the
achievement of FDCA Flagship Plant product sales income and milestone payments from License
Agreement, the outstanding settlement amounts for the construction of the FDCA Flagship Plant
withheld and securing the funding from a government-related investment initiative.
evaluated, where necessary, whether financing of expected shortages in liquidity will be sufficient
based on inspection of underlying documents for at least 12 months from the date of preparation of
the financial statements.
To consider whether any additional facts or information have become available that may be relevant
for the identified going-concern risks, including the Management Board’s expectation on the
sufficiency of the Management Board’s actions/plans to mitigate the identified risks, we:
read minutes of meetings of the Management board and those charged with governance and
relevant committees for reference to financing difficulties.
inquired of the Management Board, those charged with governance and senior management
including the Chief Operating Officer and the Commercial Director on any additional facts or
information that became available that may be relevant for the identified going-concern risks;
evaluated whether the material uncertainty with respect to going concern triggers accounting
entries such as impairment of assets.
We evaluated whether the going-concern risks including the Management Board’s plans/actions to
address the identified risks and the most significant underlying assumptions have been sufficiently
described in the notes to the financial statements. We found the disclosure in section ‘Going Concern’
in note 2.1.1. of the financial statements, where the Management Board disclosed conditions that
indicate the existence of a material uncertainty which may cast significant doubt about the entity’s
ability to continue as a going concern, to be adequate.
Key audit matters
Key audit matters are those matters that, in our professional judgement, were of most significance in
the audit of the financial statements. We have communicated the key audit matters to the Supervisory
Board. The key audit matters are not a comprehensive reflection of all matters identified by our audit
and that we discussed. In this section, we described the key audit matters and included a summary of
the audit procedures we performed on those matters.
A new key audit matter is included in 2025: 'Accounting for modifications and extinguishments of the
loans resulting from the refinancing'. In addition to the matters described in the section ‘Material
uncertainty related to going concern’ we have determined the matters described below to be the key
audit matters to be communicated in our report.
Key audit matter
Our audit work and observations
Impairment assessment of the Avantium Renewable
Polymers Cash Generating Unit – Note 5
Management identified the delay and increase in the
cost of constructing the FDCA Flagship plant as
potential indicators for impairment, in accordance with
IAS 36 – Impairment of Assets. Management defined
cash generating units (CGUs) within the group and
performed an impairment test to estimate the
recoverable amount per the end of the year.
Management compared the recoverable amount with
the carrying value of the CGU Avantium Renewable
Polymers, which did not result in an impairment
recorded by management.
The impairment assessment is significant to our audit
as the position is material to the Group (approximately
€274 million recorded in Construction in progress),
calculations are complex, involve high levels of
estimation uncertainty and judgmental assumptions
that are subject to change, and which could be subject
to management bias. The Management Board’s most
significant assumptions in determining the recoverable
amount are:
the timing of the start of commercial product sale;
the license income expected to be generated
through the sale of licenses;
and the discount rate.
Significant deviations and/or delays in these
assumptions would have had a significant effect on the
determination of the recoverable amount of the CGU.
The Group’s disclosures concerning the impairment
and the sensitivity analysis prepared by management
are included in Note 5 to the consolidated financial
statements.
In order to evaluate the reasonability of management's impairment assessment, we, with the assistance of our valuation experts, performed the
following procedures:
Assessed the appropriateness of management's defined CGUs within the group;
Assessed the composition of future cash flow forecasts and the underlying management assumptions by evaluating that:
the forecast is based on the latest budget approved by the management board and supervisory board and consistent with the information shared to
the Group's lenders,
the accuracy of the forecasts by comparing against actual past performance and previous forecasts to assess the Group's ability to forecast its
cashflows,
the consistency of the model and assumptions used,
the corroboration of forward-looking information to strategic initiatives of the company, minutes of meetings of management and supervisory board,
project oversight board minutes on the progress of testing the plant, signed agreements to support the future license revenue (i.e. license agreement,
letter of intent and non-disclosure agreements, assessing reasonability of forecast against independent scenarios based on available market
research) and off take of the plant (i.e. off take agreements) and alignment with public announcements made;
Compared the inputs for the discount rate used by management to externally obtained data, such as risk-free rates, equity market risk premiums,
country risk premiums as well as the betas of comparable companies;
Tested the mathematical accuracy of the model and assessed whether the methodology applied in the model meets the requirements per IAS 36 for
value in use;
Challenged management’s valuation analyses and sensitivities prepared by comparing these to our own independent sensitivity analyses;
Challenged management on the disclosure of the most sensitive assumptions;
Reconciled the carrying value of the CGU with audited data and assessed items included / excluded for compliance with IAS 36.
To consider whether any contradictory information regarding management's plans for the CGU exist, we:
Read the minutes of meetings of the project oversight board regarding the timeline of the Flagship plant construction,
Inspected correspondence and reports of the group's commercial team
With the procedures performed above, we determined that the methodology applied by management was in accordance with IAS 36 and assumptions
used by management to perform the impairment assessment were within PwC's independent reasonable range of assumptions. A forecast is
prospective financial information that is based on assumptions about events that may occur in the future and possible actions by an entity. It is highly
subjective in nature and its preparation requires the exercise of considerable judgement. Actual results are likely to be different from the forecast since
anticipated events frequently do not occur as expected and the deviation from the forecast may be material.
In addition, we tested the related financial statements disclosures against the applicable disclosure requirements, including those related to sources of
estimation uncertainty. We draw attention to note 5 of the consolidated financial statements which describes the key assumptions that have been
applied in the impairment testing of the Renewable Polymers CGU to estimate the recoverable amount of the CGU and that the changes in the key
assumptions as disclosed may have a material impact on the valuation of the Property, plant and equipment contained in the CGU.
Key audit matter
Our audit work and observations
Accounting for modifications and extinguishments
of the loans resulting from the refinancing – Note 17
and 18
The Group’s borrowings and shareholder loan
(collectively 'loans') are material (approximately
€119 million and €28 million respectively) and were
amended in 2025 resulting in the accounting and
presentation for loan modification and
extinguishments in the financial statements.
The accounting and presentation of the amendments
to the loans is subject to significant judgement,
including the assessment if the amendments to the
loan agreements are to be accounted for as
modifications or extinguishments, the valuation of the
loans and the appropriateness of related disclosures.
Management engaged external experts to assist in
determining the accounting treatment of the loan
modifications and extinguishments, to fair value
calculation, the effective interest rates and related
modification result.
Given the magnitude of the balances involved and the
complexity and judgement required in the valuation
and disclosure of these financial liabilities, we
considered this to be a key audit matter.
Our audit procedures included, among others, obtaining and inspecting new loan agreements and recalculating the effective interest rates applied by
management.
We assessed based on the terms and conditions of the amended loan agreements and if the amendments are to be accounted for as modifications or
extinguishments during the year, and we evaluated management’s accounting treatment in accordance with the applicable financial reporting
framework.
We reviewed the reports prepared by management’s external experts regarding the determination of the fair value of the loans, the effective interest
rates applied, and we involved our own financial instruments specialists to assess the appropriateness of the methodologies and assumptions used.
We challenged management on the completeness and accuracy of the data provided to their experts together with the reasonableness of the loan fair
value methodology and consequent effective interest rate calculations used by management's experts. We also evaluated the adequacy of
the related disclosures in the financial statements.
Based on the evidence obtained, we concurred with management’s assessment of the loan modifications and extinguishments, and found the
accounting treatment and disclosures to be appropriate.
Report on the other information included in the Annual Report
The Annual Report contains other information. This includes all information in the Annual Report in
addition to the financial statements and our auditor’s report thereon. Based on the procedures
performed as set out below, we conclude that the other information:
is consistent with the financial statements and does not contain material misstatements; and
contains all the information regarding the Management Board report and the other information  that
is required by Part 9 of Book 2 and regarding the remuneration report required by the sections
2:135b and 2:145 subsection 2 of the Dutch Civil Code.
We have read the other information. Based on our knowledge and the understanding obtained in our
audit of the financial statements or otherwise, we have considered whether the other information
contains material misstatements.
By performing our procedures, we comply with the requirements of Part 9 of Book 2 and section
2:135b subsection 7 of the Dutch Civil Code and the Dutch Standard 720. The scope of such
procedures was substantially less than the scope of those procedures performed in our audit of the
financial statements.
The Management Board is responsible for the preparation of the other information, including the
Management Board report and the other information in accordance with Part 9 of Book 2 of the Dutch
Civil Code. The Management Board and the Supervisory Board are responsible for ensuring that the
remuneration report is drawn up and published in accordance with sections 2:135b and 2:145
subsection  of the Dutch Civil Code.
Report on other legal and regulatory requirements and ESEF
Our appointment
We were appointed as auditors of Avantium N.V. by the Supervisory Board following the passing of a
resolution by the shareholders at the annual general meeting held on 14 May 2025. Our appointment
has been renewed annually by shareholders and now represents a total period of uninterrupted
engagement of 23 years.
European Single Electronic Format (ESEF)
Avantium N.V. has prepared the Annual Report in ESEF. The requirements for this are set out in the
Delegated Regulation (EU) 2019/815 with regard to regulatory technical standards on the specification
of a single electronic reporting format (hereinafter: the RTS on ESEF).
In our opinion, the Annual Report prepared in XHTML format, including the marked-up consolidated
financial statements, as included in the reporting package by Avantium N.V., complies in all material
respects with the RTS on ESEF.
The Management Board is responsible for preparing the Annual Report, including the financial
statements in accordance with the RTS on ESEF, whereby the Management Board combines the
various components into a single reporting package.
Our responsibility is to obtain reasonable assurance for our opinion whether the Annual Report in this
reporting package complies with the RTS on ESEF.
We performed our examination in accordance with Dutch law, including Dutch Standard 3950N
‘Assuranceopdrachten inzake het voldoen aan de criteria voor het opstellen van een digitaal
verantwoordingsdocument’ (assurance engagements relating to compliance with criteria for digital
reporting).
Our examination included amongst others:
Obtaining an understanding of the entity’s financial reporting process, including the preparation of
the reporting package.
Identifying and assessing the risks that the Annual Report does not comply in all material respects
with the RTS on ESEF and designing and performing further assurance procedures responsive to
those risks to provide a basis for our opinion, including:
- obtaining the reporting package and performing validations to determine whether the reporting
package containing the Inline XBRL instance document and the XBRL extension taxonomy files
have been prepared in accordance with the technical specifications as included in the RTS on
ESEF;
- examining the information related to the consolidated financial statements in the reporting
package to determine whether all required mark-ups have been applied and whether these are
in accordance with the RTS on ESEF.
No prohibited non-audit services
To the best of our knowledge and belief, we have not provided prohibited non-audit services as
referred to in article 5(1) of the European Regulation on specific requirements regarding statutory audit
of publicinterest entities.
Services rendered
The services, in addition to the audit, that we have provided to the Group, for the period to which our
statutory audit relates, are disclosed in note 44 to the financial statements.
Responsibilities for the financial statements and the audit
Responsibilities of the Management Board and the Supervisory Board for the financial
statements
The Management Board is responsible for:
the preparation and fair presentation of the financial statements in accordance with IFRS
Accounting Standards as adopted by the EU and Part 9 of Book 2 of the Dutch Civil Code; and for
such internal control as the Management Board determines is necessary to enable the preparation
of the financial statements that are free from material misstatement, whether due to fraud or error.
In preparing the financial statements, the Management Board is responsible for assessing the
Company’s ability to continue as a going concern. Based on the financial reporting frameworks
mentioned, the Management Board should prepare the financial statements using the going-concern
basis of accounting unless the Management Board either intends to liquidate the Company or to
cease operations or has no realistic alternative but to do so. The Management Board should disclose
in the financial statements any event and circumstances that may cast significant doubt on the Group’s
ability to continue as a going concern.
The Supervisory Board is responsible for overseeing the Company’s financial reporting process.
Our responsibilities for the audit of the financial statements
Our responsibility is to plan and perform an audit engagement in a manner that allows us to obtain
sufficient and appropriate audit evidence to provide a basis for our opinion. Our objectives are to
obtain reasonable assurance about whether the financial statements as a whole are free from material
misstatement, whether due to fraud or error and to issue an auditor’s report that includes our opinion.
Reasonable assurance is a high but not absolute level of assurance and is not a guarantee that an
audit conducted in accordance with the Dutch Standards on Auditing will always detect a material
misstatement when it exists. Misstatements may arise due to fraud or error. They are considered
material if, individually or in the aggregate, they could reasonably be expected to influence the
economic decisions of users taken on the basis of the financial statements. Materiality affects the
nature, timing and extent of our audit procedures and the evaluation of the effect of identified
misstatements on our opinion.
We have exercised professional judgement and have maintained professional scepticism
throughout the audit in accordance with Dutch Standards on Auditing, ethical requirements and
independence requirements. Our audit consisted, among other things of the following:
Identifying and assessing the risks of material misstatement of the financial statements, whether due
to fraud or error, designing and performing audit procedures responsive to those risks, and
obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion. The
risk of not detecting a material misstatement resulting from fraud is higher than for one resulting
from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or
intentional override of internal control.
Obtaining an understanding of internal control relevant to the audit in order to design audit
procedures that are appropriate in the circumstances, but not for the purpose of expressing an
opinion on the effectiveness of the Company’s internal control.
Evaluating the appropriateness of accounting policies used and the reasonableness of accounting
estimates and related disclosures made by the Management Board.
Concluding on the appropriateness of the Management Board’s use of the going-concern basis of
accounting, and based on the audit evidence obtained, concluding whether a material uncertainty
exists related to events and/or conditions that may cast significant doubt on the Company’s ability to
continue as a going concern. If we conclude that a material uncertainty exists, we are required to
draw attention in our auditor’s report to the related disclosures in the financial statements or, if such
disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit
evidence obtained up to the date of our auditor’s report and are made in the context of our opinion
on the financial statements as a whole. However, future events or conditions may cause the
Company to cease to continue as a going concern.
Evaluating the overall presentation, structure and content of the financial statements, including the
disclosures, and evaluating whether the financial statements represent the underlying transactions
and events in a manner that achieves fair presentation.
We are responsible for planning and performing the group audit to obtain sufficient appropriate audit
evidence regarding the financial information of the entities or business units within the group as a
basis for forming an opinion on the financial statements. We are also responsible for the direction,
supervision and review of the audit work performed for purposes of the group audit. We remain solely
responsible for our audit opinion.
We communicate with the Audit Committee regarding, among other matters, the planned scope and
timing of the audit and significant audit findings, including any significant deficiencies in internal
control that we identify during our audit. In this respect, we also issue an additional report to the Audit
Committee in accordance with article 11 of the EU Regulation on specific requirements regarding
statutory audit of public-interest entities. The information included in this additional report is consistent
with our audit opinion in this auditor’s report.
We provide the Supervisory Board with a statement that we have complied with relevant ethical
requirements regarding independence, and to communicate with them all relationships and other
matters that may reasonably be thought to bear on our independence, and where applicable, related
actions taken to eliminate threats or safeguards applied.
From the matters communicated with the Audit Committee, we determine those matters that were of
most significance in the audit of the financial statements of the current period and are therefore the
key audit matters. We describe these matters in our auditor’s report unless law or regulation
precludes public disclosure about the matter or when, in extremely rare circumstances, we determine
that a matter should not be communicated in our report because the adverse consequences of doing
so would reasonably be expected to outweigh the public interest benefits of such communication.
Amsterdam, 17 March 2026
PricewaterhouseCoopers Accountants N.V.
J.J.L. Matze RA
Supplementary
Information
References to Sustainability Reporting Frameworks
ESG
ESRS Standard
Avantium's strategic focus
ESRS reference
GRI reference
SDG reference
SASB reference
Environmental
E1 Climate Change
Industry-wide emissions
reduction by deploying our
technology
E1-5 – Actions and resources in relation to climate
change mitigation and adaptation
E1-6 – Targets related to climate change
E1-7 – Energy consumption and mix
E1-8 – Gross scope 1, 2, 3 GHG emissions
GRI 102: Climate Change 2025
GRI 103: Energy 2025
GRI 305: Emissions 2016
SDG7: Affordable and Clean
Energy
SDG12: Responsible
Consumption and Production
RT-CH-130a.1
RT-CH-110a.2
Emissions intensity of our own
FDCA Flagship Plant
E5 Resource
use and circular
economy
Circularity of PEF
E5-1 – Policies related to resource use and circular
economy
E5-2 – Actions and resources related to resource
use and circular economy
E5-3 – Targets related to resource use and circular
economy
E5-4 – Resource inflows
E5-5 – Resource outflows
GRI 308 Suppliers
Environmental Assessment 2016
GRI 414 Suppliers Social
Assessment 2016
GRI 306: Waste 2020
SDG9: Industry, Innovation and
Infrastructure
SDG12: Responsible
Consumption and Production
RT-CH-150a.1
Sustainable feedstock
Valorization of waste/by-products
of our technology
Social
S1 Own Workforce
Development of human capital
S1-1 – Policies related to own workforce
S1-2 – Engagement with own workforce and
workers’ representatives, existence of channels for
own workforce to raise concerns or needs and
approaches to remedy
S1-3 – Actions and resources related to own
workforce
S1-4 – Targets related to own workforce
S1-5 – Characteristics of the undertaking’s
employees
S1-8 – Diversity metrics
S1-14 – Work-life balance metrics
GRI 2-7 Employees 2021
GRI 401: Employment 2016
GRI 403 Occupational Health
and Safety 2018
GRI 404: Training and Education
2016
GRI 405: Diversity and Equal
Opportunity 2016
SDG3: Good Health and Well-
being
SDG4: Quality Education
SDG5: Gender Equality
SDG8: Decent Work and
Economic Growth
RT-CH-320a.1
RT-CH-320.2
RT-CH-540a.1
Health and safety in our own
operations
Governance
G1 Business
Conduct
Advocacy for a circular and fossil-
free chemical industry
G1-1 – Policies related to business conduct
G1-2 – Actions related to business conduct
G1-3 – Targets related to business conduct
GRI 2-23 Policy commitments
2021
GRI 2-28 Membership
associations 2021
SDG13: Climate Action
SDG17: Partnerships for the
Goals
RT-CH-530a.1
RT-CH-210a.1
S4 Consumer
and End-users
Consumer health and safety
S4-3 – Processes to remediate negative impacts
and channels for consumers and end-users to raise
concerns
GRI 416: Customer Health and
Safety 2016
SDG12: Responsible
Consumption and Production
Sustainability Disclosures
In this section we provide more details about different sustainability-related metrics. For explanations
and alignment of this data with the business highlights please see the Sustainability Statement (page
40) and Performance by Business Area 2025 (page 24) sections.
Energy
All locations use energy to power the operations. Avantium has full control over the energy and
related emissions of its headquarters in Amsterdam Zekeringstraat and in its DCA Flagship Plant in
Delfzijl. Avantium has limited control over the energy use and emissions of its FDCA pilot plant
operation in Geleen (Geleen pilot plant), as the facility is located on the Brightlands Chemelot Campus
and relies on shared site services within the larger chemical park. Similarly Avantium has limited
control over energy use and emissions of its location at Amsterdam Science Park where it relies on
shared site services with Science Park campus. The energy use in the Delfzijl pilot plant is limited due
to the limited activity and mothballing.
MWh
2025
2024
2023
Amsterdam headquarters
Sustainable electricity
1516
1513
1498
Self-generated solar energy
64
59
21
Natural gas
773
731
717
Geleen pilot plant
Steam
196
137
185
Sustainable electricity
991
986
935
Delfzijl pilot plant
Steam
0
26
154
Fossil-based electricity
96
244
406
Delfzijl FDCA Flagship plant
Steam
4036
n/a
n/a
Fossil-based electricity
3496
n/a
n/a
Natural gas
1596
n/a
n/a
Avantium monitors energy-related data on a monthly basis, using either direct measurements
or reports provided by energy service suppliers. Up to 5% margin of error is possible. To ensure
completeness, consistency and accuracy of the data, we follow our internal Energy and Emissions
Monitoring Procedure.
Emissions
Avantium reports its Scope 1, Scope 2 and Scope 3 emissions in line with the guidance of the
Greenhouse Gas (GHG) Protocol.
Scope 1 emissions
Scope 1 emissions are direct emissions from sources owned or controlled by the company and
typically result from combustion. For Avantium, Scope 1 emissions at office and laboratory locations
are from natural gas which is used for heating, and other Scope 1 emissions at the Geleen pilot plant
remain very low due to the limited activity level compared with industrial-scale operations. With the
start‑up of the FDCA Flagship Plant in Delfzijl, we report Scope 1 emissions for this site as well.
Reporting is based on the natural gas consumption measurements and an annual calculation
performed at the Geleen location.
Ton CO2e
2025
2024
Amsterdam headquarters
CO 2 emissions from burning natural gas*
156.44
147.84
Geleen pilot plant
CO2 direct emissions
0.19
0.19
VOC direct emissions**
0
0
Methylbromide direct emissions***
0.32
0.05
Delfzijl FDCA Flagship plant
CO 2 emissions from burning natural gas*
387.35
n/a
Total
544.30
148.08
*    In previous years emissions from burning of natural gas were reported in the same table with energy
consumption. Starting from 2025 this is adjusted and will be reported as Scope 1 emissions.
**VOCs are direct emissions to the air. The VOCs that we emit are not identified individually or as a group for a
CO₂ conversion factor.
***Methyl bromide is a greenhouse gas. It is identified individually and has a CO₂ conversion factor published by
the Intergovernmental Panel on Climate Change (IPCC), AR6 (version 2, August 2024)
Scope 2 emissions
Scope 2 accounts for emissions from the generation of energy that is purchased or otherwise brought
into the organizational boundary of the company.
We calculate Scope 2 emissions using the energy data that we monitor. Avantium uses several energy
sources: fossil‑based electricity, renewable electricity and steam.
Compressed air and a very small amount of diesel are also used, but these are not included in
Scope 2 reporting. Compressed air, used only at our Delfzijl site, is supplied by a neighboring facility
who has confirmed that it is generated from waste processing and therefore does not lead to
additional CO₂ emissions. For other fuels, only diesel is used in limited quantities and is intended
solely for the backup generator, which was not used in 2025.
Ton CO2e
2025
2024
2023
Amsterdam headquarters
Sustainable electricity
0
0
0
Self-generated solar energy
0
0
0
0
Geleen pilot plant
Steam*
44
31
41
Sustainable electricity
0
0
0
Delfzijl pilot plant
Steam
0
18
110
Fossil-based electricity
26
60
100
Delfzijl FDCA Flagship plant
Steam**
1978
n/a
n/a
Fossil-based electricity
937
n/a
n/a
Total
2985
109
251
*The same emissions conversion factor for steam used as in 2023 and 2024, because no updated factor was
provided by the Brightlands Campus.
** The emissions factor for steam used at the FDCA Flagship Plant was updated for 2025, as per the latest LCA
of EEW Energy, our steam provider.
The emissions from electricity are calculated using the location‑based method and emission factors
are from www.CO₂emissiefactoren.nl are applied. For emissions from steam and compressed air, the
market‑based method is applied, using emission factors provided by the respective energy suppliers
or generators.
Scope 3 emissions
Scope 3 emissions cover the wider value chain and typically represent the largest share of total
emissions. Avantium worked with external consultants to identify the key categories for Scope 3
emissions that are relevant to our activities. Building on this assessment, we estimate Scope 3
emissions across the defined categories: capital goods (excluding construction of the FDCA Flagship
Plant), business travel, purchased goods and services, upstream transportation, and waste treatment.
Scope 3 emissions' estimates are provided at a high level and therefore serve only as an indication of
the relative magnitude of environmental impacts.
Ton CO2e
2025
2024
Capital goods*
139
398
Business Travel**
254
579
Purchased goods and services*
2471
2218
Upstream transportation*
113
264
Waste treatment***
83
1
Total
3060
3460
*Emissions from capital goods, purchased goods and services, and upstream transportation are estimated
based on expenditure data (spend-based method) and calculated using the best-matching emission factors
rates from 2023 (3.8%), 2024 (3.3%) and 2025 (3.3%) and currency conversion rate 1.175 as on December 31,
**Emissions from business travel are based on the number of kilometers travelled and mode of travel using
calculations by Foundation myclimate
      The reported business travel emissions for 2024 were adjusted to reflect an updated calculation due to a
correction in last years' calculation.
***Emissions from waste treatment are estimated taking into account the weight of waste per type and are
calculated based on the Renewi Client Portal calculation methodology, including applying similar calculation
principles also to other service providers.
Waste
Avantium reports weight of both hazardous and non‑hazardous waste by location and by end‑of‑life
treatment. No radioactive waste was generated in 2025.
Waste monitoring is based on the reports provided by our waste collection and treatment services
providers. Up to 5% margin of error is possible. To ensure completeness, consistency and accuracy of
the data we follow our internal Waste Monitoring Procedure.
Hazardous waste
Ton
2025
2024
2023
Amsterdam headquarters
Incineration
0.8
1.8
0.8
Incineration with energy recovery
(Ton)
2.9
8.1
4.7
Re-use or recycling
0.9
2.6
3.1
Geleen pilot plant
Incineration with energy recovery
(Ton)
76.7
57.0
72.4
Re-use or recycling
2.5
0.4
5.8
Delfzijl pilot plant
Incineration with energy recovery
(Ton)
0
22.1
21.4
Re-use or recycling
0
0
14.6
Delfzijl FDCA
Flagship Plant
Incineration
31.3
n/a
n/a
Re-use or recycling
9.7
n/a
n/a
Total
124.8
92.1
122.9
Non-hazardous waste
Ton
2025
2024
2023
Amsterdam headquarters
Incineration
13.7
0
0
Incineration with energy recovery
0
11.3
19.1
Re-use or recycling
12.0
11.7
14.9
Geleen pilot plant
Incineration with energy recovery
0.7
2.2
1.0
Re-use or recycling
0.3
2.3
1.0
Delfzijl pilot plant
Incineration with energy recovery
0
2.8
16.0
Re-use or recycling)*
0
1.3
14.7
Delfzijl FDCA
Flagship Plant
Incineration with energy recovery
9.4
n/a
n/a
Re-use or recycling
17.1
n/a
n/a
Total
53.2
31.5
66.7
*Non-hazardous waste value from 2024 has been corrected due to the typing error that occurred in the 2024 report.
Incidents and accidents
In 2024, we updated our classification of the safety information in the safety procedure that is
currently implemented at Avantium, following as example, OSHA standards and Arbowet:
Injury, work‑related physical harm or disorder that requires more than basic first aid or affects the
employee’s ability to work.
Recordable process safety incident (e.g., large spills, explosions, fire, toxic clouds) – an event, or
series of events, resulting in one or more undesirable consequences, such as harm to people,
damage to the environment, or asset/business losses
First-aid case – medical attention that is usually administered immediately after the injury occurs and
at the location where it occurred. Physicians or other licensed health care professionals can still be
consulted for observation or counselling.
Other injury (e.g., paper cuts, scratches)
Process safety incident (e.g., small spills)
Near miss (e.g., falling objects, tripping) – unwanted events with no effects
Observation (e.g., wrong lock/tag out, missed procedures) – an observed act or condition without an
occurrence that has the potential to lead to a near miss or an incident
2025
2024
Injuries
0
0
Recordable process safety incidents*
1
0
First aid cases
12
1
Other injuries
12
8
Process safety incidents
133
109
Near misses
123
62
Recorded observations per person
1.88
0.65
*the one recordable incident was due to a 2 liter bottle of a solvent breaking in the laboratory.
Because of the new classification system that was started in 2024, we only report the comparison of
the two last years – 2024 and 2025.
Employment
The reporting is provided as on December 31, 2025 based on our HR system unless stated otherwise.
Types of contracts
2025
2024
2023
Employment contracts
274
303
304
      Full-time
199
218
221
      Part-time
75
85
83
FTEs
251
284
288
Interns
1
8
5
PhD students
4
5
4
Flexile contracts
5
7
21
Self-employed contractors
13
31
14
Employment metrics
2025
2024
2023
Turnover
New Contracts
25
43
95
Leavers
56
45
53
Applications per vacancy
74
26
36
Parental leave
Took parental leave
23
21
26
Returned form parental leave
2
13
3
Sick leave
6.25%
6.52%
5.49%
Diversity
Diversity Supervisory Board
2025
2024
2023
Female
40%
33%
33%
Male
60%
67%
67%
<30 years old
—%
—%
—%
30-50 years old
—%
—%
—%
>50 years old
100%
100%
100%
Dutch
20%
17%
17%
Non-Dutch
80%
83%
83%
Diversity Management Team
2025
2024
2023
Female
37.5%
29%
29%
Male
62.5%
71%
71%
<30 years old
—%
—%
—%
30-50 years old
12.5%
14%
29%
>50 years old
87.5%
86%
71%
Dutch
100%
100%
100%
Non-Dutch
—%
—%
—%
Diversity leadership* positions
2025
2024
2023
Female
52%
39%
34%
Male
48%
61%
66%
<30 years old
—%
—%
—%
30-50 years old
57%
39%
45%
>50 years old
43%
61%
55%
Dutch
71%
82%
83%
Non-Dutch
29%
18%
17%
*People who fall in the leadership positions category either report directly to the Management Team members
of have line management responsibilities. A small number of exceptions apply.
Diversity non-leadership positions
2025
2024
2023
Female
23%
24%
26%
Male
77%
76%
74%
<30 years old
11%
14%
14%
30-50 years old
58%
56%
54%
>50 years old
31%
30%
32%
Dutch
77%
76%
74%
Non-Dutch
23%
24%
26%
Diversity Overall
2025
2024
2023
Female
26%
26%
27%
Male
74%
74%
73%
<30 years old
10%
12%
12%
30-50 years old
56%
53%
52%
>50 years old
34%
35%
36%
Dutch
76%
76%
74%
Non-Dutch
24%
24%
26%
Further Information on the Materiality Assessment
To determine the scope of our sustainability focus and ensure we address the areas that matter
most to Avantium’s business and stakeholders, we carried out a double materiality assessment (DMA)
at the end of 2024 and in 2025. More details on the process for this assessment and how it is applied
to our sustainability strategy and reporting can be found in the Sustainability Statement (page 40).
Below, we outline how our stakeholders groups' interests were taken into account as part of the DMA
process, plus a list of material topics with related impacts, risks, and opportunities (IROs) that we
identified.
Stakeholder Representation
In order to determine the content of our sustainability report we took into account the view of our
stakeholders. Stakeholders are those who are affected by the business and operations of Avantium
and also those who use information published in the annual report (refer to page 18).
For the purpose of this assessment the Core Stakeholder Team was set up. Interests of each
stakeholders group were represented by a member of the Core Stakeholder Team.
Stakeholder Groups
Representation stakeholder group in CST*
Supply Chain Partners and Contractors  
Director Operations and Supply chain
Financial Partners, shareholders
Investor Relations Manager 
Collaboration partners 
Director Communications
Landlords and Communities 
Director Operations and Supply chain
Process partners (polymerization) 
Director Operations and Supply chain
Commercial partners and customers
Director Communications
Governments and Authorities and Society 
Director Communications
Employees
Director Operations and Supply chain
Technology (internal)
Director Technology and Innovation
Finance and Risk*
Risk and Control Manager
*In addition to the identified stakeholder groups, Finance and Risk was added as a separate stakeholder for
the purpose of sufficiently addressing the Financial materiality.
Material Topics With Related IROs
The table below provides a full overview of our material sustainability topics and IROs as identified
through the 2024/2025 DMA process.
Subject-matter experts assessed all of these IROs based on their likelihood, scope, scale,
irremediable character, time horizon, value chain location, and other elements and assigned them a
score between 3 and 9. Depending on their weighted scores they were allocated in one of three
categories:
1. First priority: These topics received the highest scores for scope, scale, and likelihood, meaning that
they are likely to occur and their effects will be significant. These topics will therefore be prioritized
and addressed in the coming years.
2. Second priority: These topics scored lower, but are potentially still significant. Avantium will pay
special attention to these topics during the next materiality assessment in 2027 as they are likely to
move up into the priority list.
3. Third priority: These topics did not score highly in more than one category. If these IROs were to
occur, they would have a material impact, whether on Avantium's business or on our stakeholders.
However, their significance was deemed lower than the second- and third-priority groups. For that
reason, we are not currently addressing these topics. This is open to change depending on the
outcomes of the next materiality assessment.
For an indication of which topics and associated IROs are included in which priority groups, please
refer to the Sustainability Statement (page 40).
ESRS topic
ESRS (sub-) sub-topic
Impacts/Risks/Opportunities
Value chain
Time horizon*
E1 Climate
change
Climate change
mitigation
Potential positive impact: Enabling the production of plastic with a lower carbon footprint
Actual negative impact: Generating emissions during the development of our technology
Own operations
Downstream
Medium term
Long term
Climate change
adaptation
Risk: Availability of biomass could be affected by climate change
Risk: Rising sea levels could affect our FDCA Flagship Plant, given its location
Risk: The effects of climate change can significantly affect Avantium and the value chain
Upstream
Own operations
Downstream
Short term
Medium term
Long term
Energy
Actual negative impact: Using fossil-based energy to build and operate our Flagship Plant
Own operations
Short term
Mid term
E2 Pollution
Pollution of water
Potential negative impact: Generating effluents from growing bio-based feedstocks that, if incorrectly managed, could
pollute water sources
Potential negative impact: Generating effluents from chemical processes that, if incorrectly managed, could pollute water
sources
Upstream
Own operations
Downstream
Medium term
Long term
Microplastics
Potential negative impact: Generating microplastics in the polymerization process that follows FDCA production
Downstream
Medium term
Long term
E3 Water and
marine resources
Water consumption
Actual negative impact: Using water to grow bio-based feedstock
Potential negative impact: Operating water-intensive chemical processes
Risk: Availability of water could decrease
Upstream
Own operations
Downstream
Medium term
Long term
E4 Biodiversity
and ecosystems
Direct exploitation
Actual negative impact: Cultivating biomass as feedstock changes the terrestrial ecosystem, affecting biodiversity
Upstream
Medium term
Long term
Land-use change,
freshwater change,
and sea-use change
Actual negative impact: Cultivating biomass as feedstock changes land use, affecting biodiversity
Upstream
Medium term
Long term
ESRS topic
ESRS (sub-) sub-topic
Impacts/Risks/Opportunities
Value chain
Time horizon*
E5 Resource
use and circular
economy
Resource inflows
Potential positive impact: Enabling our clients to replace fossil-based feedstock with bio-based feedstock
Potential positive impact: Using bio-based feedstock at our Flagship Plant
Actual negative impact: Using materials for chemical production processes
Risk: The effects of environmental factors (such as climate change and increased scarcity of resources) could significantly
affect Avantium and its value chain
Upstream
Short term
Medium term
Long term
Resource outflows
related to products
and services
Potential positive impact: Providing PEF with excellent properties (renewable feedstock, high gas barrier, end-of-life
solutions)
Downstream
Long term
Resource outflows
related to waste
Actual negative impact: Generating waste, including hazardous waste, in chemical production processes
Potential positive impact: Developing technologies to valorize waste and byproducts (e.g., humins)
Own operations
Downstream
Medium term
Long term
S1 Own
workforce
Adequate wages
Actual positive impact: Providing competitive compensation packages to employees
Own operations
Short term
Medium term
Work-life balance
Actual positive impact: Providing tools to improve balance – opportunities to work flexibly – at office, home or remote, part
time, additional annual leave days, etc.
Own operations
Short term
Medium term
Health and safety
Potential negative impact: Harming people’s physical health as a result of working with hazardous materials, specialized
equipment, and chemical operations at our sites
Risk: R&D activities as well as start-up and operations of the FDCA Flagship Plant can lead to safety-related incidents
Own operations
Short term
Medium term
Training and skills
development
Actual positive impact: Offering training and development opportunities to our workforce
Risk: Finding talent and the necessary skills to implement and run new processes and departments within the company
Own operations
Short term
Medium term
Diversity
Actual positive impact: Providing an inclusive workplace and ensuring fair treatment for all
Risk: Legal, reputational, or financial consequences of non-compliance with diversity-related legislation
Own operations
Short term
Medium term
S4 Consumers
and end-users
Health and safety
Potential negative impact: Harming consumers’ health through food packaging applications of PEF
Downstream
Long term
G1 Business
conduct
Management of
relationships with
suppliers, including
payment practices
Risk: Relationships with key suppliers could be disrupted, affecting operations at our FDCA Flagship Plant
Own operations
Short term
Medium term
Entity-specific
IP and data security
Risk: Cyber security due to  Avantium’s public presence and valuable IP
Risk/Opportunity: Emerging technologies, such as Artificial Intelligence (AI)
Own operations
Short term
Medium term
Long Term
* Defined as follows: Short term: currently Medium term: approximately 5 years, predominantly linked to the FDCA Flagship plant operations Long term: more than 10 years, focus on licensing business
CSRD Index
Disclosures
Page/Section Reference
General disclosures
BP-1 – Basis for preparation of the sustainability statement
About This Report (page 3 )
BP-2 – Specific information if the undertaking uses phasing-in options
Double Materiality Assessment (page 41)
GOV-1 – The role of the administrative, management and supervisory bodies in relation to sustainability
Sustainability Governance (page 77)
GOV-2 – Integration of sustainability-related performance in incentive schemes
Remuneration Report 2025 (page 88)
GOV-3 – Statement on due diligence
Not reported
GOV-4 – Risk management and internal controls over sustainability reporting
Risk Management and Internal Control (page 66)
Sustainability Disclosures (page 188)
SBM-1 – Strategy, business model and value chain
How we create value (page 18)
SBM-2 – Interests and views of stakeholders
Partnerships and Stakeholder Engagement (page 57 )
SBM-3 – Interaction of material impacts risks and opportunities with strategy and business model, and financial effects
Double Materiality Assessment (page 41)
Sustainability Strategy (page 43 )
IRO-1 – Description of the process to identify and assess material impacts, risks and opportunities and material information
to be reported
Double Materiality Assessment (page 41)
Further Information on the Materiality Assessment (page 193 )
IRO-2 – Material impacts, risks and opportunities and disclosure requirements included in the sustainability statement
Material Topics with Related IROs (page 193)
E1 Climate Change
E1-1 – Transition plan for climate change mitigation
Not reported
E1-2 – Identification of climate-related risks and scenario analysis
Not reported
E1-3 – Resilience in relation to climate change
Key Risks 2025 (page 67)
E1-4 – Policies related to climate change mitigation and adaptation
Sustainability Strategy (page 43)
E1-5 – Actions and resources in relation to climate change mitigation and adaptation
Environmental (page 44)
E1-6 – Targets related to climate change
Industry-Wide Emissions Reduction by Deploying Our Technology (page 45)
Emissions Intensity of Our Own FDCA Flagship Plant (page 46)
E1-7 – Energy consumption and mix
Energy (page 188 )
E1-8 – Gross scope 1, 2, 3 GHG emissions
Emissions (page 188 )
E1-9 – GHG removals and GHG mitigation projects financed through carbon credits
Not reported
E1-10 – Internal carbon pricing
Not reported
E1-11 – Anticipated financial effects from material physical and transition risks and potential climate-related opportunities
Not reported
E2 Pollution
E2-1 – Policies related to pollution
Not reported
Disclosures
Page/Section Reference
E2-2 – Actions and resources related to pollution
Not reported
E2-3 – Targets related to pollution
Not reported
E2-4 – Pollution of air, water and soil
Not reported
E2-5 – Substances of concern and substances of very high concern
Not reported
E3 Water and marine Resources
E3-1 – Policies related to water and marine resources
Not reported
E3-2 – Actions and resources related to water and marine resources
Not reported
E3-3 – Targets related to water and marine resources
Not reported
E3-4 – Water metrics
Not reported
E4 Biodiversity and Ecosystems
E4-1 – Biodiversity and ecosystems transition plan
Not reported
E4-2 – Policies related to biodiversity and ecosystems
Not reported
E4-3 – Actions and resources related to biodiversity and ecosystems
Not reported
E4-4 – Targets related to biodiversity and ecosystems
Not reported
E4-5 – Metrics related to biodiversity and ecosystems change
Not reported
E5 Resource use and Circular Economy
E5-1 – Policies related to resource use and circular economy
Sustainability Strategy (page 43)
E5-2 – Actions and resources related to resource use and circular economy
Environmental (page 44)
E5-3 – Targets related to resource use and circular economy
Sustainable Feedstock (page 47)
Circularity of PEF (page 48)
Valorization of Waste/By-products of our Technology (page 49)
E5-4 – Resource inflows
Sustainable Feedstock (page 47)
E5-5 – Resource outflows
Circularity of PEF (page 48)
Valorization of Waste/By-products of our Technology (page 49)
Waste (page 190)
G1 Business Conduct
G1-1 – Policies related to business conduct
Sustainability Strategy (page 43)
Code of Business Conduct (Corporate Website)
G1-2 – Actions related to business conduct
Governance (page 56)
G1-3 – Targets related to business conduct
Advocate For a Circular and Fossil-Free Chemical Industry (page 61)
Consumer Health and Safety (page 61)
G1-4 – Metrics related to corruption or bribery
Report of the Audit Committee (page 85)
G1-5 – Metrics related to political influence, including lobbying activities
Advocate For a Circular and Fossil-Free Chemical Industry (page 61)
Disclosures
Page/Section Reference
G1-6 – Payment practices
Not reported
S1 Own Workforce
S1-1 – Policies related to own workforce
Social (page 50)
Principles and Policies (Corporate Website)
S1-2 – Engagement with own workforce and workers’ representatives, existence of channels for own workforce to raise
concerns or needs and approaches to remedy
Works Council (page 52)
Principles and Policies (Corporate Website)
S1-3 – Actions and resources related to own workforce
Social (page 50)
S1-4 – Targets related to own workforce
Development of Human Capital (page 53)
Health and Safety in Our Own Operations (page 54)
S1-5 – Characteristics of the undertaking’s employees
Employment (page 191)
S1-6 – Characteristics of non-employees in the undertaking’s own workforce
Employment (page 191)
S1-7 – Collective bargaining coverage and social dialogue
Employment (page 191)
S1-8 – Diversity metrics
Development of Human Capital (page 53)
Diversity (page 191)
S1-9 – Adequate wages
Not reported
S1-10 – Social protection
Not reported
S1-11 – Persons with disabilities
Not reported
S1-12 – Training and skills development metrics
Training and Development (page 52)
S1-13 – Health and safety metrics
Health and Safety in Our Own Operations (page 54)
Incidents and Accidents (page 190)
S1-14 – Work-life balance metrics
Employment (page 191)
S1-15 – Remuneration metrics
Development of Human Capital (page 53)
S1-16 – Incidents of discrimination and other human rights incidents
Report of the Audit Committee (page 85)
S2 Workers in the value chain 
S2-1 – Policies related to workers in the value chain
Sustainable Feedstock (page 47)
Avantium Sustainable Supplier Code (Corporate Website)
S2-2 – Engagement with workers in the value chain, existence of channels for workers in the value chain to raise concerns
or needs and approaches to remedy
Not reported
S2-3 – Actions and resources related to workers in the value chain
Not reported
S2-4 – Targets related to workers in the value chain
Not reported
S3 Affected Communities 
S3-1 – Policies related to affected communities
Not reported
S3-2 – Engagement with affected communities, existence of channels for affected communities to raise concerns or needs
and approaches to remedy
Not reported
S3-3 – Actions and resources related to affected communities
Not reported
Disclosures
Page/Section Reference
S3-4 – Targets related to affected communities
Not reported
S4 Consumers and End-users
S4-1 – Policies related to consumers and end-users
Consumer Health and Safety (page 61)
S4-2 – Engagement with consumers and end-users, existence of channels for consumers and end-users to raise concerns
or needs and approaches to remedy
n/a
S4-3 – Actions and resources related to consumers and end-users
Consumer Health and Safety (page 61)
S4-4 – Targets related to consumers and end-users
Consumer Health and Safety (page 61)
GRI Index
GRI 1: Foundation 2021
GRI 2: General Disclosures
2-1 Organizational details
Financial Statements, Note 1 General Information (page 113)
2-2 Entities included in the organization’s sustainability reporting
Financial Statements, Note 2.2.1 Subsidiaries (page 118)
Business Areas 2025 (page 10)
About This Report (page 3)
2-3 Reporting period, frequency and contact point
About This Report (page 3)
2-4 Restatements of information
Financial Statements, Note 2.1.2 Changes in Accounting Policy and Disclosures, (page 118)
Sustainability Disclosures (page 188)
2-5 External assurance
About This Report (page 3 )
2-6 Activities, value chain and other business relationships
Who We Are (page 8)
How We Create Value (page 18)
2-7 Employees
Social (page 50)
2-8 Workers who are not employees
Social (page 50 )
2-9 Governance structure and composition
Corporate Governance (page 65)
2-10 Nomination and selection of the highest governance body
Corporate Governance (page 65)
2-11 Chair of the highest governance body
Message from the CEO (page 6)
Corporate Governance (page 65)
2-12 Role of the highest governance body in overseeing the management of impacts
Corporate Governance (page 65)
2-13 Delegation of responsibility for managing impacts
Corporate Governance (page 65)
2-14 Role of the highest governance body in sustainability reporting
In-control Statement (page 72)
2-15 Conflicts of interest
Independence and Conflicts of Interest (page 75)
2-16 Communication of critical concerns
Risk Management and Internal Control (page 66)
2-17 Collective knowledge of the highest governance body
Corporate Governance (page 65)
2-18 Evaluation of the performance of the highest governance body
Corporate Governance (page 65)
2-19 Remuneration policies
Remuneration Report 2025 (page 88)
2-20 Process to determine remuneration
Remuneration Report 2025 (page 88)
Corporate Governance (page 65)
2-21 Annual total compensation ratio
Internal Pau Ratio (page 97)
2-22 Statement on sustainable development strategy
Message from the CEO (page 6)
Sustainability Strategy (page 43)
2-23 Policy commitments
Advocate for a Circular and Fossil-Free Chemical Industry (page 61)
Principles and Policies (Corporate website)
GRI 1: Foundation 2021
2-24 Embedding policy commitments
Sustainability Governance (page 77)
Governance (page 56)
2-25 Process to remediate negative impacts
Risk Management and Internal Control (page 66)
Double Materiality Assessment (page 41)
2-26 Mechanisms for seeking advice and raising concerns about ethics
Whistleblower Policy /Avantium speak-up Policy (Corporate Website )
2-27 Compliance with laws and regulations
Code of Business Conduct (Corporate Website)
2-28 Membership associations
Partnerships and Stakeholder Engagement (page 57)
2-29 Approach to stakeholder engagement
Partnerships and Stakeholder Engagement (page 57)
Double Materiality Assessment (page 41)
2-30 Collective bargaining agreements
At Avantium, there are no collective bargaining agreements
GRI 3: Material Topics
3-1 Process to determine material topics
Double Materiality Assessment (page 41)
3-2 List of material topics
Material Topics With Related IROs (page 193)
References to Sustainability Reporting Frameworks (page 187)
3-3 Management of material topics
Sustainability Statement  (page 40)
GRI 303: Energy
302-1 Energy consumption within the organization
Energy (page 188)
302-4 Reduction of energy consumption
Energy (page 188 )
GRI 305: Emissions
305-1 Direct (Scope 1) GHG emissions
Scope 1 Emissions (page 188)
305-2 Energy indirect (Scope 2) GHG emissions
Scope 2 Emissions (page 189)
305-3 Other indirect (Scope 3) GHG emissions
Scope 3 Emissions (page 189)
305-5 Reduction of GHG emissions
Emissions (page 188)
Industry-Wide Emissions Reduction by Deploying Our Technology (page 45)
Emissions Intensity of Our Own FDCA Flagship Plant (page 46)
305-7 Nitrogen oxides (NOx), sulfur oxides (SOx), and other significant air emissions
Emissions (page 188)
GRI 306: Waste
306-1 Waste generation and significant waste-related impacts
Valorization of Waste/By-products of our Technology (page 49)
306-2 Management of significant waste-related impacts
Valorization of Waste/By-products of our Technology (page 49)
306-3 Waste generated
Waste (page 190)
306-4 Waste diverted from disposal
Waste (page 190 )
306-5 Waste directed to disposal
Waste (page 190 )
GRI 308: Supplier
Environmental Assessment
308-1 New suppliers that were screened using environmental criteria
Sustainable Feedstock (page 47)
GRI 401: Employment
401-1 New employee hires and employee turnover
Employment (page 191)
401-3 Parental leave
Employment (page 191)
GRI 1: Foundation 2021
GRI 403: Occupational
Health and Safety
403-1 Occupational health and safety management system
Health and Safety in Our Own Operations (page 54)
403-2 Hazard identification, risk assessment, and incident investigation
Health and Safety in Our Own Operations (page 54)
403-4 Worker participation, consultation, and communication on occupational health and
safety
Works Council (page 52)
Health and Safety in Our Own Operations (page 54)
403-5 Worker training on occupational health and safety
Health and Safety in Our Own Operations (page 54)
Training and Development (page 52)
403-6 Promotion of worker health
Social (page 50)
403-9 Work-related injuries
Health and Safety in Our Own Operations (page 54)
Incidents and Accidents (page 190)
GRI 404: Training
and Education
404-2 Programs for upgrading employee skills and transition assistance programs
Training and Development (page 52)
404-3 Percentage of employees receiving regular performance and career development
reviews
Performance Management (page 52)
GRI 405: Diversity
and Equal Opportunity
405-1 Diversity of governance bodies and employees
Development of Human Capital (page 53)
Diversity (page 191)
405-2 Ratio of basic salary and remuneration of women to men
Development of Human Capital (page 53)
GRI 414: Supplier Social
Assessment
414-1 New suppliers that were screened using social criteria
Sustainable Feedstocks (page 47)
12 In presenting and discussing Avantium’s financial position, operating results, and cash flows, Avantium
(like many other publicly listed companies) uses certain alternative performance measures (APMs) not
defined by IFRS. These APMs are used because they are an important measure of Avantium’s business
development and management performance. Please see Note 2 Alternative performance measures to the
Consolidated Financial Statements.
Key Financials
in Euro x 1,000
2025
2024
2023
2022
(restated)
2021
Revenues
14,593
21,036
19,700
17,826
10,917
Other income from government grants
3,404
4,596
5,789
7,626
6,686
Net operating expenses
(54,063)
(58,912)
(52,948)
(41,758)
(33,687)
EBITDA
(36,066)
(33,280)
(27,459)
(16,306)
(16,084)
Depreciation, amortization and impairment charge
(6,968)
(5,230)
(7,396)
(8,578)
(7,837)
Finance (costs)/income – net
(2,341)
(1,471)
221
(1,976)
(495)
Net loss for the financial year
(27,133)
(32,627)
(34,150)
(29,702)
(24,416)
Cash flow from operating activities
(27,708)
(36,001)
(18,818)
(11,166)
11,806
Cash flow from investing activities
(20,663)
(58,635)
(89,769)
(33,953)
(3,932)
Cash flow from financing activities
81,927
83,360
78,935
75,079
24,830
Net cash flow used in operating, investing, and financing activities 12
33,556
(11,277)
(29,652)
29,961
8,288
Cash and cash equivalents at end of financial year
57,466
23,898
35,216
64,870
34,911
Segment revenues
R&D Solutions
13,412
14,281
13,546
11,301
10,029
Renewable Chemistries
100
500
Renewable Polymers
526
6,478
5,592
6,056
388
Corporate allocations
655
277
562
369
Total segment revenue
14,593
21,036
19,700
17,826
10,917
Other income from government grants
R&D Solutions
121
60
87
279
279
Renewable Chemistries
821
3,536
3,610
Renewable Polymers
1,520
2,654
3,673
3,660
2,683
Corporate allocations
1,763
1,882
1,209
150
114
Total segment other income
3,404
4,596
5,789
7,625
6,686
Glossary
This glossary has been carefully compiled and we believe it to be
accurate. Definitions may, however, be based on Avantium’s
interpretation and the use of terms may differ from the meaning
assigned to them elsewhere in the industry or otherwise.
Adsorption
Adsorption is the adhesion of atoms, ions, or molecules from a
gas, liquid, or dissolved solid to a surface.
Bio-Based Economy
A bio-based economy exists when predominantly plant-based
materials (i.e., biomass rather than fossil-based raw materials like
petroleum) are used as a feedstock for making the chemicals,
materials, and products we consume.
Bio-Based Plastic
These are plastics derived from man-made polymers that can be
made from building blocks that originate from biological (once
living) systems. Most of these building blocks (monomers) are
derived from sugars. FDCA and PEF are examples of bio-based
plastic; however, at Avantium, we prefer to call PEF and FDCA
plant-based plastics, in order to prevent confusion with the term
bioplastic. A bioplastic is a plastic derived from a biopolymer,
such as DNA, insulin, cellulose, or starch.
Biomass
Organic feedstock, especially of plant origin. These feedstocks
are renewable and originally found in nature in the form of
agricultural and forestry products like corn, wheat, sugar beet,
sugar cane, rapeseed, and woody plants. The residues of these
products also contain starch, carbohydrates, fats, and proteins.
Biorefinery/Biorefining
A biorefinery is a factory that processes biomass into a range of
products with the goal of making the most efficient use of the
biomass or raw material. Biorefining aims to use every part of the
raw material so that nothing goes to waste, thereby improving
efficiencies and environmental impact.
Carbon Dioxide (CO2)
A greenhouse gas (GHG) that originates as waste from the
burning of fossil fuels and the production of electricity, fertilizers,
chemicals, steel, and cement. It is the biggest contributor to
climate change. Electrochemistry has the potential to use CO2 as
a feedstock for the sustainable production of chemicals and
materials, and is seen as a game-changer for the chemical
industry. The result is that this GHG is sequestered into products
that can replace plastics and chemicals that are traditionally
produced from fossil feedstock. Avantium’s Volta Technology is
the leading electrocatalytic platform developing CO2 utilization
solutions for a circular future.
Catalyst Testing
Catalyst testing is an important practice in the process of
developing a new or improved catalyst. Over the years, Avantium
R&D Solutions has executed numerous catalyst testing projects in
the various phases of a catalyst development trajectory, from
discovery and screening to process optimization and commercial
selection.
Circular Economy
A circular economy is based on the principles of designing out
waste and pollution, keeping products and materials in use, and
regenerating natural systems. Avantium works to advance new
technologies for a more sustainable future. PEF plays a significant
role in the circular economy.
CSRD
The EU’s Corporate Sustainability Reporting Directive.
Dawn Technology®
Dawn Technology® is the brand name of Avantium’s biorefinery
technology, which converts non-food plant-based feedstock 
such as polycotton textile waste into industrial sugars.
These sugars, such as glucose, are an excellent raw material for
chemistry and fermentation processes and are used to produce a
broad range of products.
Debt Financing Facilities
The senior debt financing arrangement granted by the Lenders to
the Company, originally established in 2022 and subsequently
amended and/or extended from time to time. “Lenders” refers to
ABN AMRO and its subsidiaries, ING Sustainable Investments
B.V., Invest‑NL, ASN, and Coöperatieve Rabobank U.A.
ESRS
The European Sustainability Reporting Standards (ESRS) are a set
of disclosure rules set out under the Corporate Sustainability
Reporting Directive (CSRD) that standardize how certain 
businesses report on their environmental, social, and governance
(ESG) efforts. These standards are not mandatory for Avantium.
First-Generation Feedstock
Carbohydrate-rich plants (e.g., sugar beet, sugar cane, corn, and
wheat) that can also be used as food or feed or for making plant-
based chemicals and materials.
Furandicarboxylic Acid (FDCA)
2.5-FDCA is an intermediate chemical for making PEF.
Flowrence®
Avantium’s Flowrence® is an advanced high-throughput platform
for high-quality testing of catalysts and adsorbents. This system
can be used for a broad range of industrial applications that
operate in gas, vapor, or trickle phases. The parallel reactor
system combines the reproducibility of larger-scale reactors with
the advantages of small-scale reactors, such as intrinsic safety,
high accuracy, low costs per experiment, and, ultimately, faster
time-to-market.
Glucose
A sugar consisting of six carbon atoms (C6), glucose is a core
building block for a bio-based economy. It serves as a feedstock
for the production of a broad range of chemicals and materials
produced via chemistry or fermentation processes. The resulting
products can be existing and new plant-based chemicals.
Glycols
A glycol is any of a class of organic compounds belonging to the
alcohol family. The term is often applied to the simplest member
of the class: MEG, a colorless, oily liquid.
Global Reporting Initiative (GRI)
International independent standards for reporting.
Life-Cycle Assessment (LCA)
The compilation and evaluation of the input, output, and potential
environmental impact of a product system throughout its life
cycle. LCAs are fundamental to understanding how Avantium’s
technologies compete with fossil-based alternatives. LCAs form
the bedrock of how we measure our footprint and describe the
sustainability benefits of our innovations.
(Double) Materiality Assessment
A double materiality assessment (DMA) is a strategic process
companies use to identify which ESG topics matter most to their
business from two perspectives: how the company’s activities
affect people and the environment, and how environmental and
social issues affect the company’s financial performance.
Methoxymethylfurfural (MMF)
An intermediate chemical produced in the sugar‑dehydration
step of Avantium’s YXY® Technology, in which plant‑based
sugars are converted into methoxymethylfurfural (MMF). MMF
serves as the key precursor for the subsequent oxidation and
purification steps that yield FDCA, the monomer used to produce
PEF.
Mono-Ethylene Glycol (MEG)
MEG is a vital ingredient for the production of polyester textiles
and film, PET and PEF resins, and engine coolants.
Polyethylene Furanoate (PEF)
PEF is a polyester made from MEG and FDCA. PEF produced by
Avantium’s YXY® Technology is a plant-based and recyclable
polymer that can be used in an enormous range of applications,
including bottles, packaging, textiles, and film. PEF’s barrier and
thermal properties are superior to conventional PET. In
combination with a significantly reduced carbon footprint, this
added functionality gives PEF all the attributes needed in a next-
generation polyester.
Polyethylene Terephthalate (PET)
PET is a transparent polyester used for bottles and film. Currently,
PET is made from fossil-based MEG and fossil-based terephthalic
acid.
Polyesters
Polyesters are polymers formed from a dicarboxylic acid and a
diol. Polyesters are very strong and stable and are particularly
useful in making fibers for clothing or plastics. Polyesters are most
commonly found as either PET or PEF.
Polylactic-co-glycolic acid (PLGA)
With our Volta Technology, we can convert CO2 into oxalic acid.
In a proprietary second, separate process step, this is then turned
into glycolic acid. By combining this glycolic acid with some lactic
acid, Avantium can produce polylactic-co-glycolic acid (PLGA), a
polymer with valuable characteristics: it has an excellent barrier
against oxygen and moisture, has good mechanical properties
and is both home compostable and marine degradable. Due to its
properties, PLGA is an excellent sustainable alternative for PE
(polyethylene). PLGA can be used, for example, as coating
material and in moulded plastic materials.
Polymers
A polymer is a chemical compound with molecules bonded
together in long, repeating chains. The term is commonly used in
the plastics and composites industry, often as a synonym for
"plastic" or "resin".
Production Operation Date
The date on which evidence is provided demonstrating that an
FDCA and/or PEF application meeting the customer specifications
of each relevant offtaker can be produced by the Flagship Plant
and that the FDCA production has commenced.
Ray Technology®
Ray Technology® is the brand name of Avantium’s technology to
produce plant-based MEG.
Renewable Resources
These are agricultural or forestry raw materials used as feedstock
for industrial products. The use of renewable resources in
industry saves fossil resources and reduces the amount of GHG
emissions.
Scope 1 Emissions
Scope 1 covers emissions from sources that an organization owns
or controls directly.
Scope 2 Emissions
Scope 2 covers emissions that a company causes indirectly when
the energy it purchases and uses is produced.
Scope 3 Emissions
Scope 3 encompasses emissions that are not produced by the
company itself, and are not the result of activities from assets
owned or controlled by it, but by those for which it is indirectly
responsible, up and down its value chain.
Second-Generation Feedstock
Non-food feedstock resulting from agricultural and forestry waste
or residual streams such as polycotton textile waste.
Sustainable Development Goals (SDGs)
The UN launched its 17 SDGs in 2013.
Throughput
The volume of chemicals a system can process per hour.
Volta Technology
Avantium’s Volta Technology, a carbon capture and utilization
(CCU) technology, is the leading electrocatalytic platform
developing CO2 as a feedstock for a circular future.
YXY® Technology
Avantium’s YXY® Technology is a catalytically driven process that
converts sugars into the key building block FDCA, which can then
be polymerized into PEF and other renewable polyesters.
Avantium_Logo_Color RGB_Horizontal.svg
If you have any questions or
remarks regarding this report,
we invite you to contact us.
Avantium N.V.
P.O. Box 2915
1000 CX Amsterdam
The Netherlands
Tel. +31 20 586 8080
E-mail ir@avantium.com
Website www.avantium.com
Published on March 18, 2026
Design and Execution
CF Report, Amsterdam,
the Netherlands
Copywriting
Narrative Labs, The Hague,
the Netherlands
Editing
Avantium N.V., Amsterdam,
the Netherlands
Photography
Natasha Lachapelle, Gerrit
Vermeulen, Ronny Benjamins